<!DOCTYPE html>
<html lang="zh-CN">
<head>
  <meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=2">
<meta name="theme-color" content="#222">
<meta name="generator" content="Hexo 5.2.0">
  <link rel="apple-touch-icon" sizes="180x180" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico">
  <link rel="icon" type="image/png" sizes="32x32" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico">
  <link rel="icon" type="image/png" sizes="16x16" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico">
  <link rel="mask-icon" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico" color="#222">

<link rel="stylesheet" href="/css/main.css">

<link rel="stylesheet" href="//fonts.googleapis.com/css?family=Lato:300,300italic,400,400italic,700,700italic|14px:300,300italic,400,400italic,700,700italic&display=swap&subset=latin,latin-ext">
<link rel="stylesheet" href="/lib/font-awesome/css/all.min.css">
  <link rel="stylesheet" href="//cdn.jsdelivr.net/gh/fancyapps/fancybox@3/dist/jquery.fancybox.min.css">
  <link rel="stylesheet" href="/lib/pace/pace-theme-corner-indicator.min.css">
  <script src="/lib/pace/pace.min.js"></script>

<script id="hexo-configurations">
    var NexT = window.NexT || {};
    var CONFIG = {"hostname":"zhenyumi.github.io","root":"/","scheme":"Gemini","version":"7.8.0","exturl":false,"sidebar":{"position":"left","display":"post","padding":18,"offset":12,"onmobile":false},"copycode":{"enable":true,"show_result":true,"style":"mac"},"back2top":{"enable":true,"sidebar":false,"scrollpercent":true},"bookmark":{"enable":true,"color":"#000000","save":"auto"},"fancybox":true,"mediumzoom":false,"lazyload":true,"pangu":true,"comments":{"style":"valine","active":null,"storage":true,"lazyload":false,"nav":null},"algolia":{"hits":{"per_page":10},"labels":{"input_placeholder":"Search for Posts","hits_empty":"We didn't find any results for the search: ${query}","hits_stats":"${hits} results found in ${time} ms"}},"localsearch":{"enable":true,"trigger":"auto","top_n_per_article":1,"unescape":false,"preload":false},"motion":{"enable":true,"async":true,"transition":{"post_block":"slideDownBigIn","post_header":"slideDownIn","post_body":"slideDownIn","coll_header":"slideLeftIn","sidebar":"slideUpIn"}},"path":"./public/search.xml"};
  </script>

  <meta name="description" content="希望能活的久一点">
<meta property="og:type" content="website">
<meta property="og:title" content="鹘横海">
<meta property="og:url" content="https://zhenyumi.github.io/page/32/index.html">
<meta property="og:site_name" content="鹘横海">
<meta property="og:description" content="希望能活的久一点">
<meta property="og:locale" content="zh_CN">
<meta property="article:author" content="向海">
<meta name="twitter:card" content="summary">

<link rel="canonical" href="https://zhenyumi.github.io/page/32/">


<script id="page-configurations">
  // https://hexo.io/docs/variables.html
  CONFIG.page = {
    sidebar: "",
    isHome : true,
    isPost : false,
    lang   : 'zh-CN'
  };
</script>

  <title>鹘横海</title>
  


  <script data-pjax>
    var _hmt = _hmt || [];
    (function() {
      var hm = document.createElement("script");
      hm.src = "https://hm.baidu.com/hm.js?aa95e0eb65e5b58f6500e4de221c0f67";
      var s = document.getElementsByTagName("script")[0];
      s.parentNode.insertBefore(hm, s);
    })();
  </script>




  <noscript>
  <style>
  .use-motion .brand,
  .use-motion .menu-item,
  .sidebar-inner,
  .use-motion .post-block,
  .use-motion .pagination,
  .use-motion .comments,
  .use-motion .post-header,
  .use-motion .post-body,
  .use-motion .collection-header { opacity: initial; }

  .use-motion .site-title,
  .use-motion .site-subtitle {
    opacity: initial;
    top: initial;
  }

  .use-motion .logo-line-before i { left: initial; }
  .use-motion .logo-line-after i { right: initial; }
  </style>
</noscript>

</head>

<body itemscope itemtype="http://schema.org/WebPage">
  <div class="container use-motion">
    <div class="headband"></div>

    <header class="header" itemscope itemtype="http://schema.org/WPHeader">
      <div class="header-inner"><div class="site-brand-container">
  <div class="site-nav-toggle">
    <div class="toggle" aria-label="切换导航栏">
      <span class="toggle-line toggle-line-first"></span>
      <span class="toggle-line toggle-line-middle"></span>
      <span class="toggle-line toggle-line-last"></span>
    </div>
  </div>

  <div class="site-meta">

    <a href="/" class="brand" rel="start">
      <span class="logo-line-before"><i></i></span>
      <h1 class="site-title">鹘横海</h1>
      <span class="logo-line-after"><i></i></span>
    </a>
      <p class="site-subtitle" itemprop="description">Hope tomorrow is still shining.  Today is another day.</p>
  </div>

  <div class="site-nav-right">
    <div class="toggle popup-trigger">
        <i class="fa fa-search fa-fw fa-lg"></i>
    </div>
  </div>
</div>




<nav class="site-nav">
  <ul id="menu" class="main-menu menu">
        <li class="menu-item menu-item-home">

    <a href="/" rel="section"><i class="fa fa-home fa-fw"></i>首页</a>

  </li>
        <li class="menu-item menu-item-about">

    <a href="/about/" rel="section"><i class="fa fa-user fa-fw"></i>关于</a>

  </li>
        <li class="menu-item menu-item-tags">

    <a href="/tags/" rel="section"><i class="fa fa-tags fa-fw"></i>标签<span class="badge">23</span></a>

  </li>
        <li class="menu-item menu-item-categories">

    <a href="/categories/" rel="section"><i class="fa fa-th fa-fw"></i>分类<span class="badge">23</span></a>

  </li>
        <li class="menu-item menu-item-archives">

    <a href="/archives/" rel="section"><i class="fa fa-archive fa-fw"></i>归档<span class="badge">364</span></a>

  </li>
        <li class="menu-item menu-item-留言板">

    <a href="/%E7%95%99%E8%A8%80%E6%9D%BF/" rel="section"><i class="fas fa-chalkboard-teacher fa-fw"></i>留言板</a>

  </li>
      <li class="menu-item menu-item-search">
        <a role="button" class="popup-trigger"><i class="fa fa-search fa-fw"></i>搜索
        </a>
      </li>
  </ul>
</nav>



  <div class="search-pop-overlay">
    <div class="popup search-popup">
        <div class="search-header">
  <span class="search-icon">
    <i class="fa fa-search"></i>
  </span>
  <div class="search-input-container">
    <input autocomplete="off" autocapitalize="off"
           placeholder="搜索..." spellcheck="false"
           type="search" class="search-input">
  </div>
  <span class="popup-btn-close">
    <i class="fa fa-times-circle"></i>
  </span>
</div>
<div id="search-result">
  <div id="no-result">
    <i class="fa fa-spinner fa-pulse fa-5x fa-fw"></i>
  </div>
</div>

    </div>
  </div>

</div>
    </header>

    
  <div class="back-to-top">
    <i class="fa fa-arrow-up"></i>
    <span>0%</span>
  </div>
  <div class="reading-progress-bar"></div>
  <a role="button" class="book-mark-link book-mark-link-fixed"></a>


    <main class="main">
      <div class="main-inner">
        <div class="content-wrap">
          

          <div class="content index posts-expand">
            
      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/5d10c738.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/5d10c738.html" class="post-title-link" itemprop="url">L10 Metabolism of Nitrogenous Compounds II Amino Acids, Porphyrins, and Neurotransmitters</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:41" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/5d10c738.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/5d10c738.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>15k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <p>Metabolism of Nitrogenous Compounds II: Amino Acids, Porphyrins, and Neurotransmitters</p>
<ul>
<li>氮化合物代谢II：氨基酸，卟啉，神经递质</li>
</ul>
<h1 id="一-pathways-of-amino-acid-degradation"><a class="markdownIt-Anchor" href="#一-pathways-of-amino-acid-degradation"></a> 一、Pathways of Amino Acid Degradation</h1>
<ul>
<li>
<p><strong>Glucogenic amino acids</strong> (生糖氨基酸) are amino acids whose carbon skeletons are degraded to one of these five intermediates:</p>
<ul>
<li>Pyruvate 丙酮酸
<ul>
<li>Ananine</li>
<li>Glycine</li>
<li>Cystenine</li>
<li>Serine</li>
<li>Threonine</li>
<li>Tryptophan</li>
</ul>
</li>
<li>α-Ketoglutarate α-酮戊二酸
<ul>
<li>Proline</li>
<li>Arginine</li>
<li>Histidine</li>
<li>Glutamine</li>
<li>Glutamate (Glutamic acid)</li>
</ul>
</li>
<li>Succinyl-CoA 琥珀酰-CoA
<ul>
<li>Methionine</li>
<li>Threonine</li>
<li>Isoleucine</li>
<li>Valine</li>
</ul>
</li>
<li>Fumarate 延胡索酸
<ul>
<li>Aspartate (Aspartic acid)</li>
<li>Tyrosine</li>
<li>Phenylalanine</li>
</ul>
</li>
<li>Oxaloacetate  草酰乙酸
<ul>
<li>Asparagine</li>
<li>Aspartate (Aspartic acid)</li>
</ul>
</li>
</ul>
<p><strong>Ketogenic amino acids</strong> (生酮氨基酸) are amino acids whose carbon skeletons are degraded to:</p>
<ul>
<li>Acetyl-CoA
<ul>
<li>Threonine</li>
<li>Tryptophan</li>
<li>Leucine</li>
<li>Isoleucine</li>
</ul>
</li>
<li>Acetoacetate 乙酰乙酸
<ul>
<li>Tryptophan</li>
<li>Leucine</li>
<li>Lycine</li>
<li>Phenylalanine</li>
<li>Tyrosine</li>
</ul>
</li>
</ul>
</li>
</ul>
<p>Some amino acids are both glucogenic and ketogenic.</p>
<h2 id="fates-of-the-amino-acid-carbon-skeletons"><a class="markdownIt-Anchor" href="#fates-of-the-amino-acid-carbon-skeletons"></a> Fates of the amino acid carbon skeletons</h2>
<p><img data-src="pics/image-20200510160826465.png" alt="image-20200510160826465" /></p>
<ul>
<li>Orange: glucogenic</li>
<li>Blue: ketogenic</li>
<li>Purple: glucogenic and ketogenic</li>
</ul>
<h2 id="pathways-of-amino-acid-degradation"><a class="markdownIt-Anchor" href="#pathways-of-amino-acid-degradation"></a> Pathways of Amino Acid Degradation</h2>
<p>Like other <strong>gasotransmitter（气体递质）</strong> molecule, nitric oxide (<strong>NO</strong>), hydrogen sulfide (<strong>H2S</strong>), derived from <strong>cysteine</strong>, is a powerful gaseous signaling molecule involved in the regulation of <u>vascular blood flow and blood pressure</u>.</p>
<ul>
<li>The cardioprotective and antihypertensive effects of dietary garlic（大蒜） are mediated in large part by the production of H2S from organic polysulfides (多硫化物) that are abundant in garlic.</li>
</ul>
<h3 id="1-glucogenic-amino-acids"><a class="markdownIt-Anchor" href="#1-glucogenic-amino-acids"></a> 1. Glucogenic Amino Acids</h3>
<h4 id="oxaloacetate-family-of-glucogenic-amino-acids"><a class="markdownIt-Anchor" href="#oxaloacetate-family-of-glucogenic-amino-acids"></a> Oxaloacetate Family of Glucogenic Amino Acids</h4>
<img data-src="pics/image-20200510161531500.png" alt="image-20200510161531500" style="zoom: 33%;" />
<ul>
<li>Asparaginase: acute lymphoblastic leukemia（急性淋巴细胞白血病）; remission</li>
</ul>
<p><strong>Asparaginase</strong> (门冬酰胺酶) catalyzes hydrolytic cleavage of the asparagine amide to aspartate and ammonium.</p>
<p><strong>Aspartate</strong> is then transaminated directly to <strong>oxaloacetate</strong> by <strong>aspartate transaminase.</strong> (谷草转氨酶)</p>
<h4 id="α-ketoglutarate-family-of-glucogenic-amino-acids"><a class="markdownIt-Anchor" href="#α-ketoglutarate-family-of-glucogenic-amino-acids"></a> α-Ketoglutarate Family of Glucogenic Amino Acids</h4>
<p><img data-src="pics/image-20200510161705576.png" alt="image-20200510161705576" /></p>
<ul>
<li>Arg, His, Pro, Glu, Gln</li>
</ul>
<h5 id="1-histidine-and-histamine"><a class="markdownIt-Anchor" href="#1-histidine-and-histamine"></a> (1) Histidine and histamine</h5>
<img data-src="pics/image-20200510161829488.png" alt="image-20200510161829488" style="zoom:33%;" />
<img data-src="pics/image-20200510161931644.png" alt="image-20200510161931644" style="zoom:33%;" />
<p><strong>Histidine</strong> also undergoes decarboxylation to generate <strong>histamine</strong> (组胺), a substance with multiple biological actions.</p>
<p>When secreted in the stomach, histamine promotes the secretion of HCl and <strong>pepsin</strong> (胃蛋白酶).</p>
<ul>
<li>It is a potent <strong>vasodilator</strong> (血管扩张剂), released locally in sites of trauma, inflammation, or allergic reaction.</li>
</ul>
<p><strong>Antihistamines</strong> (抗组胺药)are in use to treat <u>allergies and other inflammations</u>.</p>
<ul>
<li>Typically, these drugs <u>prevent the binding of histamine to its receptors</u>.</li>
</ul>
<h4 id="succinyl-coa-family-of-glucogenic-amino-acids"><a class="markdownIt-Anchor" href="#succinyl-coa-family-of-glucogenic-amino-acids"></a> Succinyl-CoA Family of Glucogenic Amino Acids</h4>
<p><img data-src="pics/image-20200510162018235.png" alt="image-20200510162018235" /></p>
<p>Isoleucine, valine, threonine, and methionine are degraded to the citric acid cycle intermediate, <strong>succinyl-CoA</strong>, by way of <strong>propionyl-CoA</strong> (丙酰辅酶A)</p>
<p><img data-src="pics/image-20200510162148393.png" alt="image-20200510162148393" /></p>
<p><strong>Branched-chain amino acid</strong> (支链氨基酸) oxidation, fatty acid β-oxidation, and the citric acid cycle share a common chemical strategy:</p>
<ul>
<li>A <u>deficiency of branched-chain α-keto acid dehydrogenase complex</u>, which metabolizes <strong>valine</strong>, <strong>leucine</strong>, and <strong>isoleucine</strong> in humans, leads a severe mental developmental defect called <strong>maple syrup urine disease</strong> (枫糖尿症).</li>
</ul>
<blockquote>
<p><strong>Maple syrup urine disease</strong> is caused by deficiency of <strong>branched-chain α-keto acid dehydrogenase complex.</strong></p>
<p>Therefore, the <strong>isoleucine</strong>, <strong>valine</strong> and <strong>leucine</strong> cannot undergo <strong>transamination</strong> and the three amino acids and their <strong>α-keto acid derivatives</strong> cannot be efficiently used.</p>
<p>Thus, they <u>accumulate in the urine</u> which gives the urine an sweet-smell odor. This disease will cause severe mental retardation and nervous developmental defect.</p>
</blockquote>
<h4 id="pyruvate-family-of-glucogenic-amino-acids"><a class="markdownIt-Anchor" href="#pyruvate-family-of-glucogenic-amino-acids"></a> Pyruvate Family of Glucogenic Amino Acids</h4>
<p>Mechanism of serine <strong>dehydratase</strong> (脱水酶) reaction:</p>
<img data-src="pics/image-20200510161152373.png" alt="image-20200510161152373" style="zoom:60%;" />
<ul>
<li>PLP;</li>
<li>Schiff base</li>
</ul>
<p><img data-src="pics/image-20200510161401532.png" alt="image-20200510161401532" /></p>
<ul>
<li>Alanine, cysteine, glycine, serine and threonine are degraded to pyruvate.</li>
<li>PLP</li>
</ul>
<h4 id="fumarate-family-of-glucogenic-amino-acids"><a class="markdownIt-Anchor" href="#fumarate-family-of-glucogenic-amino-acids"></a> Fumarate Family of Glucogenic Amino Acids</h4>
<p><img data-src="pics/image-20200510162536884.png" alt="image-20200510162536884" /></p>
<h3 id="2-ketogenic-amino-acids"><a class="markdownIt-Anchor" href="#2-ketogenic-amino-acids"></a> 2. Ketogenic amino acids</h3>
<h4 id="lysine-degradation"><a class="markdownIt-Anchor" href="#lysine-degradation"></a> Lysine Degradation</h4>
<p><img data-src="pics/image-20200510162318069.png" alt="image-20200510162318069" /></p>
<p>Although <strong>lysine</strong> is degraded by several pathways, the <u>major route</u> <u>in mammals</u>, the <strong>saccharopine pathway</strong> (酵母氨酸途径), does indeed follow this predicted strategy.</p>
<p><strong>Saccharopine</strong> is the intermediate in the two-step process that removes the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>ε</mi></mrow><annotation encoding="application/x-tex">\varepsilon</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault">ε</span></span></span></span>-amino group from lysine</p>
<ul>
<li>These two reactions are catalyzed by a bifunctional enzyme named <strong>α-aminoadipic semialdehyde synthase</strong>（α-氨基己二酸半醛合成酶）.</li>
</ul>
<p>The mammalian enzyme is a single protein composed of separate domains for the two catalytic activities.</p>
<p>Although this process uses α-ketoglutarate as the <u>amino acceptor</u>, and produces glutamate, it is more similar to the <strong>argininosuccinate synthetase–argininosuccinase</strong> reactions of the <strong>urea cycle</strong> than to a transamination</p>
<h4 id="tryptophan-degradation"><a class="markdownIt-Anchor" href="#tryptophan-degradation"></a> Tryptophan Degradation</h4>
<p>Metabolic fates of tryptophan:</p>
<ul>
<li>The major <strong>catabolic</strong> pathway degrades most of the tryptophan molecule to <u>acetoacetate and alanine.</u></li>
<li>The <strong>synthetic</strong> pathway to the <strong>nicotinamide nucleotides</strong> (烟酰胺核苷酸).</li>
</ul>
<p><img data-src="pics/image-20200510162748533.png" alt="image-20200510162748533" /></p>
<ul>
<li>
<p>Pellagra (nicotinamide deficiency) (糙皮病（烟酰胺缺乏）)</p>
</li>
<li>
<blockquote>
<p>The <strong>pellagra</strong> is caused by nicotinamide deficiency and this deficiency can be caused by low diet niacin (烟酸) or low tryptophan uptake and low level niacin absorption (caused by diet disorder, alcoholism（酒精中毒）, some kinds of drug treatment or addiction, etc.).</p>
<ul>
<li>Because the tryptophan can finally be converted into nicotinamide, the tryptophan uptake can influence the nicotinamide level.</li>
</ul>
<p>The pellagra will cause <strong>abnormal excitation</strong>, <strong>dermatitis</strong>（皮炎）, <strong>dementia</strong>（痴呆）, and <strong>diarrhea</strong>（腹泻、痢疾）, because nicotinamide plays important roles in normal biological processes.</p>
</blockquote>
</li>
</ul>
<img data-src="pics/image-20200510162850855.png" alt="image-20200510162850855" style="zoom: 25%;" />
<p>The <strong>amide nitrogen of glutamine</strong> is used in many <u>amidotransferase reactions</u> leading to <strong>purine</strong> and <u>pyrimidine nucleotides, amino sugars, and nicotinamide nucleotides.</u></p>
<h4 id="phenylalanine-and-tyrosine-degradation"><a class="markdownIt-Anchor" href="#phenylalanine-and-tyrosine-degradation"></a> Phenylalanine and Tyrosine Degradation</h4>
<img data-src="pics/image-20200510163022500.png" alt="image-20200510163022500" style="zoom: 70%;" />
<ul>
<li>Catabolism of phenylalanine and tyrosine to fumarate and acetoacetate</li>
</ul>
<p>The phenylalanine hydroxylation system:</p>
<p>Conversion of phenylalanine to tyrosine is catalyzed by <strong>phenylalanine hydroxylase</strong> (苯丙氨酸羟化酶).</p>
<p><img data-src="pics/image-20200510163338915.png" alt="image-20200510163338915" /></p>
<ul>
<li>
<p>Aromatic amino acid hydroxylase:</p>
<ul>
<li>Phe hydroxylase;</li>
<li>Tyr hydroxylase;</li>
<li>Trp hydroxylase.</li>
</ul>
</li>
<li>
<p>Cofactor: Tetrahydrobiopterin (BH4)</p>
</li>
</ul>
<p>A hereditary deficiency of <strong>phenylalanine hydroxylase</strong> is responsible for <strong>phenylketonuria (PKU)</strong> (苯丙酮尿症)</p>
<ul>
<li>In PKU, phenylalanine accumulates to very high levels (<strong>hyperphenylalaninemia</strong> (高苯丙氨酸血症)) because of the block in conversion to tyrosine, and much of this phenylalanine is metabolized via pathways that are normally little used—particularly <u>transamination to phenylpyruvate (a phenylketone), and also subsequent conversion of phenylpyruvate to phenyllactate and phenylacetate.</u></li>
</ul>
<p><img data-src="pics/image-20200510163520874.png" alt="image-20200510163520874" /></p>
<h5 id="1-phenylketonuria-pku-a-hereditary-deficiency-of-phenylalanine-hydroxylase"><a class="markdownIt-Anchor" href="#1-phenylketonuria-pku-a-hereditary-deficiency-of-phenylalanine-hydroxylase"></a> (1) Phenylketonuria (PKU): a hereditary deficiency of phenylalanine hydroxylase</h5>
<p>1/10,000;</p>
<p>An autosomal recessive trait, meaning that two parents heterozygous for the trait have 1 chance in 4 of having a phenylketonuric child;</p>
<ul>
<li>2% of the population are carriers;</li>
</ul>
<p><strong>Phenylalanine</strong> accumulates to very high levels (hyperphenylalanine);</p>
<ul>
<li><u>Phenylpyruvate, phenyllactate, phenylacetate in urine</u> in enormous quantities (1-2 grams per day);</li>
</ul>
<p>If undetected and untreated, PKU leads to <strong>profound mental retardation</strong>;</p>
<ul>
<li>Phenylalanine itself is the neurotoxic molecule;</li>
</ul>
<p>Fortunately, PKU can readily be detected at birth, and many hospitals carry out <u>routine screening of newborns;</u></p>
<ul>
<li>If the condition is detected early, the onset of retardation can be prevented by feeding for several years a <u>synthetic diet low in phenylalanine and rich in tyrosine</u>, to allow normal development of the nervous system.</li>
</ul>
<hr />
<h5 id="2-alkaptonuria-dark-urine-disease"><a class="markdownIt-Anchor" href="#2-alkaptonuria-dark-urine-disease"></a> (2) Alkaptonuria - <strong>“dark urine disease”</strong></h5>
<blockquote>
<p>Alkaptonuria is caused by deficiency of <strong>homogentisate dioxygenase</strong> in humans.</p>
<p>The <strong>tyrosine</strong> can be converted into <strong>p-hydroxyphenylpyruvate</strong>, the <strong>p-hydroxyphenylpyruvate</strong> can then be converted into <strong>homogentisate</strong> catalyzed by homogentisate dioxygenase.</p>
<p>Therefore, the deficiency of homogentisate dioxygenase makes the <strong>homogentisate accumulation</strong> inside of the cells and accumulation in urine, the oxidation of homogentisate during emiction will turn the urine into a dark color.</p>
</blockquote>
<p>p-Hydroxyphenylpyruvate is converted to homogentisate by <strong>p-hydroxyphenylpyruvate dioxygenase</strong> (对羟基苯丙酮酸), an unusual iron-containing enzyme, which catalyzes <strong>decarboxylation</strong>, <u>a ring hydroxylation, and side chain migration</u>, using <strong>ascorbate</strong> as a cofactor.</p>
<p>Procollagen <strong>prolyl hydroxylase</strong> catalyzes the same chemistry.</p>
<p>This reaction involves a mechanism called the <strong>NIH shift</strong>, after scientists at the NIH, who described a ring hydroxylation that proceeds via formation of an <strong>epoxide</strong> (环氧) intermediate and migration of the alkyl side chain.</p>
<blockquote>
<p>The NIH shift is the intramolecular movement of a hydrogen atom in an aromatic ring during a hydroxylation reaction.</p>
</blockquote>
<p><img data-src="pics/image-20200510163933312.png" alt="image-20200510163933312" /></p>
<p><strong>Alkaptonuria</strong> (“dark urine disease”, 黑尿症): <strong>homogentisate</strong> (尿黑酸) accumulates and is excreted in large amounts in the urine; its oxidation on standing causes the urine to become dark.</p>
<p>A hereditary deficiency of <strong>homogentisate dioxygenase</strong>.</p>
<h1 id="二-amino-acids-as-biosynthetic-precursors"><a class="markdownIt-Anchor" href="#二-amino-acids-as-biosynthetic-precursors"></a> 二、Amino Acids as Biosynthetic Precursors</h1>
<h2 id="s-adenosylmethionine-adomet-and-biological-methylation"><a class="markdownIt-Anchor" href="#s-adenosylmethionine-adomet-and-biological-methylation"></a> S-Adenosylmethionine （AdoMet） and biological methylation</h2>
<blockquote>
<p>AdoMet is an <u>active form of methionine</u>, which can be generated from methionine and ATP.</p>
<p>AdoMet always involves in <strong>transmethylations</strong> (such as biosynthesis of <strong>creatine</strong> and <strong>phosphatidylcholine</strong>) as an methyl group donor and then forms an S-adenosylhomocysteine (AdoHcy). AdoMet plays an important roles in DNA and protein methylation.</p>
</blockquote>
<img data-src="pics/image-20200510164044629.png" alt="image-20200510164044629" style="zoom: 50%;" />
<p>Most, though not all, of the group transfer reactions involving AdoMet are <u>transmethylations</u> (转甲基化), in which the methyl group is transferred to an acceptor, with the other product being S-adenosylhomocysteine (AdoHcy, S-腺苷同型半胱氨酸).</p>
<p><img data-src="pics/image-20200510164114714.png" alt="image-20200510164114714" /></p>
<ul>
<li>Epigenetics</li>
</ul>
<img data-src="pics/image-20200510164129605.png" alt="image-20200510164129605" style="zoom: 33%;" />
<p>There are indications that protein <strong>methylation protects proteins</strong>, in at least two ways:</p>
<ol>
<li>By <u>blocking sites of ubiquitination</u>, methylation evidently helps protect proteins from turnover.</li>
<li>Spontaneous damage of protein molecules during aging causes deamidation, isomerization, and racemization (脱酰胺，异构化，外消旋) of their asparagine and aspartate residues.
<ul>
<li>A methylation reaction can <u>initiate the repair</u> of these damaged residues.</li>
</ul>
</li>
</ol>
<h2 id="methyl-group-metabolism-and-homocystinuria-同型胱氨酸尿症"><a class="markdownIt-Anchor" href="#methyl-group-metabolism-and-homocystinuria-同型胱氨酸尿症"></a> Methyl group metabolism and homocystinuria (同型胱氨酸尿症)</h2>
<p><img data-src="pics/image-20200510164451860.png" alt="image-20200510164451860" /></p>
<p><strong>Serine hydroxymethyltransferase</strong> (丝氨酸羟甲基转移酶) catalyzes the entry of one-carbon units into the tetrahydrofolate (THF) pool.</p>
<p>A deficiency of <strong>methylenetetrahydrofolate reductase (MTHFR, 亚甲基四氢叶酸还原酶)</strong> or <strong>methionine synthase</strong> blocks the conversion of homocysteine to methionine.</p>
<ol>
<li>Serine hydroxymethyltransferase;</li>
<li>Methylenetetrahydrofolate reductase (MTHFR);</li>
<li>Methionine synthase;</li>
<li>Cystathionine β-synthase.</li>
</ol>
<p>Severe <strong>mental retardation</strong>（智力迟钝,智力缺陷）, damage to vessels, dislocation of the lens of the eyes</p>
<p>Whereas the one-carbon and methyl cycles are found in virtually all cells, <u>liver and kidney possess an additional route for methionine synthesis</u> that involves a different kind of transmethylation.</p>
<p><img data-src="pics/image-20200510164610758.png" alt="image-20200510164610758" /></p>
<p>Homocysteine can be remethylated using <strong>betaine</strong> (甜菜碱) as the methyl donor in a reaction catalyzed by the cytosolic <strong>betaine-homocysteine methyltransferase.</strong></p>
<ul>
<li>Betaine, also known as <u>trimethylglycine</u>, is formed from the mitochondrial oxidation of <u>choline</u>（胆碱）.</li>
</ul>
<p><strong>Homocysteinemia</strong> (同型半胱氨酸血症) can result from:</p>
<ul>
<li>
<p>Genetic defects in:</p>
<ul>
<li><strong>Cystathionine</strong> (胱硫醚) β-synthase</li>
</ul>
</li>
<li>
<p>Methionine synthase</p>
<ul>
<li>5,10-Methylenetetrahydrofolate reductase （MTHFR）</li>
</ul>
</li>
<li>
<p>Dietary deficiency of:</p>
<ul>
<li>Folic acid</li>
<li>Vitamin B6</li>
<li>Vitamin B12</li>
</ul>
</li>
</ul>
<h2 id="glutamate-and-polyamines"><a class="markdownIt-Anchor" href="#glutamate-and-polyamines"></a> Glutamate And Polyamines</h2>
<p><img data-src="pics/image-20200510164732781.png" alt="image-20200510164732781" /></p>
<ul>
<li><strong>Polyamines</strong> (多胺) are required for <u>cell proliferation</u> because of their roles in <u>stabilizing duplex DNA structures</u></li>
</ul>
<blockquote>
<p><strong>Polyamines</strong> are special compounds including <strong>spermidine</strong> (亚精胺), <strong>spermine</strong>（精胺,精素） which are synthesized from glutamate.</p>
<p>Because the amino groups of polyamines are always <strong>positively charged</strong>, the polyamines can stabilize conformations of negatively charged nucleotides, therefore they play important roles in duplex DNA structure stabilization during cell proliferation.</p>
</blockquote>
<p>In addition to serving as a precursor for <strong>ornithine</strong> and the <strong>polyamines</strong>, glutamate is one of several amino acids serving as precursors to compounds that function in transmission of nerve impulses.</p>
<ul>
<li>Decarboxylation of glutamate yields –aminobutyric acid, or GABA (氨基丁酸).</li>
</ul>
<p>In addition, glutamate itself is a <strong>neurotransmitter</strong>.</p>
<img data-src="pics/image-20200510164850783.png" alt="image-20200510164850783" style="zoom:50%;" />
<h2 id="glutathione-谷胱甘肽-and-the-γ-glutamyl-cycle-γ-谷氨酰循环"><a class="markdownIt-Anchor" href="#glutathione-谷胱甘肽-and-the-γ-glutamyl-cycle-γ-谷氨酰循环"></a> Glutathione (谷胱甘肽) and the γ-glutamyl cycle (γ-谷氨酰循环)</h2>
<p><img data-src="pics/image-20200510165152576.png" alt="+ " /></p>
<ul>
<li>Transport amino acids into cells</li>
</ul>
<p>The enzymes involved are:</p>
<ol>
<li><strong>Glutamylcysteine</strong> (谷氨酰半胱氨酸) synthase</li>
<li>Glutathione synthase</li>
<li>Glutamyl <strong>transpeptidase</strong> (转肽酶)</li>
<li>Glutamyl <strong>cyclotransferase</strong> (环转移酶)</li>
<li>5-Oxoprolinase</li>
<li><strong>Dipeptidase</strong> (二肽酶)</li>
</ol>
<p><img data-src="pics/image-20200510165300698.png" alt="image-20200510165300698" /></p>
<p><strong>Glutathione</strong> reacts with such a compound (denoted RX) as shown here, followed by cleavage of the γ-glutamyl and glycyl residues and then acetylation by acetyl-CoA to give a <strong>mercapturic acid.</strong></p>
<p>This more soluble, less toxic derivative of the original compound can then be excreted in the <strong>urine</strong>.</p>
<h2 id="biosynthesis-of-nitric-oxide-and-creatine-phosphate-from-arginine"><a class="markdownIt-Anchor" href="#biosynthesis-of-nitric-oxide-and-creatine-phosphate-from-arginine"></a> Biosynthesis of nitric oxide and creatine phosphate from arginine</h2>
<img data-src="pics/image-20200510165419401.png" alt="image-20200510165419401" style="zoom:70%;" />
<ul>
<li>In kidney</li>
<li>In <strong>NO</strong> synthesis, the Nw-hydroxy-L-arginine intermediate remains tightly</li>
<li>bound to <strong>NO synthase (NOS)</strong>.</li>
</ul>
<h2 id="biosynthesis-of-thyroid-hormones-as-residues-in-the-protein-thyroglobulin-甲状腺球蛋白"><a class="markdownIt-Anchor" href="#biosynthesis-of-thyroid-hormones-as-residues-in-the-protein-thyroglobulin-甲状腺球蛋白"></a> Biosynthesis of thyroid hormones as residues in the protein thyroglobulin （甲状腺球蛋白）</h2>
<p>Biosynthesis of <strong>thyroid hormones</strong> (甲状腺激素) as residues in the <strong>protein thyroglobulin</strong> (甲状腺球蛋白)</p>
<ul>
<li>The iodinated forms of tyrosine—triiodothyronine (T3) and thyroxine (T4) —are released from these proteins by proteolytic degradation.</li>
</ul>
<p>One result of iodine deficiency is <strong>goiter</strong> (甲状腺肿), a condition in which the thyroid gland grows abnormally large as it attempts to scavenge all available iodine.</p>
<img data-src="pics/image-20200510165602336.png" alt="image-20200510165602336" style="zoom:30%;" />
<ul>
<li>Thyroglobulin：
<ul>
<li>2750 aa</li>
<li>140 Tyr</li>
<li>20% Tyr: iodinated</li>
</ul>
</li>
</ul>
<p><img data-src="pics/image-20200510165712615.png" alt="image-20200510165712615" /></p>
<p>Tyrosin:</p>
<ul>
<li>The synthesis of <strong>melanins</strong> (黑色素) occurs in pigment-producing cells, the melanocytes.</li>
</ul>
<p><strong>Albinism</strong> (白化病): genetic deficiency of tyrosinase;</p>
<blockquote>
<p><strong>Albinism</strong> is caused by deficiency of <strong>tyrosinase</strong>, which catalyzes the conversion from <strong>tyrosine</strong> into <strong>dopaquinone</strong> (DQ, 多巴醌) and <strong>DoPa</strong> (多巴,二羟基苯丙氨酸, <strong>dihydroxyphenylalanine</strong>) into DQ.</p>
<ul>
<li>The DQs can subsequently be converted into important molecules involving <strong>pigments</strong> such as melanin.</li>
</ul>
<p>The albinism will cause an individual to lose pigmentation therefore lose colors. One example is the albino mice.</p>
</blockquote>
<ul>
<li>The albino (white) mice and rats commonly used in research have an inherited defect in tyrosinase</li>
<li>Dark vs. white
<ul>
<li>SNP: single nucleotide polymorphism</li>
<li>SLC24A5: Ala111Thr</li>
<li>Melanin reduction</li>
</ul>
</li>
</ul>
<h1 id="三-porphyrin-and-heme-metabolism"><a class="markdownIt-Anchor" href="#三-porphyrin-and-heme-metabolism"></a> 三、Porphyrin and Heme Metabolism</h1>
<h2 id="biosynthetic-pathways-to-tetrapyrroles-四吡咯"><a class="markdownIt-Anchor" href="#biosynthetic-pathways-to-tetrapyrroles-四吡咯"></a> Biosynthetic pathways to tetrapyrroles (四吡咯)</h2>
<p><img data-src="pics/image-20200510165956586.png" alt="image-20200510165956586" /></p>
<p>Tetrapyrroles include:</p>
<ul>
<li>Heme</li>
<li>Chlorophylls 叶绿素</li>
<li>Phycobilins 藻胆色素</li>
<li>Cobalamins 钴胺素</li>
</ul>
<p>All are synthesized from <strong>δ-aminolevulinic acid</strong> （ALA）, which is formed differently in plants from the way it is formed in bacterial and animal cells.</p>
<h2 id="the-heme-biosynthetic-pathway"><a class="markdownIt-Anchor" href="#the-heme-biosynthetic-pathway"></a> The heme biosynthetic pathway</h2>
<p><img data-src="pics/image-20200510170254398.png" alt="image-20200510170254398" /></p>
<p>All of the nitrogen of heme is derived from <strong>glycine</strong>, and all of the carbon is derived from <strong>succinate</strong> and <strong>glycine</strong>.</p>
<ul>
<li>Hence, this synthesis is often called the <strong>succinate-glycine pathway.</strong></li>
</ul>
<p><strong>Congenital erythropoietic porphyria</strong> (先天性卟啉症): <strong>uroporphyrinogen III synthase</strong> defective, the symmetrical (and metabolically useless) type I prorphyrins accumulate beyond the capacity of the body to excrete them. Urine turn to red, skin is photosensitive (like darkness), teeth become fluorescent,  RBC destroyed, anemia, …… Vampires</p>
<blockquote>
<p>The <strong>congenital erythropoietic porphyri</strong>a is caused by deficiency of <strong>uroporphyrinogen III synthase</strong>, therefore the useless <strong>type Ⅰ porphyrins</strong> (uroporphyrinogen Ⅰ) can be produced instead of the production of <strong>uroporphyrinogen III</strong> .</p>
<p>The <strong>uroporphyrinogen Ⅰ</strong>can be further converted into <strong>coproporphyrinogen Ⅰ</strong> and causes accumulation of these two molecules.</p>
<p>Because the <strong>uroporphyrinogen III</strong> can be used for the biosynthesis of some important molecules including heme, cobalamins (in bacteria), chloroplasts (in plants), etc. . Therefore, the congenital erythropoietic porphyria will cause the urine turned to red because of <u>excess coproporphyrinogen I production</u>, making the skin more <u>susceptible</u> to light and making the teeth to be fluorescent.</p>
</blockquote>
<p><strong>ALA synthetase</strong>: major control point: <strong>heme</strong> and related compound feedback-inhibit the enzyme</p>
<p><img data-src="pics/image-20200510170403306.png" alt="image-20200510170403306" /></p>
<p><img data-src="pics/image-20200510170502703.png" alt="image-20200510170502703" /></p>
<p>Porphyrin biosynthesis involves:</p>
<ol>
<li>Formation of a <strong>pyrrole</strong> (吡咯) ring.</li>
<li>Condensation of four pyrrole moieties, giving a cyclic <strong>tetrapyrrole</strong> (环四吡咯).</li>
<li>Side chain modifications and ring oxidations.</li>
</ol>
<p><strong>Porphyrias</strong> (卟啉症) involve abnormal accumulations of heme precursors, either from overproduction of the <u>unnatural type I porphyrins</u> or from abnormally high flux through d-ALA synthetase.</p>
<h2 id="catabolism-of-heme"><a class="markdownIt-Anchor" href="#catabolism-of-heme"></a> Catabolism of heme</h2>
<img data-src="pics/image-20200513120512144.png" alt="image-20200513120512144" style="zoom:67%;" />
<ul>
<li>Billiverdin: 胆绿素</li>
<li>Billrubin: 胆红素</li>
</ul>
<p>Most of the heme comes from breakdown of aged <strong>erythrocytes</strong>, but some comes from <strong>cytochromes</strong> and <strong>other heme proteins.</strong></p>
<p>Heme protein degradation in animals releases <strong>amino acids</strong> and <strong>iron</strong>, which are reused, and <u>bilirubin</u>, which must be solubilized for excretion.</p>
<p>Jaundice（黄疸）: skin and the whites of the eyes</p>
<p>Liver diseases, bile duct obstruction (gallstones), Rh incompability reactions of infants, or in premature infants</p>
<ul>
<li>Jaundiced infants are often placed under intense fluorescent light, which rearranges the structure of circulating bilirubin to more soluble products.</li>
</ul>
<h1 id="四-amino-acids-and-their-metabolites-as-neurotransmitters-and-biological-regulators"><a class="markdownIt-Anchor" href="#四-amino-acids-and-their-metabolites-as-neurotransmitters-and-biological-regulators"></a> 四、Amino Acids and Their Metabolites as Neurotransmitters and Biological Regulators</h1>
<p><img data-src="pics/image-20200510170654546.png" alt="image-20200510170654546" /></p>
<p><u>Glutamate, tyrosine, glycine, and tryptophan</u> serve as neurotransmitters or precursors to neurotransmitters.</p>
<ul>
<li>
<p>The pathway to <strong>serotonin</strong> (血清素) begins with hydroxylation of <strong>tryptophan</strong> (四氢生物蝶呤) by a <strong>tetrahydrobiopterin</strong>-dependent aromatic amino acid hydroxylase, <u>similar to phenylalanine hydroxylase.</u></p>
</li>
<li>
<p>This reaction is followed by a <strong>PLP-dependent decarboxylation</strong> to yield <strong>serotonin</strong>.</p>
</li>
<li>
<p><u>Tryptophan hydroxylase and tyrosine hydroxylase</u> are both <strong>tetrahydrobiopterin-dependent monooxygenases</strong> and are mechanistically and structurally related to phenylalanine hydroxylase.</p>
</li>
</ul>
<p>The mechanism of all three members of the aromatic amino acid hydroxylase family involves an <strong>NIH shift</strong>, with migration of a hydride accompanying the hydroxylation.</p>
<h2 id="biosynthesis-of-the-catecholamines儿茶酚胺dopamine-norepinephrine-and-epinephrine"><a class="markdownIt-Anchor" href="#biosynthesis-of-the-catecholamines儿茶酚胺dopamine-norepinephrine-and-epinephrine"></a> Biosynthesis of the catecholamines（儿茶酚胺）—dopamine, norepinephrine, and epinephrine</h2>
<ul>
<li>儿茶酚胺:-多巴胺，去甲肾上腺素，肾上腺素</li>
</ul>
<p><strong>Tyrosine hydroxylase</strong> catalyzes the <u>rate-limiting step</u> of catecholamine synthesis, and it is <u>feedback inhibited</u> by the end products of the pathway—dopamine, norepinephrine, and epinephrine.</p>
<img data-src="pics/image-20200510170741854.png" alt="image-20200510170741854" style="zoom: 33%;" />
<h3 id="1-the-toxicity-of-catecholamins"><a class="markdownIt-Anchor" href="#1-the-toxicity-of-catecholamins"></a> 1. The Toxicity of Catecholamins</h3>
<blockquote>
<p>The catecholamines involves epinephrine, dopamine, and norepinephrine, which are all important signal molecules and act especially as neurotransmitters and hormones.</p>
<p>Under normal conditions, they regulate normal cellular activity including <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Heart_rate">heart rate</a>, <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Blood_pressure">blood pressure</a>, <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Blood_glucose">blood glucose</a> and controls specific signal pathways inside of the cells. The extreme level especially high level of catecholamines are toxic because it will cause cell necrosis, if this happens in brain, an irreversible damage will be caused</p>
</blockquote>
<h1 id="五-amino-acid-biosynthesis"><a class="markdownIt-Anchor" href="#五-amino-acid-biosynthesis"></a> 五、Amino Acid Biosynthesis</h1>
<p><img data-src="pics/image-20200510170748757.png" alt="image-20200510170748757" /></p>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/2487d667.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/2487d667.html" class="post-title-link" itemprop="url">L11 Nucleotide Metabolism</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:41" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/2487d667.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/2487d667.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>18k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <ul>
<li>核苷酸代谢</li>
</ul>
<h1 id="一-outlines-of-pathways-in-nucleotide-metabolism"><a class="markdownIt-Anchor" href="#一-outlines-of-pathways-in-nucleotide-metabolism"></a> 一、Outlines of Pathways in Nucleotide Metabolism</h1>
<h2 id="overview-of-nucleotide-metabolism"><a class="markdownIt-Anchor" href="#overview-of-nucleotide-metabolism"></a> Overview of nucleotide metabolism</h2>
<p><img data-src="C:/Users/74768/Desktop/image-20200516213907002.png" alt="image-20200516213907002" /></p>
<ul>
<li>precursors to nucleic acid （RNA, DNA)；</li>
<li>critical elements energy metabolism （ATP）；</li>
<li>carriers of activated metabolites for biosynthesis (CDP-sugar)；</li>
<li>structural moieties of coenzymes （FAD， NAD）；</li>
<li>metabolic regulators and signal molecule (cAMP)</li>
</ul>
<p>De novo pathways for synthesis and utilization of ribonucleotides (orange) and deoxyribonucleotides (blue).</p>
<p>Nucleotides arise through de novo synthesis from low-molecular-weight precursors or through salvage of nucleosides or bases.</p>
<h2 id="reutilization-of-purine-and-pyrimidine-bases"><a class="markdownIt-Anchor" href="#reutilization-of-purine-and-pyrimidine-bases"></a> Reutilization of purine and pyrimidine bases</h2>
<p>The figure shows relationships between nucleic acid catabolism (blue) and resynthesis of nucleotides by <strong>salvage pathways</strong> (red).</p>
<p><img data-src="pics/image-20200516214051127.png" alt="image-20200516214051127" /></p>
<ul>
<li>
<p>Involved Terms:</p>
<ul>
<li>核碱基（英语：<strong>Nucleobase</strong>）是指一类含氮碱基（nitrogenous base），在生物学上通常简单地称之碱基（base）。是在DNA和RNA中，起配对作用的部分。核碱基都是杂环化合物，其氮原子位于环上或取代氨基上，其中一部分（取代氨基，以及嘌呤环的1位氮、嘧啶环的3位氮）直接参与碱基配对。</li>
<li>核苷（英语：<strong>Nucleoside</strong>）是一类糖甘胺（glycosylamine）分子，组成物是碱基加上环状核糖或脱氧核糖。例如胞苷、尿苷、腺苷、鸟苷与腺苷，这些核苷加上一个磷酸基团就是核苷酸，为DNA与RNA的组成单位。</li>
<li>A <strong>nucleo<u>tide</u></strong> is composed of three distinctive chemical sub-units: a <strong>five-carbon sugar molecule</strong>, a <strong>nitrogenous base</strong>—which two together are called a <strong>nucleo<u>side</u></strong>—and one phosphate group. With all three joined, a nucleotide is also termed a “<strong>nucleoside <u>mono</u>phosphate</strong>”, “<strong>nucleoside <u>di</u>phosphate</strong>” or “<strong>nucleoside <u>tri</u>phosphate</strong>”, <u>depending on how many phosphates make up the phosphate group.</u></li>
<li><img data-src="pics/image-20200703111630879.png" alt="image-20200703111630879" /></li>
<li></li>
</ul>
</li>
<li>
<p><em>De Novo</em>（再次）: Most organisms can synthesize purine and pyrimidine nucleotides from low-molecule-weight precursors in amounts sufficient for their needs.</p>
</li>
<li>
<p>Salvage: Most organisms can also synthesize nucleotides from nucleosides or bases.</p>
</li>
</ul>
<p><img data-src="pics/image-20200516214918789.png" alt="image-20200516214918789" /></p>
<p>The most common route for cleavage to the free base (nucleobase) involves the action of a <strong>nucleoside phosphorylase</strong>（核苷磷酸化酶）.</p>
<h3 id="1-prpp-a-central-metabolite-in-de-novo-and-salvage-pathways"><a class="markdownIt-Anchor" href="#1-prpp-a-central-metabolite-in-de-novo-and-salvage-pathways"></a> 1. PRPP: A Central Metabolite in De Novo and Salvage Pathways</h3>
<p><img data-src="pics/image-20200516215228776.png" alt="image-20200516215228776" /></p>
<p>PRPP is an activated <strong>ribose-5-phosphate</strong>（核糖-5-磷酸） derivative used in both salvage and de novo pathways.</p>
<p>It is formed through the action of <strong>PRPP synthetase</strong>, which activates <strong>carbon 1</strong> of ribose-5-phosphate by transferring to it the pyrophosphate moiety of ATP</p>
<p><img data-src="pics/image-20200516215320237.png" alt="image-20200516215320237" /></p>
<p>A <strong>phosphoribosyltransferase</strong>（磷酸核糖转移酶） reaction catalyzes the <strong>reversible</strong> transfer of a free base to the ribose of PRPP, displacing pyrophosphate and producing a <strong>nucleoside monophosphate.</strong></p>
<p>Because the <u>deoxyribose（去氧核醣） analog of PRPP is absent</u> from most cells, these enzymes are <strong>not</strong> involved directly in deoxyribonucleotide metabolism.</p>
<h1 id="二-de-novo-biosynthesis-of-purine-nucleotides"><a class="markdownIt-Anchor" href="#二-de-novo-biosynthesis-of-purine-nucleotides"></a> 二、De Novo Biosynthesis of Purine Nucleotides</h1>
<h2 id="low-molecular-weight-precursors-to-the-purine-ring"><a class="markdownIt-Anchor" href="#low-molecular-weight-precursors-to-the-purine-ring"></a> Low-molecular-weight precursors to the purine ring</h2>
<p>The source of each atom in the ring, as established with isotopic tracer studies of uric acid synthesis.</p>
<img data-src="pics/image-20200516215354530.png" alt="image-20200516215354530" style="zoom:67%;" />
<h2 id="from-prpp-to-imp"><a class="markdownIt-Anchor" href="#from-prpp-to-imp"></a> From PRPP to IMP</h2>
<p><img data-src="C:/Users/74768/Desktop/image-20200516215520401.png" alt="image-20200516215520401" /></p>
<p>The enzymes involved are:</p>
<ol>
<li>PRPP amidotransferase 酰胺转移酶</li>
<li>GAR synthetase</li>
<li>GAR transformylase 转甲酰酶</li>
<li>FGAR amidotransferase</li>
<li>AIR synthetase</li>
<li>AIR carboxylase</li>
<li>SAICAR synthetase</li>
<li>Adenylosuccinate lyase</li>
<li>AICAR transformylase</li>
<li>IMP cyclohydrolase 环水解酶</li>
</ol>
<h2 id="model-of-the-purinosome嘌呤体"><a class="markdownIt-Anchor" href="#model-of-the-purinosome嘌呤体"></a> Model of the purinosome（嘌呤体）</h2>
<img data-src="pics/image-20200516215640535.png" alt="image-20200516215640535" style="zoom:50%;" />
<p>The figure shows a hypothetical model for a <u>multi-enzyme complex in animal cells</u> that transforms <strong>PRPP to IMP</strong>.</p>
<p>Serine <strong>hydroxymethyltransferase</strong> (<strong>SHMT</strong>，丝氨酸羟甲基转移酶) and the trifunctional enzyme <strong>C1-tetrahydrofolate (THF) synthase</strong>, also proposed to be part of the complex, channel one-carbon units from serine into 10-formyl-THF（10-甲酰基-THF） for the transformylase reactions.</p>
<img data-src="pics/image-20200516215822417.png" alt="image-20200516215822417" style="zoom:45%;" />
<p>IMP, the first fully formed <strong>purine</strong> nucleotide, is a branch point between adenine and guanine nucleotide biosynthesis.</p>
<ul>
<li>Inosine-5‘-monophosphate （IMP）：肌苷-5’-单磷酸</li>
</ul>
<h2 id="pathways-from-imp-to-gmp-and-amp"><a class="markdownIt-Anchor" href="#pathways-from-imp-to-gmp-and-amp"></a> Pathways from IMP to GMP and AMP</h2>
<p><img data-src="pics/image-20200516215921086.png" alt="image-20200516215921086" /></p>
<p>Enzymes are as follows:</p>
<ol>
<li>G-1 = IMP dehydrogenase</li>
<li>G-2 = GMP synthetase</li>
<li>A-1 = Adenylosuccinate synthetase</li>
<li>A-2 = Adenylosuccinate lyase</li>
</ol>
<p><strong>Nucleotides</strong> are active in metabolism primarily as the <strong>nucleoside triphosphates</strong>.</p>
<p>GMP and AMP are converted to their corresponding triphosphates through two <strong>successive phosphorylation</strong> reactions.</p>
<ul>
<li>Conversion to the diphosphates involves specific <strong>ATP-dependent kinases</strong>.</li>
</ul>
<img data-src="pics/image-20200516215951315.png" alt="image-20200516215951315" style="zoom:70%;" />
<p><strong>Nucleoside diphosphate kinase</strong>, an equilibrium-driven enzyme, transfers a phosphoryl group from ATP in the synthesis of all other <strong>nucleoside triphosphates</strong>.</p>
<img data-src="pics/image-20200516220021308.png" alt="image-20200516220021308" style="zoom:67%;" />
<h2 id="regulation-of-de-novo-purine-biosynthesis"><a class="markdownIt-Anchor" href="#regulation-of-de-novo-purine-biosynthesis"></a> Regulation of de novo purine biosynthesis</h2>
<img data-src="pics/image-20200516220033592.png" alt="image-20200516220033592" style="zoom:50%;" />
<h2 id="utilization-of-adenine-nucleotides-in-coenzyme-biosynthesis"><a class="markdownIt-Anchor" href="#utilization-of-adenine-nucleotides-in-coenzyme-biosynthesis"></a> Utilization of Adenine Nucleotides in Coenzyme Biosynthesis</h2>
<p><img data-src="pics/image-20200516220139881.png" alt="image-20200516220139881" /></p>
<p>An important metabolic role of <strong>purine nucleotides</strong> is the <u>synthesis of coenzymes</u>, primarily those containing an adenylate moiety.</p>
<p>These include:</p>
<ol>
<li>Flavin nucleotides 黄素核苷酸</li>
<li>Nicotinamide nucleotides 烟酰胺核苷酸</li>
<li>Coenzyme A</li>
</ol>
<h2 id="purine-degradation-and-formation-of-uric-acid"><a class="markdownIt-Anchor" href="#purine-degradation-and-formation-of-uric-acid"></a> Purine Degradation and Formation of Uric Acid</h2>
<p><img data-src="pics/image-20200516220225713.png" alt="image-20200516220225713" /></p>
<ul>
<li>All purine degradation leads to uric acid.</li>
</ul>
<h3 id="1-purine-degradation-and-gout"><a class="markdownIt-Anchor" href="#1-purine-degradation-and-gout"></a> 1. Purine Degradation and Gout</h3>
<h4 id="catabolism-of-uric-acid-to-ammonia-and-co2"><a class="markdownIt-Anchor" href="#catabolism-of-uric-acid-to-ammonia-and-co2"></a> Catabolism of uric acid to ammonia and CO2</h4>
<p><strong>Uric acid</strong> and its urate salts are quite insoluble.</p>
<ol>
<li><u>Birds, reptiles, and insects</u>: disposition of <strong>excess nitrogen</strong> that uses very little water: the waste material is excreted essentially as <u>uric acid crystals</u>;</li>
<li><strong>Mammalians</strong>: difficulties, <u>allantoin（尿囊素） by urate oxidase</u>;
<ul>
<li><u>Humans and most primates: no urate oxidase→ high blood uric acid.</u></li>
<li>Uric acid is powerful <u>scavenger of free radicals</u>, providing protection against oxidative damage.</li>
</ul>
</li>
</ol>
<p>In North America and Europe, <strong>3/1000</strong> suffer from <u>hyperuricemia</u>-chronic elevation of blood uric acids well beyond the already high levels.</p>
<img data-src="pics/image-20200516220435146.png" alt="image-20200516220435146" style="zoom:50%;" />
<p>Prolonged or acute elevation of blood urate leads to its <strong>precipitation</strong>（沉淀,析出）, as <u>crystals of sodium urate</u>, resulting in a painful <strong>arthritis</strong>（关节炎）, which, if untreated, leads to ultimately to severe degeneration of the joints.</p>
<p>Eating and drinking <u>purine-rich</u> foods are apt to（适应） stimulate acute gouty attacks in susceptible individuals. Because such foods include “rich” items such as <u>liver</u>, <u>sweetbreads, anchovies,</u> and wine, gout is historically associated with an excess of high living.</p>
<p>Gout results either from <u>overproduction</u> of purine nucleotides, leading to uric acid synthesis, or from <u>impaired uric acid excretion</u> through the kidney.</p>
<p><img data-src="pics/image-20200516220520592.png" alt="image-20200516220520592" /></p>
<p>Several known genetic alterations in purine metabolism can lead to purine oversynthesis, uric acid overproduction, and gout.</p>
<ol>
<li>
<p><strong>Elevated activity of PRPP synthetase</strong>: mutations cause the enzyme to become resistant to <strong>feedback inhibition</strong> by purine nucleotides. PRPP ↑➔ amidotransferase reaction↑ ➔ <em>de novo</em> purine biosynthesis↑ ➔ uric acid↑➔ gout;</p>
</li>
<li>
<p><u>Deficiency</u> of the salvage enzyme <strong>hypoxanthine</strong>（次黄嘌呤）-guanine phosphoribosyltransferase (<strong>HGPRT</strong>) ↓or adenine phosphoribosyltransferase (<strong>APRT</strong>) ↓➔ consumes PRPP ↓➔ PRPP ↑ ➔ de novo purine biosynthesis↑ ➔uric acid↑➔gout;</p>
</li>
<li>
<p>Patients with <strong>glucose-6-phosphatase (G6P)</strong> <u>deficiency</u> are also gouty. PRPP is the key. G6Pase deficiency ↓➔ G6P accumulation in the liver ↑ ➔ pentose phosphate pathway (PPP) ↑ ➔ ribose-5-phosphate (R5P) ↑ ➔ increases PRPP ↑ ➔uric acid↑➔gout;</p>
<p>Gout is also a consequence of <u>cancer chemotherapy</u>, presumably resulting from an overload of purine caused by nucleic acid degradation after death of tumor cells</p>
</li>
</ol>
<h4 id="treatment-of-gout-allopurinol别嘌呤醇"><a class="markdownIt-Anchor" href="#treatment-of-gout-allopurinol别嘌呤醇"></a> Treatment of Gout: Allopurinol（别嘌呤醇）</h4>
<img data-src="pics/image-20200516220656557.png" alt="image-20200516220656557" style="zoom:47%;" />
<p>Many cases of gout are successfully <u>treated</u> by the antimetabolite <strong>allopurinol</strong>, a <u>structural analog of hypoxanthine</u> in which the N7 and C8 positions are interchanged.</p>
<p><strong>Xanthine dehydrogenase</strong>（黄嘌呤脱氢酶） hydroxylates allopurinol at C2 (as it does hypoxanthine), giving alloxanthine, which <u>remains tightly bound to the reduced form of the enzyme.</u></p>
<p>Allopurinol is thus a <u>suicide substrate</u> that strongly <u>inhibits</u> <strong>xanthine dehydrogenase</strong>.</p>
<ul>
<li>This inhibition causes accumulation of hypoxanthine and xanthine, both of which are more soluble and, hence, more readily excreted than is uric acid.</li>
</ul>
<h2 id="salvage-pathways-of-purine-nucleotides"><a class="markdownIt-Anchor" href="#salvage-pathways-of-purine-nucleotides"></a> Salvage Pathways of Purine Nucleotides</h2>
<img data-src="pics/image-20200516220811769.png" alt="image-20200516220811769" style="zoom:50%;" />
<ul>
<li>hypoxanthine-guanine phosphoribosyltransferase (HGPRT)</li>
<li>adenine phosphoribosyltransferase (APRT).</li>
</ul>
<h3 id="1-salvage-of-purines-and-lesch-nyhan-syndrome"><a class="markdownIt-Anchor" href="#1-salvage-of-purines-and-lesch-nyhan-syndrome"></a> 1. Salvage of Purines and Lesch-Nyhan Syndrome</h3>
<p><u>“Null mutations”: total loss of the HGPRT enzyme;</u></p>
<p>In humans, as much as 90% of free purines are salvaged and reused, rather than degraded or excreted;</p>
<ul>
<li>If <strong>guanine</strong> and <strong>hypoxanthine</strong> are not salvaged, and are instead degraded by the pathway, leading to <u>excess excretion of uric acid</u>;
<ul>
<li>This is <strong>sex-linked recessive trait</strong> because the gene for HGPRT is located on the <strong>X chromosome</strong>;</li>
</ul>
</li>
</ul>
<p>Patients display a <u>severe gouty arthritis</u>, but they also have a dramatic <u>malfunction of the nervous system</u>, manifested as <u>behavioural disorders, motor disability, learning disability, hostile or aggressive behavior, or often self-directed. In the most extreme cases, patients nibble at their fingertips or, if restrained, their lips, causing severe self-mutilation. “Nailbiting”;</u></p>
<ul>
<li>No successful treatment;</li>
<li>Overproduction of uric acid can be blocked by <strong>allopurinol</strong>, but this treatment has <u>no efficacy</u> against the neurological features of Lesch-Nyhan syndrome;</li>
<li>Can be identified by prenatally（产前的；胎儿期的；出生以前的） through <strong>amniocentesis</strong> (羊膜腔穿刺术).</li>
</ul>
<h2 id="unexpected-consequence-of-defective-purine-catabolism-immunodeficiency"><a class="markdownIt-Anchor" href="#unexpected-consequence-of-defective-purine-catabolism-immunodeficiency"></a> Unexpected Consequence of Defective Purine Catabolism: Immunodeficiency</h2>
<h3 id="1-metabolic-consequences-of-adenosine-deaminase-ada-deficiency"><a class="markdownIt-Anchor" href="#1-metabolic-consequences-of-adenosine-deaminase-ada-deficiency"></a> 1. Metabolic consequences of adenosine deaminase (ADA) deficiency</h3>
<p>AdoHcy = S-adenosylhomocysteine. S-腺苷同型半胱氨酸</p>
<p><img data-src="pics/image-20200516221116093.png" alt="image-20200516221116093" /></p>
<p><strong>Severe combined immunodeficiency disease (SCID)</strong>: Patients with this condition are susceptible, often fatally, to infectious diseases because of a total inability to mount an immune response.</p>
<p><u>Both B and T lymphocytes are affected; neither class of cells can proliferate.</u></p>
<ul>
<li>Heritable lack of the degradative enzyme <strong>adenosine deamiase (ADA)</strong></li>
</ul>
<p><u>ADA also acts on 2’-deoxyadenosine</u>, which arises from the degradation of DNA.</p>
<ol>
<li>ADA deficiency ➔2’-deoxyadenosine↑ ➔ dATP↑ ➔ DNA synthesis↓ ➔ T and B cell proliferation↓ ➔ immune response↓; activation of ATP catabolism; activation of apoptosis</li>
<li>ADA deficiency ➔2’-deoxyadenosine↑ adenosine↑ ➔ AdoHcy hydrolase↓ ➔ AdoHcy↑  ➔ methyltransferase↓  ➔  methylation reactions↓</li>
</ol>
<p><strong>Standard treatment</strong>: frequent injections of <strong>purified bovine ADA covalent</strong> attached to the polymer <strong>polyethylene glycerol (PEG，聚甘油)</strong>, which corrects the metabolic abnormalities, defects in the immune system usually persist.</p>
<ul>
<li>ADA deficiency was the first human disease to be treated by <strong>gene therapy</strong>.
<ul>
<li>In 1992, a four-year-old girl with this condition was treated with a <strong>viral vector expressing ADA</strong>. She is in her <strong>twenties</strong>, relatively healthy (also with ADA-PEG)</li>
</ul>
</li>
</ul>
<h1 id="三-pyrimidine-nucleotide-metabolism"><a class="markdownIt-Anchor" href="#三-pyrimidine-nucleotide-metabolism"></a> 三、Pyrimidine Nucleotide Metabolism</h1>
<h2 id="de-novo-synthesis-of-pyrimidine-nucleotides"><a class="markdownIt-Anchor" href="#de-novo-synthesis-of-pyrimidine-nucleotides"></a> <em>De novo</em> synthesis of pyrimidine nucleotides</h2>
<img data-src="pics/image-20200516221232172.png" alt="image-20200516221232172" style="zoom: 33%;" />
<p>Pyrimidine nucleotide synthesis occurs primarily at the <strong>free base level</strong>, with c<u>onversion to a nucleotide</u> occurring late in the unbranched pathway.</p>
<p><img data-src="pics/image-20200516221511265.png" alt="image-20200516221511265" /></p>
<ul>
<li>With only <u>two precursors <strong>(aspartate</strong> and <strong>carbamoyl phosphate)</strong></u>, providing all the C and N atoms of the pyrimidine ring)</li>
</ul>
<h2 id="two-major-distinctions-from-the-purine-pathway"><a class="markdownIt-Anchor" href="#two-major-distinctions-from-the-purine-pathway"></a> Two major distinctions from the purine pathway</h2>
<p><img data-src="pics/image-20200516221531318.png" alt="image-20200516221531318" /></p>
<p>Enzyme Involved in above figure:</p>
<ol>
<li>Carbamoyl phosphate synthetase</li>
<li>Aspartate transcarbamolyase</li>
<li>dihydroorotase</li>
<li>dihydroorotate dehydrogenase</li>
<li>orotate phosphoribosyltransferase</li>
<li>OMP decarboxylase</li>
<li>UMP kinase</li>
<li>nucleoside diphosphate kinase</li>
<li>CTP synthetase</li>
</ol>
<ul>
<li>CTP is synthesized from UTP by a g<strong>lutamine-dependent amidotransferase</strong> reaction, catalyzed by CTP synthetase.</li>
</ul>
<ol>
<li><u>the pyrimidine ring is assembled as a free base, with conversion to a nucleotide</u> occurring later in the pathway, when the base <strong>orotic acid</strong> (乳清酸) is converted to <strong>orotidine monophosphate</strong> (奥洛替丁一磷酸), or <strong>OMP</strong></li>
<li>The pyrimidine pathway is <u>unbranched</u>. <strong>Uridine triphosphate</strong> (<strong>UTP</strong>) is an end product of the pathway and is also the substrate for formation of cytidine triphosphate (<strong>CTP</strong>), the other end product.</li>
</ol>
<p><img data-src="pics/image-20200516221940815.png" alt="image-20200516221940815" /></p>
<p>Pyrimidine synthesis begins with formation of <strong>carbamoyl phosphate</strong>, a reaction catalyzed by <strong>carbamoyl phosphate synthetase</strong>（氨甲酰磷酸合成酶）.</p>
<ul>
<li><strong>Carbamoyl phosphate</strong> is formed from <u>ATP, bicarbonate, and the amide nitrogen from glutamine.</u></li>
</ul>
<p>This amidotransferase reaction involves four separate chemical steps</p>
<h2 id="channeling-in-carbamoyl-phosphate-synthetase-cps"><a class="markdownIt-Anchor" href="#channeling-in-carbamoyl-phosphate-synthetase-cps"></a> Channeling in carbamoyl phosphate synthetase (CPS)</h2>
<ul>
<li>氨甲酰磷酸合成酶</li>
</ul>
<img data-src="pics/image-20200516222002885.png" alt="image-20200516222002885" style="zoom:67%;" />
<h3 id="1-carbamoyl-phosphate-synthetase-cps"><a class="markdownIt-Anchor" href="#1-carbamoyl-phosphate-synthetase-cps"></a> 1. Carbamoyl phosphate synthetase (CPS)</h3>
<p>Bacterial CPS is a <strong>heterodimer</strong> composed <u>a large subunit and a small subunit.</u> The X-ray crystal structure of <strong>E.coli CPS</strong>, substrate binding sites and domains…</p>
<ul>
<li><u>Small subunit</u>: functions as a <strong>glutaminase（谷氨酰胺酶）</strong>, catalyzing the hydrolysis of glutamine to form <strong>ammonia</strong>, which is delivered to the large subunit.</li>
<li><u>Large subunit</u>: two active sites: one binds <strong>bicarbonate</strong>, <strong>ATP,</strong> and <strong>ammonia</strong> and catalyzes <u><strong>carboxyphosphate</strong> and <strong>carbamate</strong> synthesis; the other active site</u> binds to a <strong>second ATP</strong> and catalyzes <strong>carbamoyl phosphate</strong> formation.</li>
</ul>
<p><u>The three unstable intermediates (ammonia, carboxyphosphate and carbamate) do not diffuse from the enzyme until converted to the final product, carbamoyl phosphate.</u></p>
<p>A 96 A <strong>tunnel</strong> in the interior of the enzyme through which the intermediates are channeled from one active site to the next (the dotted lines), a common feature in many enzymes and is one mechanism by which enzymes increase <strong>reaction efficiency</strong> and <u>avoid unwanted side reactions</u> with unstable intermediates…</p>
<h3 id="2-eukaryotic-cells-contains-two-forms-of-cps"><a class="markdownIt-Anchor" href="#2-eukaryotic-cells-contains-two-forms-of-cps"></a> 2. Eukaryotic cells contains two forms of CPS</h3>
<p><strong>Form I: in mitochondria</strong>, has a preference for <strong>ammonia</strong> as substrate, and is used in arginine biosynthesis and the <strong>urea</strong> cycle.</p>
<p><strong>Form II: in cytosol</strong>, has a strong preference for <strong>glutamine</strong> as nitrogen donor, for <strong>pyrimidine</strong> biosynthesis</p>
<hr />
<p>In eukaryotes the first three reactions of pyrimidine synthesis are catalyzed by a <strong>trifunctional enzyme</strong>, the <strong>CAD protein</strong>.</p>
<p>Similarly, the last two reactions are catalyzed by a <strong>bifunctional enzyme</strong>, <strong>UMP synthase.</strong></p>
<ul>
<li>CAD: carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase： 氨甲酰磷酸合成酶2，天门冬氨酸转移酶，和二氢乳清酸酶</li>
<li>Uridine monophosphate （UMP） synthetase： 尿苷酸合成酶</li>
</ul>
<p><strong>Miller syndrome</strong> （1 in 1 million ）: mutation in dihydroorotate dehydrogenase gene, developmental anomalies including <strong>cleft lip</strong>（唇裂；兔唇） or palate, absent digits（味觉缺失）, and ocular anomalies（眼部异常）. Miller syndrome is a rare condition that mainly affects the development of the face and limbs（四肢）.</p>
<p><strong>Hereditary orotic aciduria</strong>: defects in UMP synthase gene, accumulate orotic acid, a block at the orotate phosphoribosyltransferase reaction</p>
<h2 id="catabolic-pathways-in-pyrimidine-nucleotide-metabolism"><a class="markdownIt-Anchor" href="#catabolic-pathways-in-pyrimidine-nucleotide-metabolism"></a> Catabolic pathways in pyrimidine nucleotide metabolism</h2>
<img data-src="pics/image-20200516222329964.png" alt="image-20200516222329964" style="zoom: 33%;" />
<h1 id="四-glutamine-dependent-amidotransferases"><a class="markdownIt-Anchor" href="#四-glutamine-dependent-amidotransferases"></a> 四、Glutamine-Dependent Amidotransferases</h1>
<p>A common theme in purine and pyrimidine biosynthesis. Five different reactions in these two pathways:</p>
<ul>
<li>PRPP amidotransferase</li>
<li>FGAR amidotransferase</li>
<li>GMP synthetase</li>
<li>Carbamoyl phosphate synthetase</li>
<li>CTP synthetase</li>
</ul>
<p><img data-src="pics/image-20200516222438587.png" alt="image-20200516222438587" /></p>
<p>The glutamine amido group (unreactive, non-nucleophilic) is activated by hydrolysis at the active site to deliver nucleophilic ammonia in high concentrations sufficient  to aminate the specific acceptor (usually the carbonyl group of an amide). ATP serves as an energy input to force the equilibrium in the amination direction</p>
<h1 id="五-deoxyribonucleotide-biosynthesis-and-metabolism"><a class="markdownIt-Anchor" href="#五-deoxyribonucleotide-biosynthesis-and-metabolism"></a> 五、Deoxyribonucleotide Biosynthesis and Metabolism</h1>
<h2 id="overview-of-deoxyribonucleoside-triphosphate-dntp-biosynthesis"><a class="markdownIt-Anchor" href="#overview-of-deoxyribonucleoside-triphosphate-dntp-biosynthesis"></a> Overview of deoxyribonucleoside triphosphate (dNTP) biosynthesis</h2>
<p><img data-src="pics/image-20200516222601374.png" alt="image-20200516222601374" /></p>
<h3 id="1-structure-of-e-coli-ribonucleoside-diphosphate-reductase"><a class="markdownIt-Anchor" href="#1-structure-of-e-coli-ribonucleoside-diphosphate-reductase"></a> 1. Structure of E. coli ribonucleoside diphosphate reductase</h3>
<img data-src="pics/image-20200516222634260.png" alt="image-20200516222634260" style="zoom: 33%;" />
<h3 id="2-reductive-electron-transport-sequences-in-the-action-of-rndp-reductase"><a class="markdownIt-Anchor" href="#2-reductive-electron-transport-sequences-in-the-action-of-rndp-reductase"></a> 2. Reductive electron transport sequences in the action of rNDP Reductase</h3>
<p>Either thioredoxin or glutaredoxin (硫氧化还原蛋白或谷氧化还原蛋白) can reduce the oxidized form of the reductase.</p>
<p>Oxidized thioredoxin and glutaredoxin are, in turn, reduced with electrons from <strong>NADPH</strong> in reactions catalyzed by <strong>thioredoxin reductase</strong> and <strong>glutathione reductase</strong>, respectively.</p>
<p>Glutaredoxin reduction requires two molecules of <strong>glutathione</strong> (GSH, 谷胱甘肽), resulting in oxidized glutathione (GS-SG)</p>
<p><img data-src="pics/image-20200516222736641.png" alt="image-20200516222736641" /></p>
<ul>
<li>Ribonucleotide reductase uses a protein cofactor—thioredoxin or glutaredoxin—to provide electrons for reduction of the ribonucleotide substrate.</li>
</ul>
<p>Ribonucleotide reductase has <u>two classes of allosteric sites</u>.</p>
<p><strong>Activity sites</strong> influence catalytic efficiency, and <strong>specificity sites</strong> determine specificity for one or more of the four substrates.</p>
<p>Inhibition of DNA synthesis by thymidine or deoxyadenosine involves allosteric inhibition of ribonucleotide reductase by <strong>dTTP or dATP</strong>, respectively.</p>
<ul>
<li>Because deoxyribonucleotides are used only for DNA synthesis, and because one enzyme system is used for reduction of all four ribonucleotide substrates, regulation of both the activity and the specificity of ribonucleotide reductase is essential to maintain balanced pools of DNA precursors.</li>
</ul>
<p><img data-src="pics/image-20200516222816897.png" alt="image-20200516222816897" /></p>
<ul>
<li>Binding of nucleotides at the specificity sites modulates the activities if the enzyme toward different substrates, so as to maintain balanced rates of production of the four dNTPs. For example, binding of dTTP (with ATP bound in the activity site) activates the enzyme for reduction of GDP but decreases its ability to reduce either UDP or CDP.</li>
</ul>
<h2 id="regulation-of-e-coli-ribonucleotide-reductase-by-reversible-oligomerization"><a class="markdownIt-Anchor" href="#regulation-of-e-coli-ribonucleotide-reductase-by-reversible-oligomerization"></a> Regulation of E. coli ribonucleotide reductase by reversible oligomerization</h2>
<img data-src="pics/image-20200516223035865.png" alt="image-20200516223035865" style="zoom:50%;" />
<p><u>All nucleotides</u> stimulate formation of the active tetramer from dimers.</p>
<p><u>dATP binding</u> at  the activity sites shifts the equilibrium to formation of inactive <strong>octamer</strong> (八聚体).</p>
<p><u>ATP binding</u> shifts the equilibrium back to active <strong>tetramer</strong> (四聚体).</p>
<h1 id="六-thymidylate-synthase-a-target-enzyme-for-chemotherapy"><a class="markdownIt-Anchor" href="#六-thymidylate-synthase-a-target-enzyme-for-chemotherapy"></a> 六、Thymidylate Synthase: A Target Enzyme for Chemotherapy</h1>
<h2 id="biosynthesis-of-thymine-deoxyribonucleotides"><a class="markdownIt-Anchor" href="#biosynthesis-of-thymine-deoxyribonucleotides"></a> Biosynthesis of Thymine Deoxyribonucleotides</h2>
<p><strong>dUMP</strong>, the substrate for thymidylate synthesis, can arise either from <u>UDP reduction and dephosphorylation</u> or from d<u>eamination of a deoxycytidine nucleotide</u>.</p>
<p>In the reaction catalyzed by <strong>thymidylate synthase</strong> (胸苷酸合成酶), <u>5,10-methylenetetrahydrofolate</u> donates both a single-carbon methylene group and an electron pair to reduce that carbon to a methyl group.</p>
<ul>
<li>Ribonucleotides have multiple metabolic roles, while deoxyribonucleotides serve only as constituents of DNA</li>
<li>The conversion of ribose to deoxyribose, and the conversion of uracil to thymidine，</li>
<li>Both of these processes occur at the nucleotide level</li>
<li>Both processes are of great interest mechanistically, as target sites for chemotherapy for cancer or infectious diseases and from the standpoint of regulation</li>
</ul>
<h2 id="deoxyribonucleotide-biosynthesis-and-metabolism"><a class="markdownIt-Anchor" href="#deoxyribonucleotide-biosynthesis-and-metabolism"></a> Deoxyribonucleotide Biosynthesis and Metabolism</h2>
<h3 id="1-salvage-and-de-novo-synthetic-pathways-to-thymine-nucleotides"><a class="markdownIt-Anchor" href="#1-salvage-and-de-novo-synthetic-pathways-to-thymine-nucleotides"></a> 1. Salvage and de novo synthetic pathways to thymine nucleotides</h3>
<p><img data-src="pics/image-20200516223306860.png" alt="image-20200516223306860" /></p>
<p>The de novo pathways start with UDP or CDP, shown at the top.</p>
<p>Dashed arrows indicate feedback regulatory loops.</p>
<p><img data-src="pics/image-20200516223335116.png" alt="image-20200516223335116" /></p>
<ul>
<li>A goal of chemotherapy—the treatment of diseases with chemical agents—is to exploit a biochemistry difference between the diseased tissue and the host tissue in order to interfere selectively with disease process.</li>
<li><strong>Thymidylate synthase (TS)</strong>: critical for the synthesis of a deoxyribonucleotide. Any disease that involves uncontrolled cell proliferation can in principle be treated with inhibitors of TS.</li>
</ul>
<p>Inhibition of thymidylate synthase is an approach to cancer chemotherapy, by causing specific inhibition of DNA synthesis.</p>
<p><img data-src="pics/image-20200516223521633.png" alt="image-20200516223521633" /></p>
<ul>
<li>Inhibition of <strong>thymidylate synthase</strong> (胸苷酸合成酶) is an approach to cancer chemotherapy, by causing specific inhibition of DNA synthesis.</li>
</ul>
<h2 id="thymidylate-synthase-a-target-enzyme-for-chemotherapy"><a class="markdownIt-Anchor" href="#thymidylate-synthase-a-target-enzyme-for-chemotherapy"></a> Thymidylate Synthase: A Target Enzyme for Chemotherapy</h2>
<img data-src="pics/image-20200516223613582.png" alt="image-20200516223613582" style="zoom:50%;" />
<img data-src="pics/image-20200516223639582.png" alt="image-20200516223639582" style="zoom:50%;" />
<ul>
<li>Folate cofactor analogs (<strong>antifolates</strong> (抗叶酸药)) that compete quite effectively with 5,10-methylene-THF for binding to TS (Ki values as low as 0.4 nM).</li>
<li>5,10-Methylenetetrahydrofolate(THF)：5,10-亚甲基四氢叶酸</li>
</ul>
<h1 id="七-biological-and-medical-importance-of-other-nucleotide-analogs"><a class="markdownIt-Anchor" href="#七-biological-and-medical-importance-of-other-nucleotide-analogs"></a> 七、Biological and Medical Importance of Other Nucleotide Analogs</h1>
<img data-src="pics/image-20200516223704884.png" alt="image-20200516223704884" style="zoom: 33%;" />
<p>One of the earliest antiviral drugs approved for use in humans is <strong>arabinosyladenine</strong> (阿拉伯糖腺嘌呤) (araA or <strong>Vidarabine</strong> (阿糖腺苷)).</p>
<p>It is now being used to treat several viral diseases, including <strong>viral encephalitis</strong> (病毒性脑炎), a neurological disease caused by another member of the <strong>herpes virus</strong>  family.</p>
<p>Unlike <strong>acycloguanosine</strong> (无环鸟苷), <strong>araA</strong> is phosphorylated to the <strong>triphosphate</strong> level by cellular kinases.</p>
<p>The <strong>triphosphate</strong>, <strong>araATP</strong>, is a selective inhibitor <u>of DNA polymerases</u> encoded by <u>herpes viruses</u>.</p>
<img data-src="pics/image-20200516223849541.png" alt="image-20200516223849541" style="zoom:20%;" />
<p>Other analogs receiving considerable attention are those being used to combat acquired immune deficiency syndrome (<strong>AIDS</strong>) caused by HIV.</p>
<p>One such analog, 3’-azido-2’,3’-dideoxythymidine (<strong>AZT</strong>) is anabolized to the corresponding <strong>triphosphate</strong>, which is an inhibitor of <strong>viral reverse transcriptase</strong> (the enzyme that makes a DNA copy of the viral RNA).</p>
<p>Other nucleoside analogs— 2’,3’-dideoxycytidine (ddC), 2’,3’-dideoxyinosine (ddI), 3’-thiacytidine (3TC), and 2’,3’-didehydro-3’-deoxythymidine (d4T)—act by conversion to the corresponding triphosphate, which is incorporated into DNA but then blocks further replicative chain elongation because of the absence of a 3’-hydroxyl terminus (<strong>chain terminators</strong>).</p>
<ul>
<li>2‘，3’-双脱氧胞苷（DDC），2‘，3’-双脱氧肌苷（DDI），3‘-硫杂胞苷（3TC），和2’，3‘-双脱氢-3’-脱氧胸苷（d4T）</li>
</ul>
<img data-src="pics/image-20200516224155964.png" alt="image-20200516224155964" style="zoom:25%;" />
<p>An important biochemical anomaly is found in parasitic <strong>protozoans</strong> (原生动物) such as Plasmodium, and <strong>Leishmania</strong> (疟原虫  利什曼原虫).</p>
<ul>
<li>Parasitic protozoans lack the capacity for de novo purine synthesis, and they depend entirely on salvage of nucleosides and bases provided by the host.</li>
</ul>
<p>Compounds such as <u>allopurinol and formycin B</u> inhibit the growth of these organisms in culture, partly through inhibition of <strong>salvage</strong> enzymes and partly through the ability of the salvage enzymes to anabolize the analog, an ability lacking in the corresponding host enzymes.</p>
<p>For example, <strong>allopurinol</strong> is converted to an analog of <strong>inosinic acid</strong> (肌苷酸) and then to an <strong>AMP analog</strong> and is finally incorporated into <strong>RNA</strong>, where it interferes with messenger RNA coding in protein synthesis.</p>
<p>Purine salvage can also be taken advantage of, for example in the use of <strong>thiopurines</strong>  (硫嘌呤)as anti-cancer and immunosuppressive drugs.</p>
<p>Like <strong>5-fluorouracil, 6-mercaptopurine and 6-thioguanine</strong> (5-氟尿嘧啶，6-巯基嘌呤和6-硫鸟嘌呤) are prodrugs that require <u>metabolic activation</u> in order to exert their cytotoxic effects.</p>
<img data-src="pics/image-20200516224330546.png" alt="image-20200516224330546" style="zoom:50%;" />
<p>Another class of dihydrofolate reductase inhibitors is exemplified by <strong>trimethoprim</strong> (甲氧苄氨嘧啶).</p>
<p>This compound is a specific inhibitor of <u>dihydrofolate reductases of prokaryotic origin.</u></p>
<p>Trimethoprim and its relatives are widely used to treat <u>both bacterial infections and certain forms of malaria.</u></p>
<p>The success of these drugs derives from their being extremely weak inhibitors of vertebrate <u>dihydrofolate reductases.</u></p>
<p><strong>Trimethoprim</strong> is often administered in conjunction with a <strong>sulfonamide</strong> (磺胺) drug to inhibit the synthesis of folate and hence to block sequential steps in the same pathway.</p>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/4716231a.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/4716231a.html" class="post-title-link" itemprop="url">L09 Metabolism of Nitrogenous Compounds I Principles of Biosynthesis, Utilization, and Turnover</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:41" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/4716231a.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/4716231a.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>23k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <p>Metabolism of Nitrogenous Compounds I: Principles of Biosynthesis, Utilization, and Turnover</p>
<ul>
<li>含氮化合物代谢Ⅰ：生物合成，利用与周转</li>
</ul>
<h1 id="一-utilization-of-ammonia-biogenesis-of-organic-nitrogen"><a class="markdownIt-Anchor" href="#一-utilization-of-ammonia-biogenesis-of-organic-nitrogen"></a> 一、Utilization of Ammonia: Biogenesis of Organic Nitrogen</h1>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135127613.png" alt="image-20200505135127613" style="zoom:100%;" />
+ Pathways of nitrogen metabolism (purple) in the general pattern of intermediary metabolism
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135250646.png" alt="image-20200505135250646" style="zoom: 33%;" />
<ul>
<li>Reactions in assimilation of ammonia and major fates of the fixed nitrogen:</li>
</ul>
<ol>
<li>Glutamate dehydrogenase</li>
<li>Glutamine synthetase</li>
<li>Asparagine synthetase</li>
<li><strong>Carbamoyl phosphate</strong> synthetase (氨甲酰磷酸合成酶)</li>
<li>Glutamate synthase.</li>
</ol>
<ul>
<li>In <u>animals</u>, <u>glutamine</u>, rather than NH3, is the chief nitrogen source for pyrimidines (嘧啶).</li>
</ul>
<p>Ammonia in <u>high concentrations is quite toxic</u>;</p>
<ul>
<li>At <u>lower concentrations</u>, it is a <u>central metabolite</u>, serving as <u>substrate for four enzymes</u> that convert it to various organic compounds;</li>
</ul>
<p>All organisms assimilate ammonia via reactions leading to <u>glutamate, glutamine, asparagine, or carbamoyl phosphate;</u></p>
<ul>
<li><u>Carbamoyl phosphate</u> is used only in the biosynthesis of <u>arginine, urea, and the pyrimidine nucleotides;</u></li>
<li><u>Most of the nitrogen that finds its way from ammonia to amino acids glutamate and glutamine;</u></li>
</ul>
<p><u>The α-amino nitrogen of glutamate and the side chain amide nitrogen of glutamine</u> are both primary <u>source of N in biosynthetic pathways</u>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135436243.png" alt="image-20200505135436243" style="zoom:53%;" />
<h2 id="glutamate-dehydrogenase"><a class="markdownIt-Anchor" href="#glutamate-dehydrogenase"></a> Glutamate dehydrogenase</h2>
<p>Glutamate dehydrogenase catalyzes the reductive amination of <strong>α-ketoglutarate</strong>（α-酮戊二酸）</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135521051.png" alt="image-20200505135521051" style="zoom:100%;" />
+ This reaction is reversible;
+ In **bacteria** 
 + Use NADPH;
 + this enzyme has a high K~m~ for ammonia (1 mM)
 + primarily the direction of <u>glutamate formation</u>;
 + <u>Bacteria</u> growing with ammonia as their sole nitrogen source use this reaction as the <u>primary route</u> for nitrogen assimilation;
<ul>
<li>In <strong>animal</strong> cells</li>
<li>the reaction occurs in <u>both directions</u>, primarily the formation of α-ketoglutarate ➔citric acid cycle ➔ATP production ;</li>
<li>Animal cells use both <strong>NAD+ and NADP+</strong> as cofactor;</li>
<li>The animal enzyme is allosterically controlled; <u>α-ketoglutarate synthesis is inhibited by GTP and ATP and stimulated by ADP. Thus the enzyme is activated under conditions of low energy charge.</u></li>
</ul>
<h2 id="glutamate-synthase"><a class="markdownIt-Anchor" href="#glutamate-synthase"></a> Glutamate synthase</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135828030.png" alt="image-20200505135828030" style="zoom:100%;" />
+ A related enzyme that occurs only in <u>microorganisms</u>, <u>plants</u>, and <u>lower eukaryotes</u>, **glutamate synthase**, catalyzes a reaction comparable to that catalyzed by glutamate dehydrogenase but functions <u>primarily in glutamate biosynthesis</u>:
+ The amide N of glutamine replaces NH3 as the N donor 
<h2 id="glutamine-synthetase-gs"><a class="markdownIt-Anchor" href="#glutamine-synthetase-gs"></a> Glutamine synthetase (GS)</h2>
<p>Whether formed by action of glutamate dehydrogenase or glutamate synthase, or by transamination, glutamate can accept a <u>second ammonia</u> moiety to form glutamine in the reaction catalyzed by <strong>glutamine synthetase</strong> (谷氨酰胺合成酶).</p>
<p>Mn2+ is required.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505140045235.png" alt="image-20200505140045235" style="zoom:67%;" />
<p>The glutamine synthetase reaction occurs via an <strong>acyl phosphate intermediate</strong> (酰基磷酸中间物).</p>
<p>ATP phosphorylates the δ-carboxylate of glutamate to give a carboxylic-phosphoric acid anhydride (<strong>γ-glutamyl phosphate</strong>), which undergoes <u>nucleophilic attack</u> by the nitrogen of <strong>ammonia</strong> to give the amide product, glutamine.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505140215666.png" alt="image-20200505140215666" style="zoom:25%;" />
<h3 id="1-structure-of-gs"><a class="markdownIt-Anchor" href="#1-structure-of-gs"></a> 1. Structure of GS</h3>
<p>Structure of <em>Salmonella typhimurium</em> (鼠伤寒沙门氏菌) glutamine synthetase (GS):</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505140538671.png" alt="image-20200505140538671" style="zoom:100%;" />
+ Bacterial glutamine synthetase is a dodecamer, with 12 identical subunits forming two facing hexagonal arrays. 
<h3 id="2-regulation-of-glutamine-synthetase-gs"><a class="markdownIt-Anchor" href="#2-regulation-of-glutamine-synthetase-gs"></a> 2. Regulation of Glutamine Synthetase (GS)</h3>
<h4 id="prokaryotic"><a class="markdownIt-Anchor" href="#prokaryotic"></a> Prokaryotic</h4>
<p><u>Prokaryotic</u> <strong>glutamine synthetase</strong> is controlled by:</p>
<ol>
<li>Cumulative feedback inhibition</li>
</ol>
<ul>
<li>Involves the action of <u>eight specific feedback inhibitors</u>.</li>
<li>Metabolic <u>end products</u> of glutamine (<strong>trp</strong>, <strong>his</strong>, <strong>glucosamine-6-phosphate</strong> (葡糖胺-6-磷酸), <strong>carbamoyl phosphate</strong>, <strong>CTP</strong>, and <strong>AMP</strong>)</li>
<li>Indicators of the general status of amino acid metabolism (<strong>ala</strong>, <strong>gly</strong>)</li>
</ul>
<ol start="2">
<li>Covalent modification</li>
</ol>
<ul>
<li><strong>Adenylylation</strong> (腺苷酰化) of a specific <strong>tyrosine</strong> residue (Tyr 397)</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505141102935.png" alt="image-20200505141102935" style="zoom:50%;" />
<p>Regulation of the activity of bacterial <strong>glutamine synthetase (GS)</strong>:</p>
<ol>
<li>The complex of <strong>AT (adenylyltransferase, 腺苷转移酶)</strong> and (a regulatory protein, <strong>P<sub>II</sub></strong>) catalyzes both the <strong>adenylylation</strong> and <strong>deadenylylation</strong> of glutamine synthetase (<strong>GS</strong>), depending on whether <strong>P<sub>II</sub></strong> is <strong>deuridylylated</strong> (脱脲基) (left) or <strong>uridylylated (尿酰化)</strong> (right).</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505141315233.png" alt="image-20200505141315233" style="zoom:100%;" />
 + Uridylylation of **P~II~** is catalyzed by **uridylyltransferase (尿酸转移酶, UT)**, and deuridylylation is catalyzed by u**ridylyl-removing enzyme (UR)**, both activities part of a bifunctional enzyme. 
<ol start="2">
<li><strong>Adenylation (腺苷酸化)</strong>: Tyr 397 react with ATP to form an ester, <u>inactivates the enzyme</u>;</li>
</ol>
<ul>
<li>Adenylylation and deadenylylation of GS are catalyzed by the same enzyme: complex of <strong>adenylyltransferase (腺苷酸转移酶, AT)</strong> and a small regulatory protein, <strong>P<sub>II</sub></strong>;</li>
<li><u><strong>UMP-PII</strong> and <strong>P<sub>II</sub></strong> controls adenylation or deadenylylation, respectively;</u></li>
<li>Reversible <strong>uridylylation</strong> of PII is catalyzed by another enzyme, a bifunctional <strong>uridylyltransferase (UT)/uridylyl-removing enzyme (UR)</strong>, <u>in response to intracellular glutamate concentrations.</u></li>
<li>UT: PII ➔ UMP-PII ➔ GS adenylylation ↓ ➔ GS activity ↑ ;</li>
<li>UR: UMP-PII ➔ PII ➔ GS adenylylation ↑ ➔ GS activity ↓;</li>
<li><strong>PII-UMP</strong> is <strong>deuridylylated</strong> by hydrolysis of the UMP residues, catalyzed by uridylyl-removing activity of the bifunctional <strong>UT/UR</strong>;</li>
<li>Glutamine ↑ ➔ UT↓ UR↑ ➔ PII ↑ ➔ PII  - AT ↑ ➔ GS adenylylation ↑ ➔ GS activity ↓ ➔ glutamine↓;</li>
<li>Glutamine ↓ ➔ UT ↑ UR↓ ➔ AMP-PII ↑ ➔ AMP-PII  - AT ↑ ➔ GS adenylylation ↓ ➔ GS activity ↑ ➔ glutamine ↑;</li>
<li>α-ketoglutarate ↑ ➔ PII  - AT ↓ ➔ GS activity ↑ ➔ glutamine ↑.</li>
</ul>
<h4 id="glutamine-plays-a-central-role-in-nitrogen-metabolism"><a class="markdownIt-Anchor" href="#glutamine-plays-a-central-role-in-nitrogen-metabolism"></a> Glutamine plays a central role in nitrogen metabolism</h4>
<p>The amide nitrogen is used in <u>biosynthesis</u> of several amino acids (including <strong>glutamic acid</strong>, <strong>tryptophan</strong> (trp), <strong>histidine</strong>), <u>purine and pyrimidine nucleotides, and amino sugars.</u></p>
<p>In <u>animals</u>, <strong>glutamine synthetase</strong> is a key participant in <strong>detoxifying ammonia</strong> formed from amino acid catabolism, particularly in <u>brain</u> cells. Glutamate and glutamine are two of the most abundant free amino acids <u>in brain cells</u>; <u>accumulation of these amino acids can deplete α-ketoglutarate, their principal precursors, thereby interfering with the citric acid cycle and energy generation.</u></p>
<p>Glutamine participates in <u>ammonia excretion</u> in the <u>kidney</u></p>
<h3 id="3-glutamate-dehydrogenaseglutamine-synthetase"><a class="markdownIt-Anchor" href="#3-glutamate-dehydrogenaseglutamine-synthetase"></a> 3. glutamate dehydrogenase/glutamine synthetase</h3>
<p>If <u>NH4+ levels are high</u>, the glutamate dehydrogenase/glutamine synthetase pathway operates:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505141840495.png" alt="image-20200505141840495" style="zoom:100%;" />
+ To assimilate NH4+ in bacteria, glutamine synthetase functions together with glutamate dehydrogenase or glutamate synthase, depending on ammonia levels. 
<h2 id="asparagine-synthetase"><a class="markdownIt-Anchor" href="#asparagine-synthetase"></a> Asparagine Synthetase</h2>
<p>Asparagine Synthetase: A similar amidation Reaction</p>
<ul>
<li>Catalyzes a reaction comparable to that of glutamine synthetase.</li>
<li>Although widespread, asparagine synthetase accounts for <u>much less</u> ammonia assimilation.</li>
<li>This enzyme uses <strong>ammonia</strong> or <strong>glutamine</strong> in catalyzing the conversion of aspartate to asparagine.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142141799.png" alt="image-20200505142141799" style="zoom:100%;" />
+ Glutamine synthetase: ATP to ADP;
+ Asparagine synthetase: ATP to AMP
<h2 id="carbamoyl-phosphate-synthetase"><a class="markdownIt-Anchor" href="#carbamoyl-phosphate-synthetase"></a> Carbamoyl phosphate synthetase</h2>
<p>The final route for assimilating ammonia first forms <strong>carbamoyl phosphate</strong>.</p>
<ul>
<li>The enzyme responsible is <strong>carbamoyl phosphate synthetase</strong> (氨甲酰磷酸合成酶).</li>
</ul>
<p>Either <strong>ammonia</strong> or <strong>glutamine</strong> can serve as the nitrogen donor:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142241723.png" alt="image-20200505142241723" style="zoom:50%;" />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142249063.png" alt="image-20200505142249063" style="zoom:100%;" />
+ Carbamoyl phosphate: generation of an intermediate for arginine (urea) (CPSI, mitochondria) and pyrimidine synthesis (CPSII, cytosol) 
<h1 id="二-the-nitrogen-economy-aspects-of-amino-acid-synthesis-and-degradation"><a class="markdownIt-Anchor" href="#二-the-nitrogen-economy-aspects-of-amino-acid-synthesis-and-degradation"></a> 二、The Nitrogen Economy: Aspects of Amino Acid Synthesis and Degradation</h1>
<h2 id="overview"><a class="markdownIt-Anchor" href="#overview"></a> Overview</h2>
<ol>
<li><strong>Nitrogen equilibrium</strong>:</li>
<li><strong>Normal nitrogen balance</strong>: the daily intake of nitrogen throughout diet <u>is equal</u> to that lost through urinary excretion and other processes, such as ammonia in sweat;</li>
<li><strong>Positive nitrogen balance</strong>: pregnancy, growth of a juvenile, or recovery from starvation;</li>
<li><strong>Negative nitrogen balance</strong>: senescence（衰老）, starvation, and certain diseases states.</li>
</ol>
<p>Although mammals can synthesize <strong>Arg</strong> and <strong>Met</strong>, the use of these amino acids for the production of <strong>urea</strong> and <strong>methyl groups</strong>, respectively, is greater than the capacity of their biosynthetic pathways;</p>
<ul>
<li>50-100 grams per day;</li>
<li>Nutritional quality of proteins.</li>
</ul>
<p>Essential and nonessential amino acids:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142618654.png" alt="image-20200505142618654" style="zoom:50%;" />
<h2 id="transamination"><a class="markdownIt-Anchor" href="#transamination"></a> Transamination</h2>
<h3 id="1-the-process"><a class="markdownIt-Anchor" href="#1-the-process"></a> 1. The Process</h3>
<p><strong>Transamination</strong> (转氨基) is the <u>reversible</u> transfer of an amino group from an α-amino acid to an <strong>α-keto acid</strong>, with <strong>pyridoxal phosphate</strong> (磷酸吡哆醛, Vitamin B<sub>6</sub>) as a <u>coenzyme</u>.</p>
<ul>
<li>Therefore transamination needs Vitamin B<sub>6</sub></li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142726022.png" alt="image-20200505142726022" style="zoom: 33%;" />
<h3 id="2-the-functions-of-transamination"><a class="markdownIt-Anchor" href="#2-the-functions-of-transamination"></a> 2. The functions of transamination</h3>
<ol>
<li>A process whereby amino acids can <u>replenish citric acid cycle intermediates</u>; Funnel <u>excess amino acids towards catabolism and energy generation</u></li>
<li><u>Redistribution of amino acid nitrogen;</u></li>
<li>Bridge the <u>amino acids composition</u> into in line with the organism’s needs;</li>
</ol>
<p>Because of the key role of <strong>glutamate</strong> in ammonia assimilation, it is a star player in transamination. Transamination uses <strong>glutamate</strong> nitrogen to <u>synthesize other amino acids</u>.</p>
<h3 id="3-aminotransferase-转氨酶"><a class="markdownIt-Anchor" href="#3-aminotransferase-转氨酶"></a> 3. Aminotransferase 转氨酶</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142906855.png" alt="image-20200505142906855" style="zoom:43%;" />
<p><strong>Aminotransferases</strong> <u>utilize a coenzyme</u>, <strong>pyridoxal phosphate (磷酸吡哆醛)</strong>, that is derived from <strong>vitamin B<sub>6</sub>.</strong></p>
<p>The functional part of the cofactor is an aldehyde functional group, <strong>CHO</strong>, attached to a <strong>pyridine ring</strong> (吡啶环).</p>
<p>The catalytic cycle begins with condensation of this <u>aldehyde with the α-amino group</u> of an amino acid, to give a <strong>Schiff base</strong> (席夫碱), or <strong>aldimine</strong> (醛亚胺), intermediate.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505143656694.png" alt="image-20200505143656694" style="zoom:100%;" />
### 4. The bi-directional feature of transamination
<p>Transamination can be used for <u>amino acid synthesis</u> and also for <u>degradation of amino acids</u> that accumulate in excess of need.</p>
<p><u>In degradation the transaminase works in concert with glutamate dehydrogenase</u>, as exemplified by the degradation of <strong>alanine</strong>:</p>
<p>Most aminotransferases use <strong>glutamate/α-ketoglutarate</strong> as one of the two α-amino/α-keto acid pairs involved.</p>
<p>Two such enzymes are important in the <u>clinical</u> diagnosis of human disease —<strong>serum glutamate-oxaloacetate transaminase</strong> (SGOT, 谷氨酸  -  草酰乙酸转氨酶) and <strong>serum glutamate-pyruvate transaminase</strong> (SGPT, 谷氨酸  -  丙酮酸转氨酶):</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505143737104.png" alt="image-20200505143737104" style="zoom:47%;" />
<ul>
<li>S指的是serum，正常情况下GOT和GPT一般存在与肝脏</li>
<li>SGOT和SGPT是检测肝脏功能的重要指标</li>
</ul>
<p>These enzymes, abundant in <u>heart and in liver</u>, are released from cells as part of the cell injury that occurs in <strong>myocardial infarction</strong> (心肌梗死), <strong>infectious hepatitis</strong> (传染性肝炎), or other damage to either organ.</p>
<p>Assays of these enzyme activities in blood serum can be used both in <u>diagnosis</u> and in monitoring the <u>progress of a patient</u>.</p>
<h1 id="三-protein-turnover"><a class="markdownIt-Anchor" href="#三-protein-turnover"></a> 三、Protein Turnover</h1>
<ul>
<li>蛋白质周转</li>
</ul>
<p>Proteins are subject to <u>continuous biosynthesis and degradation</u>, a process called <strong>protein turnover.</strong></p>
<ul>
<li>For an intracellular protein whose total concentration does not change with time, the <u>steady state level</u> is maintained by synthesis of the protein at a rate just sufficient to replenish protein lost by degradation.</li>
</ul>
<p>Many of the <u>amino acids</u> released during protein turnover are <u>reutilized</u> in the synthesis of new proteins.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505144030215.png" alt="image-20200505144030215" style="zoom:100%;" />
## Chemical Signals for Turnover
<p>The turnover rates for different proteins vary by as much as <u>1000-fold</u>, whereas differences in protein stability, as measured by denaturation in vitro, may be much less.</p>
<p>Chemical Signals for Turnover:</p>
<ol>
<li>Ubiquitination (泛素化)</li>
<li>Metal-catalyzed oxidation of particular residues</li>
<li>PEST sequences (<strong>12-60 aa</strong>)</li>
<li>particular N-terminal residues</li>
</ol>
<h3 id="1-ubiquitination"><a class="markdownIt-Anchor" href="#1-ubiquitination"></a> 1. Ubiquitination</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505153017996.png" alt="image-20200505153017996" style="zoom: 33%;" />
<p>Ubiquitin is a small (<u>76-residue</u>) protein expressed in all eukaryotic cells—it derives its name from its widespread (ubiquitous) distribution.</p>
<p>Ubiquitin is <u>covalently</u> conjugated to specific cellular proteins in an <u>ATP-dependent</u> reaction, which condenses <u>the <strong>terminal carboxyl group</strong> of ubiquitin with <strong>lysine</strong> amino groups on target proteins.</u></p>
<ul>
<li>In the first reaction, catalyzed by the <u>ubiquitin-activating enzyme E1, a thioester is formed between the C-terminal Gly residue of ubiquitin and an internal Cys residue of E1 in a two-step process.</u></li>
<li>Formation of this <u>high-energy covalent</u> linkage is driven by <u>ATP hydrolysis</u>, via a <u>ubiquitin-adenylate intermediate</u>.</li>
</ul>
<h3 id="2-structure-of-the-proteasome-26s-蛋白酶体"><a class="markdownIt-Anchor" href="#2-structure-of-the-proteasome-26s-蛋白酶体"></a> 2. Structure of the proteasome (26S) (蛋白酶体)</h3>
<p>Structure of the proteasome (26S):</p>
<p>The <u>proteasome</u> contains two major assemblies, a <u>28-subunit core particle</u> (aka the <u>20S particle</u>) and a <u>19-subunit regulatory particle</u> (aka the <u>19S particle</u>), which forms the <u>base</u> and <u>lid</u> assemblies.</p>
<ul>
<li>The <u>proteolytic active sites</u> are located within the <u>large internal space</u> (~100 x 60Å) of the <u>20S core particle</u>.</li>
<li><u>The lid and base</u> assemblies of the 19S regulatory particle control substrate entry into the 20S core particle.</li>
</ul>
<p><u>Proteins tagged with the ubiquitin pass through the tube in an ATP-dependent fashion.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505153438883.png" alt="image-20200505153438883" style="zoom:25%;" />
<h3 id="3-the-process-of-polyubiquitination"><a class="markdownIt-Anchor" href="#3-the-process-of-polyubiquitination"></a> 3. The process of polyubiquitination</h3>
<p>Enzymatic pathway for attachment of ubiquitin to target proteins:</p>
<p>E1, E2, and E3 are proteins involved in the <u>ubiquitin</u> transfer to <u>lysine</u> residues on target proteins.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505153541933.png" alt="image-20200505153541933" style="zoom:67%;" />
<ol>
<li>In the first reaction, catalyzed by the <u>ubiquitin-activating enzyme E1</u>, a thioester is formed between the <strong>C-terminal Gly residue of ubiquitin</strong> and an <strong>internal Cys</strong> residue of E1 in a two-step process;</li>
</ol>
<ul>
<li>Formation of this high energy covalent linkage is driven by <u>ATP hydrolysis</u>, via a ubiquitin-adenylate intermediate. <strong>AMP</strong> is released upon nucleophilic attack by the Cys-SH of E1;</li>
</ul>
<ol start="2">
<li>
<p>The <strong>activated ubiquitin</strong> is then transferred to a Cys-SH of one of several E2 enzymes (ubiquitin-conjugating enzymes) in a transthiolation reaction;</p>
</li>
<li>
<p>A <strong>ubiquitin-protein ligase, E3</strong>, is required for step 3—covalent attachment of ubiquitin of the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>ε</mi></mrow><annotation encoding="application/x-tex">\varepsilon</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault">ε</span></span></span></span>-NH3+ group of one or more lysine residues on the target protein via an <strong>isopeptide bond</strong>;</p>
</li>
</ol>
<p>Expenditure of the equivalent of <u>two ATPs</u> per ubiquitin added ensures that the reaction is both <u>irreversible and specific</u>;</p>
<p><strong>E3</strong> can catalyze the successive addition of a ubiquitin moiety to a previously conjugated ubiquitin, forming a <u>polyubiquitin</u> chain in which a Lys of ubiquitin forms an <u>isopeptide bond</u> with the C-terminal Gly –COOH of the succeeding ubiquitin;</p>
<p>Ubiquitin contains <u>seven lysine</u> residues, and polyubiquitination chains can involve one or more of these residues；</p>
<p><u>Two major families of E3</u> ubiquitin-protein ligases have been described:</p>
<ol>
<li>the HECT domain-containing E3s</li>
<li>the RING-finger domain-containing E3s.</li>
</ol>
<ul>
<li>These two E3 families differ in structure and in mechanism；</li>
</ul>
<p><strong>E3 ligase</strong> plays a central role in determining the <u>specificity and selectivity</u> of the proteasome system, these proteins are implicated in a number of <u>disease states</u>, <u>including neurodegenerative disorders, inflammatory diseases, muscle wasting disorders, and cancers.</u></p>
<ul>
<li>Only 2 E1 in mammals</li>
<li>About 28 E2 in humans</li>
<li>Maybe 1000 E3 in humans</li>
<li>Deubiquiting enzymes(Dubs)</li>
<li>SUMO</li>
</ul>
<h1 id="四-amino-acid-degradation-and-metabolism-of-nitrogenous-end-products"><a class="markdownIt-Anchor" href="#四-amino-acid-degradation-and-metabolism-of-nitrogenous-end-products"></a> 四、Amino Acid Degradation and Metabolism of Nitrogenous End Products</h1>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154316030.png" alt="image-20200505154316030" style="zoom:100%;" />
+ <u>Amino acid degradation</u> usually begins with conversion to the corresponding **α-keto acid** by <u>transamination or oxidative deamination</u>.
 + α-keto acid can enter the carbohydrate metabolism
<h2 id="fates-of-the-amino-acid-carbon-skeletons"><a class="markdownIt-Anchor" href="#fates-of-the-amino-acid-carbon-skeletons"></a> Fates of the amino acid carbon skeletons</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154347288.png" alt="image-20200505154347288" style="zoom:100%;" />
+ Once the nitrogen has been removed, the carbon skeleton: citric acid cycle or converted to carbohydrates; 
+ Amino acids leading to acetyl-CoA or acetoacetyl-CoA, such as leucine, contribute heavily toward ketogenesis;
+ Glucogenic（上图黄色标识amino acids） and ketogenic（上图蓝色标识amino acids）, 
 + Ketogenic: 在动物体内Acetyl-CoA不能反向生成糖
<h2 id="detoxification-and-excretion-of-ammonia"><a class="markdownIt-Anchor" href="#detoxification-and-excretion-of-ammonia"></a> Detoxification and Excretion of Ammonia</h2>
<p>Although <u>ammonia</u> is a universal participant in amino acid synthesis and degradation, its accumulation in abnormal concentration has <u>toxic</u> consequences.</p>
<p>Animals have evolved pathways, adapted to their lifestyles, for excretion of <strong>ammonia</strong>, <strong>uric acid</strong>（尿酸）, or <strong>urea</strong> as the major <u>nitrogenous end product.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154608102.png" alt="image-20200505154608102" style="zoom:40%;" />
<ul>
<li>排氨的方式：</li>
<li>Most aquatic animals: ammonia</li>
<li>Terrestrial animals, birds and insects: uric acid 尿酸</li>
<li>Mammals (except Dalmatian dog): urea 尿素</li>
</ul>
<h2 id="the-krebs-henseleit-urea-cycle"><a class="markdownIt-Anchor" href="#the-krebs-henseleit-urea-cycle"></a> The Krebs-Henseleit Urea Cycle</h2>
<p>Urea is synthesized <u>almost exclusively in the liver</u> and then transported to the kidneys for excretion.</p>
<p>The synthetic pathway, which is cyclic, was discovered by Hans Krebs and Kurt Henseleit in 1932.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154951077.png" alt="image-20200505154951077" style="zoom: 67%;" />
<ul>
<li>Liver slices:</li>
<li>Arginine: 30 fold more urea</li>
<li><strong>Ornithine</strong>（鸟氨酸） or <strong>citrulline</strong>（瓜氨酸）</li>
</ul>
<p>The proposal was correct: isolation of the enzymes</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155106520.png" alt="image-20200505155106520" style="zoom:100%;" />
+ In mitochondrion and cytosol of liver cells
 + The carbon and one nitrogen atom in urea is **carbamoyl phosphate**, synthesized from NH4+ and CO2 by **carbamoyl phosphate synthase** (CPS I)
 + The <u>second nitrogen</u> comes from **aspartate**, which reacts with **citrulline** to form **argininosuccinate**, through the action of **argininosuccinate synthetase** 
+ Transamination: aspartate, glutamate
<h2 id="argininosuccinate-synthetase-mechanism"><a class="markdownIt-Anchor" href="#argininosuccinate-synthetase-mechanism"></a> Argininosuccinate synthetase mechanism</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155224192.png" alt="image-20200505155224192" style="zoom:50%;" />
<ul>
<li><u>The second nitrogen comes from aspartate</u>, which reacts with citrulline to form <strong>argininosuccinate</strong>, through the action of argininosuccinate synthetase</li>
<li>Argininosucciase cleaves argininosuccinate in a <u>nonhydrolytic</u>, <u>nonoxidative</u> reacton to give <strong>arginine and fumarate</strong>.</li>
<li>Arginine is cleaved <u>hydrolytically</u> <strong>by arginase</strong>, to regenerate <strong>ornithine</strong> and yield one molecule of <strong>urea</strong>.</li>
</ul>
<p>Urea is synthesized by an energy-requiring cyclic pathway that begins and ends with ornithine (鸟氨酸).</p>
<p>The net reaction for one turn of the urea cycle is as follows:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200516200059457.png" alt="image-20200516200059457" style="zoom:100%;" />
<u>Four</u> (not three) high-energy phosphates are consumed in each turn of the cycle
<h2 id="regulation-of-urea-synthesis"><a class="markdownIt-Anchor" href="#regulation-of-urea-synthesis"></a> Regulation of Urea Synthesis</h2>
<p><strong>Long-term mechanism</strong>: high-protein diets, high enzymes levels; protein-free diet, enzymes reduced;</p>
<p><strong>Short-term mechanism</strong>: <u>Allosteric activation of CPS I</u> by <strong>N-acetylglutamate</strong>, which is synthesized from glutamate by <strong>N-acetylglutamate synthase</strong>;</p>
<ul>
<li>amino acids degradation↑ ➔ glutamate↑ ➔ N-acetylglutamate↑ ➔ CPS I↑ ➔ urea synthesis↑;</li>
</ul>
<p>CPS I is also regulated by <strong>covalent modification</strong>—<strong>acetylation</strong> of specific <strong>lysine</strong> residies <u>inactivates</u> the enzyme. <strong>SIRT 5</strong> deacetylates CPS I and activates it.</p>
<h2 id="hyperammonemia"><a class="markdownIt-Anchor" href="#hyperammonemia"></a> Hyperammonemia</h2>
<p>A defect in one of the <u>five enzymes</u> in the urea cycle ➔ <strong>hyperammonemia</strong> (high blood NH4+ levels);</p>
<p>Why is ammonia toxic?</p>
<ul>
<li>Ammonia depletes citric acid cycle intermediates (α-ketoglutarate) and NADH by overloading the glutamate dehydrogenase reaction ➔ an ATP deficiency;</li>
</ul>
<p>The <u>brain</u> is especially susceptible to ammonia toxicity;</p>
<p><strong>Urea</strong> is transported in the bloodstream to the <u>kidneys</u> for excretion. Measurement of <strong>blood urea nitrogen</strong> (<strong>BUN</strong>) levels provide a sensitive clinical test of kidney malfunction.</p>
<p>Blood ammonia measurements are a sensitive test of <u>liver function</u>. <u>Liver damage</u>, whether (hepatitis (肝炎), poisoning), reduces urea synthesis.</p>
<p>The accumulation of ammonia is toxic to the <u>brain</u> and thus is related to the <u>comatose condition</u>（昏迷状态） seen in advanced cases of <strong>chronic alcoholism.</strong></p>
<h3 id="1-transport-of-ammonia-to-the-liver"><a class="markdownIt-Anchor" href="#1-transport-of-ammonia-to-the-liver"></a> 1. Transport of Ammonia to the Liver</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155631808.png" alt="image-20200505155631808" style="zoom:100%;" />
+ Transport of ammonia to the liver for urea synthesis. 
+ The carrier is glutamine in most tissues but is alanine in muscle.
<p>All organs degrade amino acids and produce ammonia. <u>Two mechanisms</u> are involved in transporting this ammonia from other tissues to liver for its eventual conversion to urea.</p>
<ol>
<li>
<p><u>Most tissues</u> use <strong>glutamine synthetase</strong> to convert ammonia to the nontoxic, and electrically neutral, <strong>glutamine</strong>. The glutamine is transported in the blood to the liver, where it is cleaved hydrolytically by <strong>glutaminase</strong>.</p>
</li>
<li>
<p><strong>Muscle</strong>, which derives most of its energy from glycolysis, uses a different route, the <u>glucose-alanine cycle</u>. This cyclic process helps muscle get rid of ammonia, with the carbon from the pyruvate being returned to the liver for gluconeogenesis.</p>
</li>
</ol>
<p>Transport of ammonia to the liver for urea synthesis. The carrier is glutamine in most tissues but is alanine in muscle</p>
<h1 id="五-coenzymes-involved-in-nitrogen-metabolism"><a class="markdownIt-Anchor" href="#五-coenzymes-involved-in-nitrogen-metabolism"></a> 五、Coenzymes Involved in Nitrogen Metabolism</h1>
<ol>
<li><strong>Pyridoxal phosphate</strong> (containing B<sub>6</sub>), the cofactor for <strong>transamination</strong>；</li>
<li><strong>Folic acid</strong> <strong>coenzymes</strong>, which transfer <u>single-carbon functional group</u> in <u>synthesizing nucleotides and certain amino acids;</u></li>
<li><strong>B<sub>12</sub> or cobalamin</strong>, which participates in the <u>synthesis of methionine</u> and the <u>catabolism of methylmalonyl-CoA</u> (D-甲基丙二酰-CoA).</li>
</ol>
<h2 id="pyridoxal-phosphate"><a class="markdownIt-Anchor" href="#pyridoxal-phosphate"></a> Pyridoxal phosphate</h2>
<p>Vitamin B6 is also called <strong>pyridoxine</strong> (吡哆醇).</p>
<p>The active coenzyme has been oxidized to an aldehyde and the hydroxymethyl group at position 5 is phosphorylated.</p>
<p><strong>Pyridoxal phosphate (PLP, 磷酸吡哆醛)</strong> is the <u>predominant</u> coenzyme form</p>
<p><strong>Pyridoxamine phosphate (PMP, 磷酸吡哆胺)</strong> is an intermediate form in transamination reactions.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155831672.png" alt="image-20200505155831672" style="zoom:33%;" />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160122685.png" alt="image-20200505160122685" style="zoom:100%;" />
+ A cationic imine (the **Schiff base**) <u>lowers the energy</u> barrier to the reaction. The ability of PLP to form a stable Schiff base is the key to its versatility in enzyme reactions.
+ <u>All pyridoxal-requiring enzymes act via the formation of a Schiff base between the amino acid and coenzyme.</u>
<h2 id="folic-acid"><a class="markdownIt-Anchor" href="#folic-acid"></a> Folic Acid</h2>
<h3 id="1-tetrahydrofolate-thf-coenzymes-and-one-carbon-metabolism"><a class="markdownIt-Anchor" href="#1-tetrahydrofolate-thf-coenzymes-and-one-carbon-metabolism"></a> 1. Tetrahydrofolate (THF) Coenzymes and One-Carbon Metabolism</h3>
<p>Coenzymes derived from the vitamin <u>folic acid: single-carbon functional groups—methyl, methylene, and formyl;</u></p>
<p>British physician Lucy Wills in the 1930s found that people with a certain type of <strong>megaloblastic anemia (巨成红细胞性贫血)</strong> can be cured by treatment with <u>yeast or liver extracts</u>……</p>
<p><u>Four tons of spinach</u>  - --a few hundred mg of the active component;</p>
<ul>
<li>Leaf green vegetable</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160255637.png" alt="image-20200505160255637" style="zoom:67%;" />
<h3 id="2-conversion-of-folic-acid-to-tetrahydrofloate"><a class="markdownIt-Anchor" href="#2-conversion-of-folic-acid-to-tetrahydrofloate"></a> 2. Conversion of Folic Acid to Tetrahydrofloate</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160403204.png" alt="image-20200505160403204" style="zoom:100%;" />
+ Once inside a cell, folic acid is converted to a<u>ctive forms by two successive reductions</u> of the **pyrazine (吡嗪)** part of the **pteridine ring (蝶啶环)**. 
+ Both reactions are catalyzed by the NADPH-specific enzyme **dihydrofolate reductase (二氢叶酸还原酶)**. 
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160455034.png" alt="image-20200505160455034" style="zoom:70%;" />
<ul>
<li>Folate coenzymes contain <u>multiple glutamate residues</u>, which help them be retained within cells and bind more tightly to enzymes.</li>
<li><u>the N-5 and N-10 positions can carry single carbon units—methyl, methylene, and formal.</u></li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160543821.png" alt="image-20200505160543821" style="zoom:100%;" />
+ Dihydrofolate reductase is the target for a number of useful anticancer, antibacterial, and antiparasitic drugs.
+ Folate analogs such as methotrexate: leukemia 
<h3 id="3-human-dihydrofolate-reductase-complexed-with-ligands"><a class="markdownIt-Anchor" href="#3-human-dihydrofolate-reductase-complexed-with-ligands"></a> 3. Human dihydrofolate reductase complexed with ligands</h3>
<p>This figure shows the X-ray crystal structure of the human enzyme with bound NADPH (yellow) and <strong>methotrexate (氨甲喋呤)</strong> (red).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160629191.png" alt="image-20200505160629191" style="zoom:40%;" />
<p>The <u>additional amino group on methotrexate</u> allows formation of an additional hydrogen bond to the enzyme, which <u>increases its binding affinity to the folate binding site</u>.</p>
<p>These two ligands bind such that the pyridine ring of NADPH is in close proximity to the pteridine ring of the folate ligand, as required for the hydride transfer catalyzed by this enzyme.</p>
<p>Notice that the folate binds in a bent, rather than linear, form.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160729156.png" alt="image-20200505160729156" style="zoom:50%;" />
<p>Before World War II, one of the few effective <u>antibacterial</u> drugs available was <strong>sulfanilamide</strong>, one of the class of sulfonamide drugs (“<strong>sulfa drugs</strong>”).</p>
<p>D. D. Woods, noted a <u>structural similarity between sulfanilamide</u> and <strong>p-aminobenzoate (PABA)</strong>, <u>which was known to be essential for bacterial growth</u>.</p>
<p>Woods proposed that sulfanilamide acts by blocking the normal utilization of PABA, and he coined the term <strong>antimetabolite</strong> (抗代谢药).</p>
<p><u>PABA is not required for growth of animal cells</u>, so the drug is <u>not toxic to human cells</u>.</p>
<p><u>The enzyme incorporating PABA into folic acid is inhibited by sulfonamides.</u></p>
<p>Because animal cells do not carry out the synthetic pathway but instead take up fully formed <u>folate from the diet</u>, they are not harmed by the drug</p>
<h3 id="4-tetrahydrofolate-thf-in-the-metabolism-of-one-carbon-units"><a class="markdownIt-Anchor" href="#4-tetrahydrofolate-thf-in-the-metabolism-of-one-carbon-units"></a> 4. Tetrahydrofolate (THF) in the Metabolism of One-Carbon Units</h3>
<p><strong>Tetrahydrofolate</strong> (四氢叶酸) coenzymes <u>transfer and interconvert one-carbon units</u> at the <strong>methyl</strong> (甲基), <strong>methylene</strong> (亚甲基), and <strong>formyl</strong> (甲酰) oxidation levels.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160951140.png" alt="image-20200505160951140" style="zoom:57%;" />
<ul>
<li>Biosynthesis of purine nucleotides and the methyl group of thymidine</li>
</ul>
<p>Most organisms derive the majority of their activated one-carbon units from the <strong>β-carbon of serine</strong> and the subsequent oxidation of glycine.</p>
<p>The first of these reactions is catalyzed by <strong>serine hydroxymethyltransferase (丝氨酸羟甲基转移酶)</strong>:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161037011.png" alt="image-20200505161037011" style="zoom:100%;" />
Metabolic reactions involving synthesis, interconversion, and utilization of one-carbon adducts of tetrahydrofolate:
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161200009.png" alt="image-20200505161200009" style="zoom:100%;" />
+ Serine, glycine, methionine, and histidine
<ol>
<li>Homocysteine methytransferase (also called methionine synthase;</li>
<li>Methylene-THF reductase;</li>
<li>Serine hydroxymethyltransferase;</li>
<li>Glycine cleavage system;</li>
<li>Thymidylate synthase;</li>
<li>Methylene-THF dehydrogenase;</li>
<li>Methylene-THF cyclohydrolase;</li>
<li>10-formyl-THF synthetase;</li>
<li>Glutamate formiminotransferase;</li>
<li>5-formimino-THF cyclodeaminase;</li>
<li>5-formal-THF cycloligase</li>
</ol>
<p>Glycine can yield an additional molecule of <strong>5,10-methylenetetrahydrofolate (亚甲基四氢叶酸)</strong> through action of the glycine cleavage system, a <strong>multienzyme complex</strong> located in <strong>mitochondria</strong>:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161301177.png" alt="image-20200505161301177" style="zoom:100%;" />
## B~12~ Coenzyme
<p>A formerly incurable disease, <strong>pernicious anemia</strong> (恶性贫血), begins with a <strong>megaloblastic anemia</strong>, leads to irreversible degeneration of the <strong>nervous system</strong> if untreated;</p>
<p>In 1926 two Harvard physicians, George Minot and William Murphy, found that symptoms of this disease could be alleviated by feeding patients with large amounts of <strong>raw liver</strong>. The active material in the liver was named vitamin B<sub>12</sub></p>
<p>In England in 1956, Dorothy Hodgkin and her colleague used X-ray crystallography to complete the structure determination for this active substrate. Hodgkin was awarded the Nobel Prize for this work.</p>
<ul>
<li>Steroids, B12, penicillin and insulin structures</li>
</ul>
<h3 id="1-coenzyme-forms-of-b12"><a class="markdownIt-Anchor" href="#1-coenzyme-forms-of-b12"></a> 1. Coenzyme Forms of B<sub>12</sub></h3>
<p>Structure of vitamin B12:</p>
<p>The molecule shown here is the cyanide-containing form originally isolated (<strong>cyanocobalamin</strong> (氰钴胺)).</p>
<p>In <u>cells</u>, a water molecule or hydroxyl group takes the place of CN, forming the precursor to the coenzyme forms of B12.</p>
<p>The <strong>corrin ring</strong> (咕啉环) is shown in red.</p>
<p><strong>5,6-Dimethylbenzimidazole</strong> (DMB, 5,6-二甲基苯并咪唑), which is linked to the cobalt, is shown in blue.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161716690.png" alt="image-20200505161716690" style="zoom: 50%;" />
<ul>
<li>The metal <strong>cobalt</strong> is coordinated with a tetrapyrrole ring system, called a <strong>corrin ring</strong>, which is similar to <strong>porphyrin ring in heme</strong> compounds.</li>
</ul>
<p>Three classes of B12-dependent enzymes are now known—<u>isomerases, methyltransferases, and reductive dehalogenases (脱卤酶)</u></p>
<p>In <strong>mammals</strong>, only two reactions:</p>
<ol>
<li>The role of B12 as a <u><strong>methyl transferase</strong> in Met biosynthesis</u>, the synthesis of methionine from homocysteine</li>
<li>The <strong>isomerization of methylmalonyl-CoA</strong> to <strong>succinyl-CoA</strong> (oxidation of odd-chain fatty acids).</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505162102503.png" alt="image-20200505162102503" style="zoom:40%;" />
<ul>
<li>Two forms:</li>
</ul>
<ol>
<li>methylcobalamin;</li>
<li>5’-deoxyadenosylcobalamin</li>
</ol>
<p>The role of B12 as a methyl transferase in Met biosynthesis:</p>
<ul>
<li>B12 coenzymes have either a <u>methyl group or a 5’-deoxyadenosyl moiety linked to cobalt</u>, making them the first known <strong>organometallics</strong> (金属有机化合物) in metabolism.</li>
</ul>
<h3 id="2-fatty-acid-oxidation"><a class="markdownIt-Anchor" href="#2-fatty-acid-oxidation"></a> 2. Fatty Acid Oxidation</h3>
<p>Pathway for catabolism of propionyl-CoA:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180459257.png" alt="image-20200327180459257" style="zoom:100%;" />
#### The intramolecular isomerization catalyzed by methylmalonyl-CoA mutase
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505163330392.png" alt="image-20200505163330392" style="zoom:100%;" />
1. Step 1: Homolytic cleavage of carbon-cobalt bond and formation of 5’-deoxyadenosyl radical. 
2. Step 2: Hydrogen abstraction and formation of substitute radical; 
3. Step 3 and 4: 1.2 rearrangement involving a cyclopropyloxy radical; 
4. Step 5: Hydrogen abstraction from 5’-deoxyadenosine to give succinyl-CoA and 5’-deoxyadenosyl radical; 
5. Step 6: Reformation of carbon-cobalt bond. 
<h3 id="3-a-relationship-between-folate-and-b12-metabolism"><a class="markdownIt-Anchor" href="#3-a-relationship-between-folate-and-b12-metabolism"></a> 3. A relationship between folate and B12 metabolism</h3>
<p>This scheme is based on the <u>apparent folate deficiency seen in early stages of B12 deficiency</u> as a result of decreased flux through the methionine synthase reaction.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505163455799.png" alt="image-20200505163455799" style="zoom: 43%;" />
<h3 id="4-folic-acid-in-the-prevention-of-heart-disease-and-birth-defects"><a class="markdownIt-Anchor" href="#4-folic-acid-in-the-prevention-of-heart-disease-and-birth-defects"></a> 4. Folic Acid in the Prevention of Heart Disease and Birth Defects</h3>
<p>In the mid-1990s, correlation of <u>folate deficiency and increased risk of myocardial infarction</u>; individuals at risk for <u>heart attacks</u> also showed high levels of serum homocysteine (<strong>homocysteinemia</strong>);</p>
<p><strong>Homocysteinemia</strong> （高半胱氨酸血症）: cardiovascular disease, including coronary artery disease, stroke…</p>
<p><u>Folate deficiency</u>: birth defects, including craniofacial (cleft palate (腭裂)), the neural tube (anencephaly and spina bifida (无脑畸形和脊柱裂));</p>
<p>Neural tube defects (NTDs): 1/1000; folate acid supplementation prevents 50-75% of NTDs!!!; Take folic acids in pregnancy, but especially in the early stage (28 d for neural tube); Women of childbearing age: adequate folic acid;</p>
<p>Fortification (flour and cereal grain): mandatory in USA since 1998, ….declined</p>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/4716231a.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/4716231a.html" class="post-title-link" itemprop="url">L09 Metabolism of Nitrogenous Compounds I Principles of Biosynthesis, Utilization, and Turnover</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:41" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/4716231a.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/4716231a.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>22k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <p>Metabolism of Nitrogenous Compounds I: Principles of Biosynthesis, Utilization, and Turnover</p>
<ul>
<li>含氮化合物代谢Ⅰ：生物合成，利用与周转</li>
</ul>
<h1 id="一-utilization-of-ammonia-biogenesis-of-organic-nitrogen"><a class="markdownIt-Anchor" href="#一-utilization-of-ammonia-biogenesis-of-organic-nitrogen"></a> 一、Utilization of Ammonia: Biogenesis of Organic Nitrogen</h1>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135127613.png" alt="image-20200505135127613" /></p>
<ul>
<li>Pathways of nitrogen metabolism (purple) in the general pattern of intermediary metabolism</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135250646.png" alt="image-20200505135250646" style="zoom: 33%;" />
<ul>
<li>Reactions in assimilation of ammonia and major fates of the fixed nitrogen:</li>
</ul>
<ol>
<li>Glutamate dehydrogenase</li>
<li>Glutamine synthetase</li>
<li>Asparagine synthetase</li>
<li><strong>Carbamoyl phosphate</strong> synthetase (氨甲酰磷酸合成酶)</li>
<li>Glutamate synthase.</li>
</ol>
<ul>
<li>In <u>animals</u>, <u>glutamine</u>, rather than NH3, is the chief nitrogen source for pyrimidines (嘧啶).</li>
</ul>
<p>Ammonia in <u>high concentrations is quite toxic</u>;</p>
<ul>
<li>At <u>lower concentrations</u>, it is a <u>central metabolite</u>, serving as <u>substrate for four enzymes</u> that convert it to various organic compounds;</li>
</ul>
<p>All organisms assimilate ammonia via reactions leading to <u>glutamate, glutamine, asparagine, or carbamoyl phosphate;</u></p>
<ul>
<li><u>Carbamoyl phosphate</u> is used only in the biosynthesis of <u>arginine, urea, and the pyrimidine nucleotides;</u></li>
<li><u>Most of the nitrogen that finds its way from ammonia to amino acids glutamate and glutamine;</u></li>
</ul>
<p><u>The α-amino nitrogen of glutamate and the side chain amide nitrogen of glutamine</u> are both primary <u>source of N in biosynthetic pathways</u>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135436243.png" alt="image-20200505135436243" style="zoom:53%;" />
<h2 id="glutamate-dehydrogenase"><a class="markdownIt-Anchor" href="#glutamate-dehydrogenase"></a> Glutamate dehydrogenase</h2>
<p>Glutamate dehydrogenase catalyzes the reductive amination of <strong>α-ketoglutarate</strong>（α-酮戊二酸）</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135521051.png" alt="image-20200505135521051" /></p>
<ul>
<li>
<p>This reaction is reversible;</p>
</li>
<li>
<p>In <strong>bacteria</strong></p>
<ul>
<li>Use NADPH;</li>
<li>this enzyme has a high K<sub>m</sub> for ammonia (1 mM)</li>
<li>primarily the direction of <u>glutamate formation</u>;</li>
<li><u>Bacteria</u> growing with ammonia as their sole nitrogen source use this reaction as the <u>primary route</u> for nitrogen assimilation;</li>
</ul>
</li>
<li>
<p>In <strong>animal</strong> cells</p>
<ul>
<li>the reaction occurs in <u>both directions</u>, primarily the formation of α-ketoglutarate ➔citric acid cycle ➔ATP production ;</li>
<li>Animal cells use both <strong>NAD+ and NADP+</strong> as cofactor;</li>
<li>The animal enzyme is allosterically controlled; <u>α-ketoglutarate synthesis is inhibited by GTP and ATP and stimulated by ADP. Thus the enzyme is activated under conditions of low energy charge.</u></li>
</ul>
</li>
</ul>
<h2 id="glutamate-synthase"><a class="markdownIt-Anchor" href="#glutamate-synthase"></a> Glutamate synthase</h2>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505135828030.png" alt="image-20200505135828030" /></p>
<ul>
<li>A related enzyme that occurs only in <u>microorganisms</u>, <u>plants</u>, and <u>lower eukaryotes</u>, <strong>glutamate synthase</strong>, catalyzes a reaction comparable to that catalyzed by glutamate dehydrogenase but functions <u>primarily in glutamate biosynthesis</u>:</li>
<li>The amide N of glutamine replaces NH3 as the N donor</li>
</ul>
<h2 id="glutamine-synthetase-gs"><a class="markdownIt-Anchor" href="#glutamine-synthetase-gs"></a> Glutamine synthetase (GS)</h2>
<p>Whether formed by action of glutamate dehydrogenase or glutamate synthase, or by transamination, glutamate can accept a <u>second ammonia</u> moiety to form glutamine in the reaction catalyzed by <strong>glutamine synthetase</strong> (谷氨酰胺合成酶).</p>
<p>Mn2+ is required.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505140045235.png" alt="image-20200505140045235" style="zoom:67%;" />
<p>The glutamine synthetase reaction occurs via an <strong>acyl phosphate intermediate</strong> (酰基磷酸中间物).</p>
<p>ATP phosphorylates the δ-carboxylate of glutamate to give a carboxylic-phosphoric acid anhydride (<strong>γ-glutamyl phosphate</strong>), which undergoes <u>nucleophilic attack</u> by the nitrogen of <strong>ammonia</strong> to give the amide product, glutamine.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505140215666.png" alt="image-20200505140215666" style="zoom:25%;" />
<h3 id="1-structure-of-gs"><a class="markdownIt-Anchor" href="#1-structure-of-gs"></a> 1. Structure of GS</h3>
<p>Structure of <em>Salmonella typhimurium</em> (鼠伤寒沙门氏菌) glutamine synthetase (GS):</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505140538671.png" alt="image-20200505140538671" /></p>
<ul>
<li>Bacterial glutamine synthetase is a dodecamer, with 12 identical subunits forming two facing hexagonal arrays.</li>
</ul>
<h3 id="2-regulation-of-glutamine-synthetase-gs"><a class="markdownIt-Anchor" href="#2-regulation-of-glutamine-synthetase-gs"></a> 2. Regulation of Glutamine Synthetase (GS)</h3>
<h4 id="prokaryotic"><a class="markdownIt-Anchor" href="#prokaryotic"></a> Prokaryotic</h4>
<p><u>Prokaryotic</u> <strong>glutamine synthetase</strong> is controlled by:</p>
<ol>
<li>
<p>Cumulative feedback inhibition</p>
<ul>
<li>Involves the action of <u>eight specific feedback inhibitors</u>.</li>
<li>Metabolic <u>end products</u> of glutamine (<strong>trp</strong>, <strong>his</strong>, <strong>glucosamine-6-phosphate</strong> (葡糖胺-6-磷酸), <strong>carbamoyl phosphate</strong>, <strong>CTP</strong>, and <strong>AMP</strong>)</li>
<li>Indicators of the general status of amino acid metabolism (<strong>ala</strong>, <strong>gly</strong>)</li>
</ul>
</li>
<li>
<p>Covalent modification</p>
<ul>
<li><strong>Adenylylation</strong> (腺苷酰化) of a specific <strong>tyrosine</strong> residue (Tyr 397)</li>
</ul>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505141102935.png" alt="image-20200505141102935" style="zoom:50%;" />
<p>Regulation of the activity of bacterial <strong>glutamine synthetase (GS)</strong>:</p>
<ol>
<li>The complex of <strong>AT (adenylyltransferase, 腺苷转移酶)</strong> and (a regulatory protein, <strong>P<sub>II</sub></strong>) catalyzes both the <strong>adenylylation</strong> and <strong>deadenylylation</strong> of glutamine synthetase (<strong>GS</strong>), depending on whether <strong>P<sub>II</sub></strong> is <strong>deuridylylated</strong> (脱脲基) (left) or <strong>uridylylated (尿酰化)</strong> (right).</li>
</ol>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505141315233.png" alt="image-20200505141315233" /></p>
<ul>
<li>Uridylylation of <strong>P<sub>II</sub></strong> is catalyzed by <strong>uridylyltransferase (尿酸转移酶, UT)</strong>, and deuridylylation is catalyzed by u<strong>ridylyl-removing enzyme (UR)</strong>, both activities part of a bifunctional enzyme.</li>
</ul>
<ol start="2">
<li><strong>Adenylation (腺苷酸化)</strong>: Tyr 397 react with ATP to form an ester, <u>inactivates the enzyme</u>;
<ul>
<li>Adenylylation and deadenylylation of GS are catalyzed by the same enzyme: complex of <strong>adenylyltransferase (腺苷酸转移酶, AT)</strong> and a small regulatory protein, <strong>P<sub>II</sub></strong>;</li>
<li><u><strong>UMP-PII</strong> and <strong>P<sub>II</sub></strong> controls adenylation or deadenylylation, respectively;</u>
<ul>
<li>Reversible <strong>uridylylation</strong> of PII is catalyzed by another enzyme, a bifunctional <strong>uridylyltransferase (UT)/uridylyl-removing enzyme (UR)</strong>, <u>in response to intracellular glutamate concentrations.</u>
<ul>
<li>UT: PII ➔ UMP-PII ➔ GS adenylylation ↓ ➔ GS activity ↑ ;</li>
<li>UR: UMP-PII ➔ PII ➔ GS adenylylation ↑ ➔ GS activity ↓;</li>
</ul>
</li>
<li><strong>PII-UMP</strong> is <strong>deuridylylated</strong> by hydrolysis of the UMP residues, catalyzed by uridylyl-removing activity of the bifunctional <strong>UT/UR</strong>;
<ul>
<li>Glutamine ↑ ➔ UT↓ UR↑ ➔ PII ↑ ➔ PII -AT ↑ ➔ GS adenylylation ↑ ➔ GS activity ↓ ➔ glutamine↓;</li>
<li>Glutamine ↓ ➔ UT ↑ UR↓ ➔ AMP-PII ↑ ➔ AMP-PII -AT ↑ ➔ GS adenylylation ↓ ➔ GS activity ↑ ➔ glutamine ↑;</li>
<li>α-ketoglutarate ↑ ➔ PII -AT ↓ ➔ GS activity ↑ ➔ glutamine ↑.</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ol>
<h4 id="glutamine-plays-a-central-role-in-nitrogen-metabolism"><a class="markdownIt-Anchor" href="#glutamine-plays-a-central-role-in-nitrogen-metabolism"></a> Glutamine plays a central role in nitrogen metabolism</h4>
<p>The amide nitrogen is used in <u>biosynthesis</u> of several amino acids (including <strong>glutamic acid</strong>, <strong>tryptophan</strong> (trp), <strong>histidine</strong>), <u>purine and pyrimidine nucleotides, and amino sugars.</u></p>
<p>In <u>animals</u>, <strong>glutamine synthetase</strong> is a key participant in <strong>detoxifying ammonia</strong> formed from amino acid catabolism, particularly in <u>brain</u> cells. Glutamate and glutamine are two of the most abundant free amino acids <u>in brain cells</u>; <u>accumulation of these amino acids can deplete α-ketoglutarate, their principal precursors, thereby interfering with the citric acid cycle and energy generation.</u></p>
<p>Glutamine participates in <u>ammonia excretion</u> in the <u>kidney</u></p>
<h3 id="3-glutamate-dehydrogenaseglutamine-synthetase"><a class="markdownIt-Anchor" href="#3-glutamate-dehydrogenaseglutamine-synthetase"></a> 3. glutamate dehydrogenase/glutamine synthetase</h3>
<p>If <u>NH4+ levels are high</u>, the glutamate dehydrogenase/glutamine synthetase pathway operates:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505141840495.png" alt="image-20200505141840495" /></p>
<ul>
<li>To assimilate NH4+ in bacteria, glutamine synthetase functions together with glutamate dehydrogenase or glutamate synthase, depending on ammonia levels.</li>
</ul>
<h2 id="asparagine-synthetase"><a class="markdownIt-Anchor" href="#asparagine-synthetase"></a> Asparagine Synthetase</h2>
<p>Asparagine Synthetase: A similar amidation Reaction</p>
<ul>
<li>Catalyzes a reaction comparable to that of glutamine synthetase.</li>
<li>Although widespread, asparagine synthetase accounts for <u>much less</u> ammonia assimilation.</li>
<li>This enzyme uses <strong>ammonia</strong> or <strong>glutamine</strong> in catalyzing the conversion of aspartate to asparagine.</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142141799.png" alt="image-20200505142141799" /></p>
<ul>
<li>Glutamine synthetase: ATP to ADP;</li>
<li>Asparagine synthetase: ATP to AMP</li>
</ul>
<h2 id="carbamoyl-phosphate-synthetase"><a class="markdownIt-Anchor" href="#carbamoyl-phosphate-synthetase"></a> Carbamoyl phosphate synthetase</h2>
<p>The final route for assimilating ammonia first forms <strong>carbamoyl phosphate</strong>.</p>
<ul>
<li>The enzyme responsible is <strong>carbamoyl phosphate synthetase</strong> (氨甲酰磷酸合成酶).</li>
</ul>
<p>Either <strong>ammonia</strong> or <strong>glutamine</strong> can serve as the nitrogen donor:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142241723.png" alt="image-20200505142241723" style="zoom:50%;" />
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142249063.png" alt="image-20200505142249063" /></p>
<ul>
<li>Carbamoyl phosphate: generation of an intermediate for arginine (urea) (CPSI, mitochondria) and pyrimidine synthesis (CPSII, cytosol)</li>
</ul>
<h1 id="二-the-nitrogen-economy-aspects-of-amino-acid-synthesis-and-degradation"><a class="markdownIt-Anchor" href="#二-the-nitrogen-economy-aspects-of-amino-acid-synthesis-and-degradation"></a> 二、The Nitrogen Economy: Aspects of Amino Acid Synthesis and Degradation</h1>
<h2 id="overview"><a class="markdownIt-Anchor" href="#overview"></a> Overview</h2>
<ol>
<li><strong>Nitrogen equilibrium</strong>:
<ol>
<li><strong>Normal nitrogen balance</strong>: the daily intake of nitrogen throughout diet <u>is equal</u> to that lost through urinary excretion and other processes, such as ammonia in sweat;</li>
<li><strong>Positive nitrogen balance</strong>: pregnancy, growth of a juvenile, or recovery from starvation;</li>
<li><strong>Negative nitrogen balance</strong>: senescence（衰老）, starvation, and certain diseases states.</li>
</ol>
</li>
</ol>
<p>Although mammals can synthesize <strong>Arg</strong> and <strong>Met</strong>, the use of these amino acids for the production of <strong>urea</strong> and <strong>methyl groups</strong>, respectively, is greater than the capacity of their biosynthetic pathways;</p>
<ul>
<li>50-100 grams per day;</li>
<li>Nutritional quality of proteins.</li>
</ul>
<p>Essential and nonessential amino acids:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142618654.png" alt="image-20200505142618654" style="zoom:50%;" />
<h2 id="transamination"><a class="markdownIt-Anchor" href="#transamination"></a> Transamination</h2>
<h3 id="1-the-process"><a class="markdownIt-Anchor" href="#1-the-process"></a> 1. The Process</h3>
<p><strong>Transamination</strong> (转氨基) is the <u>reversible</u> transfer of an amino group from an α-amino acid to an <strong>α-keto acid</strong>, with <strong>pyridoxal phosphate</strong> (磷酸吡哆醛, Vitamin B<sub>6</sub>) as a <u>coenzyme</u>.</p>
<ul>
<li>Therefore transamination needs Vitamin B<sub>6</sub></li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142726022.png" alt="image-20200505142726022" style="zoom: 33%;" />
<h3 id="2-the-functions-of-transamination"><a class="markdownIt-Anchor" href="#2-the-functions-of-transamination"></a> 2. The functions of transamination</h3>
<ol>
<li>A process whereby amino acids can <u>replenish citric acid cycle intermediates</u>; Funnel <u>excess amino acids towards catabolism and energy generation</u></li>
<li><u>Redistribution of amino acid nitrogen;</u></li>
<li>Bridge the <u>amino acids composition</u> into in line with the organism’s needs;</li>
</ol>
<p>Because of the key role of <strong>glutamate</strong> in ammonia assimilation, it is a star player in transamination. Transamination uses <strong>glutamate</strong> nitrogen to <u>synthesize other amino acids</u>.</p>
<h3 id="3-aminotransferase-转氨酶"><a class="markdownIt-Anchor" href="#3-aminotransferase-转氨酶"></a> 3. Aminotransferase 转氨酶</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505142906855.png" alt="image-20200505142906855" style="zoom:43%;" />
<p><strong>Aminotransferases</strong> <u>utilize a coenzyme</u>, <strong>pyridoxal phosphate (磷酸吡哆醛)</strong>, that is derived from <strong>vitamin B<sub>6</sub>.</strong></p>
<p>The functional part of the cofactor is an aldehyde functional group, <strong>CHO</strong>, attached to a <strong>pyridine ring</strong> (吡啶环).</p>
<p>The catalytic cycle begins with condensation of this <u>aldehyde with the α-amino group</u> of an amino acid, to give a <strong>Schiff base</strong> (席夫碱), or <strong>aldimine</strong> (醛亚胺), intermediate.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505143656694.png" alt="image-20200505143656694" /></p>
<h3 id="4-the-bi-directional-feature-of-transamination"><a class="markdownIt-Anchor" href="#4-the-bi-directional-feature-of-transamination"></a> 4. The bi-directional feature of transamination</h3>
<p>Transamination can be used for <u>amino acid synthesis</u> and also for <u>degradation of amino acids</u> that accumulate in excess of need.</p>
<p><u>In degradation the transaminase works in concert with glutamate dehydrogenase</u>, as exemplified by the degradation of <strong>alanine</strong>:</p>
<p>Most aminotransferases use <strong>glutamate/α-ketoglutarate</strong> as one of the two α-amino/α-keto acid pairs involved.</p>
<p>Two such enzymes are important in the <u>clinical</u> diagnosis of human disease —<strong>serum glutamate-oxaloacetate transaminase</strong> (SGOT, 谷氨酸 - 草酰乙酸转氨酶) and <strong>serum glutamate-pyruvate transaminase</strong> (SGPT, 谷氨酸 - 丙酮酸转氨酶):</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505143737104.png" alt="image-20200505143737104" style="zoom:47%;" />
<ul>
<li>S指的是serum，正常情况下GOT和GPT一般存在与肝脏</li>
<li>SGOT和SGPT是检测肝脏功能的重要指标</li>
</ul>
<p>These enzymes, abundant in <u>heart and in liver</u>, are released from cells as part of the cell injury that occurs in <strong>myocardial infarction</strong> (心肌梗死), <strong>infectious hepatitis</strong> (传染性肝炎), or other damage to either organ.</p>
<p>Assays of these enzyme activities in blood serum can be used both in <u>diagnosis</u> and in monitoring the <u>progress of a patient</u>.</p>
<h1 id="三-protein-turnover"><a class="markdownIt-Anchor" href="#三-protein-turnover"></a> 三、Protein Turnover</h1>
<ul>
<li>蛋白质周转</li>
</ul>
<p>Proteins are subject to <u>continuous biosynthesis and degradation</u>, a process called <strong>protein turnover.</strong></p>
<ul>
<li>For an intracellular protein whose total concentration does not change with time, the <u>steady state level</u> is maintained by synthesis of the protein at a rate just sufficient to replenish protein lost by degradation.</li>
</ul>
<p>Many of the <u>amino acids</u> released during protein turnover are <u>reutilized</u> in the synthesis of new proteins.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505144030215.png" alt="image-20200505144030215" /></p>
<h2 id="chemical-signals-for-turnover"><a class="markdownIt-Anchor" href="#chemical-signals-for-turnover"></a> Chemical Signals for Turnover</h2>
<p>The turnover rates for different proteins vary by as much as <u>1000-fold</u>, whereas differences in protein stability, as measured by denaturation in vitro, may be much less.</p>
<p>Chemical Signals for Turnover:</p>
<ol>
<li>Ubiquitination (泛素化)</li>
<li>Metal-catalyzed oxidation of particular residues</li>
<li>PEST sequences (<strong>12-60 aa</strong>)</li>
<li>particular N-terminal residues</li>
</ol>
<h3 id="1-ubiquitination"><a class="markdownIt-Anchor" href="#1-ubiquitination"></a> 1. Ubiquitination</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505153017996.png" alt="image-20200505153017996" style="zoom: 33%;" />
<p>Ubiquitin is a small (<u>76-residue</u>) protein expressed in all eukaryotic cells—it derives its name from its widespread (ubiquitous) distribution.</p>
<p>Ubiquitin is <u>covalently</u> conjugated to specific cellular proteins in an <u>ATP-dependent</u> reaction, which condenses <u>the <strong>terminal carboxyl group</strong> of ubiquitin with <strong>lysine</strong> amino groups on target proteins.</u></p>
<ul>
<li>In the first reaction, catalyzed by the <u>ubiquitin-activating enzyme E1, a thioester is formed between the C-terminal Gly residue of ubiquitin and an internal Cys residue of E1 in a two-step process.</u></li>
<li>Formation of this <u>high-energy covalent</u> linkage is driven by <u>ATP hydrolysis</u>, via a <u>ubiquitin-adenylate intermediate</u>.</li>
</ul>
<h3 id="2-structure-of-the-proteasome-26s-蛋白酶体"><a class="markdownIt-Anchor" href="#2-structure-of-the-proteasome-26s-蛋白酶体"></a> 2. Structure of the proteasome (26S) (蛋白酶体)</h3>
<p>Structure of the proteasome (26S):</p>
<p>The <u>proteasome</u> contains two major assemblies, a <u>28-subunit core particle</u> (aka the <u>20S particle</u>) and a <u>19-subunit regulatory particle</u> (aka the <u>19S particle</u>), which forms the <u>base</u> and <u>lid</u> assemblies.</p>
<ul>
<li>The <u>proteolytic active sites</u> are located within the <u>large internal space</u> (~100 x 60Å) of the <u>20S core particle</u>.</li>
<li><u>The lid and base</u> assemblies of the 19S regulatory particle control substrate entry into the 20S core particle.</li>
</ul>
<p><u>Proteins tagged with the ubiquitin pass through the tube in an ATP-dependent fashion.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505153438883.png" alt="image-20200505153438883" style="zoom:25%;" />
<h3 id="3-the-process-of-polyubiquitination"><a class="markdownIt-Anchor" href="#3-the-process-of-polyubiquitination"></a> 3. The process of polyubiquitination</h3>
<p>Enzymatic pathway for attachment of ubiquitin to target proteins:</p>
<p>E1, E2, and E3 are proteins involved in the <u>ubiquitin</u> transfer to <u>lysine</u> residues on target proteins.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505153541933.png" alt="image-20200505153541933" style="zoom:67%;" />
<ol>
<li>
<p>In the first reaction, catalyzed by the <u>ubiquitin-activating enzyme E1</u>, a thioester is formed between the <strong>C-terminal Gly residue of ubiquitin</strong> and an <strong>internal Cys</strong> residue of E1 in a two-step process;</p>
<ul>
<li>Formation of this high energy covalent linkage is driven by <u>ATP hydrolysis</u>, via a ubiquitin-adenylate intermediate. <strong>AMP</strong> is released upon nucleophilic attack by the Cys-SH of E1;</li>
</ul>
</li>
<li>
<p>The <strong>activated ubiquitin</strong> is then transferred to a Cys-SH of one of several E2 enzymes (ubiquitin-conjugating enzymes) in a transthiolation reaction;</p>
</li>
<li>
<p>A <strong>ubiquitin-protein ligase, E3</strong>, is required for step 3—covalent attachment of ubiquitin of the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>ε</mi></mrow><annotation encoding="application/x-tex">\varepsilon</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault">ε</span></span></span></span>-NH3+ group of one or more lysine residues on the target protein via an <strong>isopeptide bond</strong>;</p>
</li>
</ol>
<p>Expenditure of the equivalent of <u>two ATPs</u> per ubiquitin added ensures that the reaction is both <u>irreversible and specific</u>;</p>
<p><strong>E3</strong> can catalyze the successive addition of a ubiquitin moiety to a previously conjugated ubiquitin, forming a <u>polyubiquitin</u> chain in which a Lys of ubiquitin forms an <u>isopeptide bond</u> with the C-terminal Gly –COOH of the succeeding ubiquitin;</p>
<p>Ubiquitin contains <u>seven lysine</u> residues, and polyubiquitination chains can involve one or more of these residues；</p>
<p><u>Two major families of E3</u> ubiquitin-protein ligases have been described:</p>
<ol>
<li>the HECT domain-containing E3s</li>
<li>the RING-finger domain-containing E3s.
<ul>
<li>These two E3 families differ in structure and in mechanism；</li>
</ul>
</li>
</ol>
<p><strong>E3 ligase</strong> plays a central role in determining the <u>specificity and selectivity</u> of the proteasome system, these proteins are implicated in a number of <u>disease states</u>, <u>including neurodegenerative disorders, inflammatory diseases, muscle wasting disorders, and cancers.</u></p>
<ul>
<li>Only 2 E1 in mammals</li>
<li>About 28 E2 in humans</li>
<li>Maybe 1000 E3 in humans</li>
<li>Deubiquiting enzymes(Dubs)</li>
<li>SUMO</li>
</ul>
<h1 id="四-amino-acid-degradation-and-metabolism-of-nitrogenous-end-products"><a class="markdownIt-Anchor" href="#四-amino-acid-degradation-and-metabolism-of-nitrogenous-end-products"></a> 四、Amino Acid Degradation and Metabolism of Nitrogenous End Products</h1>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154316030.png" alt="image-20200505154316030" /></p>
<ul>
<li><u>Amino acid degradation</u> usually begins with conversion to the corresponding <strong>α-keto acid</strong> by <u>transamination or oxidative deamination</u>.
<ul>
<li>α-keto acid can enter the carbohydrate metabolism</li>
</ul>
</li>
</ul>
<h2 id="fates-of-the-amino-acid-carbon-skeletons"><a class="markdownIt-Anchor" href="#fates-of-the-amino-acid-carbon-skeletons"></a> Fates of the amino acid carbon skeletons</h2>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154347288.png" alt="image-20200505154347288" /></p>
<ul>
<li>Once the nitrogen has been removed, the carbon skeleton: citric acid cycle or converted to carbohydrates;</li>
<li>Amino acids leading to acetyl-CoA or acetoacetyl-CoA, such as leucine, contribute heavily toward ketogenesis;</li>
<li>Glucogenic（上图黄色标识amino acids） and ketogenic（上图蓝色标识amino acids）,
<ul>
<li>Ketogenic: 在动物体内Acetyl-CoA不能反向生成糖</li>
</ul>
</li>
</ul>
<h2 id="detoxification-and-excretion-of-ammonia"><a class="markdownIt-Anchor" href="#detoxification-and-excretion-of-ammonia"></a> Detoxification and Excretion of Ammonia</h2>
<p>Although <u>ammonia</u> is a universal participant in amino acid synthesis and degradation, its accumulation in abnormal concentration has <u>toxic</u> consequences.</p>
<p>Animals have evolved pathways, adapted to their lifestyles, for excretion of <strong>ammonia</strong>, <strong>uric acid</strong>（尿酸）, or <strong>urea</strong> as the major <u>nitrogenous end product.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154608102.png" alt="image-20200505154608102" style="zoom:40%;" />
<ul>
<li>排氨的方式：
<ul>
<li>Most aquatic animals: ammonia</li>
<li>Terrestrial animals, birds and insects: uric acid 尿酸</li>
<li>Mammals (except Dalmatian dog): urea 尿素</li>
</ul>
</li>
</ul>
<h2 id="the-krebs-henseleit-urea-cycle"><a class="markdownIt-Anchor" href="#the-krebs-henseleit-urea-cycle"></a> The Krebs-Henseleit Urea Cycle</h2>
<p>Urea is synthesized <u>almost exclusively in the liver</u> and then transported to the kidneys for excretion.</p>
<p>The synthetic pathway, which is cyclic, was discovered by Hans Krebs and Kurt Henseleit in 1932.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505154951077.png" alt="image-20200505154951077" style="zoom: 67%;" />
<ul>
<li>Liver slices:</li>
<li>Arginine: 30 fold more urea</li>
<li><strong>Ornithine</strong>（鸟氨酸） or <strong>citrulline</strong>（瓜氨酸）</li>
</ul>
<p>The proposal was correct: isolation of the enzymes</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155106520.png" alt="image-20200505155106520" /></p>
<ul>
<li>In mitochondrion and cytosol of liver cells
<ul>
<li>The carbon and one nitrogen atom in urea is <strong>carbamoyl phosphate</strong>, synthesized from NH4+ and CO2 by <strong>carbamoyl phosphate synthase</strong> (CPS I)</li>
<li>The <u>second nitrogen</u> comes from <strong>aspartate</strong>, which reacts with <strong>citrulline</strong> to form <strong>argininosuccinate</strong>, through the action of <strong>argininosuccinate synthetase</strong></li>
</ul>
</li>
<li>Transamination: aspartate, glutamate</li>
</ul>
<h2 id="argininosuccinate-synthetase-mechanism"><a class="markdownIt-Anchor" href="#argininosuccinate-synthetase-mechanism"></a> Argininosuccinate synthetase mechanism</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155224192.png" alt="image-20200505155224192" style="zoom:50%;" />
<ul>
<li><u>The second nitrogen comes from aspartate</u>, which reacts with citrulline to form <strong>argininosuccinate</strong>, through the action of argininosuccinate synthetase</li>
<li>Argininosucciase cleaves argininosuccinate in a <u>nonhydrolytic</u>, <u>nonoxidative</u> reacton to give <strong>arginine and fumarate</strong>.</li>
<li>Arginine is cleaved <u>hydrolytically</u> <strong>by arginase</strong>, to regenerate <strong>ornithine</strong> and yield one molecule of <strong>urea</strong>.</li>
</ul>
<p>Urea is synthesized by an energy-requiring cyclic pathway that begins and ends with ornithine (鸟氨酸).</p>
<p>The net reaction for one turn of the urea cycle is as follows:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200516200059457.png" alt="image-20200516200059457" /></p>
<p><u>Four</u> (not three) high-energy phosphates are consumed in each turn of the cycle</p>
<h2 id="regulation-of-urea-synthesis"><a class="markdownIt-Anchor" href="#regulation-of-urea-synthesis"></a> Regulation of Urea Synthesis</h2>
<p><strong>Long-term mechanism</strong>: high-protein diets, high enzymes levels; protein-free diet, enzymes reduced;</p>
<p><strong>Short-term mechanism</strong>: <u>Allosteric activation of CPS I</u> by <strong>N-acetylglutamate</strong>, which is synthesized from glutamate by <strong>N-acetylglutamate synthase</strong>;</p>
<ul>
<li>amino acids degradation↑ ➔  glutamate↑ ➔ N-acetylglutamate↑ ➔ CPS I↑ ➔ urea synthesis↑;</li>
</ul>
<p>CPS I is also regulated by <strong>covalent modification</strong>—<strong>acetylation</strong> of specific <strong>lysine</strong> residies <u>inactivates</u> the enzyme. <strong>SIRT 5</strong> deacetylates CPS I and activates it.</p>
<h2 id="hyperammonemia"><a class="markdownIt-Anchor" href="#hyperammonemia"></a> Hyperammonemia</h2>
<p>A defect in one of the <u>five enzymes</u> in the urea cycle ➔ <strong>hyperammonemia</strong> (high blood NH4+ levels);</p>
<p>Why is ammonia toxic?</p>
<ul>
<li>Ammonia depletes citric acid cycle intermediates (α-ketoglutarate) and NADH by overloading the glutamate dehydrogenase reaction ➔ an ATP deficiency;</li>
</ul>
<p>The <u>brain</u> is especially susceptible to ammonia toxicity;</p>
<p><strong>Urea</strong> is transported in the bloodstream to the <u>kidneys</u> for excretion. Measurement of <strong>blood urea nitrogen</strong> (<strong>BUN</strong>) levels provide a sensitive clinical test of kidney malfunction.</p>
<p>Blood ammonia measurements are a sensitive test of <u>liver function</u>. <u>Liver damage</u>, whether (hepatitis (肝炎), poisoning), reduces urea synthesis.</p>
<p>The accumulation of ammonia is toxic to the <u>brain</u> and thus is related to the <u>comatose condition</u>（昏迷状态） seen in advanced cases of <strong>chronic alcoholism.</strong></p>
<h3 id="1-transport-of-ammonia-to-the-liver"><a class="markdownIt-Anchor" href="#1-transport-of-ammonia-to-the-liver"></a> 1. Transport of Ammonia to the Liver</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155631808.png" alt="image-20200505155631808" /></p>
<ul>
<li>Transport of ammonia to the liver for urea synthesis.</li>
<li>The carrier is glutamine in most tissues but is alanine in muscle.</li>
</ul>
<p>All organs degrade amino acids and produce ammonia. <u>Two mechanisms</u> are involved in transporting this ammonia from other tissues to liver for its eventual conversion to urea.</p>
<ol>
<li>
<p><u>Most tissues</u> use <strong>glutamine synthetase</strong> to convert ammonia to the nontoxic, and electrically neutral, <strong>glutamine</strong>.  The glutamine is transported in the blood to the liver, where it is cleaved hydrolytically by <strong>glutaminase</strong>.</p>
</li>
<li>
<p><strong>Muscle</strong>, which derives most of its energy from glycolysis, uses a different route, the <u>glucose-alanine cycle</u>. This cyclic process helps muscle get rid of ammonia, with the carbon from the pyruvate being returned to the liver for gluconeogenesis.</p>
</li>
</ol>
<p>Transport of ammonia to the liver for urea synthesis. The carrier is glutamine in most tissues but is alanine in muscle</p>
<h1 id="五-coenzymes-involved-in-nitrogen-metabolism"><a class="markdownIt-Anchor" href="#五-coenzymes-involved-in-nitrogen-metabolism"></a> 五、Coenzymes Involved in Nitrogen Metabolism</h1>
<ol>
<li><strong>Pyridoxal phosphate</strong> (containing B<sub>6</sub>), the cofactor for <strong>transamination</strong>；</li>
<li><strong>Folic acid</strong> <strong>coenzymes</strong>, which transfer <u>single-carbon functional group</u> in <u>synthesizing nucleotides and certain amino acids;</u></li>
<li><strong>B<sub>12</sub> or cobalamin</strong>, which participates in the <u>synthesis of methionine</u> and the <u>catabolism of methylmalonyl-CoA</u> (D-甲基丙二酰-CoA).</li>
</ol>
<h2 id="pyridoxal-phosphate"><a class="markdownIt-Anchor" href="#pyridoxal-phosphate"></a> Pyridoxal phosphate</h2>
<p>Vitamin B6 is also called <strong>pyridoxine</strong> (吡哆醇).</p>
<p>The active coenzyme has been oxidized to an aldehyde and the hydroxymethyl group at position 5 is phosphorylated.</p>
<p><strong>Pyridoxal phosphate (PLP, 磷酸吡哆醛)</strong> is the <u>predominant</u> coenzyme form</p>
<p><strong>Pyridoxamine phosphate (PMP, 磷酸吡哆胺)</strong> is an intermediate form in transamination reactions.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505155831672.png" alt="image-20200505155831672" style="zoom:33%;" />
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160122685.png" alt="image-20200505160122685" /></p>
<ul>
<li>A cationic imine (the <strong>Schiff base</strong>) <u>lowers the energy</u> barrier to the reaction. The ability of PLP to form a stable Schiff base is the key to its versatility in enzyme reactions.</li>
<li><u>All pyridoxal-requiring enzymes act via the formation of a Schiff base between the amino acid and coenzyme.</u></li>
</ul>
<h2 id="folic-acid"><a class="markdownIt-Anchor" href="#folic-acid"></a> Folic Acid</h2>
<h3 id="1-tetrahydrofolate-thf-coenzymes-and-one-carbon-metabolism"><a class="markdownIt-Anchor" href="#1-tetrahydrofolate-thf-coenzymes-and-one-carbon-metabolism"></a> 1. Tetrahydrofolate (THF) Coenzymes and One-Carbon Metabolism</h3>
<p>Coenzymes derived from the vitamin <u>folic acid: single-carbon functional groups—methyl, methylene, and formyl;</u></p>
<p>British physician Lucy Wills in the 1930s found that people with a certain type of <strong>megaloblastic anemia (巨成红细胞性贫血)</strong> can be cured by treatment with <u>yeast or liver extracts</u>……</p>
<p><u>Four tons of spinach</u> —a few hundred mg of the active component;</p>
<ul>
<li>Leaf green vegetable</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160255637.png" alt="image-20200505160255637" style="zoom:67%;" />
<h3 id="2-conversion-of-folic-acid-to-tetrahydrofloate"><a class="markdownIt-Anchor" href="#2-conversion-of-folic-acid-to-tetrahydrofloate"></a> 2. Conversion of Folic Acid to Tetrahydrofloate</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160403204.png" alt="image-20200505160403204" /></p>
<ul>
<li>Once inside a cell, folic acid is converted to a<u>ctive forms by two successive reductions</u> of the <strong>pyrazine (吡嗪)</strong> part of the <strong>pteridine ring (蝶啶环)</strong>.</li>
<li>Both reactions are catalyzed by the NADPH-specific enzyme <strong>dihydrofolate reductase (二氢叶酸还原酶)</strong>.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160455034.png" alt="image-20200505160455034" style="zoom:70%;" />
<ul>
<li>Folate coenzymes contain <u>multiple glutamate residues</u>, which help them be retained within cells and bind more tightly to enzymes.</li>
<li><u>the N-5 and N-10 positions can carry single carbon units—methyl, methylene, and formal.</u></li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160543821.png" alt="image-20200505160543821" /></p>
<ul>
<li>Dihydrofolate reductase is the target for a number of useful anticancer, antibacterial, and antiparasitic drugs.</li>
<li>Folate analogs such as methotrexate: leukemia</li>
</ul>
<h3 id="3-human-dihydrofolate-reductase-complexed-with-ligands"><a class="markdownIt-Anchor" href="#3-human-dihydrofolate-reductase-complexed-with-ligands"></a> 3. Human dihydrofolate reductase complexed with ligands</h3>
<p>This figure shows the X-ray crystal structure of the human enzyme with bound NADPH (yellow) and <strong>methotrexate (氨甲喋呤)</strong> (red).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160629191.png" alt="image-20200505160629191" style="zoom:40%;" />
<p>The <u>additional amino group on methotrexate</u> allows formation of an additional hydrogen bond to the enzyme, which <u>increases its binding affinity to the folate binding site</u>.</p>
<p>These two ligands bind such that the pyridine ring of NADPH is in close proximity to the pteridine ring of the folate ligand, as required for the hydride transfer catalyzed by this enzyme.</p>
<p>Notice that the folate binds in a bent, rather than linear, form.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160729156.png" alt="image-20200505160729156" style="zoom:50%;" />
<p>Before World War II, one of the few effective <u>antibacterial</u> drugs available was <strong>sulfanilamide</strong>, one of the class of sulfonamide drugs (“<strong>sulfa drugs</strong>”).</p>
<p>D. D. Woods, noted a <u>structural similarity between sulfanilamide</u> and <strong>p-aminobenzoate (PABA)</strong>, <u>which was known to be essential for bacterial growth</u>.</p>
<p>Woods proposed that sulfanilamide acts by blocking the normal utilization of PABA, and he coined the term <strong>antimetabolite</strong> (抗代谢药).</p>
<p><u>PABA is not required for growth of animal cells</u>, so the drug is <u>not toxic to human cells</u>.</p>
<p><u>The enzyme incorporating PABA into folic acid is inhibited by sulfonamides.</u></p>
<p>Because animal cells do not carry out the synthetic pathway but instead take up fully formed <u>folate from the diet</u>, they are not harmed by the drug</p>
<h3 id="4-tetrahydrofolate-thf-in-the-metabolism-of-one-carbon-units"><a class="markdownIt-Anchor" href="#4-tetrahydrofolate-thf-in-the-metabolism-of-one-carbon-units"></a> 4. Tetrahydrofolate (THF) in the Metabolism of One-Carbon Units</h3>
<p><strong>Tetrahydrofolate</strong> (四氢叶酸) coenzymes <u>transfer and interconvert one-carbon units</u> at the <strong>methyl</strong> (甲基), <strong>methylene</strong> (亚甲基), and <strong>formyl</strong> (甲酰) oxidation levels.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505160951140.png" alt="image-20200505160951140" style="zoom:57%;" />
<ul>
<li>Biosynthesis of purine nucleotides and the methyl group of thymidine</li>
</ul>
<p>Most organisms derive the majority of their activated one-carbon units from the <strong>β-carbon of serine</strong> and the subsequent oxidation of glycine.</p>
<p>The first of these reactions is catalyzed by <strong>serine hydroxymethyltransferase (丝氨酸羟甲基转移酶)</strong>:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161037011.png" alt="image-20200505161037011" /></p>
<p>Metabolic reactions involving synthesis, interconversion, and utilization of one-carbon adducts of tetrahydrofolate:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161200009.png" alt="image-20200505161200009" /></p>
<ul>
<li>Serine, glycine, methionine, and histidine</li>
</ul>
<ol>
<li>Homocysteine methytransferase (also called methionine synthase;</li>
<li>Methylene-THF reductase;</li>
<li>Serine hydroxymethyltransferase;</li>
<li>Glycine cleavage system;</li>
<li>Thymidylate synthase;</li>
<li>Methylene-THF dehydrogenase;</li>
<li>Methylene-THF cyclohydrolase;</li>
<li>10-formyl-THF synthetase;</li>
<li>Glutamate formiminotransferase;</li>
<li>5-formimino-THF cyclodeaminase;</li>
<li>5-formal-THF cycloligase</li>
</ol>
<p>Glycine can yield an additional molecule of <strong>5,10-methylenetetrahydrofolate (亚甲基四氢叶酸)</strong> through action of the glycine cleavage system, a <strong>multienzyme complex</strong> located in <strong>mitochondria</strong>:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161301177.png" alt="image-20200505161301177" /></p>
<h2 id="b12-coenzyme"><a class="markdownIt-Anchor" href="#b12-coenzyme"></a> B<sub>12</sub> Coenzyme</h2>
<p>A formerly incurable disease, <strong>pernicious anemia</strong> (恶性贫血), begins with a <strong>megaloblastic anemia</strong>, leads to irreversible degeneration of the <strong>nervous system</strong> if untreated;</p>
<p>In 1926 two Harvard physicians, George Minot and William Murphy, found that symptoms of this disease could be alleviated by feeding patients with large amounts of <strong>raw liver</strong>. The active material in the liver was named vitamin B<sub>12</sub></p>
<p>In England in 1956, Dorothy Hodgkin and her colleague used X-ray crystallography to complete the structure determination for this active substrate. Hodgkin was awarded the Nobel Prize for this work.</p>
<ul>
<li>Steroids, B12, penicillin and insulin structures</li>
</ul>
<h3 id="1-coenzyme-forms-of-b12"><a class="markdownIt-Anchor" href="#1-coenzyme-forms-of-b12"></a> 1. Coenzyme Forms of B<sub>12</sub></h3>
<p>Structure of vitamin B12:</p>
<p>The molecule shown here is the cyanide-containing form originally isolated (<strong>cyanocobalamin</strong> (氰钴胺)).</p>
<p>In <u>cells</u>, a water molecule or hydroxyl group takes the place of CN, forming the precursor to the coenzyme forms of B12.</p>
<p>The <strong>corrin ring</strong> (咕啉环) is shown in red.</p>
<p><strong>5,6-Dimethylbenzimidazole</strong> (DMB, 5,6-二甲基苯并咪唑), which is linked to the cobalt, is shown in blue.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505161716690.png" alt="image-20200505161716690" style="zoom: 50%;" />
<ul>
<li>The metal <strong>cobalt</strong> is coordinated with a tetrapyrrole ring system, called a <strong>corrin ring</strong>, which is similar to <strong>porphyrin ring in heme</strong> compounds.</li>
</ul>
<p>Three classes of B12-dependent enzymes are now known—<u>isomerases, methyltransferases, and reductive dehalogenases (脱卤酶)</u></p>
<p>In <strong>mammals</strong>, only two reactions:</p>
<ol>
<li>The role of B12 as a <u><strong>methyl transferase</strong> in Met biosynthesis</u>, the synthesis of methionine from homocysteine</li>
<li>The <strong>isomerization of methylmalonyl-CoA</strong> to <strong>succinyl-CoA</strong> (oxidation of odd-chain fatty acids).</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505162102503.png" alt="image-20200505162102503" style="zoom:40%;" />
<ul>
<li>Two forms:
<ol>
<li>methylcobalamin;</li>
<li>5’-deoxyadenosylcobalamin</li>
</ol>
</li>
</ul>
<p>The role of B12 as a methyl transferase in Met biosynthesis:</p>
<ul>
<li>B12 coenzymes have either a <u>methyl group or a 5’-deoxyadenosyl moiety linked to cobalt</u>, making them the first known <strong>organometallics</strong> (金属有机化合物) in metabolism.</li>
</ul>
<h3 id="2-fatty-acid-oxidation"><a class="markdownIt-Anchor" href="#2-fatty-acid-oxidation"></a> 2. Fatty Acid Oxidation</h3>
<p>Pathway for catabolism of propionyl-CoA:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180459257.png" alt="image-20200327180459257" /></p>
<h4 id="the-intramolecular-isomerization-catalyzed-by-methylmalonyl-coa-mutase"><a class="markdownIt-Anchor" href="#the-intramolecular-isomerization-catalyzed-by-methylmalonyl-coa-mutase"></a> The intramolecular isomerization catalyzed by methylmalonyl-CoA mutase</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505163330392.png" alt="image-20200505163330392" /></p>
<ol>
<li>Step 1: Homolytic cleavage of carbon-cobalt bond and formation of 5’-deoxyadenosyl radical.</li>
<li>Step 2: Hydrogen abstraction and formation of substitute radical;</li>
<li>Step 3 and 4: 1.2 rearrangement involving a cyclopropyloxy radical;</li>
<li>Step 5: Hydrogen abstraction from 5’-deoxyadenosine to give succinyl-CoA and 5’-deoxyadenosyl radical;</li>
<li>Step 6: Reformation of carbon-cobalt bond.</li>
</ol>
<h3 id="3-a-relationship-between-folate-and-b12-metabolism"><a class="markdownIt-Anchor" href="#3-a-relationship-between-folate-and-b12-metabolism"></a> 3. A relationship between folate and B12 metabolism</h3>
<p>This scheme is based on the <u>apparent folate deficiency seen in early stages of B12 deficiency</u> as a result of decreased flux through the methionine synthase reaction.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200505163455799.png" alt="image-20200505163455799" style="zoom: 43%;" />
<h3 id="4-folic-acid-in-the-prevention-of-heart-disease-and-birth-defects"><a class="markdownIt-Anchor" href="#4-folic-acid-in-the-prevention-of-heart-disease-and-birth-defects"></a> 4. Folic Acid in the Prevention of Heart Disease and Birth Defects</h3>
<p>In the mid-1990s,  correlation of <u>folate deficiency and increased risk of myocardial infarction</u>; individuals at risk for <u>heart attacks</u> also showed high levels of serum homocysteine (<strong>homocysteinemia</strong>);</p>
<p><strong>Homocysteinemia</strong> （高半胱氨酸血症）: cardiovascular disease, including coronary artery disease, stroke…</p>
<p><u>Folate deficiency</u>: birth defects, including craniofacial (cleft palate (腭裂)), the neural tube (anencephaly and spina bifida (无脑畸形和脊柱裂));</p>
<p>Neural tube defects (NTDs): 1/1000; folate acid supplementation prevents 50-75% of NTDs!!!; Take folic acids in pregnancy, but especially in the early stage (28 d for neural tube); Women of childbearing age: adequate folic acid;</p>
<p>Fortification (flour and cereal grain): mandatory in USA since 1998, ….declined</p>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/f2360b85.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/f2360b85.html" class="post-title-link" itemprop="url">L08 Lipid Metabolism II Membrane Lipids, Steroids, Isoprenoids, and Eicosanoids</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:40" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/f2360b85.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/f2360b85.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>27k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <p>Lipid Metabolism II: Membrane Lipids, Steroids, Isoprenoids, and Eicosanoids (脂质代谢II： 膜脂，类固醇，异戊二烯和花生酸类)</p>
<h1 id="一-metabolism-of-glycerophospholipids"><a class="markdownIt-Anchor" href="#一-metabolism-of-glycerophospholipids"></a> 一、Metabolism of Glycerophospholipids</h1>
<h2 id="intracellular-synthesis-and-transport-of-membrane-phospholipids"><a class="markdownIt-Anchor" href="#intracellular-synthesis-and-transport-of-membrane-phospholipids"></a> Intracellular synthesis and transport of membrane phospholipids</h2>
<p>The most abundant phospholipids are those derived from glycerol.</p>
<p>These <strong>glycerophospholipids</strong> are found primarily as components of <u>membranes</u>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427104534182.png" alt="image-20200427104534182" style="zoom: 40%;" />
<ul>
<li>Lipoprotein: transport lipids</li>
<li>Blood clotting</li>
<li>Lung functioning</li>
</ul>
<h2 id="pathways-in-glycerophospholipid-biosynthesis"><a class="markdownIt-Anchor" href="#pathways-in-glycerophospholipid-biosynthesis"></a> Pathways in glycerophospholipid biosynthesis</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427104629071.png" alt="image-20200427104629071" style="zoom:100%;" />
### 1. Synthesis of phosphatidic acid and CDP-DAG in bacteria 
<p>In bacteria, phospholipids: 10% of the dry weight of the cell</p>
<ul>
<li>Yet, their only known role is as components of membranes.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105032282.png" alt="image-20200427105032282" style="zoom:100%;" />
+ The energy cofactor: CTP, whose role is similar to that of UTP in polysaccharide synthesis.
+ Phosphatidic acid ➔ CDP-DAG (metabolically active) (similar to: G1P ➔ UDP-glucose) 
+ Phosophatidic acid is synthesized by two successive acylation of glycerol-3-phosphate
+ Acyl groups are brone on ACP 
<h3 id="2-synthesis-of-ps-pe-and-pg-from-cdp-dag-in-bacteria"><a class="markdownIt-Anchor" href="#2-synthesis-of-ps-pe-and-pg-from-cdp-dag-in-bacteria"></a> 2. Synthesis of PS, PE and PG from CDP-DAG in bacteria</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427104933115.png" alt="image-20200427104933115" style="zoom:100%;" />
+ PS immediately undergoes decarboxylation to PE;
+ PS does not accumulate in bacteria
<p>In E.coli, the membrane has 3 phospholipids: phosphatidylethanolamine (PE) (70-80%), phosphatidylglycerol (PG) and cardiolipin (CL).</p>
<p>The fatty acid content of these lipids is also simple, with three dominating: palmitate (16:0，棕榈酸盐(或酯)), palmitoleate (16:1c△9，棕榈油酸酯), cis-vaccenate (18:1c△11)</p>
<h3 id="3-pathways-in-glycerolphospholipids-biosynthesis-in-eukaryotic-cells"><a class="markdownIt-Anchor" href="#3-pathways-in-glycerolphospholipids-biosynthesis-in-eukaryotic-cells"></a> 3. Pathways in glycerolphospholipids biosynthesis in eukaryotic cells</h3>
<p>Most eukaryotic cells contain 6 classes of glycerolphospholipids: phosphatidylethanolamine (PE), phosphatydylglycerol (PG), and cardiolipin (CL) found in bacteria; plus phosphatidyserine (PS), phosphatidylcholine (PC), and phosphatidylinositol (PI).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105347131.png" alt="image-20200427105347131" style="zoom:100%;" />
+ Phosphatidic acid: major precursor to all six compounds. 
+ Pathways to PE, PS, PG, and CL are virtually identical to those for bacteria
+ In eukaryotic cells, additional pathways that start with the **free base-choline**（游离碱胆碱） and **ethanolamine**（ 乙醇胺,氨基乙醇,胆胺）, respectively, leading to PC and PE. 
<h4 id="three-routes-to-phosphatidic-acid-in-eukaryotic-cells"><a class="markdownIt-Anchor" href="#three-routes-to-phosphatidic-acid-in-eukaryotic-cells"></a> Three routes to phosphatidic acid in eukaryotic cells</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105524780.png" alt="image-20200427105524780" style="zoom:100%;" />
Eukaryotic cells display three biosynthetic routes to phosphatidic acid
<ol>
<li>The <u>major</u> pathway, starting with <strong>glycerol-3-phosphate</strong>（3-磷酸甘油）, is similar to that used by bacteria, except that the acyltransferases use acyl-CoAs as substrates instead of acyl-ACPs.</li>
<li>A second pathway starts with <strong>dihydroxyacetone phosphate (DHAP)</strong>, which accepts a fatty acyl at position 1 from an acyl-CoA, followed by reduction to 1-acylglycerol-3-phosphate and a second acylation.</li>
<li>The third route simply involves phosphorylation by a specific kinase of <strong>DAG</strong>.</li>
</ol>
<h3 id="4-salvage-pathways-synthesis-of-pc-and-pe-in-mammals"><a class="markdownIt-Anchor" href="#4-salvage-pathways-synthesis-of-pc-and-pe-in-mammals"></a> 4. Salvage pathways: Synthesis of PC and PE in mammals</h3>
<p>The most abundant phospholipids in most eukaryotic cells are PC and PE.</p>
<p>PC and PE can be synthesized from PS or through alternative pathways that start with free <strong>choline（胆碱）</strong> or <strong>ethanolamine（ethanolamine ）</strong> (salvage pathways), respectively.</p>
<ul>
<li>Salvage pathways to phospholipids, starting with choline or ethanolamine, are quantitatively important in eukaryotic cells.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105706789.png" alt="image-20200427105706789" style="zoom:100%;" />
+ E1: choline kinase, cytosolic
+ E2: CTP:phosphocholine cytidyltransferase, cytosolic and microsomal fractions
+ E3: CDP-choline: 1,2-diacylglycerol choline phosphotransferase, a membrane-bound in the endoplasmic reticulum
<h4 id="metabolic-activation-of-phosphocholine"><a class="markdownIt-Anchor" href="#metabolic-activation-of-phosphocholine"></a> Metabolic activation of phosphocholine</h4>
<p>CTP:phosphocholine cytidylyltransferase (胞苷酰转移酶) catalyzes <u>nucleophilic attack</u> at the <u><span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span>-phosphate of CTP</u> by a <u>phosphoryl oxygen of phosphocholine</u>, displacing the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span>, <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span>-phosphates (pyrophosphate) of CTP, forming <u>CDP-choline</u>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427110945237.png" alt="image-20200427110945237" style="zoom: 50%;" />
<hr />
<p><u>The second pathway to PE and PC begins with the conversion of phosphatidylserine (PS) to PE</u>, which is catalyzed by either of two different enzymes:</p>
<ol>
<li>
<p><strong>Phosphatidylserine decarboxylase</strong> (磷脂酰丝氨酸脱羧酶) is a <u>mitochondrial</u> enzyme that, like the corresponding bacterial enzyme, decarboxylates PS to PE.</p>
</li>
<li>
<p>The second enzyme is a calcium-activated transferase, <strong>phosphatidylethanolamine serinetransferase</strong> (磷脂酰乙醇胺丝氨酸转移酶), which exchanges free ethanolamine</p>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427113736840.png" alt="image-20200427113736840" style="zoom:100%;" />
<p><strong>S-Adenosyl-L-methionine (S-腺苷-L-甲硫氨酸)</strong> (AdoMet) is the <strong>methyl group donor</strong> in synthesis of <strong>phosphatidylcholine</strong> and numerous other methylated metabolites.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427113853969.png" alt="image-20200427113853969" style="zoom:100%;" />
<u>AdoMet is formed from methionine and ATP</u> in an <u>unusual reaction</u> catalyzed by **methionine adenosyltransferase** (蛋氨酸腺苷转移酶), in which ATP is cleaved to yield inorganic triphosphate (PPP~i~) plus an adenosyl moiety linked directly via the ribose C5 to the methionine sulfur. 
<p>The triphosphate is hydrolyzed by the enzyme to pyrophosphate(PPi) and orthophosphate (Pi), drawing the reaction to completion.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427113914514.png" alt="image-20200427113914514" style="zoom:100%;" />
#### Metabolism of Glycerophospholipids
<p>Fatty acid chains in phospholipids are <u>remodeled</u> through the concerted actions of <strong>phospholipases</strong> and specific <strong>lysophospholipid acyltransferases</strong> (溶血磷脂酰基转移酶) to meet the needs of the organism.</p>
<p>Specificities of <strong>phospholipases</strong> (磷脂酶) A1, A2, C, and D:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141249383.png" alt="image-20200428141249383" style="zoom: 67%;" />
<ul>
<li>Phospholipase A2, releases fatty acid from position 2;</li>
<li>Phospholipase A2: from cobra venom（眼镜蛇毒）, causes hemolysis and rupture of red blood cells;</li>
<li>repair of damaged phospholipids (acyl chains by ROS, reactive oxygen species).</li>
</ul>
<p>Lung surfactant（肺表面活性剂）: 60% dipalmitoylphosphatidylcholine (双棕榈酰磷脂酰胆碱) (a PC in which palmitoyl chains occupy both positions 1 and 2);</p>
<ul>
<li>Infants with respiratory distress syndrome: defects in either synthesis or secretion of this substance. Its synthesis is accelerated immediately after birth.</li>
</ul>
<h5 id="1-structure-of-phospholipase-a2"><a class="markdownIt-Anchor" href="#1-structure-of-phospholipase-a2"></a> (1) Structure of phospholipase A2</h5>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141356890.png" alt="image-20200428141356890" style="zoom:50%;" />
<p>An enzyme that metabolizes membrane phospholipids.</p>
<p>Catabolism of phospholipids at membrane–water interfaces is <u>important both in modification of membrane structure and as a source of second messengers and other regulators.</u></p>
<p>The <u>crystal structure</u> of the porcine pancreas phospholipase A2 reveals the <u>catalytic triad (D99-H48-water) and the active site Ca<sup>2+</sup> ion</u>, liganded to a second water molecule (W2).</p>
<h5 id="2-biosynthesis-of-cardiolipin-and-phosphoinositides-in-eukaryotes"><a class="markdownIt-Anchor" href="#2-biosynthesis-of-cardiolipin-and-phosphoinositides-in-eukaryotes"></a> (2) Biosynthesis of cardiolipin and phosphoinositides in eukaryotes</h5>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141444529.png" alt="image-20200428141444529" style="zoom:100%;" />
**Phosphatidylinositol** (磷脂酰肌醇) and its phosphorylated derivatives, collectively termed **phosphoinositides** (磷酸肌醇), play important roles as precursors of second messengers.
<p><strong>PIP3</strong> plays an important role as <u>a second messenger</u> in <strong>transmembrane signaling</strong>, the transmission of an extracellular signal to some element of the intracellular metabolic apparatus.</p>
<ul>
<li>PIP3 （Phosphatidylinositol (3,4,5)-trisphosphate）： 磷脂酰肌醇（3,4,5）-三磷酸</li>
</ul>
<h1 id="二-metabolism-of-sphingolipids"><a class="markdownIt-Anchor" href="#二-metabolism-of-sphingolipids"></a> 二、Metabolism of Sphingolipids</h1>
<p>Nervous tissues；a number of human genetic diseases</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141807932.png" alt="image-20200428141807932" style="zoom:100%;" />
+ Sphingolipids: from **sphingosine(鞘氨醇) derivative: sphinganine**
+ Ceramide (神经酰胺)
 + Ceramide serves as the precursors to both sphingomyelin and glucosphingolipids
+ Cerebroside (脑苷) (glucoceramide)
+ Sphingomyelin (鞘磷脂)
<h2 id="pathways-of-synthesis-of-glucosphingolipids-糖鞘脂"><a class="markdownIt-Anchor" href="#pathways-of-synthesis-of-glucosphingolipids-糖鞘脂"></a> Pathways of synthesis of glucosphingolipids (糖鞘脂)</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428142458056.png" alt="image-20200428142458056" style="zoom:100%;" />
+ A stepwise addition of **monosaccharide** units, using nucleotide-linked sugars as the activated substrates and with ceramide and the initial monosacchride acceptor
+ UDP-glucose (UDP-Glc)
+ UDP-galactose (UDP-Gal)
+ UDP-N-acetylgalactosamine (UDP-GalNAc)
+ CMP-N-acetylneuraminic acid (CMP-Sia or CMP-sialic acid)
<p>A myelinated axon (髓鞘的轴突) from the <strong>spinal cord</strong> (脊髓):</p>
<p>Myelin, an insulating layer wrapping about the axon, is rich in <strong>sphingomyelin</strong> (鞘磷脂).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428142756761.png" alt="image-20200428142756761" style="zoom:67%;" />
<h2 id="lysosomal-pathways-for-degradation-of-sphingolipids"><a class="markdownIt-Anchor" href="#lysosomal-pathways-for-degradation-of-sphingolipids"></a> Lysosomal pathways for degradation of sphingolipids</h2>
<p>Sphingolipids degradation in lysosomes（溶酶体）</p>
<ul>
<li>A family of hydrolytic enzymes</li>
</ul>
<p><u>Sphingolipodoses (also known as lipid storage diseases) (脂质贮积病)</u></p>
<p>Deficiency of one of the degradative enzymes, with concomitant accumulation within the lysosome of the substrates for the deficient enzyme</p>
<p>Help to establish the degradative pathway</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428142820361.png" alt="image-20200428142820361" style="zoom:100%;" />
<u>Tay-Sachs disease (1881):</u> 
<ul>
<li>N-acetylhexosaminidase A deficiency</li>
<li>Nervous degeneration, mental retardation, blindness, and death, usually by age of four</li>
<li>American Jews: 1/30 carries the defective gene</li>
<li>Two heterozygous parents: 25% chance in children</li>
<li>No cure</li>
<li>Early diagnosis: conjunction with amniocentesis</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428150720355.png" alt="image-20200428150720355" style="zoom:100%;" />
# 三、Steroid Metabolism
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428150747937.png" alt="image-20200428150747937" style="zoom:53%;" />
<ul>
<li><u>Ring identification system</u> (a)</li>
<li><u>Carbon numbering system</u> (b) used for steroids.</li>
<li><u>Structural conventions</u> ©, with cholestanol as the example.</li>
<li><strong>α-Substituents</strong> project <u>below</u> the plane of the steroid ring system (blue dashed wedge), and <strong>β-substituents</strong> project above that plane (red solid wedge).</li>
<li>The hydrogens at positions 5, 9, and 14 have the α-configuration, whereas the hydroxyl, the two methyl groups, the hydrogen at C-8, and the aliphatic side chain at C-17 are all β-substituents.</li>
</ul>
<p>A major component of animal cell <u>membrane</u> (modulation of <u>membrane fluidity</u>)</p>
<ul>
<li>
<p><u>Precursors</u>: steroid hormones, D3, bile acids</p>
</li>
<li>
<p><u>Medical interest</u>: atherosclerosis（动脉粥样硬化） and heart disease</p>
</li>
</ul>
<p>First isolation from gallstones, in 1784</p>
<h2 id="biosynthesis-of-cholesterol"><a class="markdownIt-Anchor" href="#biosynthesis-of-cholesterol"></a> Biosynthesis of Cholesterol</h2>
<h3 id="1-early-studies-of-cholesterol-biosynthesis"><a class="markdownIt-Anchor" href="#1-early-studies-of-cholesterol-biosynthesis"></a> 1. Early studies of cholesterol biosynthesis</h3>
<p>Cholesterol, the precursor to all steroids, derives all of its carbon atoms from <u>acetate (actually acety-CoA).</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428151659576.png" alt="image-20200428151659576" style="zoom:50%;" />
<ul>
<li>14C labelled acetate fed rats ➔ isolated liver tissues</li>
<li>Each carbon of cholesterol was found to originate from either <u>the methyl carbon (blue) or the carboxyl carbon (red) of acetate (actually, acetyl-CoA)</u></li>
<li>Squalene (30C)（鲨烯；三十碳六烯）</li>
<li>Mevalonic acid (6C)（甲羟戊酸）</li>
<li>Isopentenyl pyrophosphate (IPP) (5C)（异戊烯基焦磷酸酯）</li>
</ul>
<hr />
<p>Three distinct processes were proposed as below:</p>
<ol>
<li>Conversion of C2 fragment (acetate) to C6 isoprenoid precursor (mevalonate（甲羟戊酸）);</li>
<li>Conversion of six C6 mevalonates, via activated C5 intermediates (IPP and DPP), to the C30 squalene（鲨烯）;</li>
<li>Cyclization of squalene and its transformation to the C27 cholesterol.</li>
</ol>
<hr />
<h3 id="2-stage-1-synthesis-of-mevalonate-from-acetyl-coa"><a class="markdownIt-Anchor" href="#2-stage-1-synthesis-of-mevalonate-from-acetyl-coa"></a> 2. Stage 1: Synthesis of Mevalonate from Acetyl-CoA</h3>
<p>Biosynthesis of mevalonate and conversion to <strong>isopentenyl pyrophosphate （IPP）</strong> and <strong>dimethylallyl pyrophosphate (DPP):</strong></p>
<ul>
<li>The two carbons of the third acetyl group are shown in red.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152012371.png" alt="image-20200428152012371" style="zoom:100%;" />
+ HMG-CoA is converted into Mevalonate
<p>Is identical to reactions used in <u>ketogenesis</u>, although it occurs in <u>cytosol and the endoplasmic reticulum</u> (rather than in <u>mitochondria</u>)</p>
<p><u>HMG-CoA reductase, an integral membrane protein in the ER</u>, catalyzes the reduction of HMG-CoA to mevalonate:</p>
<ol>
<li>This multistep reaction requires two equivalents of <strong>NADPH</strong> (4 electrons) to reduce the thioester to an alcohol;</li>
<li>This is the <u>major step</u> that regulates the overall pathway of cholesterol biosynthesis.</li>
</ol>
<h3 id="3-stage-2-synthesis-of-fpp-from-mevalonate"><a class="markdownIt-Anchor" href="#3-stage-2-synthesis-of-fpp-from-mevalonate"></a> 3. Stage 2: Synthesis of FPP from Mevalonate</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152216868.png" alt="image-20200428152216868" style="zoom: 67%;" />
<ul>
<li>Mevalonate is converted into IPP/DPP</li>
</ul>
<p>The next several reactions occur in the <strong>cytosol</strong>.</p>
<p>First, mevalonate is activated by three successive phosphorylations.</p>
<ul>
<li>The first two are simple <u>nucleophilic substitutions</u> on the γ-phosphorous of ATP.</li>
<li>The third phosphorylation, at position 3, sets the stage for a decarboxylation to give the <strong>five-carbon</strong> isopentenyl pyrophosphate (<strong>IPP</strong>)</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152456470.png" alt="image-20200428152456470" style="zoom: 50%;" />
<hr />
<p>Conversion of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DPP) to farnesyl pyrophosphate (FPP) (C15):</p>
<p>Both of these head-to-tail condensations are catalyzed by the same <strong>prenyltransferase</strong> (farnesyl pyrophosphate synthase) (异戊二烯基转移酶(法尼焦磷酸合成酶)).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152625575.png" alt="image-20200428152625575" style="zoom:67%;" />
<h3 id="4-stage-3-conversion-of-farnesyl-pyrophosphate-fpp-to-squalene"><a class="markdownIt-Anchor" href="#4-stage-3-conversion-of-farnesyl-pyrophosphate-fpp-to-squalene"></a> 4. Stage 3: Conversion of farnesyl pyrophosphate (FPP) to squalene</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153120506.png" alt="image-20200428153120506" style="zoom:50%;" />
<p>Catalyzed by <strong>squalene synthase</strong>.</p>
<ol>
<li>
<p>Dissociation of the PPi group on one of the molecules of farnesyl-PPi yields an <strong>allylic carbocation.</strong></p>
</li>
<li>
<p>The double bond <strong>nucleophilically</strong> (烯丙基) attacks the <strong>carbocation</strong> (碳正离子), forming a <u>tertiary cation</u> at C3 of the first farnesyl-PPi.</p>
</li>
<li>
<p>Loss of a proton from C1 gives the activated <strong>cyclopropane</strong> (环丙烷) intermediate, presqualene-PPi （角鲨烯前体-PPi）.</p>
</li>
<li>
<p>Dissociation of the second pyrophosphate leads to rearrangement and formation of another <u>tertiary carbocation</u> intermediate（叔碳正离子中间体）.</p>
</li>
<li>
<p>Hydride transfer（氢化物转移） from NADPH completes the rearrangement, giving <strong>squalene (C30).</strong></p>
</li>
</ol>
<h3 id="5-stage-4-synthesis-of-cholesterol-from-squalene"><a class="markdownIt-Anchor" href="#5-stage-4-synthesis-of-cholesterol-from-squalene"></a> 5. Stage 4: Synthesis of Cholesterol from Squalene</h3>
<p>These reactions occur in the <strong>ER</strong>：</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153355583.png" alt="image-20200428153355583" style="zoom: 50%;" />
<h2 id="regulation-of-steroid-metabolism"><a class="markdownIt-Anchor" href="#regulation-of-steroid-metabolism"></a> Regulation of Steroid Metabolism</h2>
<p>Intracellular cholesterol levels are regulated by:</p>
<ol>
<li>controlling de novo <u>cholesterol biosynthesis</u>;</li>
<li>storing excess cholesterol in the form of <strong>cholesterol esters</strong>;</li>
<li>regulating the synthesis of the <strong>LDL receptor</strong>, which is responsible for endocytosis of cholesterol from the bloodstream;</li>
</ol>
<ul>
<li>Dietary cholesterol efficiently suppresses the endogenous synthesis of cholesterol;</li>
</ul>
<p><strong>HMG-CoA reductase</strong> represents a major target for regulation of the overall pathway</p>
<ul>
<li>HMG-CoA to Mevalonate is the <u>major step</u> in cholesterol biosynthesis</li>
</ul>
<p>Central players:</p>
<ol>
<li><strong>Insigs</strong> (insulin-induced growth response genes) 胰岛素诱导的生长反应基因,</li>
<li><strong>SREBPs</strong> (sterol regulatory element binding proteins),</li>
<li><strong>Scap</strong> (SREBP cleavage-activating protein);</li>
</ol>
<p>All of these proteins are anchored in the ER membrane by multiple transmembrane segments.</p>
<h3 id="1-insigs-control-cholesterol-synthesis-by-degrading-hmg-coa-reductase"><a class="markdownIt-Anchor" href="#1-insigs-control-cholesterol-synthesis-by-degrading-hmg-coa-reductase"></a> 1. Insigs control cholesterol synthesis by Degrading HMG-CoA reductase</h3>
<p>Insigs control cholesterol synthesis through <strong>sterol-induced protein-protein interactions</strong> <u>within the ER membrane</u></p>
<ol>
<li>Regulation of HMG-CoA reductase by <strong>ubiquitin mediated proteolysis</strong> (泛素介导的蛋白水解):</li>
</ol>
<ul>
<li>Sterol binding leads to rapid degradation of the enzyme.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153534090.png" alt="image-20200428153534090" style="zoom:33%;" />
<ul>
<li>HMG-CoA reductase: ER membrane;</li>
<li>N-terminal domain: 8 membrane-spanning segments;</li>
<li>catalytic C-terminal domain projects into the cytosol</li>
<li>Sterol binding causes HMG-CoA reductase to <u>bind to a population of Insigs</u> that are associated with a <strong>ubiquitination complex</strong> comprising gp78, Ubc7, and VCP.</li>
</ul>
<h4 id="control-of-cholesterol-biosynthesis-at-post-transcriptional-level"><a class="markdownIt-Anchor" href="#control-of-cholesterol-biosynthesis-at-post-transcriptional-level"></a> Control of cholesterol biosynthesis at post-transcriptional level</h4>
<ul>
<li>
<p><u>In sterol-depleted cells</u>, this protein is degraded very slowly, with <u>a half-time of more than 12 hours;</u></p>
</li>
<li>
<p>When <u>sterols accumulate</u> in the ER membrane, <u>HMG-CoA reductase is rapidly degraded (t1/2 less than 1 hour)</u> by the <strong>ubiquitin-proteasome pathway</strong>;</p>
</li>
</ul>
<p>Membrane sterols bind to a <u>sterol-sensing domain within the N-terminal</u> membrane domain of the enzyme;</p>
<p><u><strong>Sterol binding</strong> causes HMG-CoA reductase to bind to a population of Insigs that are associated with a ubiquitination complex comprising gp78, Ubc7, and VCP. Gp78 is an E3</u> ubiquitin ligase, which transfers ubiquitin from the Ubc7, E2 ubiquitin-conjugating enzyme, to the <u>specific lysine residues of the HMG-CoA reductase. This protein-protein interaction, stimulated by sterol binding, thus leads to ubiquitination of the HMG-CoA reductase;</u></p>
<ul>
<li><u>VCP: an ATPase, extract</u> ubiquitinated reductase from the membrane;</li>
</ul>
<p>Nonsterol isoprenoid derived from mevalonate, such as <strong>geranylgeraniol</strong> （香叶基香叶醇） is also required for the extraction and the degradation of ubiquitinated HMG-CoA reductase;</p>
<p><strong>Oxysterols</strong> and <strong>lanosterol</strong>（氧化型胆固醇） but not cholesterol itself regulate the degradation of HMG-CoA.</p>
<h3 id="2-srebp-and-scap-controls-the-cholesterol-synthesis-and-uptake"><a class="markdownIt-Anchor" href="#2-srebp-and-scap-controls-the-cholesterol-synthesis-and-uptake"></a> 2. SREBP and SCAP Controls The Cholesterol Synthesis and Uptake</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153820417.png" alt="image-20200428153820417" style="zoom:100%;" />
+ Sterol Regulatory Element-Binding Proteins (SREBPs) 
+ When <u>cholesterol levels in the cell are low, Scap transports SREBP to the Golgi</u>. 
+ Proteolytic processing by membrane-bound proteases <u>S1P and S2P releases SREBP’s transcription factor domain (bHLH),</u> which enters the nucleus and binds to sterol regulatory elements (**SRE**) in the promoters of <u>target genes</u>, stimulating their transcription. 
+ <u>High levels of cholesterol block</u> this process by <u>Insig-mediated retention of Scap–SREBP in the ER.</u>
<p><strong>SREBPs</strong> are synthesized in the integral membrane in the <strong>ER</strong>;</p>
<p><u>When cells are depleted of cholesterol, the SREBPS translocate to the Golgi</u>, where they are proteolytically processed to yield active transcription factors that enter the nucleus;</p>
<p>This process requires <strong>Scap</strong>, which serves as an <strong>escort protein</strong> (护送蛋白), and two specific bin the <strong>Golgi (S1P and S2P)</strong>;</p>
<p><u>When sterols accumulate in the ER membrane</u> (either from the de novo synthesis or from cell uptake), <u>exit of Scap-SERBP complex from the ER is inhibited</u>, blocking the proteolytic activation of SERBPs.</p>
<ul>
<li>This causes a decrease in the transcription of SERBP target genes, leading to <strong>lower rates</strong> of cholesterol <u>synthesis and uptake</u>.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200429113551508.png" alt="image-20200429113551508" style="zoom:100%;" />
#### The SREBP pathway is also controlled by membrane sterols and Insigs
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428154314716.png" alt="image-20200428154314716" style="zoom:100%;" />
In **sterol-replete cells, cholesterol** binds to **Scap** ➔ **Scap-Insigs complex** ➔ blocks the binding of Scap to COPII proteins ➔ blocks the translocation of cargo molecules (**Scap-SREBP**) from the ER to Golgi ➔ blocks proteolytic processing of **SREBP** (release of the bHLH)
<p>Regulation <u>at the transcriptional level</u>: SREBPs and Scap;</p>
<ul>
<li><u>SREBPS are transcription factors</u> that bind to the promoter of genes required to produce cholesterol, including the <strong>HMG-CoA reductase</strong>;</li>
</ul>
<p>Conversion of acetyl-CoA to cholesterol requires <u>at least 20 enzymes</u>, all of whose genes are activated by SREBP binding;</p>
<p>SREBP also activates the transcription of the <u>LDL receptor gene</u>, which mediates uptake of dietary cholesterol.</p>
<h3 id="3-summary"><a class="markdownIt-Anchor" href="#3-summary"></a> 3. Summary</h3>
<p><u>Insig proteins integrate these transcriptional and post-transcriptional regulatory mechanisms.</u> In both processes, sterol binding to a sterol-sensing domain (in HMG-CoA reductase or Scap) stimulates Insig binding.</p>
<ul>
<li><u>For HMG-CoA reductase, Insig binding means ubiquitination and degradation.</u></li>
<li><u>For Scap, Insig binding turns off a transcription activation pathway.</u></li>
</ul>
<p>Together, <u>these mechanisms ensure fine control over cellular cholesterol metabolism.</u></p>
<p>Finally, in some tissues, HMG-CoA reductase is subject to short-term regulation by <u>reversible phosphorylation/dephosphorylation</u>;</p>
<ul>
<li>Phosphorylation by AMP-activated protein kinase <strong>(AMPK) inactivates HMG-CoA reductase</strong> (Cholesterol biosynthesis is particularly expensive pathway: requiring <u>36 moles of ATP and 16 moles of NADPH</u> per mole of cholesterol; thus, under conditions of low energy charge, activated AMPK switches off cholesterol synthesis by inhibiting HMG-CoA reductase);</li>
<li>Dephosphorylation by <u>type 2A protein phosphatase activates</u> HMG-CoA reductase</li>
</ul>
<h4 id="how-do-hmg-coa-reductase-inhibitors-reduce-the-serum-cholesterol-level"><a class="markdownIt-Anchor" href="#how-do-hmg-coa-reductase-inhibitors-reduce-the-serum-cholesterol-level"></a> How do HMG-CoA reductase inhibitors reduce the serum cholesterol level?</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428154600272.png" alt="image-20200428154600272" style="zoom: 33%;" />
<p>Once the rate-limiting role of <strong>HMG-CoA reductase</strong> in cholesterol biosynthesis was understood, <u>specific inhibitors</u> were sought to lower blood cholesterol levels.</p>
<p>The compounds discovered are collectively called <strong>statins</strong>. （他汀类药物）</p>
<ul>
<li>They act by <strong>competitively inhibiting HMG-CoA reductase</strong>.</li>
<li>Each statin carries a <u>mevalonate</u>-like moiety (blue), explaining the <u>competitive</u> nature of their activity.</li>
<li>Inhibition of HMG-CoA reductase depresses <em>de novo</em> cholesterol biosynthesis and, hence, <u>intracellular cholesterol</u> levels.</li>
<li>This in turn leads to <u>increased production of LDL receptors</u>, allowing more rapid <u>clearance of extracellular cholesterol from the blood</u>, thus lowering blood cholesterol levels.</li>
</ul>
<p><strong>Lovastatin</strong> (洛伐他汀) and <strong>simvastatin</strong> (辛伐他汀) are fungal <strong>polyketides</strong> (聚酮化合物) and atorvastatin (Lipitor®,阿托伐他汀（立普妥)) is synthetic.</p>
<h4 id="statins-hmg-coa-reductase-inhibitor"><a class="markdownIt-Anchor" href="#statins-hmg-coa-reductase-inhibitor"></a> STATINS: HMG-CoA reductase inhibitor</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428220559371.png" alt="image-20200428220559371" style="zoom:100%;" />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428220651291.png" alt="Bile Acids" style="zoom:100%;" />
## Bile Acids
<p>In Chapter 17, bile acids: detergent properties and <u>emulsify dietary lipids</u> in the intestine and thereby promotes fat digestion and absorption.</p>
<ul>
<li>They are secreted from the <strong>liver</strong>, stored in the <strong>gallbladder</strong>, and passed through the <strong>bile duct</strong>（胆管） and into the <strong>intestine</strong></li>
</ul>
<p>Biosynthesis of bile acids represents the <u>major metabolic fate of cholesterol</u>, accounting for approximately <u>90%</u> of cholesterol catabolism in the normal human adult. By contrast, <strong>steroid hormone</strong> accounts for only about <u>50 mg</u> of cholesterol metabolized per day.</p>
<p>Although about <u>400-500 mg</u> of bile acids are synthesized <u>daily</u> much more than this is secreted into the intestine. Most of the bile acids secreted into the <strong>upper intestine</strong>（上肠） are absorbed in the lower small intestine and returned to the liver for reuse, through the <strong>portal blood</strong>（门脉血）.</p>
<ul>
<li>This process, which handles <u>20-30 g</u> of bile acids per day, is called the <u>enterohepatic circulation</u> (肠肝循环).</li>
<li><u>Daily elimination</u> of bile acids in the feces amounts to just <u>0.5 g/day or less</u>, which is compensated for by synthesis in the liver.</li>
</ul>
<p>The most abundant bile acids in humans are <strong>cholic acid and chenodeoxycholic acid</strong> (胆酸和鹅去氧胆酸).</p>
<ul>
<li>These are usually conjugated in amide linkage with the amino acids <u><strong>glycine</strong> or <strong>taurine</strong>（牛磺酸；氨基乙磺酸）</u>, giving compounds called bile salts.</li>
<li>​	The cholic acid conjugates with glycine and taurine are called <strong>glycocholate and taurocholate</strong> (甘氨胆酸和牛磺胆酸盐), respectively.</li>
<li>Another bile acid, <strong>deoxycholate</strong>（脱氧胆酸盐）, is abundant in the bile of some other mammals. It is widely used as laboratory reagent, to <u>solubilize membrane proteins</u></li>
</ul>
<h4 id="biosynthesis-of-bile-acids-and-salts-from-cholesterol"><a class="markdownIt-Anchor" href="#biosynthesis-of-bile-acids-and-salts-from-cholesterol"></a> Biosynthesis of bile acids and salts from cholesterol</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221010380.png" alt="image-20200428221010380" style="zoom:100%;" />
## Steroid Hormones
<p><strong>Cholesterol</strong> is the biosynthetic source of all steroid hormones;</p>
<p>In this Chapter, we introduce the biosynthetic pathways to steroid hormones; their actions are discussed in <strong>Chapter 23</strong>;</p>
<p>In general hormone control metabolism at the <u>gene level</u>;</p>
<ul>
<li>
<p>They interact with <u>intracellular protein receptors</u>;</p>
</li>
<li>
<p>The <u>hormone-receptor complexes</u> bind to specific sites in the genome and affect <u>transcription</u> of neighboring genes.</p>
</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221124603.png" alt="image-20200428221124603" style="zoom: 33%;" />
<p>Five major classes of steroid hormone</p>
<ol>
<li>the <strong>progestins</strong> (progesterone,孕激素（黄体酮）), which regulates events during pregnancy;</li>
<li>the <strong>glucocorticoids</strong> (cortisol and cortisterone, 糖皮质激素（皮质醇和皮质酮)), which promote gluconeogenesis and, in pharmacological doses, suppress inflammation reactions;</li>
<li>the <strong>mineralocorticoids</strong> (aldosterone, 盐皮质激素（醛固酮）), which regulate ion balance by promoting reabsorption of K<sup>+</sup>, Na<sup>+</sup>, Cl<sup>-</sup>, and HCO3 - in the kidney;</li>
<li>the <strong>androgens</strong> (androstenedione and testosterone, 雄激素（雄烯二酮和睾酮）), which promote male sexual development and maintain male sex characteristics;</li>
<li>the <strong>estrogens</strong> (estrone and estradiol, 雌激素（雌酮和雌二醇)), or female sex hormone, which support female characteristics.</li>
</ol>
<h2 id="biosynthesis-of-steroid-hormones"><a class="markdownIt-Anchor" href="#biosynthesis-of-steroid-hormones"></a> Biosynthesis of steroid hormones</h2>
<p>A general feature of steroid hormones is that they <u>are not stored for release</u> after synthesis; Therefore, the level of a circulating hormone is controlled <u>primarily by its rate of synthesis</u>, which is often controlled ultimately by signals from the <u>brain</u>;</p>
<p><strong>Corticotropin releasing hormone</strong> (CRH, 促肾上腺皮质激素释放激素) is released from cells in the <strong>hypothalamus</strong>（下丘脑） in response to central nervous system inputs.</p>
<ul>
<li>CRH stimulates release from the <strong>pituitary gland</strong> (垂体) of <strong>corticotropin</strong>（促肾上腺皮质激素）, or <strong>adrenocorticotropic hormone</strong> (ACTH (促肾上腺皮质激素)), which in turn stimulates the synthesis of <strong>glucocorticoids</strong> (糖皮质激素) in <strong>adrenal cortex</strong>（肾上腺皮质）.</li>
<li><strong>Glucocorticoids</strong> inhibits <strong>CRH</strong> release.</li>
</ul>
<p><u>Hydrolysis of cholesterol esters and uptake of cholesterol from cellular stores (ER and plasma membrane)</u> into <u>mitochondria</u> of cells in the target organs;</p>
<p><u>Translocation</u> of cholesterol from the <u>outer</u> mitochondrial membrane to the <u>inner</u> mitochondrial membrane (IMM) <u>is the rate-limiting step</u> in the production of all steroids, and <u>requires at least two proteins</u>:</p>
<ol>
<li><strong>steroidogenic acute regulatory (StAR) protein</strong></li>
<li><strong>cytochrome P450</strong> called <strong>cholesterol side chain cleavage enzyme</strong>（胆固醇侧链裂解酶） hydroxylates the side chain of cholesterol at C-20 and C-22 and cleaves it, to yield <strong>pregnenolone</strong> (促肾上腺皮质激素), <u>the precursor to all other steroid hormones;</u></li>
</ol>
<p><u>Prognenolone then moves to the ER, where its conversion to all of the other steroid hormones takes place.</u></p>
<h3 id="1-hierarchical分等级的-nature-of-hormonal-control"><a class="markdownIt-Anchor" href="#1-hierarchical分等级的-nature-of-hormonal-control"></a> 1. Hierarchical（分等级的） Nature of Hormonal Control</h3>
<p>An example of <u>feedback regulation</u> of a hormone:</p>
<p><strong>Corticotropin releasing hormone</strong> (CRH, 促肾上腺皮质激素释放因子) stimulates the release of <strong>β-corticotropin (ACTH)</strong> from the <strong>anterior pituitary</strong>.</p>
<p>ACTH stimulates the adrenal cortex to release <strong>cortisol</strong> (皮质醇), which feeds back on the hypothalamus to inhibit further release of CRF.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221802729.png" alt="image-20200428221802729" style="zoom:50%;" />
<hr />
<p><strong>Pregnenolone</strong> (孕烯醇酮) is an intermediate en route from cholesterol to all other known steroid compounds.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221837589.png" alt="image-20200428221837589" style="zoom:100%;" />
### 2. Biosynthetic routes from pregnenolone to other steroid hormones
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221931941.png" alt="image-20200428221931941" style="zoom:100%;" />
+ A series of <u>hydroxylation</u>, catalyzed by microsomal **cytochrome P450** mixed function oxidase; 
<ul>
<li>The first of these, catalyzed by <strong>17-α-hydroxylase</strong>, is <u>rate-determining</u> and hence plays the major role in controlling the overall pathway</li>
</ul>
<p>Human <u>enzymes deficiencies</u> have been described for all of the above enzymes;</p>
<ol>
<li>A deficiency of the <strong>21-hydroxylase</strong> ➔ synthesis of <strong>glucocorticoids</strong>（糖皮质激素） and <strong>mineralocorticorids</strong>（盐皮质激素）↓ ，progesterone and 17-hydroxyprogesterone ↑ ➔ overproduction of <strong>testosterone</strong> in the adrenal glands ↑ ➔ <u>virilization (masculinization) (男性化) of females</u>;</li>
</ol>
<p>At the same time, <strong>cortisol</strong> ↓ ➔ interferes with a feedback loop of <strong>CRH</strong> and <strong>ACTH</strong> ➔ ACTH secretion ↑ ➔ the <u>adrenals to grow (hyperplasia)</u> ➔ synthesize <strong>steroids</strong> ↑ <strong>testosterone</strong> ↑ ➔ virilization (masculinization) (男性化) of females;</p>
<ol start="2">
<li>
<p>A deficiency of the <strong>11β-hydroxylase</strong> also causes <strong>adrenal hyperplasia</strong>（肾上腺增生） and is characterized by accumulation of the <strong>mineralocorticoid</strong> 11-deoxycorticosterone, causing <strong>hypertension</strong>（高血压）, and the <strong>glucocorticoid</strong> 11-deoxycortisol;</p>
</li>
<li>
<p>A deficiency of the <strong>5α-reductase</strong> decreases <strong>androgen</strong>（男性荷尔蒙；雄性激素） levels and leads to feminization（女性化） of males;</p>
</li>
</ol>
<p>Fortunately, these and other steroid abnormalities can be treated with <strong>hormone replacement therapy</strong>, if detected early enough in life.</p>
<h1 id="四-other-isoprenoid-compounds"><a class="markdownIt-Anchor" href="#四-other-isoprenoid-compounds"></a> 四、Other Isoprenoid Compounds</h1>
<p>There are three active forms of <strong>vitamin A</strong>: <strong>all-trans-retinol,  - retinal, and  - retinoic acid</strong> (全反式视黄醇，视黄醛和视黄酸). Collectively, these are referred to as <strong>retinoids</strong> (维甲酸).</p>
<p>The vitamin can be either consumed in the diet as <strong>esterified retinol</strong>（酯化视黄醇）, or biosynthesized from <strong>β-carotene</strong> (β-胡萝卜素), a plant isoprenoid especially abundant in carrots.</p>
<p>β-carotene is cleaved in the <strong>intestine</strong> by a monooxygenase to form two molecules of all-trans-retinal (<strong>retinaldehyde</strong> (视黄醛)), which are then reduced to retinol.</p>
<p><strong>All-trans-retinol</strong> is the form which circulates in the blood, which has the highest biological activity.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428222512055.png" alt="image-20200428222512055" style="zoom:60%;" />
<h2 id="schematic-drawing-of-a-rod-cell-视杆细胞"><a class="markdownIt-Anchor" href="#schematic-drawing-of-a-rod-cell-视杆细胞"></a> Schematic drawing of a rod cell (视杆细胞)</h2>
<ol>
<li>The <u>outer segment</u> is a stack of membranous disks, which contain the photoreceptive pigments.</li>
<li>This segment is connected by a thin <u>cilium</u> to the <u>inner segment</u>, which contains the cell nucleus, cytosol, and <strong>synaptic body</strong> (突触体).</li>
<li>The potential change produced in the outer segment travels to the synaptic body and is transmitted to one or more of the neurons of the <strong>retina</strong> (视网膜).</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428222821945.png" alt="image-20200428222821945" style="zoom:30%;" />
<ul>
<li>Rod cells of the retina, the cell primarily responsible for low-light vision, with relatively little color detection（视网膜的杆状细胞，主要负责弱光视力，颜色检测相对较少）</li>
</ul>
<h3 id="1-the-chemical-changes-in-photoreception感光"><a class="markdownIt-Anchor" href="#1-the-chemical-changes-in-photoreception感光"></a> 1. The chemical changes in photoreception（感光）</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223222577.png" alt="image-20200428223222577" style="zoom:100%;" />
**11-cis-retinal and opsin（视蛋白）** in a **rod cell** (视杆细胞) combine to form **rhodopsin**. 
<ul>
<li>
<p>Absorption of <u>a photon</u> of light leads to the chemical changes shown in steps 2 and 3.</p>
</li>
<li>
<p>Step 3 involves at least 3 distinct <u>conformational changes</u> that occur in ~1 ms.</p>
</li>
</ul>
<p><u>Metarhodopsin II</u> is the species that activates <strong>transducin</strong> (转导素) (not shown) to initiate the visual cascade.</p>
<p>After about 1 second, metarhodopsin II dissociates into <strong>all-trans-retinal</strong>, which isomerizes as the <u>cycle</u> begins again.</p>
<h2 id="structures-of-other-important-isoprenoids-异戊二烯"><a class="markdownIt-Anchor" href="#structures-of-other-important-isoprenoids-异戊二烯"></a> Structures of other important isoprenoids (异戊二烯)</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223250102.png" alt="image-20200428223250102" style="zoom:50%;" />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223415780.png" alt="image-20200428223415780" style="zoom:100%;" />
# 五、Eicosanoids: Prostaglandins, Thromboxanes, and Leukotrienes
<ul>
<li>花生酸类：前列腺素，血栓素，和白三烯</li>
</ul>
<p><strong>Potent</strong> physiological properties, <u>low levels</u> in tissues, <u>rapid turnover</u>, and common metabolic origin;</p>
<p>They are called <strong>eicosanoids</strong> because of their common origin from <u>C20 polyunsaturated fatty acids,</u> the eicosaenoic acid, particularly arachidonic acid;</p>
<p><u>Act locally</u>, near their sites of synthesis;</p>
<p>Catabolized extremely <u>rapidly</u>.</p>
<h2 id="structures-of-the-major-prostaglandins-and-thromboxane-a2"><a class="markdownIt-Anchor" href="#structures-of-the-major-prostaglandins-and-thromboxane-a2"></a> Structures of the major prostaglandins and thromboxane A2</h2>
<p>The most abundant prostaglandins are those of the <u>2-series</u> are shown.</p>
<p>They are derived from <strong>arachidonic acid</strong> (花生四烯), as is thromboxane A2.</p>
<p><u>Numbering of carbons</u> begins with the carboxyl group as shown for the structure of <strong>PGG2</strong>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223543099.png" alt="image-20200428223543099" style="zoom:100%;" />
In 1930s, lipid extracts of human semen, on injection into animals, stimulated smooth muscle contraction or relaxation and affected the blood pressure;
<p>Because of their origin in the prostate gland …prostaglandins</p>
<p>1950s, first structure elucidation; 1960s, biosynthesis; 1970s, the thromboxanes and leukotrienes were discovered;</p>
<p>Later, widely expressed in many tissues;</p>
<p>Aspirin and other nonsteroidal anti-inflammation drugs (NSAIDs) inhibit PG biosynthesis</p>
<h2 id="summary-of-biosynthetic-routes-to-the-major-prostaglandins-and-thromboxane-a2"><a class="markdownIt-Anchor" href="#summary-of-biosynthetic-routes-to-the-major-prostaglandins-and-thromboxane-a2"></a> Summary of biosynthetic routes to the major prostaglandins and thromboxane A2</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223731674.png" alt="image-20200428223731674" style="zoom: 43%;" />
<ul>
<li>PLA2, phospholipase A2，磷脂酶A2</li>
<li>PLC, phospholipase C，磷脂酶C</li>
<li>DGL, diacylglycerol lipase，二酰基甘油脂酶</li>
<li>MGL, monoacylglycerol lipase，单酰基甘油脂酶</li>
</ul>
<ol>
<li>Release of <strong>arachidonic acid</strong>（花生四烯酸） from membrane phospholipids;</li>
<li>Oxygenation of arachidonate to yield <strong>PGH2</strong>, a precursor to other PGs;</li>
<li>Depending on the enzymes present in the cell, the conversion of PGH to <strong>other PGs or TxA2.</strong></li>
</ol>
<p><u>Release of arachidonic acid from membrane phospholipids</u> in stage 1: <strong>bradykinin</strong> (缓激肽) or epinephrine or by proteins such as <strong>thrombin</strong> (凝血酶);</p>
<ul>
<li><u>Bee stings: melittin promotes arachidonate release, which causes local inflammation;</u></li>
</ul>
<p>Free arachidonate is acted on, in stage 2, by <strong>PGH synthase</strong>, a <u>bifunctional</u> endoplasmic membrane with 2 activities in a single heme-containing polypeptide chain. The first, a cyclooxygenase…. The second activity, a <strong>peroxidase</strong> (过氧化物酶),… to give PGH2;</p>
<ul>
<li><u>Mammalian cells contain two distinct forms of PGH synthase, called PGHS-1 and PGHS-2</u> (or <strong>COX-1</strong> and <strong>COX-2</strong>, where COX stands for <strong>cyclooxygenase</strong>（环加氧酶）).</li>
<li>COX-1 is constitutively expressed and responsible for the physiological production of PGs</li>
<li>COX-2 is induced by <strong>cytokines</strong>, <strong>mitogens</strong>, <strong>endotoxins</strong> in inflammatory cells and is responsible for the elevated production of PGs during inflammation;</li>
<li><u>Both forms are inhibited by aspirin</u>（阿司匹林）. Aspirin <u>acetylates a specific serine residue, which in turn blocks access of the fatty acid substrate to the cyclooxygenase active site;</u></li>
<li>The anti-inflammatory and analgesic properties of <u>aspirin derive</u> from the inhibition of <strong>COX-2</strong>.</li>
<li>However, the inhibition of <strong>COX-1</strong> has undesirable <u>side effects</u> on the gastrointestinal system（肠胃系统；消化系统）, including <strong>ulceration</strong>（溃疡）;</li>
<li>Another widely used <strong>NSAID</strong> (nonsteroidal anti-inflammatory drugs), <strong>ibuprofen</strong>（布洛芬,异丁苯丙酸）, acts <u>somewhat more specifically upon COX-2</u> but is a <u>less effective</u> inhibitor than aspirin;</li>
<li><u>Highly selective COX-2 inhibitors such as Vioxx and Celebrex</u>, introduced in 1990s: recent studies, associated with <u>increased risk of heart attack and stroke</u> (Vioxx was withdrawn from the market in 2004).</li>
</ul>
<h3 id="1-mechanism-of-aspirin"><a class="markdownIt-Anchor" href="#1-mechanism-of-aspirin"></a> 1. Mechanism of Aspirin</h3>
<p><strong>COX-1</strong> is constitutively expressed in most tissues, and is responsible for the physiological production of <strong>prostaglandins</strong> (前列腺素类).</p>
<p><strong>COX-2</strong> is induced by cytokines, mitogens, and endotoxins in inflammatory cells and is responsible for the elevated production of prostaglandins during inflammation.</p>
<ul>
<li>Both isoforms are covalently modified, and hence inactivated, by reaction with <strong>aspirin (acetylsalicylic acid).</strong> (乙酰水杨酸)</li>
</ul>
<p>As shown, <u>aspirin acetylates a specific serine residue</u>, which in turn blocks access of the fatty acid substrate to the <strong>cyclooxygenase</strong> (环氧化酶) active site.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428225224535.png" alt="image-20200428225224535" style="zoom:100%;" />
### 2. Mechanism of Nonsteroidal anti-inflammatory drugs (NSAIDs)
<p><strong>Ibuprofen</strong> (布洛芬) and <strong>naproxen</strong> (萘普生) are examples of nonselective COX Inhibitors.</p>
<p><strong>Rofecoxib</strong> (罗非昔布) (Vioxx®) and <strong>celecoxib</strong> (塞来昔布) (Celebrex®) are selective COX-2 inhibitors.</p>
<ul>
<li>The phenylsulphonamide moieties, which contribute to their selectivity, are highlighted in red.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428225333379.png" alt="image-20200428225333379" style="zoom: 33%;" />
<p>Cyclooxygenase (COX) (环氧化酶) is an enzyme that is responsible for formation of prostanoids, including prostaglandins, prostacyclin and thromboxane.</p>
<h2 id="biosynthesis-of-leukotrienes"><a class="markdownIt-Anchor" href="#biosynthesis-of-leukotrienes"></a> Biosynthesis of leukotrienes</h2>
<p><strong>Leukotriene C</strong> was originally discovered in the class of white blood cells called <strong>polymorphonuclear leukocytes</strong> (PMNs，多形核白细胞) and was named after the source (leukocytes) and the <strong>triene</strong> (三烯) structure.</p>
<ul>
<li>It is <u>a potent muscle contractant</u> that is involved in the pathogenesis of <strong>asthma</strong> (哮喘), through constriction of the small airways in the lung.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428225411029.png" alt="image-20200428225411029" style="zoom:50%;" />
<ul>
<li>Arachidonic acid 5 - hydroperoxide (5-hydroperoxyeicosatetraenoic acid, 5-HPETE)</li>
</ul>
<p>LTs are formed from the initial attack on <strong>arachidonate</strong> (花生四烯酸) of a <strong>lipoxygenase</strong> (脂氧合酶), which adds O2 to C-5, giving 5-HPETE.</p>
<ul>
<li>A dehydration to give the epoxide coupled with isomerization of double bonds gives leukotriene A4.</li>
<li>Hydrolysis of the <strong>epoxide ring</strong> (环氧环) yields <strong>leukotriene B4.</strong></li>
<li>Transfer of the thiol group of glutathione yields <strong>leukotriene C4.</strong></li>
<li>Subsequent modifications of the peptide chain yield related compounds, leukotrienes D and E.</li>
</ul>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/f2360b85.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/f2360b85.html" class="post-title-link" itemprop="url">L08 Lipid Metabolism II Membrane Lipids, Steroids, Isoprenoids, and Eicosanoids</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:40" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/f2360b85.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/f2360b85.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>26k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <p>Lipid Metabolism II: Membrane Lipids, Steroids, Isoprenoids, and Eicosanoids (脂质代谢II： 膜脂，类固醇，异戊二烯和花生酸类)</p>
<h1 id="一-metabolism-of-glycerophospholipids"><a class="markdownIt-Anchor" href="#一-metabolism-of-glycerophospholipids"></a> 一、Metabolism of Glycerophospholipids</h1>
<h2 id="intracellular-synthesis-and-transport-of-membrane-phospholipids"><a class="markdownIt-Anchor" href="#intracellular-synthesis-and-transport-of-membrane-phospholipids"></a> Intracellular synthesis and transport of membrane phospholipids</h2>
<p>The most abundant phospholipids are those derived from glycerol.</p>
<p>These <strong>glycerophospholipids</strong> are found primarily as components of <u>membranes</u>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427104534182.png" alt="image-20200427104534182" style="zoom: 40%;" />
<ul>
<li>Lipoprotein: transport lipids</li>
<li>Blood clotting</li>
<li>Lung functioning</li>
</ul>
<h2 id="pathways-in-glycerophospholipid-biosynthesis"><a class="markdownIt-Anchor" href="#pathways-in-glycerophospholipid-biosynthesis"></a> Pathways in glycerophospholipid biosynthesis</h2>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427104629071.png" alt="image-20200427104629071" /></p>
<h3 id="1-synthesis-of-phosphatidic-acid-and-cdp-dag-in-bacteria"><a class="markdownIt-Anchor" href="#1-synthesis-of-phosphatidic-acid-and-cdp-dag-in-bacteria"></a> 1. Synthesis of phosphatidic acid and CDP-DAG in bacteria</h3>
<p>In bacteria, phospholipids: 10% of the dry weight of the cell</p>
<ul>
<li>Yet, their only known role is as components of membranes.</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105032282.png" alt="image-20200427105032282" /></p>
<ul>
<li>The energy cofactor: CTP, whose role is similar to that of UTP in polysaccharide synthesis.</li>
<li>Phosphatidic acid ➔ CDP-DAG (metabolically active) (similar to: G1P ➔ UDP-glucose)</li>
<li>Phosophatidic acid is synthesized by two successive acylation of glycerol-3-phosphate</li>
<li>Acyl groups are brone on ACP</li>
</ul>
<h3 id="2-synthesis-of-ps-pe-and-pg-from-cdp-dag-in-bacteria"><a class="markdownIt-Anchor" href="#2-synthesis-of-ps-pe-and-pg-from-cdp-dag-in-bacteria"></a> 2. Synthesis of PS, PE and PG from CDP-DAG in bacteria</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427104933115.png" alt="image-20200427104933115" /></p>
<ul>
<li>PS immediately undergoes decarboxylation to PE;</li>
<li>PS does not accumulate in bacteria</li>
</ul>
<p>In E.coli, the membrane has 3 phospholipids: phosphatidylethanolamine (PE) (70-80%), phosphatidylglycerol (PG) and cardiolipin (CL).</p>
<p>The fatty acid content of these lipids is also simple, with three dominating: palmitate (16:0，棕榈酸盐(或酯)), palmitoleate (16:1c△9，棕榈油酸酯), cis-vaccenate (18:1c△11)</p>
<h3 id="3-pathways-in-glycerolphospholipids-biosynthesis-in-eukaryotic-cells"><a class="markdownIt-Anchor" href="#3-pathways-in-glycerolphospholipids-biosynthesis-in-eukaryotic-cells"></a> 3. Pathways in glycerolphospholipids biosynthesis in eukaryotic cells</h3>
<p>Most eukaryotic cells contain 6 classes of glycerolphospholipids: phosphatidylethanolamine (PE), phosphatydylglycerol (PG), and cardiolipin (CL) found in bacteria; plus phosphatidyserine (PS), phosphatidylcholine (PC), and phosphatidylinositol (PI).</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105347131.png" alt="image-20200427105347131" /></p>
<ul>
<li>Phosphatidic acid: major precursor to all six compounds.</li>
<li>Pathways to PE, PS, PG, and CL are virtually identical to those for bacteria</li>
<li>In eukaryotic cells, additional pathways that start with the <strong>free base-choline</strong>（游离碱胆碱） and <strong>ethanolamine</strong>（ 乙醇胺,氨基乙醇,胆胺）, respectively, leading to PC and PE.</li>
</ul>
<h4 id="three-routes-to-phosphatidic-acid-in-eukaryotic-cells"><a class="markdownIt-Anchor" href="#three-routes-to-phosphatidic-acid-in-eukaryotic-cells"></a> Three routes to phosphatidic acid in eukaryotic cells</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105524780.png" alt="image-20200427105524780" /></p>
<p>Eukaryotic cells display three biosynthetic routes to phosphatidic acid</p>
<ol>
<li>The <u>major</u> pathway, starting with <strong>glycerol-3-phosphate</strong>（3-磷酸甘油）, is similar to that used by bacteria, except that the acyltransferases use acyl-CoAs as substrates instead of acyl-ACPs.</li>
<li>A second pathway starts with <strong>dihydroxyacetone phosphate (DHAP)</strong>, which accepts a fatty acyl at position 1 from an acyl-CoA, followed by reduction to 1-acylglycerol-3-phosphate and a second acylation.</li>
<li>The third route simply involves phosphorylation by a specific kinase of <strong>DAG</strong>.</li>
</ol>
<h3 id="4-salvage-pathways-synthesis-of-pc-and-pe-in-mammals"><a class="markdownIt-Anchor" href="#4-salvage-pathways-synthesis-of-pc-and-pe-in-mammals"></a> 4. Salvage pathways: Synthesis of PC and PE in mammals</h3>
<p>The most abundant phospholipids in most eukaryotic cells are PC and PE.</p>
<p>PC and PE can be synthesized from PS or through alternative pathways that start with free <strong>choline（胆碱）</strong> or <strong>ethanolamine（ethanolamine ）</strong> (salvage pathways), respectively.</p>
<ul>
<li>Salvage pathways to phospholipids, starting with choline or ethanolamine, are quantitatively important in eukaryotic cells.</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427105706789.png" alt="image-20200427105706789" /></p>
<ul>
<li>E1: choline kinase, cytosolic</li>
<li>E2: CTP:phosphocholine cytidyltransferase, cytosolic and microsomal fractions</li>
<li>E3: CDP-choline: 1,2-diacylglycerol choline phosphotransferase, a membrane-bound in the endoplasmic reticulum</li>
</ul>
<h4 id="metabolic-activation-of-phosphocholine"><a class="markdownIt-Anchor" href="#metabolic-activation-of-phosphocholine"></a> Metabolic activation of phosphocholine</h4>
<p>CTP:phosphocholine cytidylyltransferase (胞苷酰转移酶) catalyzes <u>nucleophilic attack</u> at the <u><span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span>-phosphate of CTP</u> by a <u>phosphoryl oxygen of phosphocholine</u>, displacing the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span>, <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span>-phosphates (pyrophosphate) of CTP, forming <u>CDP-choline</u>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427110945237.png" alt="image-20200427110945237" style="zoom: 50%;" />
<hr />
<p><u>The second pathway to PE and PC begins with the conversion of phosphatidylserine (PS) to PE</u>, which is catalyzed by either of two different enzymes:</p>
<ol>
<li>
<p><strong>Phosphatidylserine decarboxylase</strong> (磷脂酰丝氨酸脱羧酶) is a <u>mitochondrial</u> enzyme that, like the corresponding bacterial enzyme, decarboxylates PS to PE.</p>
</li>
<li>
<p>The second enzyme is a calcium-activated transferase, <strong>phosphatidylethanolamine serinetransferase</strong> (磷脂酰乙醇胺丝氨酸转移酶), which exchanges free ethanolamine</p>
</li>
</ol>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427113736840.png" alt="image-20200427113736840" /></p>
<p><strong>S-Adenosyl-L-methionine (S-腺苷-L-甲硫氨酸)</strong> (AdoMet) is the <strong>methyl group donor</strong> in synthesis of <strong>phosphatidylcholine</strong> and numerous other methylated metabolites.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427113853969.png" alt="image-20200427113853969" /></p>
<p><u>AdoMet is formed from methionine and ATP</u> in an <u>unusual reaction</u> catalyzed by <strong>methionine adenosyltransferase</strong> (蛋氨酸腺苷转移酶), in which ATP is cleaved to yield inorganic triphosphate (PPP<sub>i</sub>) plus an adenosyl moiety linked directly via the ribose C5 to the methionine sulfur.</p>
<p>The triphosphate is hydrolyzed by the enzyme to pyrophosphate(PPi) and orthophosphate (Pi), drawing the reaction to completion.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200427113914514.png" alt="image-20200427113914514" /></p>
<h4 id="metabolism-of-glycerophospholipids"><a class="markdownIt-Anchor" href="#metabolism-of-glycerophospholipids"></a> Metabolism of Glycerophospholipids</h4>
<p>Fatty acid chains in phospholipids are <u>remodeled</u> through the concerted actions of <strong>phospholipases</strong> and specific <strong>lysophospholipid acyltransferases</strong> (溶血磷脂酰基转移酶) to meet the needs of the organism.</p>
<p>Specificities of <strong>phospholipases</strong> (磷脂酶) A1, A2, C, and D:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141249383.png" alt="image-20200428141249383" style="zoom: 67%;" />
<ul>
<li>Phospholipase A2, releases fatty acid from position 2;
<ul>
<li>Phospholipase A2: from cobra venom（眼镜蛇毒）, causes hemolysis and rupture of red blood cells;</li>
</ul>
</li>
<li>repair of damaged phospholipids (acyl chains by ROS, reactive oxygen species).</li>
</ul>
<p>Lung surfactant（肺表面活性剂）: 60% dipalmitoylphosphatidylcholine (双棕榈酰磷脂酰胆碱) (a PC in which palmitoyl chains occupy both positions 1 and 2);</p>
<ul>
<li>Infants with respiratory distress syndrome: defects in either synthesis or secretion of this substance. Its synthesis is accelerated immediately after birth.</li>
</ul>
<h5 id="1-structure-of-phospholipase-a2"><a class="markdownIt-Anchor" href="#1-structure-of-phospholipase-a2"></a> (1) Structure of phospholipase A2</h5>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141356890.png" alt="image-20200428141356890" style="zoom:50%;" />
<p>An enzyme that metabolizes membrane phospholipids.</p>
<p>Catabolism of phospholipids at membrane–water interfaces is <u>important both in modification of membrane structure and as a source of second messengers and other regulators.</u></p>
<p>The <u>crystal structure</u> of the porcine pancreas phospholipase A2 reveals the <u>catalytic triad (D99-H48-water) and the active site Ca2+ ion</u>, liganded to a second water molecule (W2).</p>
<h5 id="2-biosynthesis-of-cardiolipin-and-phosphoinositides-in-eukaryotes"><a class="markdownIt-Anchor" href="#2-biosynthesis-of-cardiolipin-and-phosphoinositides-in-eukaryotes"></a> (2) Biosynthesis of cardiolipin and phosphoinositides in eukaryotes</h5>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141444529.png" alt="image-20200428141444529" /></p>
<p><strong>Phosphatidylinositol</strong> (磷脂酰肌醇) and its phosphorylated derivatives, collectively termed <strong>phosphoinositides</strong> (磷酸肌醇), play important roles as precursors of second messengers.</p>
<p><strong>PIP3</strong> plays an important role as <u>a second messenger</u> in <strong>transmembrane signaling</strong>, the transmission of an extracellular signal to some element of the intracellular metabolic apparatus.</p>
<ul>
<li>PIP3 （Phosphatidylinositol (3,4,5)-trisphosphate）： 磷脂酰肌醇（3,4,5）-三磷酸</li>
</ul>
<h1 id="二-metabolism-of-sphingolipids"><a class="markdownIt-Anchor" href="#二-metabolism-of-sphingolipids"></a> 二、Metabolism of Sphingolipids</h1>
<p>Nervous tissues；a number of human genetic diseases</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428141807932.png" alt="image-20200428141807932" /></p>
<ul>
<li>Sphingolipids: from <strong>sphingosine(鞘氨醇) derivative: sphinganine</strong></li>
<li>Ceramide  (神经酰胺)
<ul>
<li>Ceramide serves as the precursors to both sphingomyelin and glucosphingolipids</li>
</ul>
</li>
<li>Cerebroside  (脑苷) (glucoceramide)</li>
<li>Sphingomyelin  (鞘磷脂)</li>
</ul>
<h2 id="pathways-of-synthesis-of-glucosphingolipids-糖鞘脂"><a class="markdownIt-Anchor" href="#pathways-of-synthesis-of-glucosphingolipids-糖鞘脂"></a> Pathways of synthesis of glucosphingolipids (糖鞘脂)</h2>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428142458056.png" alt="image-20200428142458056" /></p>
<ul>
<li>A stepwise addition of <strong>monosaccharide</strong> units, using nucleotide-linked sugars as the activated substrates and with ceramide and the initial monosacchride acceptor</li>
<li>UDP-glucose (UDP-Glc)</li>
<li>UDP-galactose (UDP-Gal)</li>
<li>UDP-N-acetylgalactosamine (UDP-GalNAc)</li>
<li>CMP-N-acetylneuraminic acid (CMP-Sia or CMP-sialic acid)</li>
</ul>
<p>A myelinated axon (髓鞘的轴突) from the <strong>spinal cord</strong> (脊髓):</p>
<p>Myelin, an insulating layer wrapping about the axon, is rich in <strong>sphingomyelin</strong> (鞘磷脂).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428142756761.png" alt="image-20200428142756761" style="zoom:67%;" />
<h2 id="lysosomal-pathways-for-degradation-of-sphingolipids"><a class="markdownIt-Anchor" href="#lysosomal-pathways-for-degradation-of-sphingolipids"></a> Lysosomal pathways for degradation of sphingolipids</h2>
<p>Sphingolipids degradation in lysosomes（溶酶体）</p>
<ul>
<li>A family of hydrolytic enzymes</li>
</ul>
<p><u>Sphingolipodoses (also known as lipid storage diseases) (脂质贮积病)</u></p>
<p>Deficiency of one of the degradative enzymes, with concomitant accumulation within the lysosome of the substrates for the deficient enzyme</p>
<p>Help to establish the degradative pathway</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428142820361.png" alt="image-20200428142820361" /></p>
<p><u>Tay-Sachs disease (1881):</u></p>
<ul>
<li>N-acetylhexosaminidase A deficiency</li>
<li>Nervous degeneration, mental retardation, blindness, and death, usually by age of four</li>
<li>American Jews: 1/30 carries the defective gene</li>
<li>Two heterozygous parents: 25% chance in children</li>
<li>No cure</li>
<li>Early diagnosis:  conjunction with amniocentesis</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428150720355.png" alt="image-20200428150720355" /></p>
<h1 id="三-steroid-metabolism"><a class="markdownIt-Anchor" href="#三-steroid-metabolism"></a> 三、Steroid Metabolism</h1>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428150747937.png" alt="image-20200428150747937" style="zoom:53%;" />
<ul>
<li><u>Ring identification system</u> (a)</li>
<li><u>Carbon numbering system</u> (b) used for steroids.</li>
<li><u>Structural conventions</u> ©, with cholestanol as the example.</li>
<li><strong>α-Substituents</strong> project <u>below</u> the plane of the steroid ring system (blue dashed wedge), and <strong>β-substituents</strong> project above that plane (red solid wedge).
<ul>
<li>The hydrogens at positions 5, 9, and 14 have the α-configuration, whereas the hydroxyl, the two methyl groups, the hydrogen at C-8, and the aliphatic side chain at C-17 are all β-substituents.</li>
</ul>
</li>
</ul>
<p>A major component of animal cell <u>membrane</u> (modulation of <u>membrane fluidity</u>)</p>
<ul>
<li>
<p><u>Precursors</u>: steroid hormones, D3, bile acids</p>
</li>
<li>
<p><u>Medical interest</u>: atherosclerosis（动脉粥样硬化） and heart disease</p>
</li>
</ul>
<p>First isolation from gallstones, in 1784</p>
<h2 id="biosynthesis-of-cholesterol"><a class="markdownIt-Anchor" href="#biosynthesis-of-cholesterol"></a> Biosynthesis of Cholesterol</h2>
<h3 id="1-early-studies-of-cholesterol-biosynthesis"><a class="markdownIt-Anchor" href="#1-early-studies-of-cholesterol-biosynthesis"></a> 1. Early studies of cholesterol biosynthesis</h3>
<p>Cholesterol, the precursor to all steroids, derives all of its carbon atoms from <u>acetate (actually acety-CoA).</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428151659576.png" alt="image-20200428151659576" style="zoom:50%;" />
<ul>
<li>14C labelled acetate fed rats ➔ isolated liver tissues</li>
<li>Each carbon of cholesterol was found to originate from either <u>the methyl carbon (blue) or the carboxyl carbon (red) of acetate (actually, acetyl-CoA)</u>
<ul>
<li>Squalene (30C)（鲨烯；三十碳六烯）</li>
<li>Mevalonic acid (6C)（甲羟戊酸）</li>
<li>Isopentenyl pyrophosphate (IPP) (5C)（异戊烯基焦磷酸酯）</li>
</ul>
</li>
</ul>
<hr />
<p>Three distinct processes were proposed as below:</p>
<ol>
<li>Conversion of C2 fragment (acetate) to C6 isoprenoid precursor (mevalonate（甲羟戊酸）);</li>
<li>Conversion of six C6 mevalonates, via activated C5 intermediates (IPP and DPP), to the C30 squalene（鲨烯）;</li>
<li>Cyclization of squalene and its transformation to the C27 cholesterol.</li>
</ol>
<hr />
<h3 id="2-stage-1-synthesis-of-mevalonate-from-acetyl-coa"><a class="markdownIt-Anchor" href="#2-stage-1-synthesis-of-mevalonate-from-acetyl-coa"></a> 2. Stage 1: Synthesis of Mevalonate from Acetyl-CoA</h3>
<p>Biosynthesis of mevalonate and conversion to <strong>isopentenyl pyrophosphate （IPP）</strong> and <strong>dimethylallyl pyrophosphate (DPP):</strong></p>
<ul>
<li>The two carbons of the third acetyl group are shown in red.</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152012371.png" alt="image-20200428152012371" /></p>
<ul>
<li>HMG-CoA is converted into Mevalonate</li>
</ul>
<p>Is identical to reactions used in <u>ketogenesis</u>, although it occurs in <u>cytosol and the endoplasmic reticulum</u> (rather than in <u>mitochondria</u>)</p>
<p><u>HMG-CoA reductase, an integral membrane protein in the ER</u>, catalyzes the reduction of HMG-CoA to mevalonate:</p>
<ol>
<li>This multistep reaction requires two equivalents of <strong>NADPH</strong> (4 electrons) to reduce the thioester to an alcohol;</li>
<li>This is the <u>major step</u> that regulates the overall pathway of cholesterol biosynthesis.</li>
</ol>
<h3 id="3-stage-2-synthesis-of-fpp-from-mevalonate"><a class="markdownIt-Anchor" href="#3-stage-2-synthesis-of-fpp-from-mevalonate"></a> 3. Stage 2: Synthesis of FPP from Mevalonate</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152216868.png" alt="image-20200428152216868" style="zoom: 67%;" />
<ul>
<li>Mevalonate is converted into IPP/DPP</li>
</ul>
<p>The next several reactions occur in the <strong>cytosol</strong>.</p>
<p>First, mevalonate is activated by three successive phosphorylations.</p>
<ul>
<li>The first two are simple <u>nucleophilic substitutions</u> on the γ-phosphorous of ATP.</li>
<li>The third phosphorylation, at position 3, sets the stage for a decarboxylation to give the <strong>five-carbon</strong> isopentenyl pyrophosphate (<strong>IPP</strong>)</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152456470.png" alt="image-20200428152456470" style="zoom: 50%;" />
<hr />
<p>Conversion of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DPP) to farnesyl pyrophosphate (FPP) (C15):</p>
<p>Both of these head-to-tail condensations are catalyzed by the same <strong>prenyltransferase</strong> (farnesyl pyrophosphate synthase) (异戊二烯基转移酶(法尼焦磷酸合成酶)).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428152625575.png" alt="image-20200428152625575" style="zoom:67%;" />
<h3 id="4-stage-3-conversion-of-farnesyl-pyrophosphate-fpp-to-squalene"><a class="markdownIt-Anchor" href="#4-stage-3-conversion-of-farnesyl-pyrophosphate-fpp-to-squalene"></a> 4. Stage 3: Conversion of farnesyl pyrophosphate (FPP) to squalene</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153120506.png" alt="image-20200428153120506" style="zoom:50%;" />
<p>Catalyzed by <strong>squalene synthase</strong>.</p>
<ol>
<li>
<p>Dissociation of the PPi group on one of the molecules of farnesyl-PPi yields an <strong>allylic carbocation.</strong></p>
</li>
<li>
<p>The double bond <strong>nucleophilically</strong> (烯丙基) attacks the <strong>carbocation</strong> (碳正离子), forming a <u>tertiary cation</u> at C3 of the first farnesyl-PPi.</p>
</li>
<li>
<p>Loss of a proton from C1 gives the activated <strong>cyclopropane</strong> (环丙烷) intermediate, presqualene-PPi （角鲨烯前体-PPi）.</p>
</li>
<li>
<p>Dissociation of the second pyrophosphate leads to rearrangement and formation of another <u>tertiary carbocation</u> intermediate（叔碳正离子中间体）.</p>
</li>
<li>
<p>Hydride transfer（氢化物转移） from NADPH completes the rearrangement, giving <strong>squalene (C30).</strong></p>
</li>
</ol>
<h3 id="5-stage-4-synthesis-of-cholesterol-from-squalene"><a class="markdownIt-Anchor" href="#5-stage-4-synthesis-of-cholesterol-from-squalene"></a> 5. Stage 4: Synthesis of Cholesterol from Squalene</h3>
<p>These reactions occur in the <strong>ER</strong>：</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153355583.png" alt="image-20200428153355583" style="zoom: 50%;" />
<h2 id="regulation-of-steroid-metabolism"><a class="markdownIt-Anchor" href="#regulation-of-steroid-metabolism"></a> Regulation of Steroid Metabolism</h2>
<p>Intracellular cholesterol levels are regulated by:</p>
<ol>
<li>controlling de novo <u>cholesterol biosynthesis</u>;</li>
<li>storing excess cholesterol in the form of <strong>cholesterol esters</strong>;</li>
<li>regulating the synthesis of the <strong>LDL receptor</strong>, which is responsible for endocytosis of cholesterol from the bloodstream;</li>
</ol>
<ul>
<li>Dietary cholesterol efficiently suppresses the endogenous synthesis of cholesterol;</li>
</ul>
<p><strong>HMG-CoA reductase</strong> represents a major target for regulation of the overall pathway</p>
<ul>
<li>HMG-CoA to Mevalonate is the <u>major step</u> in cholesterol biosynthesis</li>
</ul>
<p>Central players:</p>
<ol>
<li><strong>Insigs</strong> (insulin-induced growth response genes) 胰岛素诱导的生长反应基因,</li>
<li><strong>SREBPs</strong> (sterol regulatory element binding proteins),</li>
<li><strong>Scap</strong> (SREBP cleavage-activating protein);</li>
</ol>
<p>All of these proteins are anchored in the ER membrane by multiple transmembrane segments.</p>
<h3 id="1-insigs-control-cholesterol-synthesis-by-degrading-hmg-coa-reductase"><a class="markdownIt-Anchor" href="#1-insigs-control-cholesterol-synthesis-by-degrading-hmg-coa-reductase"></a> 1. Insigs control cholesterol synthesis by Degrading HMG-CoA reductase</h3>
<p>Insigs control cholesterol synthesis through <strong>sterol-induced protein-protein interactions</strong> <u>within the ER membrane</u></p>
<ol>
<li>
<p>Regulation of HMG-CoA reductase by <strong>ubiquitin mediated proteolysis</strong> (泛素介导的蛋白水解):</p>
<ul>
<li>Sterol binding leads to rapid degradation of the enzyme.</li>
</ul>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153534090.png" alt="image-20200428153534090" style="zoom:33%;" />
<ul>
<li>HMG-CoA reductase: ER membrane;
<ul>
<li>N-terminal domain: 8 membrane-spanning segments;</li>
<li>catalytic C-terminal domain projects into the cytosol</li>
</ul>
</li>
<li>Sterol binding causes HMG-CoA reductase to <u>bind to a population of Insigs</u> that are associated with a <strong>ubiquitination complex</strong> comprising gp78, Ubc7, and VCP.</li>
</ul>
<h4 id="control-of-cholesterol-biosynthesis-at-post-transcriptional-level"><a class="markdownIt-Anchor" href="#control-of-cholesterol-biosynthesis-at-post-transcriptional-level"></a> Control of cholesterol biosynthesis at post-transcriptional level</h4>
<ul>
<li>
<p><u>In sterol-depleted cells</u>, this protein is degraded very slowly, with <u>a half-time of more than 12 hours;</u></p>
</li>
<li>
<p>When <u>sterols accumulate</u> in the ER membrane, <u>HMG-CoA reductase is rapidly degraded (t1/2 less than 1 hour)</u> by the <strong>ubiquitin-proteasome pathway</strong>;</p>
</li>
</ul>
<p>Membrane sterols bind to a <u>sterol-sensing domain within the N-terminal</u> membrane domain of the enzyme;</p>
<p><u><strong>Sterol binding</strong> causes HMG-CoA reductase to bind to a population of Insigs that are associated with a ubiquitination complex comprising gp78, Ubc7, and VCP. Gp78 is an E3</u> ubiquitin ligase, which transfers ubiquitin from the Ubc7, E2 ubiquitin-conjugating enzyme, to the <u>specific lysine residues of the HMG-CoA reductase. This protein-protein interaction, stimulated by sterol binding, thus leads to ubiquitination of the HMG-CoA reductase;</u></p>
<ul>
<li><u>VCP: an ATPase, extract</u> ubiquitinated reductase from the membrane;</li>
</ul>
<p>Nonsterol isoprenoid derived from mevalonate, such as <strong>geranylgeraniol</strong> （香叶基香叶醇） is also required for the extraction and the degradation of ubiquitinated HMG-CoA reductase;</p>
<p><strong>Oxysterols</strong> and <strong>lanosterol</strong>（氧化型胆固醇） but not cholesterol itself regulate the degradation of HMG-CoA.</p>
<h3 id="2-srebp-and-scap-controls-the-cholesterol-synthesis-and-uptake"><a class="markdownIt-Anchor" href="#2-srebp-and-scap-controls-the-cholesterol-synthesis-and-uptake"></a> 2. SREBP and SCAP Controls The Cholesterol Synthesis and Uptake</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428153820417.png" alt="image-20200428153820417" /></p>
<ul>
<li>Sterol Regulatory Element-Binding Proteins (SREBPs)</li>
<li>When <u>cholesterol levels in the cell are low, Scap transports SREBP to the Golgi</u>.</li>
<li>Proteolytic processing by membrane-bound proteases <u>S1P and S2P releases SREBP’s transcription factor domain (bHLH),</u> which enters the nucleus and binds to sterol regulatory elements (<strong>SRE</strong>) in the promoters of <u>target genes</u>, stimulating their transcription.</li>
<li><u>High levels of cholesterol block</u> this process by <u>Insig-mediated retention of Scap–SREBP in the ER.</u></li>
</ul>
<p><strong>SREBPs</strong> are synthesized in the integral membrane in the <strong>ER</strong>;</p>
<p><u>When cells are depleted of cholesterol, the SREBPS translocate to the Golgi</u>, where they are proteolytically processed to yield active transcription factors that enter the nucleus;</p>
<p>This process requires <strong>Scap</strong>, which serves as an <strong>escort protein</strong> (护送蛋白), and two specific bin the <strong>Golgi (S1P and S2P)</strong>;</p>
<p><u>When sterols accumulate in the ER membrane</u> (either from the de novo synthesis or from cell uptake), <u>exit of Scap-SERBP complex from the ER is inhibited</u>, blocking the proteolytic activation of SERBPs.</p>
<ul>
<li>This causes a decrease in the transcription of SERBP target genes, leading to <strong>lower rates</strong> of cholesterol <u>synthesis and uptake</u>.</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200429113551508.png" alt="image-20200429113551508" /></p>
<h4 id="the-srebp-pathway-is-also-controlled-by-membrane-sterols-and-insigs"><a class="markdownIt-Anchor" href="#the-srebp-pathway-is-also-controlled-by-membrane-sterols-and-insigs"></a> The SREBP pathway is also controlled by membrane sterols and Insigs</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428154314716.png" alt="image-20200428154314716" /></p>
<p>In <strong>sterol-replete cells, cholesterol</strong> binds to <strong>Scap</strong> ➔ <strong>Scap-Insigs complex</strong> ➔ blocks the binding of Scap to COPII proteins  ➔ blocks the translocation of cargo molecules (<strong>Scap-SREBP</strong>) from the ER to Golgi ➔ blocks proteolytic processing of <strong>SREBP</strong> (release of the bHLH)</p>
<p>Regulation <u>at the transcriptional level</u>: SREBPs and Scap;</p>
<ul>
<li><u>SREBPS are transcription factors</u> that bind to the promoter of genes required to produce cholesterol, including the <strong>HMG-CoA reductase</strong>;</li>
</ul>
<p>Conversion of acetyl-CoA to cholesterol requires <u>at least 20 enzymes</u>, all of whose genes are activated by SREBP binding;</p>
<p>SREBP also activates the transcription of the <u>LDL receptor gene</u>, which mediates uptake of dietary cholesterol.</p>
<h3 id="3-summary"><a class="markdownIt-Anchor" href="#3-summary"></a> 3. Summary</h3>
<p><u>Insig proteins integrate these transcriptional and post-transcriptional regulatory mechanisms.</u> In both processes, sterol binding to a sterol-sensing domain (in HMG-CoA reductase or Scap) stimulates Insig binding.</p>
<ul>
<li><u>For HMG-CoA reductase, Insig binding means ubiquitination and degradation.</u></li>
<li><u>For Scap, Insig binding turns off a transcription activation pathway.</u></li>
</ul>
<p>Together, <u>these mechanisms ensure fine control over cellular cholesterol metabolism.</u></p>
<p>Finally, in some tissues, HMG-CoA reductase is subject to short-term regulation by <u>reversible phosphorylation/dephosphorylation</u>;</p>
<ul>
<li>Phosphorylation by AMP-activated protein kinase <strong>(AMPK) inactivates HMG-CoA reductase</strong> (Cholesterol biosynthesis is particularly expensive pathway: requiring <u>36 moles of ATP and 16 moles of NADPH</u> per mole of cholesterol; thus, under conditions of low energy charge, activated AMPK switches off cholesterol synthesis by inhibiting HMG-CoA reductase);</li>
<li>Dephosphorylation by <u>type 2A protein phosphatase activates</u> HMG-CoA reductase</li>
</ul>
<h4 id="how-do-hmg-coa-reductase-inhibitors-reduce-the-serum-cholesterol-level"><a class="markdownIt-Anchor" href="#how-do-hmg-coa-reductase-inhibitors-reduce-the-serum-cholesterol-level"></a> How do HMG-CoA reductase inhibitors reduce the serum cholesterol level?</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428154600272.png" alt="image-20200428154600272" style="zoom: 33%;" />
<p>Once the rate-limiting role of <strong>HMG-CoA reductase</strong> in cholesterol biosynthesis was understood, <u>specific inhibitors</u> were sought to lower blood cholesterol levels.</p>
<p>The compounds discovered are collectively called <strong>statins</strong>. （他汀类药物）</p>
<ul>
<li>They act by <strong>competitively inhibiting HMG-CoA reductase</strong>.
<ul>
<li>Each statin carries a <u>mevalonate</u>-like moiety (blue), explaining the <u>competitive</u> nature of their activity.</li>
</ul>
</li>
<li>Inhibition of HMG-CoA reductase depresses <em>de novo</em> cholesterol biosynthesis and, hence, <u>intracellular cholesterol</u> levels.</li>
<li>This in turn leads to <u>increased production of LDL receptors</u>, allowing more rapid <u>clearance of extracellular cholesterol from the blood</u>, thus lowering blood cholesterol levels.</li>
</ul>
<p><strong>Lovastatin</strong> (洛伐他汀) and <strong>simvastatin</strong> (辛伐他汀) are fungal <strong>polyketides</strong> (聚酮化合物) and atorvastatin (Lipitor®,阿托伐他汀（立普妥)) is synthetic.</p>
<h4 id="statins-hmg-coa-reductase-inhibitor"><a class="markdownIt-Anchor" href="#statins-hmg-coa-reductase-inhibitor"></a> STATINS: HMG-CoA reductase inhibitor</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428220559371.png" alt="image-20200428220559371" /></p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428220651291.png" alt="Bile Acids" /></p>
<h2 id="bile-acids"><a class="markdownIt-Anchor" href="#bile-acids"></a> Bile Acids</h2>
<p>In Chapter 17, bile acids: detergent properties and <u>emulsify dietary lipids</u> in the intestine and thereby promotes fat digestion and absorption.</p>
<ul>
<li>They are secreted from the <strong>liver</strong>, stored in the <strong>gallbladder</strong>, and passed through the <strong>bile duct</strong>（胆管） and into the <strong>intestine</strong></li>
</ul>
<p>Biosynthesis of bile acids represents the <u>major metabolic fate of cholesterol</u>, accounting for approximately <u>90%</u> of cholesterol catabolism in the normal human adult. By contrast, <strong>steroid hormone</strong> accounts for only about <u>50 mg</u> of cholesterol metabolized per day.</p>
<p>Although about <u>400-500 mg</u> of bile acids are synthesized <u>daily</u> much more than this is secreted into the intestine. Most of the bile acids secreted into the <strong>upper intestine</strong>（上肠） are absorbed in the lower small intestine and returned to the liver for reuse, through the <strong>portal blood</strong>（门脉血）.</p>
<ul>
<li>This process, which handles <u>20-30 g</u> of bile acids per day, is called the <u>enterohepatic circulation</u> (肠肝循环).</li>
<li><u>Daily elimination</u> of bile acids in the feces amounts to just <u>0.5 g/day or less</u>, which is compensated for by synthesis in the liver.</li>
</ul>
<p>The most abundant bile acids in humans are <strong>cholic acid and chenodeoxycholic acid</strong> (胆酸和鹅去氧胆酸).</p>
<ul>
<li>These are usually conjugated in amide linkage with the amino acids <u><strong>glycine</strong> or <strong>taurine</strong>（牛磺酸；氨基乙磺酸）</u>, giving compounds called bile salts.
<ul>
<li>​	The cholic acid conjugates with glycine and taurine are called <strong>glycocholate and taurocholate</strong> (甘氨胆酸和牛磺胆酸盐), respectively.</li>
<li>Another bile acid, <strong>deoxycholate</strong>（脱氧胆酸盐）, is abundant in the bile of some other mammals. It is widely used as laboratory reagent, to <u>solubilize membrane proteins</u></li>
</ul>
</li>
</ul>
<h4 id="biosynthesis-of-bile-acids-and-salts-from-cholesterol"><a class="markdownIt-Anchor" href="#biosynthesis-of-bile-acids-and-salts-from-cholesterol"></a> Biosynthesis of bile acids and salts from cholesterol</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221010380.png" alt="image-20200428221010380" /></p>
<h2 id="steroid-hormones"><a class="markdownIt-Anchor" href="#steroid-hormones"></a> Steroid Hormones</h2>
<p><strong>Cholesterol</strong> is the biosynthetic source of all steroid hormones;</p>
<p>In this Chapter, we introduce the biosynthetic pathways to steroid hormones; their actions are discussed in <strong>Chapter 23</strong>;</p>
<p>In general hormone control metabolism at the <u>gene level</u>;</p>
<ul>
<li>
<p>They interact with <u>intracellular protein receptors</u>;</p>
</li>
<li>
<p>The <u>hormone-receptor complexes</u> bind to specific sites in the genome and affect <u>transcription</u> of neighboring genes.</p>
</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221124603.png" alt="image-20200428221124603" style="zoom: 33%;" />
<p>Five major classes of steroid hormone</p>
<ol>
<li>the <strong>progestins</strong> (progesterone,孕激素（黄体酮）), which regulates events during pregnancy;</li>
<li>the <strong>glucocorticoids</strong> (cortisol and cortisterone, 糖皮质激素（皮质醇和皮质酮)), which promote gluconeogenesis and, in pharmacological doses, suppress inflammation reactions;</li>
<li>the <strong>mineralocorticoids</strong> (aldosterone, 盐皮质激素（醛固酮）), which regulate ion balance by promoting reabsorption of K+, Na+, Cl-, and HCO3- in the kidney;</li>
<li>the <strong>androgens</strong> (androstenedione and testosterone, 雄激素（雄烯二酮和睾酮）), which promote male sexual development and maintain male sex characteristics;</li>
<li>the <strong>estrogens</strong> (estrone and estradiol, 雌激素（雌酮和雌二醇)), or female sex hormone, which support female characteristics.</li>
</ol>
<h2 id="biosynthesis-of-steroid-hormones"><a class="markdownIt-Anchor" href="#biosynthesis-of-steroid-hormones"></a> Biosynthesis of steroid hormones</h2>
<p>A general feature of steroid hormones is that they <u>are not stored for release</u> after synthesis; Therefore, the level of a circulating hormone is controlled <u>primarily by its rate of synthesis</u>, which is often controlled ultimately by signals from the <u>brain</u>;</p>
<p><strong>Corticotropin releasing hormone</strong> (CRH, 促肾上腺皮质激素释放激素) is released from cells in the <strong>hypothalamus</strong>（下丘脑） in response to central nervous system inputs.</p>
<ul>
<li>CRH stimulates release from the <strong>pituitary gland</strong> (垂体) of <strong>corticotropin</strong>（促肾上腺皮质激素）, or <strong>adrenocorticotropic hormone</strong> (ACTH (促肾上腺皮质激素)), which in turn stimulates the synthesis of <strong>glucocorticoids</strong> (糖皮质激素)  in <strong>adrenal cortex</strong>（肾上腺皮质）.</li>
<li><strong>Glucocorticoids</strong> inhibits <strong>CRH</strong> release.</li>
</ul>
<p><u>Hydrolysis of cholesterol esters and uptake of cholesterol from cellular stores (ER and plasma membrane)</u> into <u>mitochondria</u> of cells in the target organs;</p>
<p><u>Translocation</u> of cholesterol from the <u>outer</u> mitochondrial membrane to the <u>inner</u> mitochondrial membrane (IMM) <u>is the rate-limiting step</u> in the production of all steroids, and <u>requires at least two proteins</u>:</p>
<ol>
<li><strong>steroidogenic acute regulatory (StAR) protein</strong></li>
<li><strong>cytochrome P450</strong> called <strong>cholesterol side chain cleavage enzyme</strong>（胆固醇侧链裂解酶） hydroxylates the side chain of cholesterol at C-20 and C-22 and cleaves it, to yield <strong>pregnenolone</strong> (促肾上腺皮质激素), <u>the precursor to all other steroid hormones;</u></li>
</ol>
<p><u>Prognenolone then moves to the ER, where its conversion to all of the other steroid hormones takes place.</u></p>
<h3 id="1-hierarchical分等级的-nature-of-hormonal-control"><a class="markdownIt-Anchor" href="#1-hierarchical分等级的-nature-of-hormonal-control"></a> 1. Hierarchical（分等级的） Nature of Hormonal Control</h3>
<p>An example of <u>feedback regulation</u> of a hormone:</p>
<p><strong>Corticotropin releasing hormone</strong> (CRH, 促肾上腺皮质激素释放因子) stimulates the release of <strong>β-corticotropin (ACTH)</strong> from the <strong>anterior pituitary</strong>.</p>
<p>ACTH stimulates the adrenal cortex to release <strong>cortisol</strong> (皮质醇), which feeds back on the hypothalamus to inhibit further release of CRF.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221802729.png" alt="image-20200428221802729" style="zoom:50%;" />
<hr />
<p><strong>Pregnenolone</strong> (孕烯醇酮) is an intermediate en route from cholesterol to all other known steroid compounds.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221837589.png" alt="image-20200428221837589" /></p>
<h3 id="2-biosynthetic-routes-from-pregnenolone-to-other-steroid-hormones"><a class="markdownIt-Anchor" href="#2-biosynthetic-routes-from-pregnenolone-to-other-steroid-hormones"></a> 2. Biosynthetic routes from pregnenolone to other steroid hormones</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428221931941.png" alt="image-20200428221931941" /></p>
<ul>
<li>
<p>A series of <u>hydroxylation</u>, catalyzed by microsomal <strong>cytochrome P450</strong> mixed function oxidase;</p>
</li>
<li>
<p>The first of these, catalyzed by <strong>17-α-hydroxylase</strong>, is <u>rate-determining</u> and hence plays the major role in controlling the overall pathway</p>
</li>
</ul>
<p>Human <u>enzymes deficiencies</u> have been described for all of the above enzymes;</p>
<ol>
<li>
<p>A deficiency of the <strong>21-hydroxylase</strong> ➔ synthesis of <strong>glucocorticoids</strong>（糖皮质激素） and <strong>mineralocorticorids</strong>（盐皮质激素）↓ ，progesterone and 17-hydroxyprogesterone ↑ ➔ overproduction of <strong>testosterone</strong> in the adrenal glands ↑ ➔ <u>virilization (masculinization) (男性化) of females</u>;</p>
<p>At the same time, <strong>cortisol</strong> ↓ ➔ interferes with a feedback loop of <strong>CRH</strong> and <strong>ACTH</strong> ➔ ACTH secretion ↑ ➔ the <u>adrenals to grow (hyperplasia)</u> ➔ synthesize <strong>steroids</strong> ↑  <strong>testosterone</strong> ↑  ➔ virilization (masculinization) (男性化) of females;</p>
</li>
<li>
<p>A deficiency of the <strong>11β-hydroxylase</strong> also causes <strong>adrenal hyperplasia</strong>（肾上腺增生） and is characterized  by accumulation of the <strong>mineralocorticoid</strong> 11-deoxycorticosterone, causing <strong>hypertension</strong>（高血压）, and the <strong>glucocorticoid</strong> 11-deoxycortisol;</p>
</li>
<li>
<p>A deficiency of the <strong>5α-reductase</strong> decreases <strong>androgen</strong>（男性荷尔蒙；雄性激素） levels and leads to feminization（女性化） of males;</p>
</li>
</ol>
<p>Fortunately, these and other steroid abnormalities can be treated with <strong>hormone replacement therapy</strong>, if detected early enough in  life.</p>
<h1 id="四-other-isoprenoid-compounds"><a class="markdownIt-Anchor" href="#四-other-isoprenoid-compounds"></a> 四、Other Isoprenoid Compounds</h1>
<p>There are three active forms of <strong>vitamin A</strong>: <strong>all-trans-retinol, -retinal, and -retinoic acid</strong> (全反式视黄醇，视黄醛和视黄酸). Collectively, these are referred to as <strong>retinoids</strong> (维甲酸).</p>
<p>The vitamin can be either consumed in the diet as <strong>esterified retinol</strong>（酯化视黄醇）, or biosynthesized from <strong>β-carotene</strong> (β-胡萝卜素), a plant isoprenoid especially abundant in carrots.</p>
<p>β-carotene is cleaved in the <strong>intestine</strong> by a monooxygenase to form two molecules of all-trans-retinal (<strong>retinaldehyde</strong> (视黄醛)), which are then reduced to retinol.</p>
<p><strong>All-trans-retinol</strong> is the form which circulates in the blood, which has the highest biological activity.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428222512055.png" alt="image-20200428222512055" style="zoom:60%;" />
<h2 id="schematic-drawing-of-a-rod-cell-视杆细胞"><a class="markdownIt-Anchor" href="#schematic-drawing-of-a-rod-cell-视杆细胞"></a> Schematic drawing of a rod cell (视杆细胞)</h2>
<ol>
<li>The <u>outer segment</u> is a stack of membranous disks, which contain the photoreceptive pigments.</li>
<li>This segment is connected by a thin <u>cilium</u> to the <u>inner segment</u>, which contains the cell nucleus, cytosol, and <strong>synaptic body</strong> (突触体).</li>
<li>The potential change produced in the outer segment travels to the synaptic body and is transmitted to one or more of the neurons of the <strong>retina</strong> (视网膜).</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428222821945.png" alt="image-20200428222821945" style="zoom:30%;" />
<ul>
<li>Rod cells of the retina, the cell primarily responsible for low-light vision, with relatively little color detection（视网膜的杆状细胞，主要负责弱光视力，颜色检测相对较少）</li>
</ul>
<h3 id="1-the-chemical-changes-in-photoreception感光"><a class="markdownIt-Anchor" href="#1-the-chemical-changes-in-photoreception感光"></a> 1. The chemical changes in photoreception（感光）</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223222577.png" alt="image-20200428223222577" /></p>
<p><strong>11-cis-retinal and opsin（视蛋白）</strong> in a <strong>rod cell</strong> (视杆细胞) combine to form <strong>rhodopsin</strong>.</p>
<ul>
<li>
<p>Absorption of <u>a photon</u> of light leads to the chemical changes shown in steps 2 and 3.</p>
</li>
<li>
<p>Step 3 involves at least 3 distinct <u>conformational changes</u> that occur in ~1 ms.</p>
</li>
</ul>
<p><u>Metarhodopsin II</u> is the species that activates <strong>transducin</strong> (转导素) (not shown) to initiate the visual cascade.</p>
<p>After about 1 second, metarhodopsin II dissociates into <strong>all-trans-retinal</strong>, which isomerizes as the <u>cycle</u> begins again.</p>
<h2 id="structures-of-other-important-isoprenoids-异戊二烯"><a class="markdownIt-Anchor" href="#structures-of-other-important-isoprenoids-异戊二烯"></a> Structures of other important isoprenoids (异戊二烯)</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223250102.png" alt="image-20200428223250102" style="zoom:50%;" />
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223415780.png" alt="image-20200428223415780" /></p>
<h1 id="五-eicosanoids-prostaglandins-thromboxanes-and-leukotrienes"><a class="markdownIt-Anchor" href="#五-eicosanoids-prostaglandins-thromboxanes-and-leukotrienes"></a> 五、Eicosanoids: Prostaglandins, Thromboxanes, and Leukotrienes</h1>
<ul>
<li>花生酸类：前列腺素，血栓素，和白三烯</li>
</ul>
<p><strong>Potent</strong> physiological properties, <u>low levels</u> in tissues, <u>rapid turnover</u>, and common metabolic origin;</p>
<p>They are called <strong>eicosanoids</strong> because of their common origin from <u>C20 polyunsaturated fatty acids,</u> the eicosaenoic acid, particularly arachidonic acid;</p>
<p><u>Act locally</u>, near their sites of synthesis;</p>
<p>Catabolized extremely <u>rapidly</u>.</p>
<h2 id="structures-of-the-major-prostaglandins-and-thromboxane-a2"><a class="markdownIt-Anchor" href="#structures-of-the-major-prostaglandins-and-thromboxane-a2"></a> Structures of the major prostaglandins and thromboxane A2</h2>
<p>The most abundant prostaglandins are those of the <u>2-series</u> are shown.</p>
<p>They are derived from <strong>arachidonic acid</strong> (花生四烯), as is thromboxane A2.</p>
<p><u>Numbering of carbons</u> begins with the carboxyl group as shown for the structure of <strong>PGG2</strong>.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223543099.png" alt="image-20200428223543099" /></p>
<p>In 1930s, lipid extracts of human semen, on injection into animals, stimulated smooth muscle contraction or relaxation and affected the blood pressure;</p>
<p>Because of their origin in the prostate gland …prostaglandins</p>
<p>1950s, first structure elucidation; 1960s, biosynthesis; 1970s, the thromboxanes and leukotrienes were discovered;</p>
<p>Later, widely expressed in many tissues;</p>
<p>Aspirin and other nonsteroidal anti-inflammation drugs (NSAIDs) inhibit PG biosynthesis</p>
<h2 id="summary-of-biosynthetic-routes-to-the-major-prostaglandins-and-thromboxane-a2"><a class="markdownIt-Anchor" href="#summary-of-biosynthetic-routes-to-the-major-prostaglandins-and-thromboxane-a2"></a> Summary of biosynthetic routes to the major prostaglandins and thromboxane A2</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428223731674.png" alt="image-20200428223731674" style="zoom: 43%;" />
<ul>
<li>PLA2, phospholipase A2，磷脂酶A2</li>
<li>PLC, phospholipase C，磷脂酶C</li>
<li>DGL, diacylglycerol lipase，二酰基甘油脂酶</li>
<li>MGL, monoacylglycerol lipase，单酰基甘油脂酶</li>
</ul>
<ol>
<li>Release of <strong>arachidonic acid</strong>（花生四烯酸） from membrane phospholipids;</li>
<li>Oxygenation of arachidonate to yield <strong>PGH2</strong>, a precursor to other PGs;</li>
<li>Depending on the enzymes present in the cell, the conversion of PGH to <strong>other PGs or TxA2.</strong></li>
</ol>
<p><u>Release of arachidonic acid from membrane phospholipids</u> in stage 1: <strong>bradykinin</strong> (缓激肽) or epinephrine or by proteins such as <strong>thrombin</strong> (凝血酶);</p>
<ul>
<li><u>Bee stings: melittin promotes arachidonate release, which causes local inflammation;</u></li>
</ul>
<p>Free arachidonate is acted on, in stage 2, by <strong>PGH synthase</strong>, a <u>bifunctional</u> endoplasmic membrane with  2 activities in a single heme-containing polypeptide chain. The first, a cyclooxygenase…. The second activity, a <strong>peroxidase</strong> (过氧化物酶),… to give PGH2;</p>
<ul>
<li><u>Mammalian cells contain two distinct forms of PGH synthase, called PGHS-1 and PGHS-2</u> (or <strong>COX-1</strong> and <strong>COX-2</strong>, where COX stands for <strong>cyclooxygenase</strong>（环加氧酶）).</li>
<li>COX-1 is constitutively expressed and responsible for the physiological production of PGs</li>
<li>COX-2 is induced by <strong>cytokines</strong>, <strong>mitogens</strong>, <strong>endotoxins</strong> in inflammatory cells and is responsible for the elevated production of PGs during inflammation;</li>
<li><u>Both forms are inhibited by aspirin</u>（阿司匹林）. Aspirin  <u>acetylates a specific serine residue, which in turn blocks access of the fatty acid substrate to the cyclooxygenase active site;</u>
<ul>
<li>The anti-inflammatory and analgesic properties of <u>aspirin derive</u> from the inhibition of <strong>COX-2</strong>.
<ul>
<li>However, the inhibition of <strong>COX-1</strong> has undesirable <u>side effects</u> on the gastrointestinal system（肠胃系统；消化系统）, including <strong>ulceration</strong>（溃疡）;</li>
</ul>
</li>
<li>Another widely used <strong>NSAID</strong> (nonsteroidal anti-inflammatory drugs), <strong>ibuprofen</strong>（布洛芬,异丁苯丙酸）, acts <u>somewhat more specifically upon COX-2</u> but is a <u>less effective</u> inhibitor than aspirin;</li>
<li><u>Highly selective COX-2 inhibitors such as Vioxx and Celebrex</u>, introduced in 1990s: recent studies, associated with <u>increased risk of heart attack and stroke</u> (Vioxx was withdrawn from the market in 2004).</li>
</ul>
</li>
</ul>
<h3 id="1-mechanism-of-aspirin"><a class="markdownIt-Anchor" href="#1-mechanism-of-aspirin"></a> 1. Mechanism of Aspirin</h3>
<p><strong>COX-1</strong> is constitutively expressed in most tissues, and is responsible for the physiological production of <strong>prostaglandins</strong> (前列腺素类).</p>
<p><strong>COX-2</strong> is induced by cytokines, mitogens, and endotoxins in inflammatory cells and is responsible for the elevated production of prostaglandins during inflammation.</p>
<ul>
<li>Both isoforms are covalently modified, and hence inactivated, by reaction with <strong>aspirin (acetylsalicylic acid).</strong> (乙酰水杨酸)</li>
</ul>
<p>As shown, <u>aspirin acetylates a specific serine residue</u>, which in turn blocks access of the fatty acid substrate to the <strong>cyclooxygenase</strong> (环氧化酶) active site.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428225224535.png" alt="image-20200428225224535" /></p>
<h3 id="2-mechanism-of-nonsteroidal-anti-inflammatory-drugs-nsaids"><a class="markdownIt-Anchor" href="#2-mechanism-of-nonsteroidal-anti-inflammatory-drugs-nsaids"></a> 2. Mechanism of Nonsteroidal anti-inflammatory drugs (NSAIDs)</h3>
<p><strong>Ibuprofen</strong> (布洛芬) and <strong>naproxen</strong> (萘普生) are examples of nonselective COX Inhibitors.</p>
<p><strong>Rofecoxib</strong> (罗非昔布) (Vioxx®) and <strong>celecoxib</strong> (塞来昔布) (Celebrex®) are selective COX-2 inhibitors.</p>
<ul>
<li>The phenylsulphonamide moieties, which contribute to their selectivity, are highlighted in red.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428225333379.png" alt="image-20200428225333379" style="zoom: 33%;" />
<p>Cyclooxygenase (COX) (环氧化酶) is an enzyme that is responsible for formation of prostanoids, including prostaglandins, prostacyclin and thromboxane.</p>
<h2 id="biosynthesis-of-leukotrienes"><a class="markdownIt-Anchor" href="#biosynthesis-of-leukotrienes"></a> Biosynthesis of leukotrienes</h2>
<p><strong>Leukotriene C</strong> was originally discovered in the class of white blood cells called <strong>polymorphonuclear leukocytes</strong> (PMNs，多形核白细胞) and was named after the source (leukocytes) and the <strong>triene</strong> (三烯) structure.</p>
<ul>
<li>It is <u>a potent muscle contractant</u> that is involved in the pathogenesis of <strong>asthma</strong> (哮喘), through constriction of the small airways in the lung.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200428225411029.png" alt="image-20200428225411029" style="zoom:50%;" />
<ul>
<li>Arachidonic acid 5- hydroperoxide (5-hydroperoxyeicosatetraenoic acid, 5-HPETE)</li>
</ul>
<p>LTs are formed from the initial attack on <strong>arachidonate</strong> (花生四烯酸) of a <strong>lipoxygenase</strong> (脂氧合酶), which adds O2 to C-5, giving 5-HPETE.</p>
<ul>
<li>A dehydration to give the epoxide coupled with isomerization of double bonds gives leukotriene A4.</li>
<li>Hydrolysis of the <strong>epoxide ring</strong> (环氧环) yields <strong>leukotriene B4.</strong></li>
<li>Transfer of the thiol group of glutathione yields <strong>leukotriene C4.</strong></li>
<li>Subsequent modifications of the peptide chain yield related compounds, leukotrienes D and E.</li>
</ul>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/9bdd6c34.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/9bdd6c34.html" class="post-title-link" itemprop="url">L07 Interorgan and Intracellular Coordination of Energy Metabolism in Vertebrates</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:39" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/9bdd6c34.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/9bdd6c34.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>31k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <p>Interorgan and Intracellular Coordination of Energy Metabolism in Vertebrates</p>
<ul>
<li>脊椎动物器官间和细胞内能源代谢的协调</li>
</ul>
<h1 id="一-interdependence-of-the-major-organs-in-vertebrate-fuel-metabolism"><a class="markdownIt-Anchor" href="#一-interdependence-of-the-major-organs-in-vertebrate-fuel-metabolism"></a> 一、Interdependence of the Major Organs in Vertebrate Fuel Metabolism</h1>
<p>Metabolite concentrations represent a significant intracellular control mechanism (<u>availability of substrate</u>).</p>
<p>The major fuel depots are triacylglycerols (adipose tissue), protein (muscle), and glycogen (muscle and liver).</p>
<ul>
<li>Marathon run: glycogen ➔ fatty acids</li>
<li>Metabolic adaptation</li>
</ul>
<h2 id="fuel-inputs-and-outputs"><a class="markdownIt-Anchor" href="#fuel-inputs-and-outputs"></a> Fuel Inputs and Outputs</h2>
<p>Kidney must generate ATP for the osmotic work of transporting solutes against a concentration gradient for excretion;</p>
<p>Muscle: ATP/mechanical work of contraction;</p>
<p>Heart muscle: the energy supply must be continuous;</p>
<p>Liver: ATP/ biosynthesis purposes, plasma protein synthesis, cholesterol generation, fatty acid synthesis, gluconeogenesis, or the production of urea for nitrogen excretion;</p>
<p>Energy production must meet needs that vary widely, depending on level of exertion, composition of fuel molecules in the diet, time since last feeding, and so forth;</p>
<p>In humans the daily caloric intake may vary by <u>4-fold</u>, depending in part on the level of exertion—from <u>1500 to 6000 kcal/day (6000 to 25,000 kJ/day)</u> in an average-sized human (1 kcal is equal to <strong>1 large calorie, or Cal</strong>).</p>
<h2 id="metabolic-interactions-among-the-major-fuel-metabolizing-organs"><a class="markdownIt-Anchor" href="#metabolic-interactions-among-the-major-fuel-metabolizing-organs"></a> Metabolic interactions among the major fuel-metabolizing organs</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200408112139955.png" alt="image-20200408112139955" style="zoom:100%;" />
+ Yellow: lipid-derived metabolites
+ Blue: carbohydrate-derived metabolites
<h3 id="1-brain"><a class="markdownIt-Anchor" href="#1-brain"></a> 1. Brain</h3>
<p>The most <u>fastidious（过分挑剔的）</u>, it must use ATP in large quantities to maintain the membrane potentials essential for transmission of nerve impulses;</p>
<p>Under <u>normal conditions, use only glucose</u> to meet its prodigious energy requirement, which accounts about <u>60%</u> of the glucose utilization of a human <u>at rest</u> (about <u>120 grams of glucose per day, 1700 kJ</u>, about <u>15%</u> of the total energy consumed by one person);</p>
<p>The brain’s quantitative requirement for glucose remains <u>quite constant</u>, even when an animal is at rest or asleep;</p>
<p>The brain is a highly <u>aerobic</u> organ, <u>20%</u> of the total oxygen consumed by a human;</p>
<p>The brain has <u>no significant glucose or other fuel reserves</u>, the supply of both oxygen and glucose <u>cannot be interrupted</u>, even for a short time. Otherwise, irreversible brain damage results;</p>
<ul>
<li>No fuel reserve, therefore highly depends on external fuel molecule transport</li>
<li>However, the brain can adapt during <u>starvation</u> to use <u>ketone bodies</u> instead of glucose as major fuel.</li>
</ul>
<h3 id="2-muscle"><a class="markdownIt-Anchor" href="#2-muscle"></a> 2. Muscle</h3>
<p>Muscle can utilize <u>a variety of fuel-glucose, fatty acids, and ketone bodies;</u></p>
<p>Skeletal muscle varies widely in its energy demands and fuels it consumes, in line with its wide variations in activity;</p>
<p>In <u>resting</u> muscle, <strong>fatty acids</strong> –major energy source; during <u>exertion</u>, <strong>glucose</strong> is the primary source;</p>
<p><u>Early</u> in a period of exertion, that glucose comes from mobilization of the muscle’s <u>glycogen</u> reserves. <u>Later</u>, as glycogen reserves are depleted, <u>fatty acids</u> become the dominant fuel;</p>
<p>Skeletal muscle stores about <u>three-fourths</u> of the total glycogen in humans, with most of the rest being stored in the liver;</p>
<p>Muscle lacks the enzyme <strong>glucose-6-phosphatase,</strong> so glucose phosphate derived from glycogen cannot be converted to free glucose for export-they are retained for use by the muscle cells. Therefore, glucose phosphate produced from muscle glycogen cannot be released for use by other tissues; (Gluconeogenesis bypass 3 cannot occur)</p>
<ul>
<li>muscle cell 缺少 glucose-6-phosphatase, 使得glucose不能运出cell，从而导致glucose只进不出</li>
</ul>
<p>During <u>exertion</u>, the flux rate through <u>glycolysis</u> exceeds that through the citric acid cycle, so <strong>lactate</strong> accumulates and is released;</p>
<p>Another metabolic product is <strong>alanine</strong>, produced via <u>transamination from pyruvate</u> in the <strong>glucose-alanine cycle;</strong></p>
<p>Both <strong>lactate and alanine</strong> are transported through the bloodstream to the liver, where they are reconverted through glyconeogenesis to glucose, for return to the muscle and other tissues by the <strong>Cori cycle</strong>; However, <u>the major fate of lactate</u> during exertion is <u>uptake by the heart</u> for use as fuel, via oxidation to CO2;</p>
<p>Muscle contains another readily mobilizable source of energy—<u>its own protein</u>. However, the breakdown of muscle protein to meet energy needs is both <u>energetically wasteful and harmful</u> to an animal, which needs its muscle to move around in order to survive. Protein breakdown is regulated to minimize amino acid catabolism except in starvation.</p>
<p>Muscle had additional energy reserve in <strong>creatine phosphate (磷酸肌酸)</strong>, which generates ATP without the need for metabolizing fuels. This reserve is exhausted early in a period of exertion and must be replenished, along with glycogen stores, as muscle rests after prolonged exertion.</p>
<h4 id="cori-cycle"><a class="markdownIt-Anchor" href="#cori-cycle"></a> Cori Cycle</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415102536917.png" alt="image-20200415102536917" style="zoom:100%;" />
#### Glucose-Alanine Cycle
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415102554736.png" alt="image-20200415102554736" style="zoom:100%;" />
+ Transport of ammonia (toxic) from the muscle to liver for urea synthesis
+ 蛋白质代谢产生的产物之一是氨
<h3 id="3-heart"><a class="markdownIt-Anchor" href="#3-heart"></a> 3. Heart</h3>
<p>The metabolism of heart muscle <u>differs from that of skeletal muscle</u> in three important aspects:</p>
<ol>
<li>Work output is <u>far less variable</u> than in skeletal muscle;</li>
<li>The heart is a <u>completely aerobic tissue</u>, while skeletal muscle can function anaerobically for limited periods. <u>Mitochondria</u> are much more densely packed in heart than in other cells, making up nearly <u>half the volume</u> of a heart cell;</li>
<li>The heart contains <u>negligible energy reserve</u> as glycogen or lipids, although there is a small amount of creatine phosphate. Therefore, supply of both oxygen and fuels from the blood <u>must be continuous</u> to meet the unending energy demands of the heart.</li>
</ol>
<p>The heart uses <u>a variety of fuels</u>—mainly fatty acids but also <strong>glucose, lactate, and ketone bodies.</strong></p>
<h3 id="4-adipose-tissue"><a class="markdownIt-Anchor" href="#4-adipose-tissue"></a> 4. Adipose Tissue</h3>
<p>Adipose tissue represents the major fuel depot for an animal. The total stored TG amount to some <u>555,000 kJ (133,000 Cal)</u> in an average-sized human. This is enough fuel, to sustain life for several <u>months</u> in the absence of further caloric intake;</p>
<p>The adipocyte is designed for <u>continuous synthesis and breakdown of TG</u>, with breakdown controlled largely via the activation of <u>hormone-sensitive triglyceride lipase;</u></p>
<p>Because <u>adipocytes lack the enzyme <strong>glycerol kinase</strong></u>, some <u>glucose catabolism must occur for TG synthesis to take place</u>—specifically, the formation of dihydroxyacetone phosphate (<strong>DHAP</strong>), for reduction to <u>glycerol-3-phosphate</u>;</p>
<p><u>Glucose acts as a sensor in adipose tissue metabolism</u>.</p>
<ul>
<li>Intracellular (adipocyte) glucose levels ↑ ➔ DHAP ↑ ➔ glycerol-3-phosphate ↑ ➔ TG synthesis ↑;</li>
<li>Intracellular glucose levels ↓ ➔ DHAP ↓ ➔ glycerol-3-phosphate ↓ ➔ TG synthesis ↓.</li>
</ul>
<h3 id="5-liver"><a class="markdownIt-Anchor" href="#5-liver"></a> 5. Liver</h3>
<h4 id="liver-i-metabolite-synthesis"><a class="markdownIt-Anchor" href="#liver-i-metabolite-synthesis"></a> Liver (I)  -  Metabolite Synthesis</h4>
<p><u>A primary role of liver is the synthesis of fuel components for use by other organs.</u> In fact, most of the low-molecular-weight metabolites that appear in the blood through digestion are taken up by the liver for this metabolic processing;</p>
<p>The liver is a major site for <u>fatty acid synthesis</u>; it also <u>produces glucose</u>, both from its own glycogen stores and from <u>gluconeogenesis</u>, <u>the latter using lactate and alanine from muscle, glycerol from adipose tissue, and the amino acids</u> not needed for protein synthesis; <strong>ketone bodies</strong> are also manufactured largely in the liver;</p>
<p>In liver, the level of <strong>malonyl-CoA</strong> is a determinant of the fate of fatty acyl-CoAs. When fuel is abundant↑ ➔ malonyl-CoA ↑ ➔ carnitine acyltransferase I (<strong>CPT1</strong>) ↓ ➔ transport of fatty acyl-CoAs into mitochondria ↓ ➔ β-oxidation ↓ and ketogenesis ↓ ;</p>
<p>When fuel is inadequate↓ ➔ malonyl-CoA ↓ ➔ carnitine acyltransferase I (<strong>CPT1</strong>) ↑ ➔ transport of fatty acyl-CoAs into mitochondria ↑ ➔ β-oxidation ↑ and ketogenesis ↑ .</p>
<h4 id="liver-ii-buffer-blood-glucose"><a class="markdownIt-Anchor" href="#liver-ii-buffer-blood-glucose"></a> Liver (II)  -  Buffer Blood Glucose</h4>
<p><u>An important role of liver is to buffer the level of blood glucose</u>. It does this largely through the action of <strong>hexokinase IV</strong> (己糖激酶Ⅳ，previously called <strong>glucokinase (葡(萄)糖激酶)</strong>), an enzyme specific to liver, with a <u>high K<sub>1/2</sub> (about 7.5 mM)</u> for glucose, and partly a <strong>high-K<sub>m</sub> transporter protein</strong>, the <strong>glucose transporter (GLUT2)</strong>.</p>
<ul>
<li>
<p>Thus, high blood glucose levels ↑ ➔ uptake and phosphorylation of glucose ↑ ➔ glycogen systhesis ↑;</p>
</li>
<li>
<p><strong>Glucose-6-phosphate</strong> accumulation ↑ ➔ activates the β form of glycogen synthase ↑;</p>
</li>
<li>
<p><strong>Glucose</strong> itself binds to <strong>glycogen phosphorylase a</strong>, increases its dephosphorylation and results in <u>inactivation</u> ↓ ；</p>
</li>
</ul>
<p>Thus, liver senses the <strong>fed state</strong> and acts to store fuel derived from glucose. Liver also senses the <strong>fasted state</strong> and increase the synthesis and export of glucose when blood glucose levels are low.</p>
<p>The liver can use a variety of fuel sources, including <strong>glucose, fatty acids, and amino acids.</strong></p>
<h3 id="6-blood"><a class="markdownIt-Anchor" href="#6-blood"></a> 6. Blood</h3>
<p>All the organs are connected by the bloodstream, which transport what may be one organ’s waste product but another organ’s fuel</p>
<ul>
<li>Blood transport O2 and CO2</li>
<li><u>Lipoprotein: CM and VLDL</u></li>
<li><strong>RBC</strong>: no mitochondria, depend exclusively upon <u>anaerobic glycolysis</u> to their limited energy needs</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415104406401.png" alt="image-20200415104406401" style="zoom: 50%;" />
<h1 id="二-hormonal-regulation-of-fuel-metabolism"><a class="markdownIt-Anchor" href="#二-hormonal-regulation-of-fuel-metabolism"></a> 二、Hormonal Regulation of Fuel Metabolism</h1>
<p>Maintenance of blood glucose within narrow limits is critical to <u>brain function.</u></p>
<p>One of the most important roles of <u>liver</u> is to serve as a “glucostat （葡萄糖调节剂）” monitoring and stabilizing blood glucose levels.</p>
<p>The key hormones regulating fuel metabolism are <strong><u>insulin</u></strong>, which promotes glucose use, and <strong>glucagon</strong> and <strong>epinephrine</strong>, which increase blood glucose.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105324000.png" alt="image-20200415105324000" style="zoom: 67%;" />
<ul>
<li>Several hours after a meal: 80 mg/100 ml or 4.4 mM; Shortly after the meal: 120 mg/100 ml, 6.6 mM, uptake by cells;</li>
<li><strong>Islets of Langerhans (胰岛；郎格罕氏岛)</strong> contain at least five different cell types, each specialized for synthesis of one hormone:</li>
<li>
<ol>
<li>the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span> (or A) cells produce <strong>glucagon</strong>（胰高血糖素）;</li>
</ol>
</li>
<li>
<ol start="2">
<li>the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>δ</mi></mrow><annotation encoding="application/x-tex">\delta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.69444em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.03785em;">δ</span></span></span></span> (or D) cells, <strong>somatostatin（生长激素抑制素）</strong>;</li>
</ol>
</li>
<li>
<ol start="3">
<li>the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>ϵ</mi></mrow><annotation encoding="application/x-tex">\epsilon</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault">ϵ</span></span></span></span> cells, <strong>ghrelin（生长素释放肽）</strong>;</li>
</ol>
</li>
<li>
<ol start="4">
<li>the F cells, pancreatic polypeptide;</li>
</ol>
</li>
<li>
<ol start="5">
<li><span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> (or B) cells, <strong>insulin（胰岛素）</strong>.</li>
</ol>
</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105453858.png" alt="image-20200415105453858" style="zoom:100%;" />
## Insulin regulation of fuel metabolism
<p>Insulin signals the <u>fed state</u> and thereby promotes</p>
<ol>
<li><strong>uptake</strong> of fuel substrates into some cells,</li>
<li><strong>storage</strong> of fuels (lipids and glycogen),</li>
<li><strong>biosynthesis</strong> of macromolecules (nucleic acids and protein);</li>
</ol>
<p>The <u>specific effects</u> include:</p>
<ol>
<li>increased uptake of glucose in muscle and adipose tissue;</li>
<li>activation of glycolysis in liver;</li>
<li>increased synthesis of fatty acids and TG in liver and adipose tissue;</li>
<li>inhibition of gluconeogenesis in liver;</li>
<li>increased glycogen synthesis in liver and muscle;</li>
<li>increased uptake of amino acids into muscle with consequent activation of muscle protein synthesis;</li>
<li>inhibition of protein degradation;</li>
<li>cell growth-promoting effect.</li>
</ol>
<p>Because of its promotion of biosynthesis, it is appropriate to consider insulin a <strong>growth hormone.</strong></p>
<h3 id="1-glucose-promote-insulin-release-from-the-beta-cells"><a class="markdownIt-Anchor" href="#1-glucose-promote-insulin-release-from-the-beta-cells"></a> 1. Glucose promote insulin release from the beta cells</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105658818.png" alt="image-20200415105658818" style="zoom: 67%;" />
<h4 id="how-β-cells-release-insulin"><a class="markdownIt-Anchor" href="#how-β-cells-release-insulin"></a> How β cells release insulin</h4>
<p>The β cells take up and catabolize glucose ↑ ➔ ATP levels ↑ ➔ closure of ATP-gated K<sup>+</sup> channels and depolarization of the plasma membrane ↑ ➔ cytosolic [Ca<sup>2+</sup>] ↑ ➔ triggers exocytosis of insulin granules ↑.</p>
<h4 id="the-ovweview-of-insulin-regulation-pathway"><a class="markdownIt-Anchor" href="#the-ovweview-of-insulin-regulation-pathway"></a> The ovweview of Insulin regulation pathway</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105813925.png" alt="image-20200415105813925" style="zoom:100%;" />
+ 4EBP1: eukaryotic initiation 4E-binding protein 
+ S6K: ribosomal protein S6 kinase
+ LKB1: Liver kinase B1
+ CaMKKb:Ca^2+^/calmodulin-dependent protein kinase kinase b
+ IRS: insulin receptor substrate 
+ PGC-1: peroxisome proliferator-activated receptor-gamma coactivator 1
+ TSC: tuberous sclerosis complex
+ PI3K: phosphoinositide 3-kinase
<h3 id="2-insulin-facilitate-glucose-uptake-into-muscle-and-adipose-cells"><a class="markdownIt-Anchor" href="#2-insulin-facilitate-glucose-uptake-into-muscle-and-adipose-cells"></a> 2. Insulin facilitate glucose uptake into muscle and adipose cells</h3>
<p>The <u>mechanism by which insulin stimulates glucose uptake</u> into muscle and adipose cells in an area of intense investigation;</p>
<p>One important action involves the glucose transporter, <strong>GLUT4</strong>. Before stimulation by insulin, this transporter is not present on the cell surface; rather, it is localized in vesicles in the <u>cytosol</u>. The protein is translocated to the <u>cell surface in response to insulin</u>, where it facilitates glucose uptake.</p>
<p>An important consequence of glucose uptake in <strong>adipocytes</strong> is its conversion to glycerol-3-phosphate, which combines with fatty acids to stimulate TG synthesis.</p>
<h3 id="3-actions-of-glucagon-in-liver-that-lead-to-a-rise-in-blood-glucose"><a class="markdownIt-Anchor" href="#3-actions-of-glucagon-in-liver-that-lead-to-a-rise-in-blood-glucose"></a> 3. Actions of glucagon in liver that lead to a rise in blood glucose</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415111507445.png" alt="image-20200415111507445" style="zoom:67%;" />
<ul>
<li>The primary target of glucagon is the <u>liver</u>, and its principal effect is to increase cyclic AMP levels in liver cells.</li>
<li>PFK: phosphofructokinase</li>
<li>PK: pyruvate kinase</li>
<li>F2,6BP: β-D-Fructose-2,6-bisphosphate</li>
<li>PEP: phosphoenolpyruvate</li>
</ul>
<p>A 3.5 kDa polypeptide</p>
<p>Produced by <strong>alpha-cells</strong> (α-cells); sense blood sugar; release in response to low blood sugar.</p>
<h3 id="4-actions-of-glucagon-in-adipose-cells"><a class="markdownIt-Anchor" href="#4-actions-of-glucagon-in-adipose-cells"></a> 4. Actions of glucagon in adipose cells</h3>
<p>Control of <u>lipolysis in adipose cells</u> by a cAMP-mediated cascade system:</p>
<p>Hormonal activation of a β–adrenergic <strong>G-protein coupled receptor （GPCR）</strong> on the plasma membrane leads to elevation of cAMP levels, which in turn, activates protein kinase A (PKA). PKA phosphorylates <strong>perilipin</strong> (<strong>PL</strong>, 周脂素) and <strong>hormone-sensitive lipase (</strong> <strong>HSL</strong>, 激素敏感性脂肪酶).</p>
<ol>
<li>
<p>PL and HSL are phosphorylated.</p>
</li>
<li>
<p>CGI-58 dissociates from phosphorylated-PL, and binds ATGL.</p>
</li>
<li>
<p>Phosphorylated HSL is recruited to the lipid droplet and activated by phosphorylated-PL.</p>
</li>
</ol>
<p>Phosphorylated-PL also recruits the ATGL/CGI-58 complex to the lipid droplet, activating this lipase.</p>
<ol start="4">
<li>Activated ATGL hydrolyzes TG to activated HSL hydrolyzes DG to cytoplasmic MGL hydrolyzes MG to free glycerol + FFA.</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417161040138.png" alt="image-20200417161040138" style="zoom:67%;" />
<ul>
<li>HSL: hormone-sensitive lipase</li>
<li>CGI-58: comparative gene identification-58CGI</li>
<li>ATGL: adipose triglyceride lipase</li>
<li>DG: diacylglycerol</li>
<li>MGL: monoglyceride lipase</li>
</ul>
<p>In adipose tissue, glucagon also increases cAMP. There the <u>chief effect of cAMP</u> is to promote TAG mobilization via phosphorylation of hormone-sensitive lipase and perilipin, yielding glycerol and fatty acids.</p>
<h2 id="epinephrine"><a class="markdownIt-Anchor" href="#epinephrine"></a> Epinephrine</h2>
<p>The <strong>catecholamines (儿茶酚胺)</strong> epinephrine (肾上腺素) and norepinephrine (去甲肾上腺素), when released from <u>presynaptic nerve endings</u>, function as neurotransmitters;</p>
<p>When released from <u>adrenal medulla</u> in response to low blood glucose levels, epinephrine interacts with second-messenger systems in many tissues, with varied effects;</p>
<p>In <u>muscle</u>, <strong>epinephrine</strong> activates adenylate cyclase with concomitant（伴随的） <u>activation of glycolysis and inhibition of glycogen synthesis;</u> <u>TG breakdown in adipose tissue</u> is also stimulated, providing fuel for the muscle tissue;</p>
<p>Inhibits insulin secretion and stimulates glucagon secretion; increases glucose production and release by the liver, the net result is to increase blood glucose levels;</p>
<p><u>Unlike glucagon</u>, the catecholamines have <u>short-lived</u> metabolic effects.</p>
<h3 id="1-endocrine-regulation-of-food-intake-and-energy-homeostasis-in-mammals"><a class="markdownIt-Anchor" href="#1-endocrine-regulation-of-food-intake-and-energy-homeostasis-in-mammals"></a> 1. Endocrine regulation of food intake and energy homeostasis in mammals</h3>
<p>The effects of the major endocrine regulators on <strong>AMPK</strong> signaling in brain, adipose tissue, liver, and skeletal muscle.</p>
<h2 id="coordination-of-energy-homeostasis"><a class="markdownIt-Anchor" href="#coordination-of-energy-homeostasis"></a> Coordination of Energy Homeostasis</h2>
<p><strong>AMPK</strong> ( AMP-activated protein kinase ) and <strong>mTOR</strong> (<u>mammalian target of rapamycin</u>) protein kinases play central roles in orchestrating the <u>metabolic activity</u> of mammalian cells.</p>
<p>AMPK is activated when the energy charge of the cell is <u>low</u>.</p>
<p>Mammalian <strong>AMP-activated protein kinase (AMPK)</strong>:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417162115046.png" alt="image-20200417162115046" style="zoom: 33%;" />
<ul>
<li>X-ray crystal structure of the heterotrimeric enzyme (AMPK)</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171740854.png" alt="image-20200417171740854" style="zoom: 50%;" />
<ul>
<li>Green arrow: activation of AMPK</li>
<li>Red cycles: inhibition of AMPK</li>
</ul>
<h3 id="1-amp-activated-protein-kinase-ampk"><a class="markdownIt-Anchor" href="#1-amp-activated-protein-kinase-ampk"></a> 1. AMP-Activated Protein Kinase (AMPK)</h3>
<p>AMPK, serine/threonine protein kinase, found in all eukaryotes, <u>is activated when the energy charge of the cell is low (i.e., high AMP:ATP ratio)</u>;</p>
<ul>
<li>在机体内部缺少能量的时候，AMPK被激活</li>
</ul>
<p>AMP:ATP ratio ↑(nutrient starvation or hypoxia（氧不足）) ➔ AMPK ↑ ➔ pathways that lead to ATP production ↑; pathways that utilize ATP ↓ ➔ATP production ↑;</p>
<ul>
<li>AMPK: heterotrimer, a catalytic subunit (<span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span>) and two regulatory subunits (<span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> and <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span>);</li>
<li><u>Binding of AMP</u> to four nucleotide-binding sites in the <u><span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span> subunit</u> ➔ activation of the catalytic $\alpha $ subunit;</li>
<li><u>Activation of AMPK also requires phosphorylation of a specific threonine residue in the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span> subunit</u>, and AMP binding to the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span> subunit allosterically protects against dephosphorylation of this residue in the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span> subunit;</li>
<li><u>Two upstream kinases</u>, <strong>LKB1</strong> and Ca<sup>2+</sup>/calmodulin-dependent protein kinase kinase <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> (<strong>CaMKK<span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span></strong>), are known to <u>phosphorylate the critical Thr residue.</u></li>
</ul>
<h4 id="ampk-enhances-energy-producing-pathways-and-inhibits-energy-requiring-pathways"><a class="markdownIt-Anchor" href="#ampk-enhances-energy-producing-pathways-and-inhibits-energy-requiring-pathways"></a> AMPK enhances energy-producing pathways and inhibits energy-requiring pathways</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417162658580.png" alt="image-20200417162658580" style="zoom: 80%;" />
<ul>
<li>4EBP1: eukaryotic initiation 4E-binding protein</li>
<li>S6K: ribosomal protein S6 kinase</li>
<li>LKB1: Liver kinase B1</li>
<li>CaMKKb:Ca<sup>2+</sup>/calmodulin-dependent protein kinase kinase b</li>
<li>IRS: insulin receptor substrate</li>
<li>PGC-1: peroxisome proliferator-activated receptor-gamma coactivator 1</li>
<li>TSC: tuberous sclerosis complex</li>
<li>PI3K: phosphoinositide 3-kinase</li>
</ul>
<p>AMPK phosphorylates multiple substrates that <u>enhance energy-producing pathways</u>, including targets that stimulate <u>glucose uptake</u> (via retranslocation of <strong>GLUT4</strong> to the plasma membrane), <u>glycolysis in heart</u> (via stimulation of the kinase activity of the heart-specific PFK-2/FBPase-2), and <u>mitochondrial biogenesis</u>;</p>
<p>At the same time, other AMPK targets <u>inhibit energy-requiring pathways</u>, including <u>hepatic gluconeogenesis</u> (via decreased transcription of gluconeogenic enzymes), <u>fatty acid synthesis</u> (via acetyl-CoA carboxylase), <u>TG synthesis</u> (via glycerophosphate acyltransferase and hormone-sensitive lipase), <u>cholesterol synthesis</u> (via HMG-CoA reductase).</p>
<h3 id="2-mammalian-target-of-rapamycinmtor"><a class="markdownIt-Anchor" href="#2-mammalian-target-of-rapamycinmtor"></a> 2. Mammalian Target of Rapamycin（mTOR)</h3>
<p>mTOR is the other main player in the regulation of energy homeostasis.</p>
<ul>
<li>Like AMPK, highly conserved serine/threonine protein kinase found in all eukaryotes.</li>
<li><u>In contrast to AMPK, mTOR is active under nutrient-rich conditions and inactive under nutrient-poor conditions;</u></li>
</ul>
<p>Activated mTOR <u>promotes anabolic processes</u>, including cell proliferation, protein synthesis, and biosynthesis, but <u>inhibits catabolic processes</u>;</p>
<p>mTOR exists as two distinct multiprotein complexes: a rapamycin-<strong>sensitive</strong> complex (<u><strong>mTORC1</strong>: mTOR, mLST8, raptor and PRAS40</u>) and a rapamycin-<strong>insensitive</strong> complex (<u><strong>mTORC2</strong>: mTOR, mLST8, rictor, Sin1 and PRR5/Protor</u>);</p>
<p>mTOR was discovered during biochemical studies with the bacterial macrolide, <strong>rapamycin (雷帕霉素)</strong>, a potent immunosuppressant（免疫抑制剂）. <u>Rapamycin binds to a small cellular protein, FKBP12, and this FKBP12-rapamycin complex allosterically inhibits mTORC1, but has no effect on mTORC2.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417163658878.png" alt="image-20200417163658878" style="zoom:100%;" />
+ Rapamycin extends life span of old mice;
+ Immnuosuppressant drug
<h4 id="mtor-downstream-substrates-4ebp1-and-s6k"><a class="markdownIt-Anchor" href="#mtor-downstream-substrates-4ebp1-and-s6k"></a> mTOR downstream substrates: 4EBP1 and S6K</h4>
<p>The two best-characterized <u>substrates</u> of <strong>mTORC1</strong> are <strong>4EBP1</strong> (eukaryotic initiation 4E-binding protein) and <strong>S6K</strong> (ribosomal protein S6 kinase);</p>
<ol>
<li><strong>4EBP1</strong> normally <u>inhibits</u> the translation initiation factor <strong>eIF4E</strong>; <u>phosphorylation of 4EBP1</u> by <strong>mTORC1</strong> suppresses its ability to bind eIF4E and <u>inhibit translation;</u></li>
</ol>
<ul>
<li>Double negative regulation = Positive regulation</li>
</ul>
<ol start="2">
<li><u>Phosphorylation of <strong>S6K</strong> by <strong>mTOR</strong> activates this downstream protein kinase</u>, which <strong>phosphorylates</strong> a number of proteins involved in translational control;</li>
</ol>
<p><u>The net effect of phosphorylation of 4EBP1 and S6K by mTORC1 is thus stimulation of protein synthesis and ribosome biogenesis.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417163825580.png" alt="image-20200417163825580" style="zoom:50%;" />
<h4 id="upstream-regulators-of-mtor-tsc12"><a class="markdownIt-Anchor" href="#upstream-regulators-of-mtor-tsc12"></a> Upstream Regulators of mTOR: TSC1/2</h4>
<p>mTOR activity is regulated by a number of upstream inputs, most of which are transmitted through the <strong>tuberous sclerosis complex</strong> (<strong>TSC</strong>);</p>
<p>This complex, first discovered as a <u>tumor suppressor</u>, is composed of <strong>TSC1 (hamartin)</strong> and <strong>TSC2 (tuberin)</strong>;</p>
<p><strong>TSC2</strong> contains a <strong>GTPase activating protein</strong> (<strong>GAP</strong>) domain ➔ that <u>inactivates</u> the small Ras-like GTPase <strong>Rheb</strong>;</p>
<ul>
<li><strong>Rheb</strong> ↓ ➔ <u>normally activates mTOR ↑ , thus loss of TSC1 or TSC2 leads to hyperactivation of mTORC1;</u></li>
</ul>
<p><strong>TSC</strong> serves as an <u>integration point</u> for regulation of mTORC1, receiving inputs from <u>a wide variety of environmental signals</u>, including growth factors (e.g., <u>insulin and epidermal growth factor), energy status, and nutrient availability;</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417164115250.png" alt="image-20200417164115250" style="zoom:67%;" />
<h4 id="insulin-signaling-regulation-of-mtor-activity"><a class="markdownIt-Anchor" href="#insulin-signaling-regulation-of-mtor-activity"></a> Insulin signaling regulation of mTOR activity</h4>
<ol>
<li>
<p><strong>Insulin</strong> signaling begins with phosphorylation of an <strong>insulin receptor substrate (IRS)</strong> protein by the <strong>tyrosine kinase</strong> activity of the <strong>plasma membrane insulin receptor</strong>;</p>
</li>
<li>
<p><strong>Phosphorylated IRS</strong> activates phosphoinositide 3-kinase (<strong>PI3K</strong>), which converts membrane phosphatidylinositol 4,5-bisphosphate (<strong>PIP2</strong>) to phosphatidylinositol 3,4,5-triphosphate (<strong>PIP<sub>3</sub></strong>), a second messenger with a variety of intracellular targets.</p>
</li>
<li>
<p><strong>PIP3</strong> activates yet another protein kinase (<strong>PKD1</strong>), which then activates a third protein kinase <strong>Akt</strong>;</p>
</li>
<li>
<p><strong>Akt (also called PKB)</strong> then <u>phosphorylates TSC, inactivating the complex, resulting in activation of mTORC1;</u></p>
</li>
</ol>
<p><u>Activated Akt also stimulates <strong>GLUT4</strong></u> translocation to the plasma membrane, accounting for insulin-stimulated glucose transport in muscle cells.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417164957386.png" alt="image-20200417164957386" style="zoom:80%;" />
<h3 id="3-ampk-suppresses-mtor"><a class="markdownIt-Anchor" href="#3-ampk-suppresses-mtor"></a> 3. AMPK suppresses mTOR</h3>
<p><strong>Activated AMPK</strong> phosphorylates the <strong>TSC</strong> complex, which suppresses mTORC1 by inhibiting <strong>Rheb</strong>;</p>
<p>Activated AMPK also directly inhibits mTORC1 by phosphorylation of the <strong>raptor subunit</strong> of the complex;</p>
<p>AMPK also modulates the insulin signaling pathway by phosphorylating <strong>IRS</strong>, thereby <u>increasing</u> the sensitivity of the cell to insulin.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417165143836.png" alt="image-20200417165143836" style="zoom:80%;" />
<hr />
<p>In summary, AMPK and mTOR play opposing roles in controlling metabolic activity of cells in response to intracellular and extracellular signals.</p>
<h3 id="4-sirtuins"><a class="markdownIt-Anchor" href="#4-sirtuins"></a> 4. Sirtuins</h3>
<p><strong>Sirtuins (沉默调节蛋白)</strong> are a highly conserved family of <strong>NAD±dependent protein deacetylases.</strong> (去乙酰化酶)</p>
<p>Sirtuins are named after the founding member of the family, yeast Sir2 (silent information regulator 2), which <u>deacetylates histones to regulate gene expression (silencing)</u> of the mating type locus in yeast.</p>
<p>Sirtuins are now known to act on <u>many proteins</u> besides histones, and they are <u>structurally conserved</u> from bacteria to humans.</p>
<p>Mammals possess seven sirtuins (<strong>SIRT1-7</strong>), which differ in their cellular localization (nucleus, mitochondria, cytoplasm) and protein targets.</p>
<p>For most protein targets, <u>deacetylation increases</u> the activity of the target protein.</p>
<p>The <u>deacetylase activity of sirtuins</u> is sensitive to changes in the cellular NAD+ levels, <u>being enhanced at high NAD+/NADH ratio</u>.</p>
<p>Thus, <u>sirtuins act as metabolic sensors of the cellular redox state</u>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417165905948.png" alt="image-20200417165905948" style="zoom:100%;" />
#### Catalytic core of sirtuins is evolutionarily conserved:
<p>X-ray crystal structures of the catalytic cores of sirtuins from:</p>
<ol>
<li>Yeast</li>
<li>Archaea 古菌域</li>
<li>eubacterium 真杆菌</li>
<li>Human</li>
<li>yeast Hst2 sirtuin with bound acetylated peptide substrate and carba-NAD+, a substrate analog</li>
</ol>
<p>Show a high degree of structural similarity.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417170012990.png" alt="image-20200417170012990" style="zoom: 20%;" />
<h4 id="pgc-1-and-sirt1-control-the-reprogramming-of-fuel-utilization-pathways-in-response-to-fasting"><a class="markdownIt-Anchor" href="#pgc-1-and-sirt1-control-the-reprogramming-of-fuel-utilization-pathways-in-response-to-fasting"></a> PGC-1 and SIRT1 control the reprogramming of fuel utilization pathways in response to fasting</h4>
<p>A <u>high NAD+/NADH ratio</u>, in response to low nutrients (fasting), <u>activates SIRT1</u> to <u>deacetylate PGC-1, upregulating</u> its transcriptional coactivator function.</p>
<ul>
<li>Tissue-specific transcriptional activation programs result in increased gluconeogenesis (liver) and increased fatty acid oxidation (skeletal and heart muscle).</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417170113194.png" alt="image-20200417170113194" style="zoom:20%;" />
<ul>
<li>PGC-1: peroxisome proliferator-activated receptor-gamma coactivator 1</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417170139302.png" alt="image-20200417170139302" style="zoom:67%;" />
<p><strong>Calorie restriction (CR)</strong> extends lifespan in organisms ranging from yeast to primates.</p>
<p><u>The mechanisms are not fully understood, but sirtuins are important mediators of this response.</u></p>
<p>Although <strong>resveratrol (白藜芦醇)</strong> and newer classes of <strong>SIRT1 activators</strong> do indeed confer many phenotypes of CR on fed animals, they are not likely to represent a simple “<u>fountain of youth.</u>”</p>
<p>Nonetheless, pharmacological manipulation of sirtuin function holds great promise for treatment of <u>aging-related diseases.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171218924.png" alt="image-20200417171218924" style="zoom:67%;" />
<ul>
<li>Resveratrol: found in red grapes (and thus red wine), berries</li>
<li>CR delays the onset of aging-associated diseases (diabetes, cancer, cardiovascular diseases, and brain atrophy)</li>
</ul>
<h3 id="5-fuel-and-hormonal-control-of-food-intake-in-the-arcuate-nucleus-弓状核-of-the-hypothalamus-下丘脑"><a class="markdownIt-Anchor" href="#5-fuel-and-hormonal-control-of-food-intake-in-the-arcuate-nucleus-弓状核-of-the-hypothalamus-下丘脑"></a> 5. Fuel and hormonal control of food intake in the arcuate nucleus (弓状核) of the hypothalamus (下丘脑)</h3>
<p>Activation of AMPK promotes food intake;</p>
<ul>
<li>inhibition of AMPK suppresses food intake.</li>
</ul>
<p><strong>Insulin</strong> acts through the phosphoinositide 3-kinase (PI3K) cascade to inhibit food intake.</p>
<p><strong>Leptin</strong> (瘦素) has both direct and indirect effects (through PI3K and AMPK) on mTOR.</p>
<p><strong>Adiponectin</strong> (脂联素) and <strong>ghrelin</strong> stimulate food intake by activating AMPK.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171332793.png" alt="image-20200417171332793" style="zoom: 50%;" />
<ul>
<li>In mammals, the brain coordinates whole body energy homeostasis. The brain receives information about the quality and quantity of nutrients being consumed, the levels of fuels already present in the blood, and the amounts of energy present in various storage depots in the body.</li>
<li>The most important endocrine regulators of food intake are insulin and leptin (inhibit intake), and ghrelin and adiponectin (promote intake). Each of these act via specific receptors on particular cells in the <strong>arcuate nucleus</strong> to initiate signaling pathways that converge on AMPK and mTOR.</li>
</ul>
<h1 id="三-responses-to-metabolic-stress-starvation-diabetes"><a class="markdownIt-Anchor" href="#三-responses-to-metabolic-stress-starvation-diabetes"></a> 三、Responses to Metabolic Stress: Starvation, Diabetes</h1>
<p>Major events in the storage, retrieval, and use of fuels in the fed and unfed states and in early starvation:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171915579.png" alt="image-20200417171915579" style="zoom:100%;" />
An excellent way to understand how the interorgan and hormonal relationships actually integrate fuel metabolism is to examine the effects of metabolic stress：
<ol>
<li>Prolonged fasting, in which the intake of fuel substrates is inadequate;</li>
<li><strong>Diabetes mellitus</strong>, in which a functional insufficiency of insulin impairs the ability of the body to use glucose, even when the sugar is present in abundance.</li>
</ol>
<h2 id="glucose-levels-are-maintained-during-normal-feeding-cycles"><a class="markdownIt-Anchor" href="#glucose-levels-are-maintained-during-normal-feeding-cycles"></a> Glucose levels are maintained during normal feeding cycles</h2>
<p><u>Shortly after a carbohydrate-containing meal</u>, blood glucose elevation occurs. <u>Stimulates insulin secretion; Suppresses glucagon secretion</u></p>
<p>Insulin promotes uptake of glucose into the <u>liver</u>, stimulates glycogen synthesis, suppress glycogen breakdown;</p>
<p>Flux through <strong>hexokinase IV</strong> increases in response to elevated glucose levels, providing substrates for glycogen synthesis;</p>
<p>Activation of acetyl-CoA carboxylase (ACC) in the liver stimulates <u>fatty acid synthesis</u> with subsequent transport to adipose tissue as TAG in VLDL;</p>
<p>The increased levels of glycogenic intermediates and fatty acids stimulate <u>TAG synthesis;</u></p>
<p>Increased glucose uptake into <u>muscle</u> increases levels of substrates for <u>glycogen synthesis.</u></p>
<hr />
<p><u>Several hours later</u>, when blood glucose levels begin to fall, the above events are reversed;</p>
<p><u>Insulin secretion slows and glucagon secretion increases;</u></p>
<p>This <u>promotes glycogen mobilization</u> in liver via the cAMP-dependent cascade; mechanisms that activate glycogen phosphorylase and <u>inactivate glycogen synthase;</u></p>
<p><u>TAG breakdown</u> in adipocytes is activated as well, via the action of hormone-sensitive lipase, generating fatty acids for use as fuel by liver and muscle;</p>
<p>At the same time, the decrease in insulin levels <u>reduces glucose use</u> by muscle, liver, and adipose tissue;</p>
<p>Consequently, nearly all the glucose produced in the liver is expected to the blood and is available for use by the brain</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417172521248.png" alt="image-20200417172521248" style="zoom:50%;" />
<ul>
<li><u>Metabolic adaptations</u> promote alternative fuel use during starvation so that glucose homeostasis is maintained for <u>several weeks</u>.</li>
</ul>
<h2 id="starvation"><a class="markdownIt-Anchor" href="#starvation"></a> Starvation</h2>
<h3 id="1-using-carbohydrates-and-tag"><a class="markdownIt-Anchor" href="#1-using-carbohydrates-and-tag"></a> 1. Using Carbohydrates and TAG</h3>
<ul>
<li><u>Glycogen, 6700 kJ</u>, this source of blood glucose will be exhausted in just <u>a few hours</u>;</li>
</ul>
<p>It is critical for <u>brain function</u> that blood glucose levels be maintained <u>near 4.4 mM</u>, the organism adapts metabolically to increase the use of fuels other than carbohydrate, primarily <u>fat</u>;</p>
<p><u>565,000 kJ TG</u>, largely in adipose tissue; <u>100,000 kJ</u> mobilizable <u>proteins</u>, largely in muscle, enough to permit survival for <u>up to several months</u>. However, use of these stores presents <u>problems</u>:</p>
<ul>
<li><u>TAG mobilization</u> generates metabolic fuel largely in the form of <u>acetyl-CoA</u>, whose further oxidation in the citric acid cycle requires <u>oxaloacetate</u>, which must be replenished (补充) via anaplerotic (回补) pathways.</li>
</ul>
<p>The most important of these processes is the <strong>pyruvate carboxylase</strong> reaction, with most of the pyruvate coming from <u>carbohydrate catabolism</u>. When carbohydrate availability is limited, the resupply of <u>citric acid cycle intermediates is limited</u>, and flux through <u>the cycle may be reduced</u>.</p>
<p>During carbohydrate limitation, citric acid cycle intermediates can be provided from <u>other sources</u>:</p>
<ul>
<li>The glycerol released from <strong>lipolysis</strong>, but not produced enough amounts to maintain levels of citric acid cycle intermediates</li>
</ul>
<h3 id="2-using-proteins"><a class="markdownIt-Anchor" href="#2-using-proteins"></a> 2. Using Proteins</h3>
<p><u>Intermediates from protein catabolism and transamination</u>, but this process is energetically wasteful and has the undesirable effect of wasting the muscle and weakening the fasting subject.</p>
<ul>
<li>Proteolysis is accelerated during the first few days of starvation. <u>A major fate of the released amino acids is gluconeogenesis.</u></li>
</ul>
<p>During this time, the <u>liver and muscle</u> are <u>shifting to fatty acids</u> as the dominant fuels for their own use.</p>
<p>Meanwhile, the increased use of carbon for gluconeogenesis diminishes the amount of <strong>oxaloacetate</strong> available to combine with acetyl-CoA in the citric acid cycle.</p>
<h3 id="3-use-ketonebodies"><a class="markdownIt-Anchor" href="#3-use-ketonebodies"></a> 3. Use Ketonebodies</h3>
<p><strong>Fat breakdown↑</strong> ➔ acetyl-CoA and reduced electron carriers accumulate ↑ in the liver ➔ cannot be oxidized ➔ <strong>ketone bodies accumulation ↑.</strong></p>
<p>Thus, <u>brain</u> adapts to reduce glucose levels by increasing the use of <u>ketone bodies</u> as alternative energy substrates. This trend continues for the duration of starvation.</p>
<p>On the <u>3rd day, 1/3 energy from ketone bodies</u>; By <u>day 40, 2/3 energy from ketone bodies.</u></p>
<ul>
<li><u>This adaptation reduces the need for gluconeogenesis and spares the mobilization of muscle proteins.</u> About <u>75 grams</u> proteins consumed per day on <u>day 3;</u> About <u>20 gram</u> proteins consumed per day on <u>day 40</u>.</li>
</ul>
<p>The metabolic changes accompanying starvation compromise the organism’s abilities to responds to <u>further stress</u>, such as <u>extreme cold or infection</u>.</p>
<p>However, the adaptations do allow life to continue for <u>many weeks</u> without food intake, the total period being determined largely by the size of the <u>fat deposits</u>.</p>
<h2 id="diabetes"><a class="markdownIt-Anchor" href="#diabetes"></a> Diabetes</h2>
<p><strong>Diabetes</strong> results either from insulin deficiency or from defects in the insulin response mechanism.</p>
<ul>
<li><u>Diabetes is a major public health issue worldwide</u></li>
<li>It is estimated that more than <u>12% of the adult population</u> in the United States is afflicted with this disease.</li>
<li>China: about 21 millions; India: about 32 millions. Type I: 5～10%; Type II: 90-95%.</li>
</ul>
<p>Diabetes can be thought of as “<u>starvation in the midst of plenty</u>” because cells are unable to utilize the glucose that accumulates in the blood.</p>
<ol>
<li><strong>Type 1 diabetes</strong>, formerly called <u>insulin-dependent diabetes</u>, or juvenile diabetes because of its typical early onset, often involves <strong>autoimmune</strong> destruction of the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> cells of the pancreas, which can be caused by various factors, including <u>viral infections.</u></li>
</ol>
<p>Some forms of type 1 diabetes have a <u>genetic</u> origin. <u>Mutations in the insulin</u> structure can render the hormone inactive, and other mutations cause defects in the <u>conversion</u> of preproinsulin or proinsulin to the active hormone. Either way, type 1 diabetes is characterized by <u>insulin deficiency</u>, can be <u>treated by administration of insulin</u>.</p>
<ol start="2">
<li><strong>Type 2 diabetes</strong>, formerly called <u>adult-onset diabetes, obesity-related diabetes</u>, or <u>non-insulin-dependent diabetes mellitus</u>, is characterized by <u>insulin resistance</u>—patients cannot respond to therapeutic doses of insulin. Type 2 diabetes accounts for <u>more than 95%</u> of people with diabetes</li>
</ol>
<h3 id="1-obesity-and-insulin-resistance-in-type-2-diabetes"><a class="markdownIt-Anchor" href="#1-obesity-and-insulin-resistance-in-type-2-diabetes"></a> 1. Obesity and insulin resistance in type 2 diabetes</h3>
<p>The specific defects that led to <u>insulin resistance</u> in type 2 diabetes are <u>not</u> known, but <u>several clues</u> are beginning to shed some light on the disease;</p>
<ol>
<li>Most people with type 2 diabetes are also <u>obese</u>, in fact, <u>obesity is so closely associated with insulin resistance</u> that there must be a mechanistic link;</li>
</ol>
<ul>
<li>Like diabetes, the prevalence of <u>obesity</u> has dramatically <u>increased</u> in the United States since 1970s, with <u>34%</u> of adults classified as obese in 2010;</li>
</ul>
<p>The close relationship between <u>type 2 diabetes and metabolic syndrome</u>.</p>
<ul>
<li>Metabolic syndrome, which afflicts with 50 million Americans, is defined by <u>abnormal obesity, hypertension, high blood sugar, and, more importantly, insulin resistance</u>. These metabolic abnormalities often <u>precede both cardiovascular disease and diabetes;</u></li>
</ul>
<p>Common to both obesity and metabolic syndrome is <u>excess fuel intake and abnormal accumulation of lipid in “ectopic sites”, primarily liver and skeletal muscle.</u></p>
<h4 id="abnormal-lipid-accumulation-cause-insulin-resistance-in-type-2-diabetes"><a class="markdownIt-Anchor" href="#abnormal-lipid-accumulation-cause-insulin-resistance-in-type-2-diabetes"></a> Abnormal lipid accumulation cause insulin resistance in type 2 diabetes</h4>
<p>The <u>lipid overload</u> hypothesis state that <u>fat accumulation in muscle cells</u>, <u>blocks the insulin signaling pathway that normally stimulates translocation of GLUT4</u> ( the major glucose transporter in muscle) <u>to the membrane</u>. Thus, insulin no longer efficiently stimulates <u>glucose transport</u>, that is , the cell is insulin resistant.</p>
<p>The <strong>Inflammation</strong> hypothesis states that as <u>adipose cell increase in size with excess lipids</u>, they secrete <u>inflammatory adipokines</u>, including TNF-α, interleukins, and resistin. These cytokines bind to their receptors in peripheral tissues such <u>as muscle and stimulate an inhibitory phosphorylation of IRS</u>, making it a <u>poor substrate for the insulin receptor tyrosine kinase</u>. Once again, insulin signaling is shut down, and the cell becomes insulin resistant.</p>
<p>Thus, although type 2 diabetes has long been characterized by defects in carbohydrate metabolism, <u>abnormal lipid metabolism may be the root of the disease.</u></p>
<h4 id="insulin-resistance-in-type-2-diabetes"><a class="markdownIt-Anchor" href="#insulin-resistance-in-type-2-diabetes"></a> insulin resistance in Type 2 diabetes</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417180528155.png" alt="image-20200417180528155" style="zoom:100%;" />
### 2. The metabolic abnormalities in diabetes
<p>The insulin deficiency blocks the <u>uptake of glucose</u> into muscle and adipose tissue and reduces glucose catabolism in all tissues.</p>
<ul>
<li><u>Proteolysis in muscle and lipolysis in adipose tissue are enhanced.</u></li>
<li>In the <u>liver, gluconeogenesis from amino acids and citric acid cycle intermediates is stimulated</u> as the cells attempt to remedy the perceived lack of usable glucose, and f<u>atty acid oxidation and ketogenesis are also increased.</u></li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417180657621.png" alt="image-20200417180657621" style="zoom:100%;" />
The insufficient production of insulin or the failure of insulin to act normally in promoting glucose utilization lead to: 
<ol>
<li>glucose accumulation in the blood;</li>
<li>starves the cells of nutrients;</li>
<li>promotes metabolic responses similar to those of fasting;</li>
</ol>
<p><u>Liver cells</u> attempt to generate more glucose by stimulating <u>gluconeogenesis</u>. Most of the substrates come from <u>amino acids</u>, which in turn come largely from degradation of muscle proteins;</p>
<ul>
<li><u>Glucose cannot be reused for resynthesis of amino acids or of fatty acids</u>, so a person with diabetes may <strong>lose weight</strong> even while consuming with would normally be adequate calories in the diet.</li>
</ul>
<p>As cells attempt to generate usable energy sources, <u>TG depots are mobilized</u> in response to the abnormally <u>low insulin-to-glucagon ratio</u>;</p>
<ul>
<li><u>Fatty acid oxidation</u> is elevated, with concomitant generation of <u>acetyl-CoA</u>;</li>
</ul>
<p>Flux through the <u>citric acid cycle may decrease</u> because of the accumulation of reduced electron carriers and/or <u>oxaloacetate limitation</u>;</p>
<p>In liver, <u>both effects accelerate ketone bodies formation</u>, generating increased levels of organic acids in the blood (<strong>ketosis</strong>). These acids can lower the blood pH from the normal value of <u>7.4 to 6.8 or lower</u> (<strong>ketoacidosis</strong>);</p>
<p><u>Decarboxylation of acetoacetate</u>, which is stimulated at low pH, generate <strong>acetone</strong>, which can be smelled on the breath of patients with ketoacidosis;</p>
<p>A special danger is that such people may <u>lose consciousness</u>, and this, coupled with a <u>sweet organic odor</u> in the breath, may give the impression that they are intoxicated, when in fact their <u>lives are in jeopardy</u>.</p>
<p>The excessive concentrations of glucose in body fluids generate other metabolic problems, quite different from anything seen in starvation.</p>
<ul>
<li>At the blood glucose levels above <u>10 mM</u>, the kidney can no longer reabsorb all of the glucose out of the blood filtrate, and <u>glucose</u> is spilled in to the <u>urine</u>, sometimes in amounts approaching 100 grams per day. In fact, the Latin name diabetes mellitus literally means “honey-sweet urine.” Glucose excretion creates an <u>osmotic load</u>, which causes large amounts of water to be excreted as well, and under these conditions the kidney cannot absorb most of this water. In fact, the earliest indications of diabetes are often <u>frequent and excessive urination, coupled with excessive thirst</u>. Long before biochemistry was a science, <u>the loss of nutrients, excessive urination, and breakdown of fat and protein were recognized as hallmarks of diabetes.</u></li>
</ul>
<p>In <u>type 1diabetes</u>, the metabolic imbalance is usually more severe and difficult to control than in the milder and more common type 2 diabetes. The latter can often be controlled by <u>exercise and dietary restriction of carbohydrate</u>, whereas the <u>treatment of type 1 diabetes involves daily self-injection of insulin</u>. For many years this insulin was purified from bovine pancreas, and its high cost, coupled with occasional problems resulting from the minor structural differences between human and bovine insulin. In the late 1970s, the gene for human insulin was cloned into E.coli in a form that allowed it to be expressed.</p>
<h2 id="diabetes-vs-starvation"><a class="markdownIt-Anchor" href="#diabetes-vs-starvation"></a> Diabetes vs. starvation</h2>
<p>In <strong>starvation</strong>, glucose utilization is abnormally low because of inadequate glucose supplies.</p>
<p>In <strong>diabetes mellitus</strong>, glucose utilization is similarly low, but the reason in this case is that the hormonal stimulus to glucose utilization-namely, insulin—is defective. As a result, glucose is actually present in excessive amounts.</p>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/9bdd6c34.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/9bdd6c34.html" class="post-title-link" itemprop="url">L07 Interorgan and Intracellular Coordination of Energy Metabolism in Vertebrates</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:39" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/9bdd6c34.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/9bdd6c34.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>31k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <p>Interorgan and Intracellular Coordination of Energy Metabolism in Vertebrates</p>
<ul>
<li>脊椎动物器官间和细胞内能源代谢的协调</li>
</ul>
<h1 id="一-interdependence-of-the-major-organs-in-vertebrate-fuel-metabolism"><a class="markdownIt-Anchor" href="#一-interdependence-of-the-major-organs-in-vertebrate-fuel-metabolism"></a> 一、Interdependence of the Major Organs in Vertebrate Fuel Metabolism</h1>
<p>Metabolite concentrations represent a significant intracellular control mechanism (<u>availability of substrate</u>).</p>
<p>The major fuel depots are triacylglycerols (adipose tissue), protein (muscle), and glycogen (muscle and liver).</p>
<ul>
<li>Marathon run: glycogen ➔ fatty acids</li>
<li>Metabolic adaptation</li>
</ul>
<h2 id="fuel-inputs-and-outputs"><a class="markdownIt-Anchor" href="#fuel-inputs-and-outputs"></a> Fuel Inputs and Outputs</h2>
<p>Kidney must generate ATP for the osmotic work of transporting solutes against a concentration gradient for excretion;</p>
<p>Muscle: ATP/mechanical work of contraction;</p>
<p>Heart muscle: the energy supply must be continuous;</p>
<p>Liver: ATP/ biosynthesis purposes, plasma protein synthesis, cholesterol generation, fatty acid synthesis, gluconeogenesis, or the production of urea for nitrogen excretion;</p>
<p>Energy production must meet needs that vary widely, depending on level of exertion, composition of fuel molecules in the diet, time since last feeding, and so forth;</p>
<p>In humans the daily caloric intake may vary by <u>4-fold</u>, depending in part on the level of exertion—from <u>1500 to 6000 kcal/day (6000 to 25,000 kJ/day)</u> in an average-sized human (1 kcal is equal to <strong>1 large calorie, or Cal</strong>).</p>
<h2 id="metabolic-interactions-among-the-major-fuel-metabolizing-organs"><a class="markdownIt-Anchor" href="#metabolic-interactions-among-the-major-fuel-metabolizing-organs"></a> Metabolic interactions among the major fuel-metabolizing organs</h2>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200408112139955.png" alt="image-20200408112139955" /></p>
<ul>
<li>Yellow: lipid-derived metabolites</li>
<li>Blue: carbohydrate-derived metabolites</li>
</ul>
<h3 id="1-brain"><a class="markdownIt-Anchor" href="#1-brain"></a> 1. Brain</h3>
<p>The most <u>fastidious（过分挑剔的）</u>, it must use ATP in large quantities to maintain the membrane potentials essential for transmission of nerve impulses;</p>
<p>Under <u>normal conditions, use only glucose</u> to meet its prodigious energy requirement, which accounts about <u>60%</u> of the glucose utilization of a human <u>at rest</u> (about <u>120 grams of glucose per day, 1700 kJ</u>, about <u>15%</u> of the total energy consumed by one person);</p>
<p>The brain’s quantitative requirement for glucose remains <u>quite constant</u>, even when an animal is at rest or asleep;</p>
<p>The brain is a highly <u>aerobic</u> organ, <u>20%</u> of the total oxygen consumed by a human;</p>
<p>The brain has <u>no significant glucose or other fuel reserves</u>, the supply of both oxygen and glucose <u>cannot be interrupted</u>, even for a short time. Otherwise, irreversible brain damage results;</p>
<ul>
<li>No fuel reserve, therefore highly depends on external fuel molecule transport</li>
<li>However, the brain can adapt during <u>starvation</u> to use <u>ketone bodies</u> instead of glucose as major fuel.</li>
</ul>
<h3 id="2-muscle"><a class="markdownIt-Anchor" href="#2-muscle"></a> 2. Muscle</h3>
<p>Muscle can utilize <u>a variety of fuel-glucose, fatty acids, and ketone bodies;</u></p>
<p>Skeletal muscle varies widely in its energy demands and fuels it consumes, in line with its wide variations in activity;</p>
<p>In <u>resting</u> muscle, <strong>fatty acids</strong> –major energy source; during <u>exertion</u>, <strong>glucose</strong> is the primary source;</p>
<p><u>Early</u> in a period of exertion, that glucose comes from mobilization of the muscle’s <u>glycogen</u> reserves. <u>Later</u>, as glycogen reserves are depleted, <u>fatty acids</u> become the dominant fuel;</p>
<p>Skeletal muscle stores about <u>three-fourths</u> of the total glycogen in humans, with most of the rest being stored in the liver;</p>
<p>Muscle lacks the enzyme <strong>glucose-6-phosphatase,</strong> so glucose phosphate derived from glycogen cannot be converted to free glucose for export-they are retained for use by the muscle cells. Therefore, glucose phosphate produced from muscle glycogen cannot be released for use by other tissues;  (Gluconeogenesis bypass 3 cannot occur)</p>
<ul>
<li>muscle cell 缺少 glucose-6-phosphatase, 使得glucose不能运出cell，从而导致glucose只进不出</li>
</ul>
<p>During <u>exertion</u>, the flux rate through <u>glycolysis</u> exceeds that through the citric acid cycle, so <strong>lactate</strong> accumulates and is released;</p>
<p>Another metabolic product is <strong>alanine</strong>, produced via <u>transamination from pyruvate</u> in the <strong>glucose-alanine cycle;</strong></p>
<p>Both <strong>lactate and alanine</strong> are transported through the bloodstream to the liver, where they are reconverted through glyconeogenesis to glucose, for return to the muscle and other tissues by the <strong>Cori cycle</strong>; However, <u>the major fate of lactate</u> during exertion is <u>uptake by the heart</u> for use as fuel, via oxidation to CO2;</p>
<p>Muscle contains another readily mobilizable source of energy—<u>its own protein</u>. However, the breakdown of muscle protein to meet energy needs is both <u>energetically wasteful and harmful</u> to an animal, which needs its muscle to move around in order to survive. Protein breakdown is regulated to minimize amino acid catabolism except in starvation.</p>
<p>Muscle had additional energy reserve in <strong>creatine phosphate (磷酸肌酸)</strong>, which generates ATP without the need for metabolizing fuels. This reserve is exhausted early in a period of exertion and must be replenished, along with glycogen stores, as muscle rests after prolonged exertion.</p>
<h4 id="cori-cycle"><a class="markdownIt-Anchor" href="#cori-cycle"></a> Cori Cycle</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415102536917.png" alt="image-20200415102536917" /></p>
<h4 id="glucose-alanine-cycle"><a class="markdownIt-Anchor" href="#glucose-alanine-cycle"></a> Glucose-Alanine Cycle</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415102554736.png" alt="image-20200415102554736" /></p>
<ul>
<li>Transport of ammonia (toxic) from the muscle to liver for urea synthesis</li>
<li>蛋白质代谢产生的产物之一是氨</li>
</ul>
<h3 id="3-heart"><a class="markdownIt-Anchor" href="#3-heart"></a> 3. Heart</h3>
<p>The metabolism of heart muscle <u>differs from that of skeletal muscle</u> in three important aspects:</p>
<ol>
<li>Work output is <u>far less variable</u> than in skeletal muscle;</li>
<li>The heart is a <u>completely aerobic tissue</u>, while skeletal muscle can function anaerobically for limited periods. <u>Mitochondria</u> are much more densely packed in heart than in other cells, making up nearly <u>half the volume</u> of a heart cell;</li>
<li>The heart contains <u>negligible energy reserve</u> as glycogen or lipids, although there is a small amount of creatine phosphate. Therefore, supply of both oxygen and fuels from the blood <u>must be continuous</u> to meet the unending energy demands of the heart.</li>
</ol>
<p>The heart uses <u>a variety of fuels</u>—mainly fatty acids but also <strong>glucose, lactate, and ketone bodies.</strong></p>
<h3 id="4-adipose-tissue"><a class="markdownIt-Anchor" href="#4-adipose-tissue"></a> 4. Adipose Tissue</h3>
<p>Adipose tissue represents the major fuel depot for an animal. The total stored TG amount to some <u>555,000 kJ (133,000 Cal)</u> in an average-sized human. This is enough fuel, to sustain life for several <u>months</u> in the absence of further caloric intake;</p>
<p>The adipocyte is designed for <u>continuous synthesis and breakdown of TG</u>, with breakdown controlled largely via the activation of <u>hormone-sensitive triglyceride lipase;</u></p>
<p>Because <u>adipocytes lack the enzyme <strong>glycerol kinase</strong></u>, some <u>glucose catabolism must occur for TG synthesis to take place</u>—specifically, the formation of dihydroxyacetone phosphate (<strong>DHAP</strong>), for reduction to <u>glycerol-3-phosphate</u>;</p>
<p><u>Glucose acts as a sensor in adipose tissue metabolism</u>.</p>
<ul>
<li>Intracellular (adipocyte) glucose levels ↑ ➔ DHAP ↑ ➔ glycerol-3-phosphate ↑ ➔ TG synthesis ↑;</li>
<li>Intracellular glucose levels ↓ ➔ DHAP ↓ ➔ glycerol-3-phosphate ↓ ➔ TG synthesis ↓.</li>
</ul>
<h3 id="5-liver"><a class="markdownIt-Anchor" href="#5-liver"></a> 5. Liver</h3>
<h4 id="liver-i-metabolite-synthesis"><a class="markdownIt-Anchor" href="#liver-i-metabolite-synthesis"></a> Liver (I) - Metabolite Synthesis</h4>
<p><u>A primary role of liver is the synthesis of fuel components for use by other organs.</u> In fact, most of the low-molecular-weight metabolites that appear in the blood through digestion are taken up by the liver for this metabolic processing;</p>
<p>The liver is a major site for <u>fatty acid synthesis</u>; it also <u>produces glucose</u>, both from its own glycogen stores and from <u>gluconeogenesis</u>, <u>the latter using lactate and alanine from muscle, glycerol from adipose tissue, and the amino acids</u> not needed for protein synthesis; <strong>ketone bodies</strong> are also manufactured largely in the liver;</p>
<p>In liver, the level of <strong>malonyl-CoA</strong> is a determinant of the fate of fatty acyl-CoAs. When fuel is abundant↑ ➔ malonyl-CoA ↑ ➔ carnitine acyltransferase I (<strong>CPT1</strong>) ↓  ➔ transport of fatty acyl-CoAs into mitochondria  ↓  ➔ β-oxidation ↓ and ketogenesis ↓ ;</p>
<p>When fuel is inadequate↓ ➔ malonyl-CoA ↓ ➔ carnitine acyltransferase I (<strong>CPT1</strong>) ↑  ➔ transport of fatty acyl-CoAs into mitochondria ↑  ➔ β-oxidation ↑ and ketogenesis ↑ .</p>
<h4 id="liver-ii-buffer-blood-glucose"><a class="markdownIt-Anchor" href="#liver-ii-buffer-blood-glucose"></a> Liver (II) - Buffer Blood Glucose</h4>
<p><u>An important role of liver is to buffer the level of blood glucose</u>. It does this largely through the action of <strong>hexokinase IV</strong> (己糖激酶Ⅳ，previously called <strong>glucokinase (葡(萄)糖激酶)</strong>), an enzyme specific to liver, with a <u>high K<sub>1/2</sub> (about 7.5 mM)</u> for glucose, and partly a <strong>high-K<sub>m</sub> transporter protein</strong>, the <strong>glucose transporter (GLUT2)</strong>.</p>
<ul>
<li>
<p>Thus, high blood glucose levels  ↑  ➔ uptake and phosphorylation of glucose ↑  ➔ glycogen systhesis ↑;</p>
</li>
<li>
<p><strong>Glucose-6-phosphate</strong> accumulation ↑ ➔ activates the β form of glycogen synthase ↑;</p>
</li>
<li>
<p><strong>Glucose</strong> itself binds to <strong>glycogen phosphorylase a</strong>, increases its dephosphorylation and results in <u>inactivation</u> ↓ ；</p>
</li>
</ul>
<p>Thus, liver senses the <strong>fed state</strong> and acts to store fuel derived from glucose. Liver also senses the <strong>fasted state</strong> and increase the synthesis and export of glucose when blood glucose levels are low.</p>
<p>The liver can use a variety of fuel sources, including <strong>glucose, fatty acids, and amino acids.</strong></p>
<h3 id="6-blood"><a class="markdownIt-Anchor" href="#6-blood"></a> 6. Blood</h3>
<p>All the organs are connected by the bloodstream, which transport what may be one organ’s waste product but another organ’s fuel</p>
<ul>
<li>Blood transport O2 and CO2</li>
<li><u>Lipoprotein: CM and VLDL</u></li>
<li><strong>RBC</strong>: no mitochondria, depend exclusively upon <u>anaerobic glycolysis</u> to their limited energy needs</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415104406401.png" alt="image-20200415104406401" style="zoom: 50%;" />
<h1 id="二-hormonal-regulation-of-fuel-metabolism"><a class="markdownIt-Anchor" href="#二-hormonal-regulation-of-fuel-metabolism"></a> 二、Hormonal Regulation of Fuel Metabolism</h1>
<p>Maintenance of blood glucose within narrow limits is critical to <u>brain function.</u></p>
<p>One of the most important roles of <u>liver</u> is to serve as a “glucostat （葡萄糖调节剂）” monitoring and stabilizing blood glucose levels.</p>
<p>The key hormones regulating fuel metabolism are <strong><u>insulin</u></strong>, which promotes glucose use, and <strong>glucagon</strong> and <strong>epinephrine</strong>, which increase blood glucose.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105324000.png" alt="image-20200415105324000" style="zoom: 67%;" />
<ul>
<li>Several hours after a meal: 80 mg/100 ml or 4.4 mM; Shortly after the meal: 120 mg/100 ml, 6.6 mM, uptake by cells;</li>
<li><strong>Islets of Langerhans (胰岛；郎格罕氏岛)</strong> contain at least five different cell types, each specialized for synthesis of one hormone:
<ul>
<li>
<ol>
<li>the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span> (or A) cells produce <strong>glucagon</strong>（胰高血糖素）;</li>
</ol>
</li>
<li>
<ol start="2">
<li>the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>δ</mi></mrow><annotation encoding="application/x-tex">\delta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.69444em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.03785em;">δ</span></span></span></span> (or D) cells, <strong>somatostatin（生长激素抑制素）</strong>;</li>
</ol>
</li>
<li>
<ol start="3">
<li>the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>ϵ</mi></mrow><annotation encoding="application/x-tex">\epsilon</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault">ϵ</span></span></span></span> cells, <strong>ghrelin（生长素释放肽）</strong>;</li>
</ol>
</li>
<li>
<ol start="4">
<li>the F cells, pancreatic polypeptide;</li>
</ol>
</li>
<li>
<ol start="5">
<li><span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> (or B) cells, <strong>insulin（胰岛素）</strong>.</li>
</ol>
</li>
</ul>
</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105453858.png" alt="image-20200415105453858" /></p>
<h2 id="insulin-regulation-of-fuel-metabolism"><a class="markdownIt-Anchor" href="#insulin-regulation-of-fuel-metabolism"></a> Insulin regulation of fuel metabolism</h2>
<p>Insulin signals the <u>fed state</u> and thereby promotes</p>
<ol>
<li><strong>uptake</strong> of fuel substrates into some cells,</li>
<li><strong>storage</strong> of fuels (lipids and glycogen),</li>
<li><strong>biosynthesis</strong> of macromolecules (nucleic acids and protein);</li>
</ol>
<p>The <u>specific effects</u> include:</p>
<ol>
<li>increased uptake of glucose in muscle and adipose tissue;</li>
<li>activation of glycolysis in liver;</li>
<li>increased synthesis of fatty acids and TG in liver and adipose tissue;</li>
<li>inhibition of gluconeogenesis in liver;</li>
<li>increased glycogen synthesis  in liver and muscle;</li>
<li>increased uptake of amino acids into muscle with consequent activation of muscle protein synthesis;</li>
<li>inhibition of protein degradation;</li>
<li>cell growth-promoting effect.</li>
</ol>
<p>Because of its promotion of biosynthesis, it is appropriate to consider insulin a <strong>growth hormone.</strong></p>
<h3 id="1-glucose-promote-insulin-release-from-the-beta-cells"><a class="markdownIt-Anchor" href="#1-glucose-promote-insulin-release-from-the-beta-cells"></a> 1. Glucose promote insulin release from the beta cells</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105658818.png" alt="image-20200415105658818" style="zoom: 67%;" />
<h4 id="how-β-cells-release-insulin"><a class="markdownIt-Anchor" href="#how-β-cells-release-insulin"></a> How β cells release insulin</h4>
<p>The β cells take up and catabolize glucose ↑ ➔ ATP levels ↑ ➔ closure of ATP-gated K+ channels and depolarization of the plasma membrane ↑ ➔ cytosolic [Ca2+] ↑ ➔ triggers exocytosis of insulin granules ↑.</p>
<h4 id="the-ovweview-of-insulin-regulation-pathway"><a class="markdownIt-Anchor" href="#the-ovweview-of-insulin-regulation-pathway"></a> The ovweview of Insulin regulation pathway</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415105813925.png" alt="image-20200415105813925" /></p>
<ul>
<li>4EBP1: eukaryotic initiation 4E-binding protein</li>
<li>S6K: ribosomal protein S6 kinase</li>
<li>LKB1: Liver kinase B1</li>
<li>CaMKKb:Ca2+/calmodulin-dependent protein kinase kinase b</li>
<li>IRS: insulin receptor substrate</li>
<li>PGC-1: peroxisome proliferator-activated receptor-gamma coactivator 1</li>
<li>TSC: tuberous sclerosis complex</li>
<li>PI3K: phosphoinositide 3-kinase</li>
</ul>
<h3 id="2-insulin-facilitate-glucose-uptake-into-muscle-and-adipose-cells"><a class="markdownIt-Anchor" href="#2-insulin-facilitate-glucose-uptake-into-muscle-and-adipose-cells"></a> 2. Insulin facilitate glucose uptake into muscle and adipose cells</h3>
<p>The <u>mechanism by which insulin stimulates glucose uptake</u> into muscle and adipose cells in an area of intense investigation;</p>
<p>One important action involves the glucose transporter, <strong>GLUT4</strong>. Before stimulation by insulin, this transporter is not present on the cell surface; rather, it is localized in vesicles in the <u>cytosol</u>. The protein is translocated to the <u>cell surface in response to insulin</u>, where it facilitates glucose uptake.</p>
<p>An important consequence of glucose uptake in <strong>adipocytes</strong> is its conversion to glycerol-3-phosphate, which combines with fatty acids to stimulate TG synthesis.</p>
<h3 id="3-actions-of-glucagon-in-liver-that-lead-to-a-rise-in-blood-glucose"><a class="markdownIt-Anchor" href="#3-actions-of-glucagon-in-liver-that-lead-to-a-rise-in-blood-glucose"></a> 3. Actions of glucagon in liver that lead to a rise in blood glucose</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200415111507445.png" alt="image-20200415111507445" style="zoom:67%;" />
<ul>
<li>The primary target of glucagon is the <u>liver</u>, and its principal effect is to increase cyclic AMP levels in liver cells.</li>
<li>PFK: phosphofructokinase</li>
<li>PK: pyruvate kinase</li>
<li>F2,6BP: β-D-Fructose-2,6-bisphosphate</li>
<li>PEP: phosphoenolpyruvate</li>
</ul>
<p>A 3.5 kDa polypeptide</p>
<p>Produced by <strong>alpha-cells</strong> (α-cells); sense blood sugar; release in response to low blood sugar.</p>
<h3 id="4-actions-of-glucagon-in-adipose-cells"><a class="markdownIt-Anchor" href="#4-actions-of-glucagon-in-adipose-cells"></a> 4. Actions of glucagon in adipose cells</h3>
<p>Control of <u>lipolysis in adipose cells</u> by a cAMP-mediated cascade system:</p>
<p>Hormonal activation of a β–adrenergic <strong>G-protein coupled receptor （GPCR）</strong> on the plasma membrane leads to elevation of cAMP levels, which in turn, activates protein kinase A (PKA).  PKA phosphorylates <strong>perilipin</strong> (<strong>PL</strong>, 周脂素) and <strong>hormone-sensitive lipase (</strong> <strong>HSL</strong>, 激素敏感性脂肪酶).</p>
<ol>
<li>
<p>PL and HSL are phosphorylated.</p>
</li>
<li>
<p>CGI-58 dissociates from phosphorylated-PL, and binds ATGL.</p>
</li>
<li>
<p>Phosphorylated HSL is recruited to the lipid droplet and activated by phosphorylated-PL.</p>
<p>Phosphorylated-PL also recruits the ATGL/CGI-58 complex to the lipid droplet, activating this lipase.</p>
</li>
<li>
<p>Activated ATGL hydrolyzes TG to activated HSL hydrolyzes DG to cytoplasmic MGL hydrolyzes MG to free glycerol + FFA.</p>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417161040138.png" alt="image-20200417161040138" style="zoom:67%;" />
<ul>
<li>HSL: hormone-sensitive lipase</li>
<li>CGI-58: comparative gene identification-58CGI</li>
<li>ATGL: adipose triglyceride lipase</li>
<li>DG: diacylglycerol</li>
<li>MGL: monoglyceride lipase</li>
</ul>
<p>In adipose tissue, glucagon also increases cAMP. There the <u>chief effect of cAMP</u> is to promote TAG mobilization via phosphorylation of hormone-sensitive lipase and perilipin, yielding glycerol and fatty acids.</p>
<h2 id="epinephrine"><a class="markdownIt-Anchor" href="#epinephrine"></a> Epinephrine</h2>
<p>The <strong>catecholamines (儿茶酚胺)</strong> epinephrine (肾上腺素) and norepinephrine (去甲肾上腺素), when released from <u>presynaptic nerve endings</u>, function as neurotransmitters;</p>
<p>When released from <u>adrenal medulla</u> in response to low blood glucose levels, epinephrine interacts with second-messenger systems in many tissues, with varied effects;</p>
<p>In <u>muscle</u>, <strong>epinephrine</strong> activates adenylate cyclase with concomitant（伴随的） <u>activation of glycolysis and inhibition of glycogen synthesis;</u> <u>TG breakdown in adipose tissue</u> is also stimulated, providing fuel for the muscle tissue;</p>
<p>Inhibits insulin secretion and stimulates glucagon secretion; increases glucose production and release by the liver, the net result is to increase blood glucose levels;</p>
<p><u>Unlike glucagon</u>, the catecholamines have <u>short-lived</u> metabolic effects.</p>
<h3 id="1-endocrine-regulation-of-food-intake-and-energy-homeostasis-in-mammals"><a class="markdownIt-Anchor" href="#1-endocrine-regulation-of-food-intake-and-energy-homeostasis-in-mammals"></a> 1. Endocrine regulation of food intake and energy homeostasis in mammals</h3>
<p>The effects of the major endocrine regulators on <strong>AMPK</strong> signaling in brain, adipose tissue, liver, and skeletal muscle.</p>
<h2 id="coordination-of-energy-homeostasis"><a class="markdownIt-Anchor" href="#coordination-of-energy-homeostasis"></a> Coordination of Energy Homeostasis</h2>
<p><strong>AMPK</strong> ( AMP-activated protein kinase ) and <strong>mTOR</strong> (<u>mammalian target of rapamycin</u>) protein kinases play central roles in orchestrating the <u>metabolic activity</u> of mammalian cells.</p>
<p>AMPK is activated when the energy charge of the cell is <u>low</u>.</p>
<p>Mammalian <strong>AMP-activated protein kinase (AMPK)</strong>:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417162115046.png" alt="image-20200417162115046" style="zoom: 33%;" />
<ul>
<li>X-ray crystal structure of the heterotrimeric enzyme (AMPK)</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171740854.png" alt="image-20200417171740854" style="zoom: 50%;" />
<ul>
<li>Green arrow: activation of AMPK</li>
<li>Red cycles: inhibition of AMPK</li>
</ul>
<h3 id="1-amp-activated-protein-kinase-ampk"><a class="markdownIt-Anchor" href="#1-amp-activated-protein-kinase-ampk"></a> 1. AMP-Activated Protein Kinase (AMPK)</h3>
<p>AMPK, serine/threonine protein kinase, found in all eukaryotes, <u>is activated when the energy charge of the cell is low (i.e., high AMP:ATP ratio)</u>;</p>
<ul>
<li>在机体内部缺少能量的时候，AMPK被激活</li>
</ul>
<p>AMP:ATP ratio ↑(nutrient starvation or hypoxia（氧不足）) ➔ AMPK ↑ ➔ pathways that lead to ATP production ↑; pathways that utilize ATP ↓ ➔ATP production ↑;</p>
<ul>
<li>AMPK: heterotrimer, a catalytic subunit (<span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span>) and two regulatory subunits (<span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> and <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span>);
<ul>
<li><u>Binding of AMP</u> to four nucleotide-binding sites in the <u><span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span> subunit</u> ➔ activation of the catalytic $\alpha $ subunit;</li>
<li><u>Activation of AMPK also requires phosphorylation of a specific threonine residue in the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span> subunit</u>, and AMP binding to the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>γ</mi></mrow><annotation encoding="application/x-tex">\gamma</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05556em;">γ</span></span></span></span> subunit allosterically protects against dephosphorylation of this residue in the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.43056em;vertical-align:0em;"></span><span class="mord mathdefault" style="margin-right:0.0037em;">α</span></span></span></span> subunit;
<ul>
<li><u>Two upstream kinases</u>, <strong>LKB1</strong> and Ca2+/calmodulin-dependent protein kinase kinase <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> (<strong>CaMKK<span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span></strong>), are known to <u>phosphorylate the critical Thr residue.</u></li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="ampk-enhances-energy-producing-pathways-and-inhibits-energy-requiring-pathways"><a class="markdownIt-Anchor" href="#ampk-enhances-energy-producing-pathways-and-inhibits-energy-requiring-pathways"></a> AMPK enhances energy-producing pathways and inhibits energy-requiring pathways</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417162658580.png" alt="image-20200417162658580" style="zoom: 80%;" />
<ul>
<li>4EBP1: eukaryotic initiation 4E-binding protein</li>
<li>S6K: ribosomal protein S6 kinase</li>
<li>LKB1: Liver kinase B1</li>
<li>CaMKKb:Ca2+/calmodulin-dependent protein kinase kinase b</li>
<li>IRS: insulin receptor substrate</li>
<li>PGC-1: peroxisome proliferator-activated receptor-gamma coactivator 1</li>
<li>TSC: tuberous sclerosis complex</li>
<li>PI3K: phosphoinositide 3-kinase</li>
</ul>
<p>AMPK phosphorylates multiple substrates that <u>enhance energy-producing pathways</u>, including targets that stimulate <u>glucose uptake</u> (via retranslocation of <strong>GLUT4</strong> to the plasma membrane), <u>glycolysis in heart</u> (via stimulation of the kinase activity of the heart-specific PFK-2/FBPase-2), and <u>mitochondrial biogenesis</u>;</p>
<p>At the same time, other AMPK targets <u>inhibit energy-requiring pathways</u>, including <u>hepatic gluconeogenesis</u> (via decreased transcription of gluconeogenic enzymes), <u>fatty acid synthesis</u> (via acetyl-CoA carboxylase), <u>TG synthesis</u> (via glycerophosphate acyltransferase and hormone-sensitive lipase), <u>cholesterol synthesis</u> (via HMG-CoA reductase).</p>
<h3 id="2-mammalian-target-of-rapamycinmtor"><a class="markdownIt-Anchor" href="#2-mammalian-target-of-rapamycinmtor"></a> 2. Mammalian Target of Rapamycin（mTOR)</h3>
<p>mTOR is the other main player in the regulation of energy homeostasis.</p>
<ul>
<li>Like AMPK, highly conserved serine/threonine protein kinase found in all eukaryotes.</li>
<li><u>In contrast to AMPK, mTOR is active under nutrient-rich conditions and inactive under nutrient-poor conditions;</u></li>
</ul>
<p>Activated mTOR <u>promotes anabolic processes</u>, including cell proliferation, protein synthesis, and biosynthesis, but <u>inhibits catabolic processes</u>;</p>
<p>mTOR exists as two distinct multiprotein complexes: a rapamycin-<strong>sensitive</strong> complex (<u><strong>mTORC1</strong>: mTOR, mLST8, raptor and PRAS40</u>) and a rapamycin-<strong>insensitive</strong> complex (<u><strong>mTORC2</strong>: mTOR, mLST8, rictor, Sin1 and PRR5/Protor</u>);</p>
<p>mTOR was discovered during biochemical studies with the bacterial macrolide, <strong>rapamycin (雷帕霉素)</strong>, a potent immunosuppressant（免疫抑制剂）. <u>Rapamycin binds to a small cellular protein, FKBP12, and this FKBP12-rapamycin complex allosterically inhibits mTORC1, but has no effect on mTORC2.</u></p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417163658878.png" alt="image-20200417163658878" /></p>
<ul>
<li>Rapamycin extends life span of old mice;</li>
<li>Immnuosuppressant drug</li>
</ul>
<h4 id="mtor-downstream-substrates-4ebp1-and-s6k"><a class="markdownIt-Anchor" href="#mtor-downstream-substrates-4ebp1-and-s6k"></a> mTOR downstream substrates: 4EBP1 and S6K</h4>
<p>The two best-characterized <u>substrates</u> of <strong>mTORC1</strong> are <strong>4EBP1</strong> (eukaryotic initiation 4E-binding protein) and <strong>S6K</strong> (ribosomal protein S6 kinase);</p>
<ol>
<li>
<p><strong>4EBP1</strong> normally <u>inhibits</u> the translation initiation factor <strong>eIF4E</strong>; <u>phosphorylation of 4EBP1</u> by <strong>mTORC1</strong> suppresses its ability to bind eIF4E and <u>inhibit translation;</u></p>
<ul>
<li>Double negative regulation = Positive regulation</li>
</ul>
</li>
<li>
<p><u>Phosphorylation of <strong>S6K</strong> by <strong>mTOR</strong> activates this downstream protein kinase</u>, which <strong>phosphorylates</strong> a number of proteins involved in translational control;</p>
</li>
</ol>
<p><u>The net effect of phosphorylation of 4EBP1 and S6K by mTORC1 is thus stimulation of protein synthesis and ribosome biogenesis.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417163825580.png" alt="image-20200417163825580" style="zoom:50%;" />
<h4 id="upstream-regulators-of-mtor-tsc12"><a class="markdownIt-Anchor" href="#upstream-regulators-of-mtor-tsc12"></a> Upstream Regulators of mTOR: TSC1/2</h4>
<p>mTOR activity is regulated by a number of upstream inputs, most of which are transmitted through the <strong>tuberous sclerosis complex</strong> (<strong>TSC</strong>);</p>
<p>This complex, first discovered as a <u>tumor suppressor</u>, is composed of <strong>TSC1 (hamartin)</strong>  and <strong>TSC2 (tuberin)</strong>;</p>
<p><strong>TSC2</strong> contains a <strong>GTPase activating protein</strong> (<strong>GAP</strong>) domain ➔ that <u>inactivates</u> the small Ras-like GTPase <strong>Rheb</strong>;</p>
<ul>
<li><strong>Rheb</strong> ↓ ➔ <u>normally activates mTOR ↑ , thus loss of TSC1 or TSC2 leads to hyperactivation of mTORC1;</u></li>
</ul>
<p><strong>TSC</strong> serves as an <u>integration point</u> for regulation of mTORC1, receiving inputs from <u>a wide variety of environmental signals</u>, including growth factors (e.g., <u>insulin and epidermal growth factor), energy status, and nutrient availability;</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417164115250.png" alt="image-20200417164115250" style="zoom:67%;" />
<h4 id="insulin-signaling-regulation-of-mtor-activity"><a class="markdownIt-Anchor" href="#insulin-signaling-regulation-of-mtor-activity"></a> Insulin signaling regulation of mTOR activity</h4>
<ol>
<li>
<p><strong>Insulin</strong> signaling begins with phosphorylation of an <strong>insulin receptor substrate (IRS)</strong> protein by the <strong>tyrosine kinase</strong> activity of the <strong>plasma membrane insulin receptor</strong>;</p>
</li>
<li>
<p><strong>Phosphorylated IRS</strong> activates phosphoinositide 3-kinase (<strong>PI3K</strong>), which converts membrane phosphatidylinositol 4,5-bisphosphate (<strong>PIP2</strong>) to phosphatidylinositol 3,4,5-triphosphate (<strong>PIP<sub>3</sub></strong>), a second messenger with a variety of intracellular targets.</p>
</li>
<li>
<p><strong>PIP3</strong> activates yet another protein kinase (<strong>PKD1</strong>), which then activates a third protein kinase <strong>Akt</strong>;</p>
</li>
<li>
<p><strong>Akt  (also called PKB)</strong> then <u>phosphorylates TSC, inactivating the complex, resulting in activation of mTORC1;</u></p>
<p><u>Activated Akt also stimulates <strong>GLUT4</strong></u> translocation to the plasma membrane, accounting for insulin-stimulated glucose transport in muscle cells.</p>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417164957386.png" alt="image-20200417164957386" style="zoom:80%;" />
<h3 id="3-ampk-suppresses-mtor"><a class="markdownIt-Anchor" href="#3-ampk-suppresses-mtor"></a> 3. AMPK suppresses mTOR</h3>
<p><strong>Activated AMPK</strong> phosphorylates the <strong>TSC</strong> complex, which suppresses  mTORC1 by inhibiting <strong>Rheb</strong>;</p>
<p>Activated AMPK also directly inhibits mTORC1 by phosphorylation of the <strong>raptor subunit</strong> of the complex;</p>
<p>AMPK also modulates the insulin signaling pathway by phosphorylating <strong>IRS</strong>, thereby <u>increasing</u> the sensitivity of the cell to insulin.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417165143836.png" alt="image-20200417165143836" style="zoom:80%;" />
<hr />
<p>In summary, AMPK and mTOR play opposing roles in controlling metabolic activity of cells in response to intracellular and extracellular signals.</p>
<h3 id="4-sirtuins"><a class="markdownIt-Anchor" href="#4-sirtuins"></a> 4. Sirtuins</h3>
<p><strong>Sirtuins (沉默调节蛋白)</strong> are a highly conserved family of <strong>NAD±dependent protein deacetylases.</strong> (去乙酰化酶)</p>
<p>Sirtuins are named after the founding member of the family, yeast Sir2 (silent information regulator 2), which <u>deacetylates histones to regulate gene expression (silencing)</u> of the mating type locus in yeast.</p>
<p>Sirtuins are now known to act on <u>many proteins</u> besides histones, and they are <u>structurally conserved</u> from bacteria to humans.</p>
<p>Mammals possess seven sirtuins (<strong>SIRT1-7</strong>), which differ in their cellular localization (nucleus, mitochondria, cytoplasm) and protein targets.</p>
<p>For most protein targets, <u>deacetylation increases</u> the activity of the target protein.</p>
<p>The <u>deacetylase activity of sirtuins</u> is sensitive to changes in the cellular NAD+ levels, <u>being enhanced at high NAD+/NADH ratio</u>.</p>
<p>Thus, <u>sirtuins act as metabolic sensors of the cellular redox state</u>.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417165905948.png" alt="image-20200417165905948" /></p>
<h4 id="catalytic-core-of-sirtuins-is-evolutionarily-conserved"><a class="markdownIt-Anchor" href="#catalytic-core-of-sirtuins-is-evolutionarily-conserved"></a> Catalytic core of sirtuins is evolutionarily conserved:</h4>
<p>X-ray crystal structures of the catalytic cores of sirtuins from:</p>
<ol>
<li>Yeast</li>
<li>Archaea 古菌域</li>
<li>eubacterium 真杆菌</li>
<li>Human</li>
<li>yeast Hst2 sirtuin with bound acetylated peptide substrate and carba-NAD+, a substrate analog</li>
</ol>
<p>Show a high degree of structural similarity.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417170012990.png" alt="image-20200417170012990" style="zoom: 20%;" />
<h4 id="pgc-1-and-sirt1-control-the-reprogramming-of-fuel-utilization-pathways-in-response-to-fasting"><a class="markdownIt-Anchor" href="#pgc-1-and-sirt1-control-the-reprogramming-of-fuel-utilization-pathways-in-response-to-fasting"></a> PGC-1 and SIRT1 control the reprogramming of fuel utilization pathways in response to fasting</h4>
<p>A <u>high NAD+/NADH ratio</u>, in response to low nutrients (fasting), <u>activates SIRT1</u> to <u>deacetylate PGC-1, upregulating</u> its transcriptional coactivator function.</p>
<ul>
<li>Tissue-specific transcriptional activation programs result in increased gluconeogenesis (liver) and increased fatty acid oxidation (skeletal and heart muscle).</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417170113194.png" alt="image-20200417170113194" style="zoom:20%;" />
<ul>
<li>PGC-1: peroxisome proliferator-activated receptor-gamma coactivator 1</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417170139302.png" alt="image-20200417170139302" style="zoom:67%;" />
<p><strong>Calorie restriction (CR)</strong> extends lifespan in organisms ranging from yeast to primates.</p>
<p><u>The mechanisms are not fully understood, but sirtuins are important mediators of this response.</u></p>
<p>Although <strong>resveratrol (白藜芦醇)</strong> and newer classes of <strong>SIRT1 activators</strong> do indeed confer many phenotypes of CR on fed animals, they are not likely to represent a simple “<u>fountain of youth.</u>”</p>
<p>Nonetheless, pharmacological manipulation of sirtuin function holds great promise for treatment of <u>aging-related diseases.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171218924.png" alt="image-20200417171218924" style="zoom:67%;" />
<ul>
<li>Resveratrol: found in red grapes (and thus red wine), berries</li>
<li>CR delays the onset of aging-associated diseases (diabetes, cancer, cardiovascular diseases, and brain atrophy)</li>
</ul>
<h3 id="5-fuel-and-hormonal-control-of-food-intake-in-the-arcuate-nucleus-弓状核-of-the-hypothalamus-下丘脑"><a class="markdownIt-Anchor" href="#5-fuel-and-hormonal-control-of-food-intake-in-the-arcuate-nucleus-弓状核-of-the-hypothalamus-下丘脑"></a> 5. Fuel and hormonal control of food intake in the arcuate nucleus (弓状核) of the hypothalamus (下丘脑)</h3>
<p>Activation of AMPK promotes food intake;</p>
<ul>
<li>inhibition of AMPK suppresses food intake.</li>
</ul>
<p><strong>Insulin</strong> acts through the phosphoinositide 3-kinase (PI3K) cascade to inhibit food intake.</p>
<p><strong>Leptin</strong> (瘦素) has both direct and indirect effects (through PI3K and AMPK) on mTOR.</p>
<p><strong>Adiponectin</strong> (脂联素) and <strong>ghrelin</strong> stimulate food intake by activating AMPK.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171332793.png" alt="image-20200417171332793" style="zoom: 50%;" />
<ul>
<li>In mammals, the brain coordinates whole body energy homeostasis. The brain receives information about the quality and quantity of nutrients being consumed, the levels of fuels already present in the blood, and the amounts of energy present in various storage depots in the body.</li>
<li>The most important endocrine regulators of food intake are insulin and leptin (inhibit intake), and ghrelin and adiponectin (promote intake). Each of these act via specific receptors on particular cells in the <strong>arcuate nucleus</strong> to initiate signaling pathways that converge on AMPK and mTOR.</li>
</ul>
<h1 id="三-responses-to-metabolic-stress-starvation-diabetes"><a class="markdownIt-Anchor" href="#三-responses-to-metabolic-stress-starvation-diabetes"></a> 三、Responses to Metabolic Stress: Starvation, Diabetes</h1>
<p>Major events in the storage, retrieval, and use of fuels in the fed and unfed states and in early starvation:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417171915579.png" alt="image-20200417171915579" /></p>
<p>An excellent way to understand how the interorgan and hormonal relationships actually integrate fuel metabolism is to examine the effects of metabolic stress：</p>
<ol>
<li>Prolonged fasting, in which the intake of fuel substrates is inadequate;</li>
<li><strong>Diabetes mellitus</strong>, in which a functional insufficiency of insulin impairs the ability of the body to use glucose, even when the sugar is present in abundance.</li>
</ol>
<h2 id="glucose-levels-are-maintained-during-normal-feeding-cycles"><a class="markdownIt-Anchor" href="#glucose-levels-are-maintained-during-normal-feeding-cycles"></a> Glucose levels are maintained during normal feeding cycles</h2>
<p><u>Shortly after a carbohydrate-containing meal</u>, blood glucose elevation occurs. <u>Stimulates insulin secretion; Suppresses glucagon secretion</u></p>
<p>Insulin promotes uptake of glucose into the <u>liver</u>, stimulates glycogen synthesis, suppress glycogen breakdown;</p>
<p>Flux through <strong>hexokinase IV</strong> increases in response to elevated glucose levels, providing substrates for glycogen synthesis;</p>
<p>Activation of acetyl-CoA carboxylase (ACC) in the liver stimulates <u>fatty acid synthesis</u> with subsequent transport to adipose tissue as TAG in VLDL;</p>
<p>The increased levels of glycogenic intermediates and fatty acids stimulate <u>TAG synthesis;</u></p>
<p>Increased glucose uptake into <u>muscle</u> increases levels of substrates for <u>glycogen synthesis.</u></p>
<hr />
<p><u>Several hours later</u>, when blood glucose levels begin to fall, the above events are reversed;</p>
<p><u>Insulin secretion slows and glucagon secretion increases;</u></p>
<p>This <u>promotes glycogen mobilization</u> in liver via the cAMP-dependent cascade; mechanisms that activate glycogen phosphorylase and <u>inactivate glycogen synthase;</u></p>
<p><u>TAG breakdown</u> in adipocytes is activated as well, via the action of  hormone-sensitive lipase, generating fatty acids for use as fuel by liver and muscle;</p>
<p>At the same time, the decrease in insulin levels <u>reduces glucose use</u> by muscle, liver, and adipose tissue;</p>
<p>Consequently, nearly all the glucose produced in the liver is expected to the blood and is available for use by the brain</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417172521248.png" alt="image-20200417172521248" style="zoom:50%;" />
<ul>
<li><u>Metabolic adaptations</u> promote alternative fuel use during starvation so that glucose homeostasis is maintained for <u>several weeks</u>.</li>
</ul>
<h2 id="starvation"><a class="markdownIt-Anchor" href="#starvation"></a> Starvation</h2>
<h3 id="1-using-carbohydrates-and-tag"><a class="markdownIt-Anchor" href="#1-using-carbohydrates-and-tag"></a> 1. Using Carbohydrates and TAG</h3>
<ul>
<li><u>Glycogen, 6700 kJ</u>, this source of blood glucose will be exhausted in just <u>a few hours</u>;</li>
</ul>
<p>It is critical for <u>brain function</u> that blood glucose levels be maintained <u>near 4.4 mM</u>, the organism adapts metabolically to increase the use of fuels other than carbohydrate, primarily <u>fat</u>;</p>
<p><u>565,000 kJ TG</u>, largely in adipose tissue; <u>100,000 kJ</u> mobilizable <u>proteins</u>, largely in muscle, enough to permit survival for <u>up to several months</u>. However, use of these stores presents <u>problems</u>:</p>
<ul>
<li><u>TAG mobilization</u> generates metabolic fuel largely in the form of <u>acetyl-CoA</u>, whose further oxidation in the citric acid cycle requires <u>oxaloacetate</u>, which must be replenished (补充) via anaplerotic (回补) pathways.</li>
</ul>
<p>The most important of these processes is the <strong>pyruvate carboxylase</strong> reaction, with most of the pyruvate coming from <u>carbohydrate catabolism</u>. When carbohydrate availability is limited, the resupply of <u>citric acid cycle intermediates is limited</u>, and flux through <u>the cycle may be reduced</u>.</p>
<p>During carbohydrate limitation, citric acid cycle intermediates can be provided from <u>other sources</u>:</p>
<ul>
<li>The glycerol released from <strong>lipolysis</strong>, but not produced enough amounts to maintain levels of citric acid cycle intermediates</li>
</ul>
<h3 id="2-using-proteins"><a class="markdownIt-Anchor" href="#2-using-proteins"></a> 2. Using Proteins</h3>
<p><u>Intermediates from protein catabolism and transamination</u>, but this process is energetically wasteful and has the undesirable effect of wasting the muscle and weakening the fasting subject.</p>
<ul>
<li>Proteolysis is accelerated during the first few days of starvation. <u>A major fate of the released amino acids is gluconeogenesis.</u></li>
</ul>
<p>During this time, the <u>liver and muscle</u> are <u>shifting to fatty acids</u> as the dominant fuels for their own use.</p>
<p>Meanwhile, the increased use of carbon for gluconeogenesis diminishes the amount of <strong>oxaloacetate</strong> available to combine with acetyl-CoA in the citric acid cycle.</p>
<h3 id="3-use-ketonebodies"><a class="markdownIt-Anchor" href="#3-use-ketonebodies"></a> 3. Use Ketonebodies</h3>
<p><strong>Fat breakdown↑</strong> ➔ acetyl-CoA and reduced electron carriers accumulate ↑ in the liver ➔  cannot be oxidized ➔ <strong>ketone bodies accumulation ↑.</strong></p>
<p>Thus, <u>brain</u> adapts to reduce glucose levels by increasing the use of <u>ketone bodies</u> as alternative energy substrates. This trend continues for the duration of starvation.</p>
<p>On the <u>3rd day, 1/3 energy from ketone bodies</u>; By <u>day 40, 2/3 energy from ketone bodies.</u></p>
<ul>
<li><u>This adaptation reduces the need for gluconeogenesis and spares the mobilization of muscle proteins.</u> About <u>75 grams</u> proteins consumed per day on <u>day 3;</u> About <u>20 gram</u> proteins consumed per day on <u>day 40</u>.</li>
</ul>
<p>The metabolic changes accompanying starvation compromise the organism’s abilities to responds to <u>further stress</u>, such as <u>extreme cold or infection</u>.</p>
<p>However, the adaptations do allow life to continue for <u>many weeks</u> without food intake, the total period being determined largely by the size of the <u>fat deposits</u>.</p>
<h2 id="diabetes"><a class="markdownIt-Anchor" href="#diabetes"></a> Diabetes</h2>
<p><strong>Diabetes</strong> results either from insulin deficiency or from defects in the insulin response mechanism.</p>
<ul>
<li><u>Diabetes is a major public health issue worldwide</u></li>
<li>It is estimated that more than <u>12% of the adult population</u> in the United States is afflicted with this disease.</li>
<li>China: about 21 millions; India: about 32 millions. Type I: 5～10%; Type II: 90-95%.</li>
</ul>
<p>Diabetes can be thought of as “<u>starvation in the midst of plenty</u>” because cells are unable to utilize the glucose that accumulates in the blood.</p>
<ol>
<li>
<p><strong>Type 1 diabetes</strong>, formerly called <u>insulin-dependent diabetes</u>, or juvenile diabetes because of its typical early onset, often involves <strong>autoimmune</strong> destruction of the <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span> cells of the pancreas, which can be caused by various factors, including <u>viral infections.</u></p>
<p>Some forms of type 1 diabetes have a <u>genetic</u> origin. <u>Mutations in the insulin</u> structure can render the hormone inactive, and other mutations cause defects in the <u>conversion</u> of preproinsulin or proinsulin to the active hormone. Either way, type 1 diabetes is characterized by <u>insulin deficiency</u>, can be <u>treated by administration of insulin</u>.</p>
</li>
<li>
<p><strong>Type 2 diabetes</strong>, formerly called <u>adult-onset diabetes, obesity-related diabetes</u>, or <u>non-insulin-dependent diabetes mellitus</u>, is characterized by <u>insulin resistance</u>—patients cannot respond to therapeutic doses of insulin.  Type 2 diabetes accounts for <u>more than 95%</u> of people with diabetes</p>
</li>
</ol>
<h3 id="1-obesity-and-insulin-resistance-in-type-2-diabetes"><a class="markdownIt-Anchor" href="#1-obesity-and-insulin-resistance-in-type-2-diabetes"></a> 1. Obesity and insulin resistance in type 2 diabetes</h3>
<p>The specific defects that led to <u>insulin resistance</u> in type 2 diabetes are <u>not</u> known, but <u>several clues</u> are beginning to shed some light on the disease;</p>
<ol>
<li>Most people with type 2 diabetes are also <u>obese</u>, in fact, <u>obesity is so closely associated with insulin resistance</u> that there must be a mechanistic link;
<ul>
<li>Like diabetes, the prevalence of <u>obesity</u> has dramatically <u>increased</u> in the United States since 1970s, with <u>34%</u> of adults classified as obese in 2010;</li>
</ul>
</li>
</ol>
<p>The close relationship between <u>type 2 diabetes and metabolic syndrome</u>.</p>
<ul>
<li>Metabolic syndrome, which afflicts with 50 million Americans, is defined by <u>abnormal obesity, hypertension, high blood sugar, and, more importantly, insulin resistance</u>. These metabolic abnormalities often <u>precede both cardiovascular disease and diabetes;</u></li>
</ul>
<p>Common to both obesity and metabolic syndrome is <u>excess fuel intake and abnormal accumulation of lipid in “ectopic sites”, primarily liver and skeletal muscle.</u></p>
<h4 id="abnormal-lipid-accumulation-cause-insulin-resistance-in-type-2-diabetes"><a class="markdownIt-Anchor" href="#abnormal-lipid-accumulation-cause-insulin-resistance-in-type-2-diabetes"></a> Abnormal lipid accumulation cause insulin resistance in type 2 diabetes</h4>
<p>The <u>lipid overload</u> hypothesis state that <u>fat accumulation in muscle cells</u>, <u>blocks the insulin signaling pathway that normally stimulates translocation of GLUT4</u> ( the major glucose transporter in muscle) <u>to the membrane</u>. Thus, insulin no longer efficiently stimulates <u>glucose transport</u>, that is , the cell is insulin resistant.</p>
<p>The <strong>Inflammation</strong> hypothesis states that as <u>adipose cell increase in size with excess lipids</u>, they secrete <u>inflammatory adipokines</u>, including TNF-α, interleukins, and resistin. These cytokines bind to their receptors in peripheral tissues such <u>as muscle and stimulate an inhibitory phosphorylation of IRS</u>, making it a <u>poor substrate for the insulin receptor tyrosine kinase</u>. Once again, insulin signaling is shut down, and the cell becomes insulin resistant.</p>
<p>Thus, although type 2 diabetes has long been characterized by defects in carbohydrate metabolism, <u>abnormal lipid metabolism may be the root of the disease.</u></p>
<h4 id="insulin-resistance-in-type-2-diabetes"><a class="markdownIt-Anchor" href="#insulin-resistance-in-type-2-diabetes"></a> insulin resistance in Type 2 diabetes</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417180528155.png" alt="image-20200417180528155" /></p>
<h3 id="2-the-metabolic-abnormalities-in-diabetes"><a class="markdownIt-Anchor" href="#2-the-metabolic-abnormalities-in-diabetes"></a> 2. The metabolic abnormalities in diabetes</h3>
<p>The insulin deficiency blocks the <u>uptake of glucose</u> into muscle and adipose tissue and reduces glucose catabolism in all tissues.</p>
<ul>
<li><u>Proteolysis in muscle and lipolysis in adipose tissue are enhanced.</u></li>
<li>In the <u>liver, gluconeogenesis from amino acids and citric acid cycle intermediates is stimulated</u> as the cells attempt to remedy the perceived lack of usable glucose, and f<u>atty acid oxidation and ketogenesis are also increased.</u></li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200417180657621.png" alt="image-20200417180657621" /></p>
<p>The insufficient production of insulin or the failure of insulin to act normally in promoting glucose utilization lead to:</p>
<ol>
<li>glucose accumulation in the blood;</li>
<li>starves the cells of nutrients;</li>
<li>promotes metabolic responses similar to those of fasting;</li>
</ol>
<p><u>Liver cells</u> attempt to generate more glucose by stimulating <u>gluconeogenesis</u>. Most of the substrates come from <u>amino acids</u>, which in turn come largely from degradation of muscle proteins;</p>
<ul>
<li><u>Glucose cannot be reused for resynthesis of amino acids or of fatty acids</u>, so a person with diabetes may <strong>lose weight</strong> even while consuming with would normally be adequate calories in the diet.</li>
</ul>
<p>As cells attempt to generate usable energy sources, <u>TG depots are mobilized</u> in response to the abnormally <u>low insulin-to-glucagon ratio</u>;</p>
<ul>
<li><u>Fatty acid oxidation</u> is elevated, with concomitant generation of <u>acetyl-CoA</u>;</li>
</ul>
<p>Flux through the <u>citric acid cycle may decrease</u> because of the accumulation of reduced electron carriers and/or <u>oxaloacetate limitation</u>;</p>
<p>In liver, <u>both effects accelerate ketone bodies formation</u>, generating increased levels of organic acids in the blood (<strong>ketosis</strong>). These acids can lower the blood pH from the normal value of <u>7.4 to 6.8 or lower</u> (<strong>ketoacidosis</strong>);</p>
<p><u>Decarboxylation of acetoacetate</u>, which is stimulated at low pH, generate <strong>acetone</strong>, which can be smelled on the breath of patients with ketoacidosis;</p>
<p>A special danger is that such people may <u>lose consciousness</u>, and this, coupled with a <u>sweet organic odor</u> in the breath, may give the impression that they are intoxicated, when in fact their <u>lives are in jeopardy</u>.</p>
<p>The excessive concentrations of glucose in body fluids generate other metabolic problems, quite different from anything seen in starvation.</p>
<ul>
<li>At the blood glucose levels above <u>10 mM</u>, the kidney can no longer reabsorb all of the glucose out of the blood filtrate, and <u>glucose</u> is spilled in to the <u>urine</u>, sometimes in amounts approaching 100 grams per day. In fact, the Latin name diabetes mellitus literally means “honey-sweet urine.” Glucose excretion creates an <u>osmotic load</u>, which causes large amounts of water to be excreted as well, and under these conditions the kidney cannot absorb most of  this water. In fact, the earliest indications of diabetes are often <u>frequent and excessive urination, coupled with excessive thirst</u>. Long before biochemistry was a science, <u>the loss of nutrients, excessive urination, and breakdown of fat and protein were recognized as hallmarks of diabetes.</u></li>
</ul>
<p>In <u>type 1diabetes</u>, the metabolic imbalance is usually more severe and difficult to control than in the milder and more common type 2 diabetes. The latter can often be controlled by <u>exercise and dietary restriction of carbohydrate</u>, whereas the <u>treatment of type 1 diabetes involves daily self-injection of insulin</u>. For many years this insulin was purified from bovine pancreas, and its high cost, coupled with occasional problems resulting from the minor structural differences between human and bovine insulin. In the late 1970s, the gene for human insulin was cloned into E.coli in a form that allowed it to be expressed.</p>
<h2 id="diabetes-vs-starvation"><a class="markdownIt-Anchor" href="#diabetes-vs-starvation"></a> Diabetes vs. starvation</h2>
<p>In <strong>starvation</strong>, glucose utilization is abnormally low because of inadequate glucose supplies.</p>
<p>In <strong>diabetes mellitus</strong>, glucose utilization is similarly low, but the reason in this case is that the hormonal stimulus to glucose utilization-namely, insulin—is defective. As a result, glucose is actually present in excessive amounts.</p>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/3de102c6.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/3de102c6.html" class="post-title-link" itemprop="url">L06 Lipid Metabolism I Fatty Acids, Triacylglycerols, and Lipoproteins</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:38" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/3de102c6.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/3de102c6.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>29k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <h1 id="一-utilization-and-transport-of-fat-and-cholesterol"><a class="markdownIt-Anchor" href="#一-utilization-and-transport-of-fat-and-cholesterol"></a> 一、Utilization and Transport of Fat and Cholesterol</h1>
<p>Lipids play important roles in:</p>
<ol>
<li>Energy metabolism;</li>
<li>As membrane constitutes;</li>
<li>Hormones, fat-soluble vitamins, thermal insulators, biological regulators such as prostaglandins（前列腺素类）</li>
</ol>
<p>Overview of intermediary metabolism with fatty acid and triacylglycerol pathways highlighted:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327161250436.png" alt="image-20200327161250436" /></p>
<ul>
<li>The catabolism of fat begins with the hydrolysis of TG to yield glycerol and FFA (free fatty acid) 95% energy from FFA, 5% from glycerol</li>
</ul>
<h2 id="fat-storage-in-a-plant-seedling"><a class="markdownIt-Anchor" href="#fat-storage-in-a-plant-seedling"></a> Fat storage in a plant seedling</h2>
<p>The electron micrograph shows a cell from a <u>cucumber cotyledon (seed leaf, 黄瓜子叶)</u> a few days after germination.</p>
<p>Fat stored in <u>lipid bodies</u> is degraded, oxidized, and converted to <u>carbohydrate</u> in neighboring <strong>glyoxysomes</strong> (or <strong>microbodies</strong>) to support the growth of the plant.</p>
<ul>
<li>Fats as energy reserves in plant</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327161446667.png" alt="image-20200327161446667" style="zoom:50%;" />
<p>The bulk of the lipid in most organisms: <strong>triacylglycerol (formerly called triglycerides): TG, TAG, fat or neutral fat</strong></p>
<p>A mammal contains 5-25% body weight as lipids, 90% TAG, stored in adipocyte/adipose tissue, primary energy reserve, plant seed contains great quantities of fat.</p>
<ul>
<li>1 kJ = 0.239 kcal (Cal)</li>
<li>1 kcal (Cal)=4.185 kJ</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327161814365.png" alt="image-20200327161814365" style="zoom: 67%;" />
<ul>
<li>Fat has <u>six times</u> more caloric content by weight than carbohydrate because fat is more highly reduced and is anhydrous （无水的(尤指结晶水)）.</li>
</ul>
<h3 id="1-fat-function-examples"><a class="markdownIt-Anchor" href="#1-fat-function-examples"></a> 1. Fat Function Examples</h3>
<h4 id="bird-migration"><a class="markdownIt-Anchor" href="#bird-migration"></a> Bird Migration</h4>
<p>Some small land birds prepare for migration: increases body weight 15% per day, all TG, fly nonstop 60 hrs;</p>
<p>Hibernating animal: store several months’ worth of food;</p>
<p>thermal insulator;</p>
<p>Cushion.</p>
<h4 id="junk-foods"><a class="markdownIt-Anchor" href="#junk-foods"></a> Junk Foods</h4>
<p>About 40% of the caloric value of Western diet</p>
<p>Nutritionist recommendation: 25-30% from fat for cardiovascular health</p>
<p>In addition, excess carbohydrate is readily converted to fat，one can of regular coke: about 40 g sugar</p>
<p>Obesity and diabetes (type II diabetes)</p>
<h2 id="fat-digestion-and-absorption"><a class="markdownIt-Anchor" href="#fat-digestion-and-absorption"></a> Fat Digestion and Absorption</h2>
<h3 id="1-overview-of-fat-digestion-absorption-storage-and-mobilization-in-the-human"><a class="markdownIt-Anchor" href="#1-overview-of-fat-digestion-absorption-storage-and-mobilization-in-the-human"></a> 1. Overview of fat digestion, absorption, storage, and mobilization in the human</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327163504781.png" alt="image-20200327163504781" style="zoom:80%;" />
<ul>
<li>Pancreatic lipase: Pancreatic lipase, also known as pancreatic triacylglycerol lipase, is an enzyme secreted from the pancreas. As the primary lipase enzyme that hydrolyzes (breaks down) dietary fat molecules in the human digestive system, it is one of the main digestive enzymes, converting triglyceride substrates found in ingested oils to monoglycerides and free fatty acids.</li>
<li>The products of fat digestion: glycerol, free fatty acids, monoacylglycerols, diacylglycerols</li>
<li>Less than 10% of the original TAG remains unhydrolyzed</li>
<li>Through intestinal mucosal cells</li>
<li>Resynthesis of TG from the digestive products: endoplasmic reticulum and Golgi complex of mucosal cells</li>
<li>TG emerge into the <u>lymph system</u>, complexed with protein to form chylomicron (CM), transport fat to tissues</li>
</ul>
<p>TAG three primary sources:</p>
<ol>
<li>the diet;</li>
<li>de novo biosynthesis, particularly in liver;</li>
<li>storage depots in adipocytes.</li>
</ol>
<h3 id="2-utilization-and-transport-of-fat-and-cholesterol"><a class="markdownIt-Anchor" href="#2-utilization-and-transport-of-fat-and-cholesterol"></a> 2. Utilization and Transport of Fat and Cholesterol</h3>
<p>A major problem for the digestion, absorption, and transport of dietary lipids: their insolubility in aqueous media. How to solve this problem?</p>
<h4 id="action-of-bile-salts-in-emulsifying-乳化-fats-in-the-intestine"><a class="markdownIt-Anchor" href="#action-of-bile-salts-in-emulsifying-乳化-fats-in-the-intestine"></a> Action of bile salts in emulsifying (乳化) fats in the intestine</h4>
<p><strong>Cholic acid (胆酸)</strong>, a typical <strong>bile acid (胆汁酸)</strong>, ionizes to give its cognate bile salt.</p>
<ul>
<li>
<p>The <u>hydrophobic surface</u> of the bile salt molecule associates with <strong>triacylglycerol (三酰甘油)</strong>, and several such complexes aggregate to form a <strong>micelle</strong> (微团).</p>
</li>
<li>
<p>The <u>polar surface</u> of the bile salts faces outward, allowing the micelle to associate with <strong>pancreatic lipase/colipase (辅脂酶)</strong>.</p>
</li>
</ul>
<p>Hydrolytic action of this enzyme <u>frees the fatty acids</u> to associate in a much smaller micelle that can be absorbed through the intestinal mucosa.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327163836480.png" alt="image-20200327163836480" /></p>
<ul>
<li>Bile salts: synthesized in liver and stored in <strong>gallbladder（胆囊）</strong></li>
<li>detergent</li>
<li>gallstone 胆(结)石</li>
</ul>
<h4 id="how-to-transport-fat-and-cholesterol-to-tissue-via-blood"><a class="markdownIt-Anchor" href="#how-to-transport-fat-and-cholesterol-to-tissue-via-blood"></a> How to transport fat and cholesterol to tissue via blood?</h4>
<p><strong>Lipoproteins</strong> (脂蛋白) are <u>lipid–protein complexes</u> that allow movement of a polar lipids through aqueous environments.</p>
<h5 id="1-generalized-structure-of-a-plasma-lipoprotein"><a class="markdownIt-Anchor" href="#1-generalized-structure-of-a-plasma-lipoprotein"></a> (1) Generalized structure of a plasma lipoprotein</h5>
<p>The spherical particle, part of which is shown, contains neutral lipids in the interior and phospholipids, cholesterol, and protein at the surface.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164110360.png" alt="image-20200327164110360" style="zoom:67%;" />
<ul>
<li>Apoprotein (载脂蛋白): the polypeptide components of lipoproteins; mainly synthesized in the liver （80%）, 20% produced in intestinal mucosal cells</li>
<li>FFA binds to albumin（清蛋白,白蛋白） in blood</li>
</ul>
<h5 id="2-classification-by-centrifugation-and-functions-of-lipoproteins"><a class="markdownIt-Anchor" href="#2-classification-by-centrifugation-and-functions-of-lipoproteins"></a> (2) Classification (by centrifugation) and Functions of Lipoproteins</h5>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164213417.png" alt="image-20200327164213417" /></p>
<ul>
<li>CM: chylomicron 乳糜微粒</li>
<li>VLDL: very low-density lipoprotein 极低密度脂蛋白</li>
<li>IDL: intermediate-density lipoprotein 中等密度脂蛋白</li>
<li>LDL: low-density lipoprotein 低密度脂蛋白</li>
<li>HDL: high-density lipoprotein 高密度脂蛋白</li>
</ul>
<p>A total of 10 major apolipoproteins in human lipoproteins</p>
<p>ApoE4 is associated with Alzheimer’s disease</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164345139.png" alt="image-20200327164345139" style="zoom: 50%;" />
<ul>
<li>LCAT (lecithin-cholesterol acyltransferase): 卵磷脂胆固醇酰基转移酶</li>
<li>Lipoprotein lipase (LPL): 脂蛋白脂酶</li>
<li>Lipoprotein help maintain 500 mg/100ml human blood in emulsified form: 120 mg TAG, 220 mg cholesterol (2/3 esterified, 1/3 free cholesterol), 160 mg phospholipids</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164453896.png" alt="image-20200327164453896" style="zoom: 50%;" />
<ul>
<li>B48 and B100 are encoded by the same gene through a mechanism involving RNA editing.</li>
<li>RNA editing: 小肠内的CAA被 <strong>Cytidine derminase (胞苷脱氨酶)</strong> 修饰之后变为UAA，成为stop codon</li>
</ul>
<h5 id="3-binding-of-a-chylomicron-to-lipoprotein-lipase-on-the-inner-surface-of-a-capillary"><a class="markdownIt-Anchor" href="#3-binding-of-a-chylomicron-to-lipoprotein-lipase-on-the-inner-surface-of-a-capillary"></a> (3) Binding of a chylomicron to lipoprotein lipase on the inner surface of a capillary</h5>
<p>The chylomicron is anchored by <strong>lipoprotein lipase (LPL)</strong>, which is linked by a <strong>polysaccharide</strong> chain to the lumenal surface of the endothelial cell.</p>
<p>When activated by <strong>apoprotein C-II</strong>, the <strong>lipase hydrolyzes</strong> the triacylglycerols in the chylomicron, allowing uptake into the cell of the glycerol and the free fatty acids.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164611446.png" alt="image-20200327164611446" style="zoom:40%;" />
<ul>
<li>Following a high-fat meal, CM is so abundant in blood that they give the plasma a milky appearance.</li>
<li>Apo C-II deficiency in human: high CM and high TAG in blood</li>
</ul>
<h4 id="overview-of-lipoprotein-transport-pathways-and-fates"><a class="markdownIt-Anchor" href="#overview-of-lipoprotein-transport-pathways-and-fates"></a> Overview of lipoprotein transport pathways and fates</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164718558.png" alt="image-20200327164718558" /></p>
<p>Overall aspects of lipoprotein metabolism and transport</p>
<ul>
<li>CM: transport TG from intestine to other tissues (heart, muscle and adipose tissue);</li>
<li>VLDL: transport TG from liver to other tissues (heart, muscle and adipose tissue);</li>
<li>LDL:  transport cholesterol from liver to other tissues;</li>
<li>HDL: return excess cholesterol from tissues to the liver for metabolism or excretion.</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200421195329517.png" alt="image-20200421195329517" /></p>
<p>Liver is a major site of apolipoprotein synthesis （80%）, damage to this organ causes endogenously synthesized fat to accumulate there because it cannot be transported to peripheral tissues, resulting in <strong>fatty liver</strong>.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164801289.png" alt="image-20200327164801289" style="zoom: 50%;" />
<p>Plasma cholesterol: 3.5-6.7 mM or 130-260 mg/100 mL; Above 200 mg/100 mL is a major factor for heart disease</p>
<p><strong>Cholesterol</strong> <u>accumulation in the blood</u> is correlated with development of <strong>atherosclerotic plaque.</strong> (动脉粥样硬化斑块)</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164925414.png" alt="image-20200327164925414" /></p>
<p>High cholesterol level (insoluble, accumulated in white blood cells (macrophages) ➔deposited at the sites of injury or damage on inner arterial walls ➔ these cells become engorged with fatty deposits, which then harden into <u>plaque</u>; ➔ this situation, called <strong>atherosclerosis (动脉粥样硬化)</strong>, ultimately blocks key blood vessels and causes myocardial infarctions and heart attacks.</p>
<p>Why? must understand how cholesterol is taken up from LDL into cells</p>
<p><strong>Feedback regulation of HMG-CoA reductase (3-hydroxy-3-methylglutaryl-CoA reductase) activity:</strong></p>
<p>Fibroblasts obtained from a normal subject or from a patient homozygous for f<u>amilial hypercholesterolemia (FH Homozygote)</u> were grown in monolayer cultures.</p>
<ol>
<li>At time zero, the medium was replaced with fresh medium <u>depleted of lipoproteins</u>, and HMG-CoA reductase activity was measured in extracts prepared at the indicated times.</li>
<li>Twenty-four hours after addition of the lipoprotein-deficient medium, human LDL was added to the cells at the indicated levels, and HMG-CoA reductase activity was measured at the indicated time.</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165127510.png" alt="image-20200327165127510" style="zoom: 50%;" />
<ul>
<li>Familial hypercholesterolemia (FH,家族性高胆固醇血症): which results from mutations in the LDLR gene.</li>
<li>Individuals with the rare homozygous from of FH (about 1 in 1 million)，cholesterol: &gt; 600-1200 mg/100ml plasma</li>
<li>Develop atherosclerosis early in life and usually die of heart disease before 20.</li>
<li>Heterozygous : 1 in 500; cholesterol: 250-500 mg/100 ml; high risk to have heart attacks at age 30-40</li>
</ul>
<h4 id="results-and-data-interpretation"><a class="markdownIt-Anchor" href="#results-and-data-interpretation"></a> Results and data interpretation</h4>
<ul>
<li>In the presence of LDL, normal cells showed low HMA-CoA reductase activity</li>
<li>In the absence of LDL, the same cells showed 50-100-fold higher activity</li>
<li>Results showed that cholesterol is transported into the cells and it regulates its own synthesis</li>
</ul>
<p>In contrast, the FH cells showed high level enzyme activity in the presence or absence of LDL, suggesting they were deficient in ability to take up cholesterol from medium</p>
<p>These results suggest that cholesterol is taken into cells through action of a <u>specific receptor</u>, which is deficient or defective in FH patients</p>
<p>In shorter order, <u>Brown and Goldstein</u>  demonstrated the existence of the receptor, the <u>LDL receptor</u> and demonstrated a new mechanism by which cells can interact with their environment-<u>receptor-mediated endocytosis</u></p>
<h5 id="1-receptor-mediated-endocytosis-of-ldl"><a class="markdownIt-Anchor" href="#1-receptor-mediated-endocytosis-of-ldl"></a> (1) Receptor-mediated endocytosis of LDL</h5>
<p>LDL was conjugated with <strong>ferritin (铁蛋白)</strong> to permit electron microscopic visualization.</p>
<p>The LDL–ferritin (dark dots) binds to a coated pit on the surface of a cultured human fibroblast.</p>
<p>The plasma membrane closes over the <u>coated pit</u>, forming an endocytotic vesicle.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165352567.png" alt="image-20200327165352567" style="zoom:33%;" />
<h5 id="2-structure-of-a-clathrin-网格蛋白-coated-pit"><a class="markdownIt-Anchor" href="#2-structure-of-a-clathrin-网格蛋白-coated-pit"></a> (2) Structure of a clathrin (网格蛋白)-coated pit:</h5>
<ol>
<li>
<p><strong>Clathrin</strong>, the major protein in <u>coated pits</u>, forms <strong>triskelions</strong> (三脚蛋白复合体) (named after the symbol of three legs radiating from the center), which assemble into polyhedral lattices composed of hexagons and pentagons, such as the barrel shown in the next panel.</p>
</li>
<li>
<p>Image reconstruction from <u>electron cryomicroscopy</u> of a clathrin barrel formed from 36 triskelions. A single clathrin triskelion is highlighted in light blue.</p>
</li>
<li>
<p>A coated pit on the inner surface of the plasma membrane of a cultured mammalian cell is visualized by freeze-fracture electron microscopy.</p>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165532485.png" alt="image-20200327165532485" style="zoom: 25%;" />
<ul>
<li>The <u>cage-like structure</u> of the pit is due to the clathrin lattice.</li>
</ul>
<h5 id="3-involvement-of-ldl-receptors-in-cholesterol-uptake-and-metabolism"><a class="markdownIt-Anchor" href="#3-involvement-of-ldl-receptors-in-cholesterol-uptake-and-metabolism"></a> (3) Involvement of LDL receptors in cholesterol uptake and metabolism</h5>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165703575.png" alt="image-20200327165703575" /></p>
<ul>
<li>Cholesterol：
<ul>
<li>Down regulate the HMG-CoA reductase (decrease the protein level) <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rarr</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.36687em;vertical-align:0em;"></span><span class="mrel">→</span></span></span></span> block cholesterol biosynthesis</li>
<li>Promote ACAT, promote synthesis of cholesterol ester</li>
<li>Down regulate the synthesis of LDL receptor <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rarr</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.36687em;vertical-align:0em;"></span><span class="mrel">→</span></span></span></span> down regulate the cholesterol uptake</li>
</ul>
</li>
</ul>
<h3 id="3-cholesterol-regulatory-effects"><a class="markdownIt-Anchor" href="#3-cholesterol-regulatory-effects"></a> 3. Cholesterol regulatory effects</h3>
<ol>
<li>It suppresses endogenous cholesterol synthesis by <u>inhibiting HMG-CoA</u> reductase and also suppressing transcription of the gene encoding the enzyme and accelerating degradation of the enzyme protein;</li>
<li><u>It activates acyl-CoA:cholesterol acyltransferase (ACAT)</u>, an intracellular enzyme that synthesizes cholesterol ester from cholesterol and a long-chain acyl CoA. This promotes the storage of excess cholesterol in the forms of droplets of cholesterol esters;</li>
<li>It regulates the synthesis of the LDL receptor itself by somehow reducing the content of mRNA for the receptor. High cholesterol level lessen the synthesis of LDL receptor</li>
</ol>
<h4 id="how-do-elevated-cholesterol-levels-lead-to-atherosclerosis-plaque-formation"><a class="markdownIt-Anchor" href="#how-do-elevated-cholesterol-levels-lead-to-atherosclerosis-plaque-formation"></a> How do elevated cholesterol levels lead to atherosclerosis (plaque formation)?</h4>
<p>How do elevated cholesterol levels lead to atherosclerosis (plaque formation)?</p>
<ol>
<li>在高胆固醇的情况下：<strong>LDL</strong> is oxidized to <strong>oxidized LDL</strong>➔</li>
<li>uptake by <strong>scavenger LDL receptor</strong> in white blood cells (<u>macrophages</u>) ➔</li>
<li>oxidized LDL receptor is <u>not</u> down-regulated by cholesterol, so cholesterol uptake into the cells is virtually <u>unlimited</u> ➔</li>
<li>which converted these cells to a cholesterol-engorged species called a <u>foam cell</u> ➔</li>
<li>These events have a <u>chemotactic effect</u>（趋化作用）, causing more macrophages to migrate to the site ➔</li>
<li>leading them to accumulate more cholesterol ➔</li>
<li><u>plaque formation</u> ➔</li>
<li>blocks key blood vessels and causes <u>myocardial infarctions and heart attacks</u>.</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165959968.png" alt="image-20200327165959968" style="zoom: 50%;" />
<p>“Good cholesterol” vs. “bad cholesterol”-inappropriate terms</p>
<ul>
<li>
<p>Cholesterol in LDL is considered “bad”, because prolonged elevation of LDL levels is what leads to atherosclerosis;</p>
</li>
<li>
<p>Cholesterol in HDL is considered “good” because high level of HDL counteracts atherosclerosis. This is because HDL returns excess cholesterol from peripheral cells to the liver and lower total serum cholesterol.</p>
</li>
</ul>
<p>Smoking ; Physical exercise</p>
<h4 id="statins-hmg-coa-reductase-inhibitor"><a class="markdownIt-Anchor" href="#statins-hmg-coa-reductase-inhibitor"></a> STATINS: HMG-CoA reductase inhibitor</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170138131.png" alt="image-20200327170138131" style="zoom:80%;" />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170158250.png" alt="image-20200327170158250" style="zoom: 50%;" />
<h5 id="1-hmg-coa-reductase-inhibitors-reduce-blood-cholesterol-level"><a class="markdownIt-Anchor" href="#1-hmg-coa-reductase-inhibitors-reduce-blood-cholesterol-level"></a> (1) HMG-CoA reductase inhibitors reduce blood cholesterol level</h5>
<p>HMG-CoA reductase inhibitor ➔ de novo cholesterol biosynthesis ↓ ➔ intracellular cholesterol level ↓ ➔ LDL receptor ↑  ➔ clearance of extracellular cholesterol ↑ ➔ the level of blood cholesterol ↓ .</p>
<p>One such inhibitor, called <strong>lovastatin (洛弗斯塔特因)</strong>, was approved by FDA in 1987.</p>
<hr />
<p>Lipitor:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170346923.png" alt="image-20200327170346923" style="zoom:50%;" />
<p>Atorvastatin was first made in August 1985 at Warner-Lambert’s Parke-Davis research facility in Ann Arbor, Michigan by a team led by Bruce Roth. From 1996 to 2012 under the trade name Lipitor, atorvastatin became the world’s best-selling medication to that point, with more than US$125 billion in sales over approximately 14.5 years.</p>
<p>The discovery of the LDL receptor and receptor-mediated endocytosis earned Michael S. Brown (1/2) and Joseph L. Goldstein (1/2) the Nobel Prize in Physiology or Medicine in 1985</p>
<hr />
<p><strong>Polyunsaturated fatty acid (PUFA)</strong> (also known as <u>omega-3 fatty acids</u>) ingestion is correlated with low plasma cholesterol levels.</p>
<p>The mechanisms involved are not completely understood.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170528623.png" alt="image-20200327170528623" /></p>
<ul>
<li>
<p>Red meat: rich in both saturated fatty acid and cholesterol;</p>
</li>
<li>
<p>Fish or fish oils: help reduce cholesterol and TAG</p>
</li>
</ul>
<h4 id="mobilization-of-adipose-cell-triacylglycerols-by-lipolysis"><a class="markdownIt-Anchor" href="#mobilization-of-adipose-cell-triacylglycerols-by-lipolysis"></a> Mobilization of adipose cell triacylglycerols by lipolysis</h4>
<p><u>Three lipases</u> act sequentially to hydrolyze TG to glycerol and FFA.</p>
<p>These enzymes act at the oil–water interface of the lipid droplet.</p>
<p><strong>FFA</strong> are exported to the blood plasma, where they are bound to <u>albumin</u> for transport to liver and other tissues for subsequent oxidation.</p>
<p><strong>Glycerol</strong> is released to the blood to be taken up by <u>liver cells</u>, where it serves as a <u>gluconeogenic</u> substrate.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170621837.png" alt="image-20200327170621837" style="zoom: 50%;" />
<ul>
<li>Adipose triglyceride lipase (ATGL)</li>
<li>Hormone-sensitive lipase (HSL) (also known as triacylglycerol lipase)</li>
<li>Monoacylglycerol lipase (MGL)</li>
<li>FFA: free fatty acid</li>
</ul>
<h5 id="control-of-lipolysis-in-adipose-cells-by-a-camp-mediated-cascade-system"><a class="markdownIt-Anchor" href="#control-of-lipolysis-in-adipose-cells-by-a-camp-mediated-cascade-system"></a> Control of lipolysis in adipose cells by a cAMP-mediated cascade system</h5>
<ul>
<li>Hormonal activation of a <strong>β–adrenergic G-protein</strong> coupled receptor on the plasma membrane leads to elevation of cAMP levels, which in turn, activates <strong>protein kinase A (PKA)</strong>.  PKA phosphorylates <strong>perilipin (PL)</strong> and <strong>HSL</strong>.</li>
</ul>
<ol>
<li>CGI-58 dissociates from phosphorylated-PL, and binds ATGL.</li>
<li>Phosphorylated HSL is recruited to the lipid droplet and activated by phosphorylated-PL.</li>
<li>Phosphorylated-PL also recruits the ATGL/CGI-58 complex to the lipid droplet, activating this lipase.</li>
<li>Activated ATGL hydrolyzes TG to DG; activated HSL hydrolyzes DG to MG;  cytoplasmic MGL hydrolyzes MG to free glycerol + FFA.</li>
</ol>
<p>Glucagon（胰高血糖素）; Epinephrine（肾上腺素）; Beta-corticotropin</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327171645831.png" alt="image-20200327171645831" style="zoom: 33%;" />
<ul>
<li>HSL: hormone-sensitive lipase</li>
<li>CGI-58: comparative gene identification-CGI58</li>
<li>ATGL: adipose triglyceride lipase</li>
<li>DG: diacylglycerol</li>
<li>MGL: monoglyceride lipase</li>
</ul>
<hr />
<h5 id="2-knoops-experiments-to-determine-the-β-oxidation-of-fatty-acids"><a class="markdownIt-Anchor" href="#2-knoops-experiments-to-determine-the-β-oxidation-of-fatty-acids"></a> (2) Knoop’s experiments to determine the β-oxidation of fatty acids</h5>
<ul>
<li>When dogs fed fatty acids that had an <u>even-numbered</u> carbon chain, the final breakdown product, recovered from urine, was <strong>phenylacetic acid (苯乙酸)</strong>.</li>
<li>When the fed fatty acid had an <u>odd-numbered</u> chain, the product was <strong>benzoic acid (苯甲酸)</strong>.</li>
<li>These results led Knoop to propose that fatty acids are oxidized in a stepwise fashion, with initial attack on <u>carbon 3 (the β-carbon with respect to the carboxyl group)</u>.</li>
<li>This attack would release the terminal two carbons, and the remainder of the fatty acid molecule could undergo another oxidation.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327172048446.png" alt="image-20200327172048446" style="zoom:50%;" />
<ul>
<li>German chemist Franz Knoop, Metabolic tracers (terminal methyl group of fatty acids was labelled with a phenyl group),1904 (40 years before radioactive tracers); 1940s, Lehninger, ATP is required (activation)…; By the mid-1950s…</li>
</ul>
<h1 id="二-fatty-acid-oxidation"><a class="markdownIt-Anchor" href="#二-fatty-acid-oxidation"></a> 二、Fatty Acid Oxidation</h1>
<h2 id="overview-of-the-fatty-acid-oxidation-pathway"><a class="markdownIt-Anchor" href="#overview-of-the-fatty-acid-oxidation-pathway"></a> Overview of the fatty acid oxidation pathway</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327173914331.png" alt="image-20200327173914331" style="zoom: 33%;" />
<ul>
<li>Fatty acid oxidation and biosynthesis (quite similar in plants, animals and microorganisms).</li>
<li>Brain cannot use fatty acid, but use glucose, under starvation, use ketone bodies.</li>
</ul>
<h2 id="fatty-acid-activation"><a class="markdownIt-Anchor" href="#fatty-acid-activation"></a> Fatty Acid Activation</h2>
<p>Fatty acids are <u>activated</u> for oxidation by <u>ATP-dependent acylation of coenzyme A.</u></p>
<p>The loss of pyrophosphate is equivalent to <u>2 ATP’s</u> used for activation.</p>
<p>The further hydrolysis of pyrophosphate makes the activation step <u>irreversible</u>.（放出能量很多）</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327173946670.png" alt="image-20200327173946670" /></p>
<ul>
<li>ER and mitochondrial outside membrane: a series of <u>acyl-CoA synthetases</u> specific for short-chain, medium-chain, or long-chain fatty acids.</li>
</ul>
<h3 id="1-mechanism-of-acyl-coa-synthetase-reactions"><a class="markdownIt-Anchor" href="#1-mechanism-of-acyl-coa-synthetase-reactions"></a> 1. Mechanism of acyl-CoA synthetase reactions</h3>
<p>The figure shows reversible formation of the activated fatty acyl adenylate, <u>nucleophilic attack by the thiol sulfur of CoA-SH on the activated carboxyl group</u>, and the quasi-irreversible pyrophosphatase reaction, which draws the overall reaction toward fatty acyl-CoA.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174138614.png" alt="image-20200327174138614" style="zoom:33%;" />
<ul>
<li>A two-step mechanism</li>
</ul>
<h3 id="2-transport-fatty-acyl-coa-into-mitochondria"><a class="markdownIt-Anchor" href="#2-transport-fatty-acyl-coa-into-mitochondria"></a> 2. Transport fatty acyl-CoA into mitochondria</h3>
<p><strong>Carnitine (肉碱)</strong> transports acyl-CoAs into mitochondria for oxidation.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174242257.png" alt="image-20200327174242257" style="zoom:67%;" />
<p><strong>The carnitine acyltransferase system, for transport of fatty acyl-CoAs into mitochondria:</strong></p>
<p>Carnitine acyltransferase I (also called carnitine pamitoyltransferase I (<u>CPT1) ) is strongly inhibited by malonyl-CoA</u>（丙二酰辅酶A）, the first committed intermediate in fatty acid synthesis (to avoid “<u>futile cycle</u>”, i.e., oxidation and resynthesis occur at the same time);</p>
<p>CPT II is insensitive to malonyl-CoA;</p>
<p>Entry of fatty acids into mitochondria is <u>rate-limiting</u> for β-oxidation and is the primary point of regulation;</p>
<p>Thus, conditions in the cell that favor fatty acid synthesis prevent the transfer of fatty acyl moieties to their intracellular sites of oxidation and, prevent that oxidation.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174320906.png" alt="image-20200327174320906" style="zoom: 33%;" />
<h3 id="3-outline-of-the-β-oxidation-of-fatty-acids"><a class="markdownIt-Anchor" href="#3-outline-of-the-β-oxidation-of-fatty-acids"></a> 3. Outline of the β-oxidation of fatty acids</h3>
<p>In the diagram a 16-carbon saturated fatty acyl-CoA (palmitoyl-CoA) undergoes seven cycles of oxidation to yield eight molecules of acetyl-CoA.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174812957.png" alt="image-20200327174812957" style="zoom:50%;" />
<ul>
<li>In mitochondrial matrix</li>
<li>Four steps;</li>
<li>The fatty acyl chain is shortened by two carbons at a time;</li>
<li>Release one acetyl CoA ( go to citric acid cycle)</li>
</ul>
<h4 id="reaction-1-the-initial-dehydrogenation"><a class="markdownIt-Anchor" href="#reaction-1-the-initial-dehydrogenation"></a> Reaction 1: The Initial Dehydrogenation</h4>
<p>The first reaction is catalyzed by an <strong>acyl-CoA dehydrogenase</strong>, which catalyzes the removal of two hydrogen atoms from the <u>α- and β-carbons</u> to give a <u>trans α, β-unsaturated acyl CoA (trans-D2-enoyl-CoA)</u> as the product.</p>
<p>The pro-R hydrogen on the β-carbon is then transferred as a hydride equivalent to <strong>FAD</strong> to give the trans double bond and enzyme-bound FADH2.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175114264.png" alt="image-20200327175114264" style="zoom:80%;" />
<ul>
<li><u>3 acyl-CoA dehydrogenases</u>: for short-, medium-, and long-chain fatty acyl-CoA</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175154854.png" alt="image-20200327175154854" /></p>
<ul>
<li>Prosthetic group: FAD （将电子给FAD）</li>
<li>Electron transfer flavoprotein (ETF)</li>
<li>2H go to CoQ, through respiratory chain, <u>produce 1.5 ATP</u> (like NADH dehydrogenase and succinate dehydrogenase)</li>
</ul>
<h4 id="reactions-2-and-3-hydration-and-dehydrogenation"><a class="markdownIt-Anchor" href="#reactions-2-and-3-hydration-and-dehydrogenation"></a> Reactions 2 and 3: Hydration and Dehydrogenation</h4>
<p>Like <u>succinate oxidation</u>, an initial FAD-dependent fatty acyl-CoA oxidation is followed by hydration and <u>NAD±dependent dehydrogenation (2.5 ATP)</u>；</p>
<p>Enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase, respectively；</p>
<p>Both reactions are <u>stereospecific</u>；</p>
<p>Products: L-β-hydroxyacyl-CoA and b-ketoacyl-CoA, respectively。</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175341683.png" alt="image-20200327175341683" style="zoom: 67%;" />
<h4 id="reaction-4-thiolytic-cleavage-硫解"><a class="markdownIt-Anchor" href="#reaction-4-thiolytic-cleavage-硫解"></a> Reaction 4: Thiolytic Cleavage 硫解</h4>
<p>The fourth and last reaction in each cycle of the β-oxidation pathway involves <u>attack of the nucleophilic thiol sulfur of coenzyme A on the electron-poor keto carbon</u> of 3-ketoacyl-CoA, with cleavage of the bond and release of acetyl-CoA.</p>
<p>The other product is a shortened fatty acyl-CoA, ready to begin a new cycle of oxidation:</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175459751.png" alt="image-20200327175459751" /></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175511888.png" alt="image-20200327175511888" style="zoom:33%;" />
<ul>
<li>Nucleophilic thiol sulfur of coenzyme A on the electron-poor keto carbon of 3-ketoacyl-CoA, with cleavage of the α-β bond and release of acetyl-CoA and a shortened fatty acyl-CoA, ready to begin a new cycle of oxidation</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175550024.png" alt="image-20200327175550024" style="zoom:50%;" />
<ul>
<li>Fatty acids are oxidized by repeated cycles of <u>dehydrogenation, hydration, dehydrogenation, and thiolytic cleavage</u>, with each cycle yielding acetyl-CoA and a fatty acyl-CoA shorter by two carbons than the input acyl-CoA.</li>
</ul>
<h3 id="4-energy-yield-from-fatty-acid-oxidation"><a class="markdownIt-Anchor" href="#4-energy-yield-from-fatty-acid-oxidation"></a> 4. Energy Yield from Fatty Acid Oxidation</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175653199.png" alt="image-20200327175653199" style="zoom: 67%;" />
<ul>
<li>β-oxidation: even numbers of carbon atoms and fully saturated fatty acids: C16 palmitoyl-CoA: produces 8 acetyl-CoA</li>
</ul>
<h4 id="β-oxidation-pathway-for-unsaturated-fatty-acids"><a class="markdownIt-Anchor" href="#β-oxidation-pathway-for-unsaturated-fatty-acids"></a> β-Oxidation pathway for unsaturated fatty acids</h4>
<p>Many natural unsaturated fatty acids contain <u>one or more double bonds: cis configuration</u></p>
<ul>
<li>
<p>Enoyl-CoA hydratase: acts only on t<u>rans compounds</u></p>
</li>
<li>
<p>2 additional enzymes, <strong>enoyl-CoA isomerase (烯酰-CoA异构酶)</strong> and <strong>2,4-dienoyl-CoA reductase (2,4-二烯酰基 - 辅酶A还原酶)</strong>, must come into play</p>
</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175944970.png" alt="image-20200327175944970" style="zoom:50%;" />
<p>For <strong>monounsaturated fatty</strong> acid:</p>
<ol>
<li>Enoyl-CoA <strong>isomerase</strong> converts <u>cis</u>-Δ3-enoyl-CoA to the corresponding <strong>trans</strong>-Δ2-enoyl-CoA
<ul>
<li>需要转换成trans才能进行后续的氧化</li>
</ul>
</li>
<li>Enoyl-CoA <strong>hydratase</strong> acts on trans-Δ2-enyol-CoA, all subsequent reactions are identical to those for saturated fatty acids</li>
</ol>
<h4 id="β-oxidation-pathway-for-polyunsaturated-fatty-acids"><a class="markdownIt-Anchor" href="#β-oxidation-pathway-for-polyunsaturated-fatty-acids"></a> β-Oxidation pathway for polyunsaturated fatty acids</h4>
<p>This example, using <strong>linoleyl-CoA (亚油酰辅酶A(18C))</strong>, shows sites of action of enoyl-CoA <strong>isomerase</strong> and 2,4-dienoyl-CoA <strong>reductase</strong>, enzymes specific to unsaturated fatty acid oxidation (identified with red type).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180258321.png" alt="image-20200327180258321" style="zoom: 50%;" />
<h4 id="oxidation-of-fatty-acid-with-odd-number-carbon-chains"><a class="markdownIt-Anchor" href="#oxidation-of-fatty-acid-with-odd-number-carbon-chains"></a> Oxidation of Fatty Acid with Odd-number Carbon Chains</h4>
<p><u>Odd-numbered fatty acid</u> chains yield upon β-oxidation 1 mole of <strong>propionyl-CoA</strong>, whose conversion to <u>succinyl-CoA</u> involves a <u>biotin</u>-dependent carboxylation and a coenzyme B<sub>12</sub>–dependent rearrangement.</p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180338605.png" alt="image-20200327180338605" /></p>
<ul>
<li><u>Most of the fatty acids</u> in natural lipids contain <u>even-numbered</u> carbon chains;</li>
<li><u>A small proportion of fatty acids</u> have <u>odd-numbered</u> carbon chains;</li>
<li><u>The last step presents a special metabolic problem</u>: five-carbon homolog of acetoactyl-CoA;</li>
<li>Thiolytic cleavage of this substrate yields 1 molecule of acetyl and <u>propionyl-CoA</u>.</li>
</ul>
<h4 id="pathway-for-catabolism-of-propionyl-coa"><a class="markdownIt-Anchor" href="#pathway-for-catabolism-of-propionyl-coa"></a> Pathway for catabolism of propionyl-CoA</h4>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180459257.png" alt="image-20200327180459257" /></p>
<h2 id="control-of-fatty-acid-oxidation"><a class="markdownIt-Anchor" href="#control-of-fatty-acid-oxidation"></a> Control of Fatty Acid Oxidation</h2>
<p>In most cells, fatty acid oxidation is controlled by <u>availability of substrates</u> for oxidation, the fatty acids themselves</p>
<ol>
<li>Fat mobilization control by <u>hormones (glucagon and epinephrine);</u></li>
<li><u>Malonyl-CoA</u>（丙二酰辅酶A）: inhibits fatty acyl-CoA movement into mitochondria by the acylcarnitine shuttle.
<ul>
<li>Malonyl-CoA是fatty acid biosyhthesis的重要组分</li>
</ul>
</li>
</ol>
<h2 id="ketogenesis-酮体生成"><a class="markdownIt-Anchor" href="#ketogenesis-酮体生成"></a> Ketogenesis 酮体生成</h2>
<p>During <u>fasting or starvation</u>, when carbohydrate intake is too low ➔ <strong>oxaloacetate （草酰乙酸）</strong> levels ⬇ ➔ flux through citrate synthase ⬇ ➔ <u>acetyl-CoA</u> levels ⬆</p>
<p>Under these conditions, 2 moles of acetyl-CoA undergo a reversal of the thiolase reaction to give <strong>acetoacetyl-CoA (乙酰乙酰CoA)</strong>.</p>
<p>Acetoacetyl-CoA can react in turn with a 3rd mole of acetyl-CoA to give <strong>3-hydroxy-3-methylglutaryl-CoA (3-羟基-3-甲基戊二酰-CoA) (HMG-CoA)</strong>, catalyzed by <u>HMG-CoA synthase</u>.</p>
<p>In the <u>cytosol</u>, HMG-CoA is an early intermediate in <u>cholesterol</u> biosynthesis. In the <u>mitochondria</u>, HMG-CoA is acted on by <strong>HMG-CoA lyase</strong> (裂解酶) to yield <strong>acetoacetate</strong> plus acetyl-CoA.</p>
<p>Acetoacetate undergoes <u>NADH-dependent reduction</u> to give <strong>D-β-hydroxybutyrate (D-β-羟丁酸)</strong> or in very small amounts spontaneous decarboxylation（自动脱羧（不需要酶参与）） to acetone.</p>
<p>Collectively, <u>acetoacetate, acetone, and <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span>-hydroxybutyrate are called <strong>ketone bodies (酮体).</strong></u></p>
<ul>
<li>In cytosol: HMG-CoA ➔ ➔ ➔ ➔ cholesterol (Chapter 19)</li>
<li>IN mitochondria: HMG-CoA ➔ ➔ ➔ ➔ ketone bodies</li>
</ul>
<h3 id="1-biosynthesis-of-ketone-bodies-in-the-liver"><a class="markdownIt-Anchor" href="#1-biosynthesis-of-ketone-bodies-in-the-liver"></a> 1. Biosynthesis of ketone bodies in the liver</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327223654181.png" alt="image-20200327223654181" style="zoom: 50%;" />
<ul>
<li>Ketogenesis occurs primarily in liver, because of the <u>high level of HMG-CoA synthase</u> in that tissue;</li>
</ul>
<h3 id="2-use-of-ketone-bodies"><a class="markdownIt-Anchor" href="#2-use-of-ketone-bodies"></a> 2. Use of  ketone bodies</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327223729204.png" alt="image-20200327223729204" /></p>
<ul>
<li>
<p><strong>β-Ketoacyl-CoA transferase</strong> is present in <u>all tissues except liver</u> so that liver does not compete with the peripheral tissues (<u>brain and heart</u>) for use of ketone bodies;</p>
</li>
<li>
<p>Acetoacetyl-CoA is converted to acetyl-CoA, which goes to TCA for energy production;</p>
<ul>
<li>Ketogenesis becomes extremely important in starvation: brain, heart (Chapter 18);</li>
<li>Under normal conditions, heart also uses ketone bodies;</li>
<li>In untreated diabetes, ketone bodies production &gt; the capacity of peripheral tissues to use ➔ ketosis, acidosis and ketoacidosis.</li>
</ul>
</li>
</ul>
<h1 id="三-fatty-acid-biosynthesis"><a class="markdownIt-Anchor" href="#三-fatty-acid-biosynthesis"></a> 三、Fatty Acid Biosynthesis</h1>
<h2 id="relationship-of-fatty-acid-synthesis-to-carbohydrate-metabolism"><a class="markdownIt-Anchor" href="#relationship-of-fatty-acid-synthesis-to-carbohydrate-metabolism"></a> Relationship of Fatty Acid Synthesis to Carbohydrate Metabolism</h2>
<p>The majority of the <u>stored fuel</u> in most animal cells: <u>fat</u></p>
<p>A large proportion of the <u>caloric intake</u> of many animal diets, certainly most human diets: <strong>carbohydrate</strong></p>
<p><u>Convert carbohydrate to fat (fatty acid synthesis)</u></p>
<p><u>Acetyl-CoA</u>: central metabolite can be from pyruvate and fatty acid oxidation (from carbohydrate and fat breakdown)</p>
<p><u>In animals, acetyl-CoA cannot undergo net conversion to carbohydrate</u> (because the virtual irreversibility of the pyruvate dehydrogenase reaction)</p>
<p>As noted in Chapter14, t<u>he glyoxylate cycle in plants and some microorganisms permits a bypass of this step,</u> with <u>net conversion of acetyl-CoA to gluconeogenic precursors. </u></p>
<ul>
<li><u>However, in animals the conversion of carbohydrate to fat is unidirectional.</u></li>
</ul>
<p>Although fatty acids synthesis is regulated, <u>the total capacity for fat storage is not.</u></p>
<h3 id="1-acetyl-coa-as-a-key-intermediate-between-fat-and-carbohydrate-metabolism"><a class="markdownIt-Anchor" href="#1-acetyl-coa-as-a-key-intermediate-between-fat-and-carbohydrate-metabolism"></a> 1. Acetyl-CoA as a key intermediate between fat and carbohydrate metabolism</h3>
<p><u>Citrate</u> serves as a <u>carrier</u> to transport <u>acetyl units</u> from the <u>mitochondrion to the cytosol</u> for fatty acid synthesis.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224004142.png" alt="image-20200327224004142" style="zoom: 50%;" />
<h2 id="early-studies-of-fatty-acid-synthesis"><a class="markdownIt-Anchor" href="#early-studies-of-fatty-acid-synthesis"></a> Early Studies of Fatty Acid Synthesis</h2>
<p>Early in the twentieth century, <u>most fatty acids</u> in lipids contain <u>even-numbered</u> chains; it is reasonable to expect that the biosynthetic process involves some stepwise addition of activated two-carbon fragments;</p>
<p>This process was demonstrated experimentally in the <u>1940s using isotopic tracers;</u></p>
<p>David Rittenberg and Konrad Bloch (1940s): fed to mice with a<u>cetate labeled with the stable isotopes13C and deuterium  (<sup>13</sup>C<sup>2</sup>H<sub>3</sub>C<sup>13</sup>COO-) and found both isotopes incorporated into fatty acids;</u></p>
<p>Once the <strong>β-oxidation</strong> pathway had been discovered, it was generally thought that fatty acid synthesis would simply by <u>a reversal</u> of its degradation pathway;</p>
<p>In the late <u>1950s</u>, FA synthesis absolutely requires <u>bicarbonate</u>, which was <u>not</u> in the final product. This led to the discovery of <strong>malonyl-CoA (丙二酰-CoA)</strong>, the first committed intermediate;</p>
<h2 id="biosynthesis-of-palmitate-棕榈酸-from-acetyl-coa"><a class="markdownIt-Anchor" href="#biosynthesis-of-palmitate-棕榈酸-from-acetyl-coa"></a> Biosynthesis of Palmitate (棕榈酸) from Acetyl-CoA</h2>
<h4 id="malonyl-coa-to-palmitate"><a class="markdownIt-Anchor" href="#malonyl-coa-to-palmitate"></a> Malonyl-CoA to Palmitate</h4>
<p>Successive addition of two-carbon units. Each cycle contains 7 steps:</p>
<ol>
<li>acetyl-CoA carboxylase (ACC)</li>
<li>malonyl-CoA-ACP transferase (MAT)</li>
<li>acetyl-CoA-ACP transferase</li>
<li>condensation (KS)</li>
<li>reduction</li>
<li>dehydration</li>
<li>reduction</li>
</ol>
<ul>
<li>ACP is the acyl carrier for synthesis</li>
<li>NADPH is the electron for both reduction reactions</li>
</ul>
<p>7 Acetyl-CoA + 7CO2 + 7ATP    ➔    7 malonyl-CoA + 7ADP + 7Pi</p>
<p>8 Acetyl-CoA + 7ATP + 14 NADPH +14H+  ➔ palmitate + 14NADP+ 8CoA-SH + 6H2O + 7ADP + 7Pi</p>
<ul>
<li>Needs energy (ATP)</li>
<li>Reducing equivalent (NADPH)</li>
</ul>
<p>Although the chemistries of fatty acid synthesis and degradation are <u>similar</u>, <u>the two pathways differ in</u>:</p>
<ol>
<li>the enzymes involved</li>
<li>acyl group carriers: Acetyl-CoA vs ACP (acyl carrier protein)</li>
<li>stereochemistry of the intermediates: L vs D configuration</li>
<li>electron carriers: FAD/NAD+ vs NADPH</li>
<li>intracellular location: cytosol ➔ mitochondria vs cytosol</li>
<li>regulation.</li>
</ol>
<h3 id="1-synthesis-of-malonyl-coa-丙二酰-coa"><a class="markdownIt-Anchor" href="#1-synthesis-of-malonyl-coa-丙二酰-coa"></a> 1. Synthesis of malonyl-CoA (丙二酰-CoA)</h3>
<p>Synthesis of <strong>malonyl-CoA</strong> is the <u>first committed step</u> in fatty acid biosynthesis from acetyl-CoA and bicarbonate, catalyzed by <strong>acetyl-CoA carboxylase (ACC).</strong></p>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224350243.png" alt="image-20200327224350243" /></p>
<h3 id="2-acetyl-coa-carboxylase-acc"><a class="markdownIt-Anchor" href="#2-acetyl-coa-carboxylase-acc"></a> 2. Acetyl-CoA carboxylase (ACC)</h3>
<p><u>Biotin cofactor</u>: bound a lysine epsila-amino group, covalently bound N-carboxybiotin intermediate;</p>
<p>The <u>first committed step</u> in the synthetic pathway;</p>
<p>This reaction is so <u>exergonic (放能)</u> as to be virtually <u>irreversible</u>;</p>
<p><u>Prokaryotic E.coli: three separate proteins</u>:</p>
<ol>
<li>a small <u>carrier protein</u> that contains the bound biotin;</li>
<li>a <u>biotin carboxylase</u>, which catalyzes the formation of N-carboxybiotin;</li>
<li>a <u>transcarboxylase</u>, that transfers the activated carboxyl group from N-carboxybiotin to acetyl-CoA;</li>
</ol>
<p><u>Eukaryotes: a single protein containing two identical polypeptide chains. Inactive dimers; Active filamentous form</u> (can be seen under electron microscope): in the presence of citrate;</p>
<ul>
<li>The balance between the two forms: regulation of fatty acids synthesis;</li>
</ul>
<p><u>Primary regulator: long-chain fatty acyl-CoAs (not citrate).</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224500249.png" alt="image-20200327224500249" style="zoom:67%;" />
<h3 id="3-chemical-similarities-between-oxidation-and-synthesis-of-a-fatty-acid"><a class="markdownIt-Anchor" href="#3-chemical-similarities-between-oxidation-and-synthesis-of-a-fatty-acid"></a> 3. Chemical similarities between oxidation and synthesis of a fatty acid</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224602371.png" alt="image-20200327224602371" style="zoom: 80%;" />
<ul>
<li>This is one of the best examples of the statement that anabolic pathways are never the simple reversal of catabolic pathways.</li>
</ul>
<h3 id="4-acyl-carrier-proteinsacp"><a class="markdownIt-Anchor" href="#4-acyl-carrier-proteinsacp"></a> 4. Acyl Carrier Proteins（ACP）</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224723138.png" alt="image-20200327224723138" /></p>
<p>All of the intermediates in <u>fatty acid oxidation</u> are <u>activated</u> via their linkage to a carrier molecule, <u>coenzyme A</u>；</p>
<p>In <u>fatty acid synthesis</u>, a <u>similar activation</u>, the carrier is a small protein called <u>acyl carrier protein (ACP)</u></p>
<p>The chemistry of activation is identical to that in acyl-CoAs；</p>
<p>A phosphopantetheine moiety, derived from <u>pantothenic acid (泛酸)</u>, is linked to a serine group in the polypeptide.</p>
<hr />
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224900230.png" alt="image-20200327224900230" /></p>
<ul>
<li><u>Malonyl/acetyl-CoA-ACP transacylase (MAT)</u> loads fatty acid synthase with substrates.</li>
<li>The acyl groups (<u>acetyl or malonyl</u>) are transferred from the <u>SH group</u> of CoA to the SH group of the phosphopantetheine moiety of acyl carrier protein (<u>ACP</u>).</li>
<li>The reactions shown here produce acetyl-KS and malonyl-ACP, which are used in the remaining reactions of the cycle.</li>
</ul>
<h4 id="synthesis-of-palmitate-starting-with-malonyl-acp-and-acetyl-ks"><a class="markdownIt-Anchor" href="#synthesis-of-palmitate-starting-with-malonyl-acp-and-acetyl-ks"></a> Synthesis of palmitate, starting with malonyl-ACP and acetyl-KS</h4>
<p>The first cycle of four reactions generates butyryl-ACP (丁酰ACP).</p>
<p>Following translocation from ACP, <u>butyryl</u>-KS reacts with a second molecule of <u>malonyl-ACP</u>, leading to a second cycle of two-carbon addition.</p>
<p>A total of seven such cycles generates <u>palmitoyl-ACP</u>.</p>
<p>Hydrolysis of this product releases palmitate by <u>thioesterase (TE).</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327225306075.png" alt="image-20200327225306075" style="zoom: 67%;" />
<ul>
<li>NADPH provides the electron for both reduction reactions; <u>NADPH 来自PPP pathway</u></li>
<li>D-3-hydroxyacyl-CoA–synthesis</li>
<li>L-3-hydroxyacyl-CoA–fatty acid oxidation</li>
</ul>
<h4 id="malonyl-coa-to-palmitate-2"><a class="markdownIt-Anchor" href="#malonyl-coa-to-palmitate-2"></a> Malonyl-CoA to Palmitate</h4>
<p>Successive addition of two-carbon units. Each cycle contains 7 steps:</p>
<ol>
<li>acetyl-CoA carboxylase (ACC)</li>
<li>malonyl-CoA-ACP transferase (MAT)</li>
<li>acetyl-CoA-ACP transferase</li>
<li>condensation (KS)</li>
<li>reduction</li>
<li>dehydration</li>
<li>reduction</li>
</ol>
<ul>
<li>ACP is the acyl carrier for synthesis</li>
<li>NADPH is the electron for both reduction reactions</li>
</ul>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200408115255479.png" alt="image-20200408115255479" /></p>
<ul>
<li>Needs energy (ATP)</li>
<li>Reducing equivalent (NADPH)</li>
</ul>
<p>Although the chemistries of fatty acid synthesis and degradation are similar, the two pathways differ in:</p>
<ol>
<li>the enzymes involved</li>
<li>acyl group carriers: Acetyl-CoA vs ACP (acyl carrier protein)</li>
<li>stereochemistry of the intermediates: L vs D configuration</li>
<li>electron carriers: FAD/NAD+ vs NADPH</li>
<li>intracellular location: cytosol ➔ mitochondria vs cytosol</li>
<li>regulation.</li>
</ol>
<h3 id="5-structure-and-swinging-arm-mechanism-in-the-umammalianu-fatty-acid-synthase-complex"><a class="markdownIt-Anchor" href="#5-structure-and-swinging-arm-mechanism-in-the-umammalianu-fatty-acid-synthase-complex"></a> 5. Structure and swinging arm mechanism in the <u>mammalian</u> fatty acid synthase complex</h3>
<p><img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327225553567.png" alt="image-20200327225553567" /></p>
<p><u>Malonyl-CoA</u> represents an <u>activated source of two-carbon fragments for fatty acid biosynthesis</u>, with the loss of CO2 driving C-C bond formation.</p>
<p>In eukaryotes, fatty acid synthesis is carried out by a <u>megasynthase</u>, an organized multienzyme complex that contains multifunctional proteins.</p>
<h3 id="6-transport-of-acetyl-units-and-reducing-equivalents-used-in-fatty-acid-synthesis"><a class="markdownIt-Anchor" href="#6-transport-of-acetyl-units-and-reducing-equivalents-used-in-fatty-acid-synthesis"></a> 6. Transport of acetyl units and reducing equivalents used in fatty acid synthesis</h3>
<p><u>Citrate</u> serves as a carrier of <u>two-carbon fragments from mitochondria to cytosol</u> for fatty acid biosynthesis.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327225747410.png" alt="image-20200327225747410" style="zoom:80%;" />
<ul>
<li>1 = citrate synthase</li>
<li>2 = citrate lyase</li>
<li>3 = malate dehydrogenase</li>
<li>4 = malic enzyme</li>
<li>5 = pyruvate carboxylase （使得Pyruvate → OA）</li>
</ul>
<p>Because acetyl-CoA is generated in the mitochondrial matrix, it must be transported to the cytosol for use in fatty acid synthesis.</p>
<p>Like longer-chain acyl-CoA, acetyl-CoA cannot penetrate the inner membrane</p>
<h2 id="elongation-of-fatty-acid-chains"><a class="markdownIt-Anchor" href="#elongation-of-fatty-acid-chains"></a> Elongation of Fatty Acid Chains</h2>
<p>Fatty acid synthase actions lead primarily to <u>palmitate</u>;</p>
<p>In eukaryotic cells: elongation occurs in both <u>mitochondria</u> and <u>endoplasmic reticulum</u> (microsomal elongation system).</p>
<h2 id="fatty-acid-desaturation-去饱和"><a class="markdownIt-Anchor" href="#fatty-acid-desaturation-去饱和"></a> Fatty Acid Desaturation 去饱和</h2>
<p>The most <u>common monounsaturated fatty acids</u> in animal lipids are <strong>oleic acid (油酸)</strong> (18:1cΔ9 acid) and <strong>palmitoleic acid (棕榈油酸)</strong> (16:1cΔ9 acid), synthesized from stearate and palmitate by a microsomal system called fatty acyl-CoA desaturase;</p>
<p><u>Mammals are unable to introduce double bonds beyond 9</u> in the fatty acid chain. They cannot synthesize either <strong>linoleic acid (亚油酸)</strong> (18:2cΔ9, 12) and <strong>linolenic acid (亚麻酸)</strong> (18:3cΔ9,12,15). There are called <u>essential fatty acids</u>: must be provided in the <u>diet</u>;</p>
<p><strong>Arachidonate acid (花生四烯酸酸)</strong>: precursors of <u>eicosanoids (类花生酸)</u> (prostaglandins (前列腺素类) and thromboxanes (血栓烷)).(Chapter 19)</p>
<h2 id="pathway-for-synthesis-of-polyunsaturated-fatty-acids-pufas-in-plants-and-animals"><a class="markdownIt-Anchor" href="#pathway-for-synthesis-of-polyunsaturated-fatty-acids-pufas-in-plants-and-animals"></a> Pathway for synthesis of polyunsaturated fatty acids (PUFAs) in plants and animals</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327230438790.png" alt="image-20200327230438790" style="zoom:50%;" />
<h2 id="regulation-of-fatty-acid-synthesis-in-animal-cells"><a class="markdownIt-Anchor" href="#regulation-of-fatty-acid-synthesis-in-animal-cells"></a> Regulation of fatty acid synthesis in animal cells</h2>
<p>The rate-limiting enzyme, <u>acetyl-CoA carboxylase (ACC)</u>, is controlled by <u>both allosteric (citrate and long-chain fatty acids) and covalent modification</u> mechanisms.</p>
<ol>
<li>Phosphorylation by AMP-activated protein kinase (<strong>AMPK</strong>， AMP活化的蛋白激酶) or cyclic AMP–dependent protein kinase (<strong>PKA</strong>) <u>inactivates ACC</u>.</li>
<li><u>Insulin stimulates fatty acid synthesis</u> by increasing <u>glucose uptake</u> and increasing flux through pyruvate dehydrogenase （PDH） to produce <u>acetyl-CoA.</u>
<ul>
<li>The <u>dephosphorylated</u> form of <strong>PDH</strong> is the enzymatically <u>active</u> form.</li>
</ul>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327230612615.png" alt="image-20200327230612615" style="zoom:50%;" />
<h2 id="control-of-fatty-acid-synthesis"><a class="markdownIt-Anchor" href="#control-of-fatty-acid-synthesis"></a> Control of Fatty Acid Synthesis</h2>
<p>Much of the fatty acid synthesis in animals takes places in adipose tissues;</p>
<p>Hormonal mechanism: major;</p>
<ol>
<li>
<p>Insulin:</p>
<ol>
<li><u>Insulin</u> ➜ glucose entry into cells ↑➜ acetyl-CoA↑;</li>
<li><u>Insulin</u> ➜ activates pyruvate dehydrogenase (PDH) ↑➜ acetyl-CoA↑;</li>
<li><u>Insulin</u> ➜ activates citrate lyase ↑➜ the level of citrate in mitochondrial matrix↑ ➜ acetyl-CoA in cytosol↑;</li>
</ol>
</li>
<li>
<p><u>Fasting/starvation</u> ➜ <u>AMPK ↑ PKA ↑</u> ➜ inactivation of Acetyl-CoA carboxylase (ACC) (covalent modification);</p>
</li>
<li>
<p><u>Long-chain fatty acyl-CoA</u>➜ ACC polymerization↓➜ ACC activity ↓(allosteric regulation);</p>
</li>
<li>
<p><u>Citrate</u>➜ ACC polymerization ↑ ➜ ACC activity ↑(allosteric regulation)</p>
</li>
<li>
<p><u>Availability of NADPH</u>: from both the transport of citrate out of mitochondria and the <u>pentose phosphate pathway (PPP)</u> (60%).</p>
<ul>
<li>AMPK (AMP-activated protein kinase): activated by increased cellular AMP:ATP ratio (fasting/starvation);</li>
<li>AMPK acts as a sensor of cellular energy status;</li>
<li>AMPK and PKA phosphorylate and inhibits ACC</li>
</ul>
</li>
</ol>
<h1 id="四-biosynthesis-of-triacylglycerols"><a class="markdownIt-Anchor" href="#四-biosynthesis-of-triacylglycerols"></a> 四、Biosynthesis of Triacylglycerols</h1>
<h2 id="glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis-甘油再生"><a class="markdownIt-Anchor" href="#glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis-甘油再生"></a> Glycerolipid/free fatty acid cycle and glyceroneogenesis 甘油再生</h2>
<p>Mammals hydrolyze and resynthesize TG in a glycerolipid/free fatty acid <u>(GL/FFA) cycle</u>.</p>
<p>FFA are released from TG by lipases acting on lipid droplets.</p>
<ul>
<li><strong>ATGL</strong>, adipose triglyceride lipase;</li>
<li><strong>HSL</strong>, hormone-sensitive lipase;</li>
<li><strong>MGL</strong>, monoacylglycerol lipase.</li>
</ul>
<p>Some of the <strong>FFAs</strong> are released into the blood for transport and oxidation, but <u>~75%</u> are re-esterified back to TG.</p>
<p>ATP hydrolysis in this futile cycle is shown in red.</p>
<ul>
<li>GPAT: glycerolphosphate acyltransferase;</li>
<li>LPA: lysophosphatidic acid</li>
<li>PA: phosphatidic acid</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327230937904.png" alt="image-20200327230937904" style="zoom:50%;" />
<ul>
<li>Major precursors (TG): fatty acyl-CoAs and glycerol-3-phosphate (limiting substrate)</li>
<li>Adipose tissue, liver, heart</li>
<li>需要一个GAP，它由DHAP转化而来，是糖代谢<u>（糖异生）</u>的产物</li>
</ul>
<h2 id="glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis"><a class="markdownIt-Anchor" href="#glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis"></a> Glycerolipid/free fatty acid cycle and glyceroneogenesis</h2>
<p>The glycerol backbone is produced via glyceroneogenesis, involving reactions catalyzed by pyruvate carboxylase and phosphoenolpyruvate carboxykinase (<strong>PEPCK</strong>), and reversal of glycolytic steps to give <strong>DHAP</strong>. 磷酸烯醇丙酮酸羧激酶</p>
<p>DHAP is reduced to <u>glycerol-3-phosphate</u>.</p>
<p>AMP-activated protein kinase (AMPK)-dependent phosphorylation of GPAT and HSL inhibits these steps of the cycle.</p>
<p>The lysophosphatidic acid (<strong>LPA</strong>, 溶血磷脂酸), phosphatidic acid (<strong>PA</strong>, 磷脂酸), and sn-1,2-diacylglycerol (<strong>DAG</strong>) intermediates in the TG resynthesis pathway are also <u>important lipid signaling molecules.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327231230101.png" alt="image-20200327231230101" style="zoom:50%;" />
<ul>
<li>Heat production (thermogenesis) and body temperature maintenance;</li>
<li>Elevated FFA level  is associated with Type 2 diabetes and insulin resistance.</li>
</ul>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  

      
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/3de102c6.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h2 class="post-title" itemprop="name headline">
          
            <a href="/posts/3de102c6.html" class="post-title-link" itemprop="url">L06 Lipid Metabolism I Fatty Acids, Triacylglycerols, and Lipoproteins</a>
        </h2>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>
              

              <time title="创建时间：2020-07-17 21:57:33 / 修改时间：21:57:38" itemprop="dateCreated datePublished" datetime="2020-07-17T21:57:33+08:00">2020-07-17</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Biochemistry-II-Metabolism/" itemprop="url" rel="index"><span itemprop="name">Biochemistry II (Metabolism)</span></a>
                </span>
            </span>

          
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/3de102c6.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/3de102c6.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>29k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
          <h1 id="一-utilization-and-transport-of-fat-and-cholesterol"><a class="markdownIt-Anchor" href="#一-utilization-and-transport-of-fat-and-cholesterol"></a> 一、Utilization and Transport of Fat and Cholesterol</h1>
<p>Lipids play important roles in:</p>
<ol>
<li>Energy metabolism;</li>
<li>As membrane constitutes;</li>
<li>Hormones, fat-soluble vitamins, thermal insulators, biological regulators such as prostaglandins（前列腺素类）</li>
</ol>
<p>Overview of intermediary metabolism with fatty acid and triacylglycerol pathways highlighted:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327161250436.png" alt="image-20200327161250436" style="zoom:100%;" />
+ The catabolism of fat begins with the hydrolysis of TG to yield glycerol and FFA (free fatty acid) 95% energy from FFA, 5% from glycerol
<h2 id="fat-storage-in-a-plant-seedling"><a class="markdownIt-Anchor" href="#fat-storage-in-a-plant-seedling"></a> Fat storage in a plant seedling</h2>
<p>The electron micrograph shows a cell from a <u>cucumber cotyledon (seed leaf, 黄瓜子叶)</u> a few days after germination.</p>
<p>Fat stored in <u>lipid bodies</u> is degraded, oxidized, and converted to <u>carbohydrate</u> in neighboring <strong>glyoxysomes</strong> (or <strong>microbodies</strong>) to support the growth of the plant.</p>
<ul>
<li>Fats as energy reserves in plant</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327161446667.png" alt="image-20200327161446667" style="zoom:50%;" />
<p>The bulk of the lipid in most organisms: <strong>triacylglycerol (formerly called triglycerides): TG, TAG, fat or neutral fat</strong></p>
<p>A mammal contains 5-25% body weight as lipids, 90% TAG, stored in adipocyte/adipose tissue, primary energy reserve, plant seed contains great quantities of fat.</p>
<ul>
<li>1 kJ = 0.239 kcal (Cal)</li>
<li>1 kcal (Cal)=4.185 kJ</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327161814365.png" alt="image-20200327161814365" style="zoom: 67%;" />
<ul>
<li>Fat has <u>six times</u> more caloric content by weight than carbohydrate because fat is more highly reduced and is anhydrous （无水的(尤指结晶水)）.</li>
</ul>
<h3 id="1-fat-function-examples"><a class="markdownIt-Anchor" href="#1-fat-function-examples"></a> 1. Fat Function Examples</h3>
<h4 id="bird-migration"><a class="markdownIt-Anchor" href="#bird-migration"></a> Bird Migration</h4>
<p>Some small land birds prepare for migration: increases body weight 15% per day, all TG, fly nonstop 60 hrs;</p>
<p>Hibernating animal: store several months’ worth of food;</p>
<p>thermal insulator;</p>
<p>Cushion.</p>
<h4 id="junk-foods"><a class="markdownIt-Anchor" href="#junk-foods"></a> Junk Foods</h4>
<p>About 40% of the caloric value of Western diet</p>
<p>Nutritionist recommendation: 25-30% from fat for cardiovascular health</p>
<p>In addition, excess carbohydrate is readily converted to fat，one can of regular coke: about 40 g sugar</p>
<p>Obesity and diabetes (type II diabetes)</p>
<h2 id="fat-digestion-and-absorption"><a class="markdownIt-Anchor" href="#fat-digestion-and-absorption"></a> Fat Digestion and Absorption</h2>
<h3 id="1-overview-of-fat-digestion-absorption-storage-and-mobilization-in-the-human"><a class="markdownIt-Anchor" href="#1-overview-of-fat-digestion-absorption-storage-and-mobilization-in-the-human"></a> 1. Overview of fat digestion, absorption, storage, and mobilization in the human</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327163504781.png" alt="image-20200327163504781" style="zoom:80%;" />
<ul>
<li>Pancreatic lipase: Pancreatic lipase, also known as pancreatic triacylglycerol lipase, is an enzyme secreted from the pancreas. As the primary lipase enzyme that hydrolyzes (breaks down) dietary fat molecules in the human digestive system, it is one of the main digestive enzymes, converting triglyceride substrates found in ingested oils to monoglycerides and free fatty acids.</li>
<li>The products of fat digestion: glycerol, free fatty acids, monoacylglycerols, diacylglycerols</li>
<li>Less than 10% of the original TAG remains unhydrolyzed</li>
<li>Through intestinal mucosal cells</li>
<li>Resynthesis of TG from the digestive products: endoplasmic reticulum and Golgi complex of mucosal cells</li>
<li>TG emerge into the <u>lymph system</u>, complexed with protein to form chylomicron (CM), transport fat to tissues</li>
</ul>
<p>TAG three primary sources:</p>
<ol>
<li>the diet;</li>
<li>de novo biosynthesis, particularly in liver;</li>
<li>storage depots in adipocytes.</li>
</ol>
<h3 id="2-utilization-and-transport-of-fat-and-cholesterol"><a class="markdownIt-Anchor" href="#2-utilization-and-transport-of-fat-and-cholesterol"></a> 2. Utilization and Transport of Fat and Cholesterol</h3>
<p>A major problem for the digestion, absorption, and transport of dietary lipids: their insolubility in aqueous media. How to solve this problem?</p>
<h4 id="action-of-bile-salts-in-emulsifying-乳化-fats-in-the-intestine"><a class="markdownIt-Anchor" href="#action-of-bile-salts-in-emulsifying-乳化-fats-in-the-intestine"></a> Action of bile salts in emulsifying (乳化) fats in the intestine</h4>
<p><strong>Cholic acid (胆酸)</strong>, a typical <strong>bile acid (胆汁酸)</strong>, ionizes to give its cognate bile salt.</p>
<ul>
<li>
<p>The <u>hydrophobic surface</u> of the bile salt molecule associates with <strong>triacylglycerol (三酰甘油)</strong>, and several such complexes aggregate to form a <strong>micelle</strong> (微团).</p>
</li>
<li>
<p>The <u>polar surface</u> of the bile salts faces outward, allowing the micelle to associate with <strong>pancreatic lipase/colipase (辅脂酶)</strong>.</p>
</li>
</ul>
<p>Hydrolytic action of this enzyme <u>frees the fatty acids</u> to associate in a much smaller micelle that can be absorbed through the intestinal mucosa.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327163836480.png" alt="image-20200327163836480" style="zoom:100%;" />
+ Bile salts: synthesized in liver and stored in **gallbladder（胆囊）**
+ detergent
+ gallstone 胆(结)石
<h4 id="how-to-transport-fat-and-cholesterol-to-tissue-via-blood"><a class="markdownIt-Anchor" href="#how-to-transport-fat-and-cholesterol-to-tissue-via-blood"></a> How to transport fat and cholesterol to tissue via blood?</h4>
<p><strong>Lipoproteins</strong> (脂蛋白) are <u>lipid–protein complexes</u> that allow movement of a polar lipids through aqueous environments.</p>
<h5 id="1-generalized-structure-of-a-plasma-lipoprotein"><a class="markdownIt-Anchor" href="#1-generalized-structure-of-a-plasma-lipoprotein"></a> (1) Generalized structure of a plasma lipoprotein</h5>
<p>The spherical particle, part of which is shown, contains neutral lipids in the interior and phospholipids, cholesterol, and protein at the surface.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164110360.png" alt="image-20200327164110360" style="zoom:67%;" />
<ul>
<li>Apoprotein (载脂蛋白): the polypeptide components of lipoproteins; mainly synthesized in the liver （80%）, 20% produced in intestinal mucosal cells</li>
<li>FFA binds to albumin（清蛋白,白蛋白） in blood</li>
</ul>
<h5 id="2-classification-by-centrifugation-and-functions-of-lipoproteins"><a class="markdownIt-Anchor" href="#2-classification-by-centrifugation-and-functions-of-lipoproteins"></a> (2) Classification (by centrifugation) and Functions of Lipoproteins</h5>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164213417.png" alt="image-20200327164213417" style="zoom:100%;" />
+ CM: chylomicron 乳糜微粒
+ VLDL: very low-density lipoprotein 极低密度脂蛋白
+ IDL: intermediate-density lipoprotein 中等密度脂蛋白
+ LDL: low-density lipoprotein 低密度脂蛋白
+ HDL: high-density lipoprotein 高密度脂蛋白
<p>A total of 10 major apolipoproteins in human lipoproteins</p>
<p>ApoE4 is associated with Alzheimer’s disease</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164345139.png" alt="image-20200327164345139" style="zoom: 50%;" />
<ul>
<li>LCAT (lecithin-cholesterol acyltransferase): 卵磷脂胆固醇酰基转移酶</li>
<li>Lipoprotein lipase (LPL): 脂蛋白脂酶</li>
<li>Lipoprotein help maintain 500 mg/100ml human blood in emulsified form: 120 mg TAG, 220 mg cholesterol (2/3 esterified, 1/3 free cholesterol), 160 mg phospholipids</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164453896.png" alt="image-20200327164453896" style="zoom: 50%;" />
<ul>
<li>B48 and B100 are encoded by the same gene through a mechanism involving RNA editing.</li>
<li>RNA editing: 小肠内的CAA被 <strong>Cytidine derminase (胞苷脱氨酶)</strong> 修饰之后变为UAA，成为stop codon</li>
</ul>
<h5 id="3-binding-of-a-chylomicron-to-lipoprotein-lipase-on-the-inner-surface-of-a-capillary"><a class="markdownIt-Anchor" href="#3-binding-of-a-chylomicron-to-lipoprotein-lipase-on-the-inner-surface-of-a-capillary"></a> (3) Binding of a chylomicron to lipoprotein lipase on the inner surface of a capillary</h5>
<p>The chylomicron is anchored by <strong>lipoprotein lipase (LPL)</strong>, which is linked by a <strong>polysaccharide</strong> chain to the lumenal surface of the endothelial cell.</p>
<p>When activated by <strong>apoprotein C-II</strong>, the <strong>lipase hydrolyzes</strong> the triacylglycerols in the chylomicron, allowing uptake into the cell of the glycerol and the free fatty acids.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164611446.png" alt="image-20200327164611446" style="zoom:40%;" />
<ul>
<li>Following a high-fat meal, CM is so abundant in blood that they give the plasma a milky appearance.</li>
<li>Apo C-II deficiency in human: high CM and high TAG in blood</li>
</ul>
<h4 id="overview-of-lipoprotein-transport-pathways-and-fates"><a class="markdownIt-Anchor" href="#overview-of-lipoprotein-transport-pathways-and-fates"></a> Overview of lipoprotein transport pathways and fates</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164718558.png" alt="image-20200327164718558" style="zoom:100%;" />
Overall aspects of lipoprotein metabolism and transport 
<ul>
<li>CM: transport TG from intestine to other tissues (heart, muscle and adipose tissue);</li>
<li>VLDL: transport TG from liver to other tissues (heart, muscle and adipose tissue);</li>
<li>LDL: transport cholesterol from liver to other tissues;</li>
<li>HDL: return excess cholesterol from tissues to the liver for metabolism or excretion.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200421195329517.png" alt="image-20200421195329517" style="zoom:100%;" />
Liver is a major site of apolipoprotein synthesis （80%）, damage to this organ causes endogenously synthesized fat to accumulate there because it cannot be transported to peripheral tissues, resulting in **fatty liver**.
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164801289.png" alt="image-20200327164801289" style="zoom: 50%;" />
<p>Plasma cholesterol: 3.5-6.7 mM or 130-260 mg/100 mL; Above 200 mg/100 mL is a major factor for heart disease</p>
<p><strong>Cholesterol</strong> <u>accumulation in the blood</u> is correlated with development of <strong>atherosclerotic plaque.</strong> (动脉粥样硬化斑块)</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327164925414.png" alt="image-20200327164925414" style="zoom:100%;" />
High cholesterol level (insoluble, accumulated in white blood cells (macrophages) ➔deposited at the sites of injury or damage on inner arterial walls ➔ these cells become engorged with fatty deposits, which then harden into <u>plaque</u>; ➔ this situation, called **atherosclerosis (动脉粥样硬化)**, ultimately blocks key blood vessels and causes myocardial infarctions and heart attacks.
<p>Why? must understand how cholesterol is taken up from LDL into cells</p>
<p><strong>Feedback regulation of HMG-CoA reductase (3-hydroxy-3-methylglutaryl-CoA reductase) activity:</strong></p>
<p>Fibroblasts obtained from a normal subject or from a patient homozygous for f<u>amilial hypercholesterolemia (FH Homozygote)</u> were grown in monolayer cultures.</p>
<ol>
<li>At time zero, the medium was replaced with fresh medium <u>depleted of lipoproteins</u>, and HMG-CoA reductase activity was measured in extracts prepared at the indicated times.</li>
<li>Twenty-four hours after addition of the lipoprotein-deficient medium, human LDL was added to the cells at the indicated levels, and HMG-CoA reductase activity was measured at the indicated time.</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165127510.png" alt="image-20200327165127510" style="zoom: 50%;" />
<ul>
<li>Familial hypercholesterolemia (FH,家族性高胆固醇血症): which results from mutations in the LDLR gene.</li>
<li>Individuals with the rare homozygous from of FH (about 1 in 1 million)，cholesterol: &gt; 600-1200 mg/100ml plasma</li>
<li>Develop atherosclerosis early in life and usually die of heart disease before 20.</li>
<li>Heterozygous : 1 in 500; cholesterol: 250-500 mg/100 ml; high risk to have heart attacks at age 30-40</li>
</ul>
<h4 id="results-and-data-interpretation"><a class="markdownIt-Anchor" href="#results-and-data-interpretation"></a> Results and data interpretation</h4>
<ul>
<li>In the presence of LDL, normal cells showed low HMA-CoA reductase activity</li>
<li>In the absence of LDL, the same cells showed 50-100-fold higher activity</li>
<li>Results showed that cholesterol is transported into the cells and it regulates its own synthesis</li>
</ul>
<p>In contrast, the FH cells showed high level enzyme activity in the presence or absence of LDL, suggesting they were deficient in ability to take up cholesterol from medium</p>
<p>These results suggest that cholesterol is taken into cells through action of a <u>specific receptor</u>, which is deficient or defective in FH patients</p>
<p>In shorter order, <u>Brown and Goldstein</u> demonstrated the existence of the receptor, the <u>LDL receptor</u> and demonstrated a new mechanism by which cells can interact with their environment-<u>receptor-mediated endocytosis</u></p>
<h5 id="1-receptor-mediated-endocytosis-of-ldl"><a class="markdownIt-Anchor" href="#1-receptor-mediated-endocytosis-of-ldl"></a> (1) Receptor-mediated endocytosis of LDL</h5>
<p>LDL was conjugated with <strong>ferritin (铁蛋白)</strong> to permit electron microscopic visualization.</p>
<p>The LDL–ferritin (dark dots) binds to a coated pit on the surface of a cultured human fibroblast.</p>
<p>The plasma membrane closes over the <u>coated pit</u>, forming an endocytotic vesicle.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165352567.png" alt="image-20200327165352567" style="zoom:33%;" />
<h5 id="2-structure-of-a-clathrin-网格蛋白-coated-pit"><a class="markdownIt-Anchor" href="#2-structure-of-a-clathrin-网格蛋白-coated-pit"></a> (2) Structure of a clathrin (网格蛋白)-coated pit:</h5>
<ol>
<li>
<p><strong>Clathrin</strong>, the major protein in <u>coated pits</u>, forms <strong>triskelions</strong> (三脚蛋白复合体) (named after the symbol of three legs radiating from the center), which assemble into polyhedral lattices composed of hexagons and pentagons, such as the barrel shown in the next panel.</p>
</li>
<li>
<p>Image reconstruction from <u>electron cryomicroscopy</u> of a clathrin barrel formed from 36 triskelions. A single clathrin triskelion is highlighted in light blue.</p>
</li>
<li>
<p>A coated pit on the inner surface of the plasma membrane of a cultured mammalian cell is visualized by freeze-fracture electron microscopy.</p>
</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165532485.png" alt="image-20200327165532485" style="zoom: 25%;" />
<ul>
<li>The <u>cage-like structure</u> of the pit is due to the clathrin lattice.</li>
</ul>
<h5 id="3-involvement-of-ldl-receptors-in-cholesterol-uptake-and-metabolism"><a class="markdownIt-Anchor" href="#3-involvement-of-ldl-receptors-in-cholesterol-uptake-and-metabolism"></a> (3) Involvement of LDL receptors in cholesterol uptake and metabolism</h5>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165703575.png" alt="image-20200327165703575" style="zoom:100%;" />
+ Cholesterol：
 + Down regulate the HMG-CoA reductase (decrease the protein level) $\rarr$ block cholesterol biosynthesis
 + Promote ACAT, promote synthesis of cholesterol ester
 + Down regulate the synthesis of LDL receptor $\rarr$ down regulate the cholesterol uptake
<h3 id="3-cholesterol-regulatory-effects"><a class="markdownIt-Anchor" href="#3-cholesterol-regulatory-effects"></a> 3. Cholesterol regulatory effects</h3>
<ol>
<li>It suppresses endogenous cholesterol synthesis by <u>inhibiting HMG-CoA</u> reductase and also suppressing transcription of the gene encoding the enzyme and accelerating degradation of the enzyme protein;</li>
<li><u>It activates acyl-CoA:cholesterol acyltransferase (ACAT)</u>, an intracellular enzyme that synthesizes cholesterol ester from cholesterol and a long-chain acyl CoA. This promotes the storage of excess cholesterol in the forms of droplets of cholesterol esters;</li>
<li>It regulates the synthesis of the LDL receptor itself by somehow reducing the content of mRNA for the receptor. High cholesterol level lessen the synthesis of LDL receptor</li>
</ol>
<h4 id="how-do-elevated-cholesterol-levels-lead-to-atherosclerosis-plaque-formation"><a class="markdownIt-Anchor" href="#how-do-elevated-cholesterol-levels-lead-to-atherosclerosis-plaque-formation"></a> How do elevated cholesterol levels lead to atherosclerosis (plaque formation)?</h4>
<p>How do elevated cholesterol levels lead to atherosclerosis (plaque formation)?</p>
<ol>
<li>在高胆固醇的情况下：<strong>LDL</strong> is oxidized to <strong>oxidized LDL</strong>➔</li>
<li>uptake by <strong>scavenger LDL receptor</strong> in white blood cells (<u>macrophages</u>) ➔</li>
<li>oxidized LDL receptor is <u>not</u> down-regulated by cholesterol, so cholesterol uptake into the cells is virtually <u>unlimited</u> ➔</li>
<li>which converted these cells to a cholesterol-engorged species called a <u>foam cell</u> ➔</li>
<li>These events have a <u>chemotactic effect</u>（趋化作用）, causing more macrophages to migrate to the site ➔</li>
<li>leading them to accumulate more cholesterol ➔</li>
<li><u>plaque formation</u> ➔</li>
<li>blocks key blood vessels and causes <u>myocardial infarctions and heart attacks</u>.</li>
</ol>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327165959968.png" alt="image-20200327165959968" style="zoom: 50%;" />
<p>“Good cholesterol” vs. “bad cholesterol”-inappropriate terms</p>
<ul>
<li>
<p>Cholesterol in LDL is considered “bad”, because prolonged elevation of LDL levels is what leads to atherosclerosis;</p>
</li>
<li>
<p>Cholesterol in HDL is considered “good” because high level of HDL counteracts atherosclerosis. This is because HDL returns excess cholesterol from peripheral cells to the liver and lower total serum cholesterol.</p>
</li>
</ul>
<p>Smoking ; Physical exercise</p>
<h4 id="statins-hmg-coa-reductase-inhibitor"><a class="markdownIt-Anchor" href="#statins-hmg-coa-reductase-inhibitor"></a> STATINS: HMG-CoA reductase inhibitor</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170138131.png" alt="image-20200327170138131" style="zoom:80%;" />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170158250.png" alt="image-20200327170158250" style="zoom: 50%;" />
<h5 id="1-hmg-coa-reductase-inhibitors-reduce-blood-cholesterol-level"><a class="markdownIt-Anchor" href="#1-hmg-coa-reductase-inhibitors-reduce-blood-cholesterol-level"></a> (1) HMG-CoA reductase inhibitors reduce blood cholesterol level</h5>
<p>HMG-CoA reductase inhibitor ➔ de novo cholesterol biosynthesis ↓ ➔ intracellular cholesterol level ↓ ➔ LDL receptor ↑ ➔ clearance of extracellular cholesterol ↑ ➔ the level of blood cholesterol ↓ .</p>
<p>One such inhibitor, called <strong>lovastatin (洛弗斯塔特因)</strong>, was approved by FDA in 1987.</p>
<hr />
<p>Lipitor:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170346923.png" alt="image-20200327170346923" style="zoom:50%;" />
<p>Atorvastatin was first made in August 1985 at Warner-Lambert’s Parke-Davis research facility in Ann Arbor, Michigan by a team led by Bruce Roth. From 1996 to 2012 under the trade name Lipitor, atorvastatin became the world’s best-selling medication to that point, with more than US$125 billion in sales over approximately 14.5 years.</p>
<p>The discovery of the LDL receptor and receptor-mediated endocytosis earned Michael S. Brown (1/2) and Joseph L. Goldstein (1/2) the Nobel Prize in Physiology or Medicine in 1985</p>
<hr />
<p><strong>Polyunsaturated fatty acid (PUFA)</strong> (also known as <u>omega-3 fatty acids</u>) ingestion is correlated with low plasma cholesterol levels.</p>
<p>The mechanisms involved are not completely understood.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170528623.png" alt="image-20200327170528623" style="zoom:100%;" />
+ Red meat: rich in both saturated fatty acid and cholesterol;
<ul>
<li>Fish or fish oils: help reduce cholesterol and TAG</li>
</ul>
<h4 id="mobilization-of-adipose-cell-triacylglycerols-by-lipolysis"><a class="markdownIt-Anchor" href="#mobilization-of-adipose-cell-triacylglycerols-by-lipolysis"></a> Mobilization of adipose cell triacylglycerols by lipolysis</h4>
<p><u>Three lipases</u> act sequentially to hydrolyze TG to glycerol and FFA.</p>
<p>These enzymes act at the oil–water interface of the lipid droplet.</p>
<p><strong>FFA</strong> are exported to the blood plasma, where they are bound to <u>albumin</u> for transport to liver and other tissues for subsequent oxidation.</p>
<p><strong>Glycerol</strong> is released to the blood to be taken up by <u>liver cells</u>, where it serves as a <u>gluconeogenic</u> substrate.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327170621837.png" alt="image-20200327170621837" style="zoom: 50%;" />
<ul>
<li>Adipose triglyceride lipase (ATGL)</li>
<li>Hormone-sensitive lipase (HSL) (also known as triacylglycerol lipase)</li>
<li>Monoacylglycerol lipase (MGL)</li>
<li>FFA: free fatty acid</li>
</ul>
<h5 id="control-of-lipolysis-in-adipose-cells-by-a-camp-mediated-cascade-system"><a class="markdownIt-Anchor" href="#control-of-lipolysis-in-adipose-cells-by-a-camp-mediated-cascade-system"></a> Control of lipolysis in adipose cells by a cAMP-mediated cascade system</h5>
<ul>
<li>Hormonal activation of a <strong>β–adrenergic G-protein</strong> coupled receptor on the plasma membrane leads to elevation of cAMP levels, which in turn, activates <strong>protein kinase A (PKA)</strong>. PKA phosphorylates <strong>perilipin (PL)</strong> and <strong>HSL</strong>.</li>
</ul>
<ol>
<li>CGI-58 dissociates from phosphorylated-PL, and binds ATGL.</li>
<li>Phosphorylated HSL is recruited to the lipid droplet and activated by phosphorylated-PL.</li>
<li>Phosphorylated-PL also recruits the ATGL/CGI-58 complex to the lipid droplet, activating this lipase.</li>
<li>Activated ATGL hydrolyzes TG to DG; activated HSL hydrolyzes DG to MG; cytoplasmic MGL hydrolyzes MG to free glycerol + FFA.</li>
</ol>
<p>Glucagon（胰高血糖素）; Epinephrine（肾上腺素）; Beta-corticotropin</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327171645831.png" alt="image-20200327171645831" style="zoom: 33%;" />
<ul>
<li>HSL: hormone-sensitive lipase</li>
<li>CGI-58: comparative gene identification-CGI58</li>
<li>ATGL: adipose triglyceride lipase</li>
<li>DG: diacylglycerol</li>
<li>MGL: monoglyceride lipase</li>
</ul>
<hr />
<h5 id="2-knoops-experiments-to-determine-the-β-oxidation-of-fatty-acids"><a class="markdownIt-Anchor" href="#2-knoops-experiments-to-determine-the-β-oxidation-of-fatty-acids"></a> (2) Knoop’s experiments to determine the β-oxidation of fatty acids</h5>
<ul>
<li>When dogs fed fatty acids that had an <u>even-numbered</u> carbon chain, the final breakdown product, recovered from urine, was <strong>phenylacetic acid (苯乙酸)</strong>.</li>
<li>When the fed fatty acid had an <u>odd-numbered</u> chain, the product was <strong>benzoic acid (苯甲酸)</strong>.</li>
<li>These results led Knoop to propose that fatty acids are oxidized in a stepwise fashion, with initial attack on <u>carbon 3 (the β-carbon with respect to the carboxyl group)</u>.</li>
<li>This attack would release the terminal two carbons, and the remainder of the fatty acid molecule could undergo another oxidation.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327172048446.png" alt="image-20200327172048446" style="zoom:50%;" />
<ul>
<li>German chemist Franz Knoop, Metabolic tracers (terminal methyl group of fatty acids was labelled with a phenyl group),1904 (40 years before radioactive tracers); 1940s, Lehninger, ATP is required (activation)…; By the mid-1950s…</li>
</ul>
<h1 id="二-fatty-acid-oxidation"><a class="markdownIt-Anchor" href="#二-fatty-acid-oxidation"></a> 二、Fatty Acid Oxidation</h1>
<h2 id="overview-of-the-fatty-acid-oxidation-pathway"><a class="markdownIt-Anchor" href="#overview-of-the-fatty-acid-oxidation-pathway"></a> Overview of the fatty acid oxidation pathway</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327173914331.png" alt="image-20200327173914331" style="zoom: 33%;" />
<ul>
<li>Fatty acid oxidation and biosynthesis (quite similar in plants, animals and microorganisms).</li>
<li>Brain cannot use fatty acid, but use glucose, under starvation, use ketone bodies.</li>
</ul>
<h2 id="fatty-acid-activation"><a class="markdownIt-Anchor" href="#fatty-acid-activation"></a> Fatty Acid Activation</h2>
<p>Fatty acids are <u>activated</u> for oxidation by <u>ATP-dependent acylation of coenzyme A.</u></p>
<p>The loss of pyrophosphate is equivalent to <u>2 ATP’s</u> used for activation.</p>
<p>The further hydrolysis of pyrophosphate makes the activation step <u>irreversible</u>.（放出能量很多）</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327173946670.png" alt="image-20200327173946670" style="zoom:100%;" />
+ ER and mitochondrial outside membrane: a series of <u>acyl-CoA synthetases</u> specific for short-chain, medium-chain, or long-chain fatty acids.
<h3 id="1-mechanism-of-acyl-coa-synthetase-reactions"><a class="markdownIt-Anchor" href="#1-mechanism-of-acyl-coa-synthetase-reactions"></a> 1. Mechanism of acyl-CoA synthetase reactions</h3>
<p>The figure shows reversible formation of the activated fatty acyl adenylate, <u>nucleophilic attack by the thiol sulfur of CoA-SH on the activated carboxyl group</u>, and the quasi-irreversible pyrophosphatase reaction, which draws the overall reaction toward fatty acyl-CoA.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174138614.png" alt="image-20200327174138614" style="zoom:33%;" />
<ul>
<li>A two-step mechanism</li>
</ul>
<h3 id="2-transport-fatty-acyl-coa-into-mitochondria"><a class="markdownIt-Anchor" href="#2-transport-fatty-acyl-coa-into-mitochondria"></a> 2. Transport fatty acyl-CoA into mitochondria</h3>
<p><strong>Carnitine (肉碱)</strong> transports acyl-CoAs into mitochondria for oxidation.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174242257.png" alt="image-20200327174242257" style="zoom:67%;" />
<p><strong>The carnitine acyltransferase system, for transport of fatty acyl-CoAs into mitochondria:</strong></p>
<p>Carnitine acyltransferase I (also called carnitine pamitoyltransferase I (<u>CPT1) ) is strongly inhibited by malonyl-CoA</u>（丙二酰辅酶A）, the first committed intermediate in fatty acid synthesis (to avoid “<u>futile cycle</u>”, i.e., oxidation and resynthesis occur at the same time);</p>
<p>CPT II is insensitive to malonyl-CoA;</p>
<p>Entry of fatty acids into mitochondria is <u>rate-limiting</u> for β-oxidation and is the primary point of regulation;</p>
<p>Thus, conditions in the cell that favor fatty acid synthesis prevent the transfer of fatty acyl moieties to their intracellular sites of oxidation and, prevent that oxidation.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174320906.png" alt="image-20200327174320906" style="zoom: 33%;" />
<h3 id="3-outline-of-the-β-oxidation-of-fatty-acids"><a class="markdownIt-Anchor" href="#3-outline-of-the-β-oxidation-of-fatty-acids"></a> 3. Outline of the β-oxidation of fatty acids</h3>
<p>In the diagram a 16-carbon saturated fatty acyl-CoA (palmitoyl-CoA) undergoes seven cycles of oxidation to yield eight molecules of acetyl-CoA.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327174812957.png" alt="image-20200327174812957" style="zoom:50%;" />
<ul>
<li>In mitochondrial matrix</li>
<li>Four steps;</li>
<li>The fatty acyl chain is shortened by two carbons at a time;</li>
<li>Release one acetyl CoA ( go to citric acid cycle)</li>
</ul>
<h4 id="reaction-1-the-initial-dehydrogenation"><a class="markdownIt-Anchor" href="#reaction-1-the-initial-dehydrogenation"></a> Reaction 1: The Initial Dehydrogenation</h4>
<p>The first reaction is catalyzed by an <strong>acyl-CoA dehydrogenase</strong>, which catalyzes the removal of two hydrogen atoms from the <u>α - and β-carbons</u> to give a <u>trans α, β-unsaturated acyl CoA (trans-D2-enoyl-CoA)</u> as the product.</p>
<p>The pro-R hydrogen on the β-carbon is then transferred as a hydride equivalent to <strong>FAD</strong> to give the trans double bond and enzyme-bound FADH2.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175114264.png" alt="image-20200327175114264" style="zoom:80%;" />
<ul>
<li><u>3 acyl-CoA dehydrogenases</u>: for short-, medium-, and long-chain fatty acyl-CoA</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175154854.png" alt="image-20200327175154854" style="zoom:100%;" />
+ Prosthetic group: FAD （将电子给FAD）
+ Electron transfer flavoprotein (ETF)
+ 2H go to CoQ, through respiratory chain, <u>produce 1.5 ATP</u> (like NADH dehydrogenase and succinate dehydrogenase)
<h4 id="reactions-2-and-3-hydration-and-dehydrogenation"><a class="markdownIt-Anchor" href="#reactions-2-and-3-hydration-and-dehydrogenation"></a> Reactions 2 and 3: Hydration and Dehydrogenation</h4>
<p>Like <u>succinate oxidation</u>, an initial FAD-dependent fatty acyl-CoA oxidation is followed by hydration and <u>NAD±dependent dehydrogenation (2.5 ATP)</u>；</p>
<p>Enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase, respectively；</p>
<p>Both reactions are <u>stereospecific</u>；</p>
<p>Products: L-β-hydroxyacyl-CoA and b-ketoacyl-CoA, respectively。</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175341683.png" alt="image-20200327175341683" style="zoom: 67%;" />
<h4 id="reaction-4-thiolytic-cleavage-硫解"><a class="markdownIt-Anchor" href="#reaction-4-thiolytic-cleavage-硫解"></a> Reaction 4: Thiolytic Cleavage 硫解</h4>
<p>The fourth and last reaction in each cycle of the β-oxidation pathway involves <u>attack of the nucleophilic thiol sulfur of coenzyme A on the electron-poor keto carbon</u> of 3-ketoacyl-CoA, with cleavage of the bond and release of acetyl-CoA.</p>
<p>The other product is a shortened fatty acyl-CoA, ready to begin a new cycle of oxidation:</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175459751.png" alt="image-20200327175459751" style="zoom:100%;" />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175511888.png" alt="image-20200327175511888" style="zoom:33%;" />
<ul>
<li>Nucleophilic thiol sulfur of coenzyme A on the electron-poor keto carbon of 3-ketoacyl-CoA, with cleavage of the α-β bond and release of acetyl-CoA and a shortened fatty acyl-CoA, ready to begin a new cycle of oxidation</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175550024.png" alt="image-20200327175550024" style="zoom:50%;" />
<ul>
<li>Fatty acids are oxidized by repeated cycles of <u>dehydrogenation, hydration, dehydrogenation, and thiolytic cleavage</u>, with each cycle yielding acetyl-CoA and a fatty acyl-CoA shorter by two carbons than the input acyl-CoA.</li>
</ul>
<h3 id="4-energy-yield-from-fatty-acid-oxidation"><a class="markdownIt-Anchor" href="#4-energy-yield-from-fatty-acid-oxidation"></a> 4. Energy Yield from Fatty Acid Oxidation</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175653199.png" alt="image-20200327175653199" style="zoom: 67%;" />
<ul>
<li>β-oxidation: even numbers of carbon atoms and fully saturated fatty acids: C16 palmitoyl-CoA: produces 8 acetyl-CoA</li>
</ul>
<h4 id="β-oxidation-pathway-for-unsaturated-fatty-acids"><a class="markdownIt-Anchor" href="#β-oxidation-pathway-for-unsaturated-fatty-acids"></a> β-Oxidation pathway for unsaturated fatty acids</h4>
<p>Many natural unsaturated fatty acids contain <u>one or more double bonds: cis configuration</u></p>
<ul>
<li>
<p>Enoyl-CoA hydratase: acts only on t<u>rans compounds</u></p>
</li>
<li>
<p>2 additional enzymes, <strong>enoyl-CoA isomerase (烯酰-CoA异构酶)</strong> and <strong>2,4-dienoyl-CoA reductase (2,4-二烯酰基  -  辅酶A还原酶)</strong>, must come into play</p>
</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327175944970.png" alt="image-20200327175944970" style="zoom:50%;" />
<p>For <strong>monounsaturated fatty</strong> acid:</p>
<ol>
<li>Enoyl-CoA <strong>isomerase</strong> converts <u>cis</u>-Δ3-enoyl-CoA to the corresponding <strong>trans</strong>-Δ2-enoyl-CoA</li>
</ol>
<ul>
<li>需要转换成trans才能进行后续的氧化</li>
</ul>
<ol start="2">
<li>Enoyl-CoA <strong>hydratase</strong> acts on trans-Δ2-enyol-CoA, all subsequent reactions are identical to those for saturated fatty acids</li>
</ol>
<h4 id="β-oxidation-pathway-for-polyunsaturated-fatty-acids"><a class="markdownIt-Anchor" href="#β-oxidation-pathway-for-polyunsaturated-fatty-acids"></a> β-Oxidation pathway for polyunsaturated fatty acids</h4>
<p>This example, using <strong>linoleyl-CoA (亚油酰辅酶A(18C))</strong>, shows sites of action of enoyl-CoA <strong>isomerase</strong> and 2,4-dienoyl-CoA <strong>reductase</strong>, enzymes specific to unsaturated fatty acid oxidation (identified with red type).</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180258321.png" alt="image-20200327180258321" style="zoom: 50%;" />
<h4 id="oxidation-of-fatty-acid-with-odd-number-carbon-chains"><a class="markdownIt-Anchor" href="#oxidation-of-fatty-acid-with-odd-number-carbon-chains"></a> Oxidation of Fatty Acid with Odd-number Carbon Chains</h4>
<p><u>Odd-numbered fatty acid</u> chains yield upon β-oxidation 1 mole of <strong>propionyl-CoA</strong>, whose conversion to <u>succinyl-CoA</u> involves a <u>biotin</u>-dependent carboxylation and a coenzyme B<sub>12</sub>–dependent rearrangement.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180338605.png" alt="image-20200327180338605" style="zoom:100%;" />
+ <u>Most of the fatty acids</u> in natural lipids contain <u>even-numbered</u> carbon chains;
+ <u>A small proportion of fatty acids</u> have <u>odd-numbered</u> carbon chains;
+ <u>The last step presents a special metabolic problem</u>: five-carbon homolog of acetoactyl-CoA;
+ Thiolytic cleavage of this substrate yields 1 molecule of acetyl and <u>propionyl-CoA</u>. 
<h4 id="pathway-for-catabolism-of-propionyl-coa"><a class="markdownIt-Anchor" href="#pathway-for-catabolism-of-propionyl-coa"></a> Pathway for catabolism of propionyl-CoA</h4>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327180459257.png" alt="image-20200327180459257" style="zoom:100%;" />
## Control of Fatty Acid Oxidation
<p>In most cells, fatty acid oxidation is controlled by <u>availability of substrates</u> for oxidation, the fatty acids themselves</p>
<ol>
<li>Fat mobilization control by <u>hormones (glucagon and epinephrine);</u></li>
<li><u>Malonyl-CoA</u>（丙二酰辅酶A）: inhibits fatty acyl-CoA movement into mitochondria by the acylcarnitine shuttle.</li>
</ol>
<ul>
<li>Malonyl-CoA是fatty acid biosyhthesis的重要组分</li>
</ul>
<h2 id="ketogenesis-酮体生成"><a class="markdownIt-Anchor" href="#ketogenesis-酮体生成"></a> Ketogenesis 酮体生成</h2>
<p>During <u>fasting or starvation</u>, when carbohydrate intake is too low ➔ <strong>oxaloacetate （草酰乙酸）</strong> levels ⬇ ➔ flux through citrate synthase ⬇ ➔ <u>acetyl-CoA</u> levels ⬆</p>
<p>Under these conditions, 2 moles of acetyl-CoA undergo a reversal of the thiolase reaction to give <strong>acetoacetyl-CoA (乙酰乙酰CoA)</strong>.</p>
<p>Acetoacetyl-CoA can react in turn with a 3rd mole of acetyl-CoA to give <strong>3-hydroxy-3-methylglutaryl-CoA (3-羟基-3-甲基戊二酰-CoA) (HMG-CoA)</strong>, catalyzed by <u>HMG-CoA synthase</u>.</p>
<p>In the <u>cytosol</u>, HMG-CoA is an early intermediate in <u>cholesterol</u> biosynthesis. In the <u>mitochondria</u>, HMG-CoA is acted on by <strong>HMG-CoA lyase</strong> (裂解酶) to yield <strong>acetoacetate</strong> plus acetyl-CoA.</p>
<p>Acetoacetate undergoes <u>NADH-dependent reduction</u> to give <strong>D-β-hydroxybutyrate (D-β-羟丁酸)</strong> or in very small amounts spontaneous decarboxylation（自动脱羧（不需要酶参与）） to acetone.</p>
<p>Collectively, <u>acetoacetate, acetone, and <span class="katex"><span class="katex-mathml"><math><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8888799999999999em;vertical-align:-0.19444em;"></span><span class="mord mathdefault" style="margin-right:0.05278em;">β</span></span></span></span>-hydroxybutyrate are called <strong>ketone bodies (酮体).</strong></u></p>
<ul>
<li>In cytosol: HMG-CoA ➔ ➔ ➔ ➔ cholesterol (Chapter 19)</li>
<li>IN mitochondria: HMG-CoA ➔ ➔ ➔ ➔ ketone bodies</li>
</ul>
<h3 id="1-biosynthesis-of-ketone-bodies-in-the-liver"><a class="markdownIt-Anchor" href="#1-biosynthesis-of-ketone-bodies-in-the-liver"></a> 1. Biosynthesis of ketone bodies in the liver</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327223654181.png" alt="image-20200327223654181" style="zoom: 50%;" />
<ul>
<li>Ketogenesis occurs primarily in liver, because of the <u>high level of HMG-CoA synthase</u> in that tissue;</li>
</ul>
<h3 id="2-use-of-ketone-bodies"><a class="markdownIt-Anchor" href="#2-use-of-ketone-bodies"></a> 2. Use of ketone bodies</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327223729204.png" alt="image-20200327223729204" style="zoom:100%;" />
+ **β-Ketoacyl-CoA transferase** is present in <u>all tissues except liver</u> so that liver does not compete with the peripheral tissues (<u>brain and heart</u>) for use of ketone bodies;
+ Acetoacetyl-CoA is converted to acetyl-CoA, which goes to TCA for energy production;
<ul>
<li>Ketogenesis becomes extremely important in starvation: brain, heart (Chapter 18);</li>
<li>Under normal conditions, heart also uses ketone bodies;</li>
<li>In untreated diabetes, ketone bodies production &gt; the capacity of peripheral tissues to use ➔ ketosis, acidosis and ketoacidosis.</li>
</ul>
<h1 id="三-fatty-acid-biosynthesis"><a class="markdownIt-Anchor" href="#三-fatty-acid-biosynthesis"></a> 三、Fatty Acid Biosynthesis</h1>
<h2 id="relationship-of-fatty-acid-synthesis-to-carbohydrate-metabolism"><a class="markdownIt-Anchor" href="#relationship-of-fatty-acid-synthesis-to-carbohydrate-metabolism"></a> Relationship of Fatty Acid Synthesis to Carbohydrate Metabolism</h2>
<p>The majority of the <u>stored fuel</u> in most animal cells: <u>fat</u></p>
<p>A large proportion of the <u>caloric intake</u> of many animal diets, certainly most human diets: <strong>carbohydrate</strong></p>
<p><u>Convert carbohydrate to fat (fatty acid synthesis)</u></p>
<p><u>Acetyl-CoA</u>: central metabolite can be from pyruvate and fatty acid oxidation (from carbohydrate and fat breakdown)</p>
<p><u>In animals, acetyl-CoA cannot undergo net conversion to carbohydrate</u> (because the virtual irreversibility of the pyruvate dehydrogenase reaction)</p>
<p>As noted in Chapter14, t<u>he glyoxylate cycle in plants and some microorganisms permits a bypass of this step,</u> with <u>net conversion of acetyl-CoA to gluconeogenic precursors. </u></p>
<ul>
<li><u>However, in animals the conversion of carbohydrate to fat is unidirectional.</u></li>
</ul>
<p>Although fatty acids synthesis is regulated, <u>the total capacity for fat storage is not.</u></p>
<h3 id="1-acetyl-coa-as-a-key-intermediate-between-fat-and-carbohydrate-metabolism"><a class="markdownIt-Anchor" href="#1-acetyl-coa-as-a-key-intermediate-between-fat-and-carbohydrate-metabolism"></a> 1. Acetyl-CoA as a key intermediate between fat and carbohydrate metabolism</h3>
<p><u>Citrate</u> serves as a <u>carrier</u> to transport <u>acetyl units</u> from the <u>mitochondrion to the cytosol</u> for fatty acid synthesis.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224004142.png" alt="image-20200327224004142" style="zoom: 50%;" />
<h2 id="early-studies-of-fatty-acid-synthesis"><a class="markdownIt-Anchor" href="#early-studies-of-fatty-acid-synthesis"></a> Early Studies of Fatty Acid Synthesis</h2>
<p>Early in the twentieth century, <u>most fatty acids</u> in lipids contain <u>even-numbered</u> chains; it is reasonable to expect that the biosynthetic process involves some stepwise addition of activated two-carbon fragments;</p>
<p>This process was demonstrated experimentally in the <u>1940s using isotopic tracers;</u></p>
<p>David Rittenberg and Konrad Bloch (1940s): fed to mice with a<u>cetate labeled with the stable isotopes13C and deuterium (<sup>13</sup>C<sup>2</sup>H<sub>3</sub>C<sup>13</sup>COO-) and found both isotopes incorporated into fatty acids;</u></p>
<p>Once the <strong>β-oxidation</strong> pathway had been discovered, it was generally thought that fatty acid synthesis would simply by <u>a reversal</u> of its degradation pathway;</p>
<p>In the late <u>1950s</u>, FA synthesis absolutely requires <u>bicarbonate</u>, which was <u>not</u> in the final product. This led to the discovery of <strong>malonyl-CoA (丙二酰-CoA)</strong>, the first committed intermediate;</p>
<h2 id="biosynthesis-of-palmitate-棕榈酸-from-acetyl-coa"><a class="markdownIt-Anchor" href="#biosynthesis-of-palmitate-棕榈酸-from-acetyl-coa"></a> Biosynthesis of Palmitate (棕榈酸) from Acetyl-CoA</h2>
<h4 id="malonyl-coa-to-palmitate"><a class="markdownIt-Anchor" href="#malonyl-coa-to-palmitate"></a> Malonyl-CoA to Palmitate</h4>
<p>Successive addition of two-carbon units. Each cycle contains 7 steps:</p>
<ol>
<li>acetyl-CoA carboxylase (ACC)</li>
<li>malonyl-CoA-ACP transferase (MAT)</li>
<li>acetyl-CoA-ACP transferase</li>
<li>condensation (KS)</li>
<li>reduction</li>
<li>dehydration</li>
<li>reduction</li>
</ol>
<ul>
<li>ACP is the acyl carrier for synthesis</li>
<li>NADPH is the electron for both reduction reactions</li>
</ul>
<p>7 Acetyl-CoA + 7CO2 + 7ATP ➔ 7 malonyl-CoA + 7ADP + 7Pi</p>
<p>8 Acetyl-CoA + 7ATP + 14 NADPH +14H+ ➔ palmitate + 14NADP+ 8CoA-SH + 6H2O + 7ADP + 7Pi</p>
<ul>
<li>Needs energy (ATP)</li>
<li>Reducing equivalent (NADPH)</li>
</ul>
<p>Although the chemistries of fatty acid synthesis and degradation are <u>similar</u>, <u>the two pathways differ in</u>:</p>
<ol>
<li>the enzymes involved</li>
<li>acyl group carriers: Acetyl-CoA vs ACP (acyl carrier protein)</li>
<li>stereochemistry of the intermediates: L vs D configuration</li>
<li>electron carriers: FAD/NAD+ vs NADPH</li>
<li>intracellular location: cytosol ➔ mitochondria vs cytosol</li>
<li>regulation.</li>
</ol>
<h3 id="1-synthesis-of-malonyl-coa-丙二酰-coa"><a class="markdownIt-Anchor" href="#1-synthesis-of-malonyl-coa-丙二酰-coa"></a> 1. Synthesis of malonyl-CoA (丙二酰-CoA)</h3>
<p>Synthesis of <strong>malonyl-CoA</strong> is the <u>first committed step</u> in fatty acid biosynthesis from acetyl-CoA and bicarbonate, catalyzed by <strong>acetyl-CoA carboxylase (ACC).</strong></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224350243.png" alt="image-20200327224350243" style="zoom:100%;" />
### 2. Acetyl-CoA carboxylase (ACC)
<p><u>Biotin cofactor</u>: bound a lysine epsila-amino group, covalently bound N-carboxybiotin intermediate;</p>
<p>The <u>first committed step</u> in the synthetic pathway;</p>
<p>This reaction is so <u>exergonic (放能)</u> as to be virtually <u>irreversible</u>;</p>
<p><u>Prokaryotic E.coli: three separate proteins</u>:</p>
<ol>
<li>a small <u>carrier protein</u> that contains the bound biotin;</li>
<li>a <u>biotin carboxylase</u>, which catalyzes the formation of N-carboxybiotin;</li>
<li>a <u>transcarboxylase</u>, that transfers the activated carboxyl group from N-carboxybiotin to acetyl-CoA;</li>
</ol>
<p><u>Eukaryotes: a single protein containing two identical polypeptide chains. Inactive dimers; Active filamentous form</u> (can be seen under electron microscope): in the presence of citrate;</p>
<ul>
<li>The balance between the two forms: regulation of fatty acids synthesis;</li>
</ul>
<p><u>Primary regulator: long-chain fatty acyl-CoAs (not citrate).</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224500249.png" alt="image-20200327224500249" style="zoom:67%;" />
<h3 id="3-chemical-similarities-between-oxidation-and-synthesis-of-a-fatty-acid"><a class="markdownIt-Anchor" href="#3-chemical-similarities-between-oxidation-and-synthesis-of-a-fatty-acid"></a> 3. Chemical similarities between oxidation and synthesis of a fatty acid</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224602371.png" alt="image-20200327224602371" style="zoom: 80%;" />
<ul>
<li>This is one of the best examples of the statement that anabolic pathways are never the simple reversal of catabolic pathways.</li>
</ul>
<h3 id="4-acyl-carrier-proteinsacp"><a class="markdownIt-Anchor" href="#4-acyl-carrier-proteinsacp"></a> 4. Acyl Carrier Proteins（ACP）</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224723138.png" alt="image-20200327224723138" style="zoom:100%;" />
All of the intermediates in <u>fatty acid oxidation</u> are <u>activated</u> via their linkage to a carrier molecule, <u>coenzyme A</u>；
<p>In <u>fatty acid synthesis</u>, a <u>similar activation</u>, the carrier is a small protein called <u>acyl carrier protein (ACP)</u></p>
<p>The chemistry of activation is identical to that in acyl-CoAs；</p>
<p>A phosphopantetheine moiety, derived from <u>pantothenic acid (泛酸)</u>, is linked to a serine group in the polypeptide.</p>
<hr />
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327224900230.png" alt="image-20200327224900230" style="zoom:100%;" />
+ <u>Malonyl/acetyl-CoA-ACP transacylase (MAT)</u> loads fatty acid synthase with substrates. 
+ The acyl groups (<u>acetyl or malonyl</u>) are transferred from the <u>SH group</u> of CoA to the SH group of the phosphopantetheine moiety of acyl carrier protein (<u>ACP</u>). 
+ The reactions shown here produce acetyl-KS and malonyl-ACP, which are used in the remaining reactions of the cycle.
<h4 id="synthesis-of-palmitate-starting-with-malonyl-acp-and-acetyl-ks"><a class="markdownIt-Anchor" href="#synthesis-of-palmitate-starting-with-malonyl-acp-and-acetyl-ks"></a> Synthesis of palmitate, starting with malonyl-ACP and acetyl-KS</h4>
<p>The first cycle of four reactions generates butyryl-ACP (丁酰ACP).</p>
<p>Following translocation from ACP, <u>butyryl</u>-KS reacts with a second molecule of <u>malonyl-ACP</u>, leading to a second cycle of two-carbon addition.</p>
<p>A total of seven such cycles generates <u>palmitoyl-ACP</u>.</p>
<p>Hydrolysis of this product releases palmitate by <u>thioesterase (TE).</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327225306075.png" alt="image-20200327225306075" style="zoom: 67%;" />
<ul>
<li>NADPH provides the electron for both reduction reactions; <u>NADPH 来自PPP pathway</u></li>
<li>D-3-hydroxyacyl-CoA–synthesis</li>
<li>L-3-hydroxyacyl-CoA–fatty acid oxidation</li>
</ul>
<h4 id="malonyl-coa-to-palmitate-2"><a class="markdownIt-Anchor" href="#malonyl-coa-to-palmitate-2"></a> Malonyl-CoA to Palmitate</h4>
<p>Successive addition of two-carbon units. Each cycle contains 7 steps:</p>
<ol>
<li>acetyl-CoA carboxylase (ACC)</li>
<li>malonyl-CoA-ACP transferase (MAT)</li>
<li>acetyl-CoA-ACP transferase</li>
<li>condensation (KS)</li>
<li>reduction</li>
<li>dehydration</li>
<li>reduction</li>
</ol>
<ul>
<li>ACP is the acyl carrier for synthesis</li>
<li>NADPH is the electron for both reduction reactions</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200408115255479.png" alt="image-20200408115255479" style="zoom:100%;" />
+ Needs energy (ATP)
+ Reducing equivalent (NADPH)
<p>Although the chemistries of fatty acid synthesis and degradation are similar, the two pathways differ in:</p>
<ol>
<li>the enzymes involved</li>
<li>acyl group carriers: Acetyl-CoA vs ACP (acyl carrier protein)</li>
<li>stereochemistry of the intermediates: L vs D configuration</li>
<li>electron carriers: FAD/NAD+ vs NADPH</li>
<li>intracellular location: cytosol ➔ mitochondria vs cytosol</li>
<li>regulation.</li>
</ol>
<h3 id="5-structure-and-swinging-arm-mechanism-in-the-umammalianu-fatty-acid-synthase-complex"><a class="markdownIt-Anchor" href="#5-structure-and-swinging-arm-mechanism-in-the-umammalianu-fatty-acid-synthase-complex"></a> 5. Structure and swinging arm mechanism in the <u>mammalian</u> fatty acid synthase complex</h3>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327225553567.png" alt="image-20200327225553567" style="zoom:100%;" />
<u>Malonyl-CoA</u> represents an <u>activated source of two-carbon fragments for fatty acid biosynthesis</u>, with the loss of CO2 driving C-C bond formation. 
<p>In eukaryotes, fatty acid synthesis is carried out by a <u>megasynthase</u>, an organized multienzyme complex that contains multifunctional proteins.</p>
<h3 id="6-transport-of-acetyl-units-and-reducing-equivalents-used-in-fatty-acid-synthesis"><a class="markdownIt-Anchor" href="#6-transport-of-acetyl-units-and-reducing-equivalents-used-in-fatty-acid-synthesis"></a> 6. Transport of acetyl units and reducing equivalents used in fatty acid synthesis</h3>
<p><u>Citrate</u> serves as a carrier of <u>two-carbon fragments from mitochondria to cytosol</u> for fatty acid biosynthesis.</p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327225747410.png" alt="image-20200327225747410" style="zoom:80%;" />
<ul>
<li>1 = citrate synthase</li>
<li>2 = citrate lyase</li>
<li>3 = malate dehydrogenase</li>
<li>4 = malic enzyme</li>
<li>5 = pyruvate carboxylase （使得Pyruvate → OA）</li>
</ul>
<p>Because acetyl-CoA is generated in the mitochondrial matrix, it must be transported to the cytosol for use in fatty acid synthesis.</p>
<p>Like longer-chain acyl-CoA, acetyl-CoA cannot penetrate the inner membrane</p>
<h2 id="elongation-of-fatty-acid-chains"><a class="markdownIt-Anchor" href="#elongation-of-fatty-acid-chains"></a> Elongation of Fatty Acid Chains</h2>
<p>Fatty acid synthase actions lead primarily to <u>palmitate</u>;</p>
<p>In eukaryotic cells: elongation occurs in both <u>mitochondria</u> and <u>endoplasmic reticulum</u> (microsomal elongation system).</p>
<h2 id="fatty-acid-desaturation-去饱和"><a class="markdownIt-Anchor" href="#fatty-acid-desaturation-去饱和"></a> Fatty Acid Desaturation 去饱和</h2>
<p>The most <u>common monounsaturated fatty acids</u> in animal lipids are <strong>oleic acid (油酸)</strong> (18:1cΔ9 acid) and <strong>palmitoleic acid (棕榈油酸)</strong> (16:1cΔ9 acid), synthesized from stearate and palmitate by a microsomal system called fatty acyl-CoA desaturase;</p>
<p><u>Mammals are unable to introduce double bonds beyond 9</u> in the fatty acid chain. They cannot synthesize either <strong>linoleic acid (亚油酸)</strong> (18:2cΔ9, 12) and <strong>linolenic acid (亚麻酸)</strong> (18:3cΔ9,12,15). There are called <u>essential fatty acids</u>: must be provided in the <u>diet</u>;</p>
<p><strong>Arachidonate acid (花生四烯酸酸)</strong>: precursors of <u>eicosanoids (类花生酸)</u> (prostaglandins (前列腺素类) and thromboxanes (血栓烷)).(Chapter 19)</p>
<h2 id="pathway-for-synthesis-of-polyunsaturated-fatty-acids-pufas-in-plants-and-animals"><a class="markdownIt-Anchor" href="#pathway-for-synthesis-of-polyunsaturated-fatty-acids-pufas-in-plants-and-animals"></a> Pathway for synthesis of polyunsaturated fatty acids (PUFAs) in plants and animals</h2>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327230438790.png" alt="image-20200327230438790" style="zoom:50%;" />
<h2 id="regulation-of-fatty-acid-synthesis-in-animal-cells"><a class="markdownIt-Anchor" href="#regulation-of-fatty-acid-synthesis-in-animal-cells"></a> Regulation of fatty acid synthesis in animal cells</h2>
<p>The rate-limiting enzyme, <u>acetyl-CoA carboxylase (ACC)</u>, is controlled by <u>both allosteric (citrate and long-chain fatty acids) and covalent modification</u> mechanisms.</p>
<ol>
<li>Phosphorylation by AMP-activated protein kinase (<strong>AMPK</strong>, AMP活化的蛋白激酶) or cyclic AMP–dependent protein kinase (<strong>PKA</strong>) <u>inactivates ACC</u>.</li>
<li><u>Insulin stimulates fatty acid synthesis</u> by increasing <u>glucose uptake</u> and increasing flux through pyruvate dehydrogenase （PDH） to produce <u>acetyl-CoA.</u></li>
</ol>
<ul>
<li>The <u>dephosphorylated</u> form of <strong>PDH</strong> is the enzymatically <u>active</u> form.</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327230612615.png" alt="image-20200327230612615" style="zoom:50%;" />
<h2 id="control-of-fatty-acid-synthesis"><a class="markdownIt-Anchor" href="#control-of-fatty-acid-synthesis"></a> Control of Fatty Acid Synthesis</h2>
<p>Much of the fatty acid synthesis in animals takes places in adipose tissues;</p>
<p>Hormonal mechanism: major;</p>
<ol>
<li>
<p>Insulin:</p>
</li>
<li>
<p><u>Insulin</u> ➜ glucose entry into cells ↑➜ acetyl-CoA↑;</p>
</li>
<li>
<p><u>Insulin</u> ➜ activates pyruvate dehydrogenase (PDH) ↑➜ acetyl-CoA↑;</p>
</li>
<li>
<p><u>Insulin</u> ➜ activates citrate lyase ↑➜ the level of citrate in mitochondrial matrix↑ ➜ acetyl-CoA in cytosol↑;</p>
</li>
<li>
<p><u>Fasting/starvation</u> ➜ <u>AMPK ↑ PKA ↑</u> ➜ inactivation of Acetyl-CoA carboxylase (ACC) (covalent modification);</p>
</li>
<li>
<p><u>Long-chain fatty acyl-CoA</u>➜ ACC polymerization↓➜ ACC activity ↓(allosteric regulation);</p>
</li>
<li>
<p><u>Citrate</u>➜ ACC polymerization ↑ ➜ ACC activity ↑(allosteric regulation)</p>
</li>
<li>
<p><u>Availability of NADPH</u>: from both the transport of citrate out of mitochondria and the <u>pentose phosphate pathway (PPP)</u> (60%).</p>
</li>
</ol>
<ul>
<li>AMPK (AMP-activated protein kinase): activated by increased cellular AMP:ATP ratio (fasting/starvation);</li>
<li>AMPK acts as a sensor of cellular energy status;</li>
<li>AMPK and PKA phosphorylate and inhibits ACC</li>
</ul>
<h1 id="四-biosynthesis-of-triacylglycerols"><a class="markdownIt-Anchor" href="#四-biosynthesis-of-triacylglycerols"></a> 四、Biosynthesis of Triacylglycerols</h1>
<h2 id="glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis-甘油再生"><a class="markdownIt-Anchor" href="#glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis-甘油再生"></a> Glycerolipid/free fatty acid cycle and glyceroneogenesis 甘油再生</h2>
<p>Mammals hydrolyze and resynthesize TG in a glycerolipid/free fatty acid <u>(GL/FFA) cycle</u>.</p>
<p>FFA are released from TG by lipases acting on lipid droplets.</p>
<ul>
<li><strong>ATGL</strong>, adipose triglyceride lipase;</li>
<li><strong>HSL</strong>, hormone-sensitive lipase;</li>
<li><strong>MGL</strong>, monoacylglycerol lipase.</li>
</ul>
<p>Some of the <strong>FFAs</strong> are released into the blood for transport and oxidation, but <u>~75%</u> are re-esterified back to TG.</p>
<p>ATP hydrolysis in this futile cycle is shown in red.</p>
<ul>
<li>GPAT: glycerolphosphate acyltransferase;</li>
<li>LPA: lysophosphatidic acid</li>
<li>PA: phosphatidic acid</li>
</ul>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327230937904.png" alt="image-20200327230937904" style="zoom:50%;" />
<ul>
<li>Major precursors (TG): fatty acyl-CoAs and glycerol-3-phosphate (limiting substrate)</li>
<li>Adipose tissue, liver, heart</li>
<li>需要一个GAP，它由DHAP转化而来，是糖代谢<u>（糖异生）</u>的产物</li>
</ul>
<h2 id="glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis"><a class="markdownIt-Anchor" href="#glycerolipidfree-fatty-acid-cycle-and-glyceroneogenesis"></a> Glycerolipid/free fatty acid cycle and glyceroneogenesis</h2>
<p>The glycerol backbone is produced via glyceroneogenesis, involving reactions catalyzed by pyruvate carboxylase and phosphoenolpyruvate carboxykinase (<strong>PEPCK</strong>), and reversal of glycolytic steps to give <strong>DHAP</strong>. 磷酸烯醇丙酮酸羧激酶</p>
<p>DHAP is reduced to <u>glycerol-3-phosphate</u>.</p>
<p>AMP-activated protein kinase (AMPK)-dependent phosphorylation of GPAT and HSL inhibits these steps of the cycle.</p>
<p>The lysophosphatidic acid (<strong>LPA</strong>, 溶血磷脂酸), phosphatidic acid (<strong>PA</strong>, 磷脂酸), and sn-1,2-diacylglycerol (<strong>DAG</strong>) intermediates in the TG resynthesis pathway are also <u>important lipid signaling molecules.</u></p>
<img data-src="https://20190531-1259353497.cos.ap-guangzhou.myqcloud.com/Biochemistry%20II%20%28Metabolism%29/image-20200327231230101.png" alt="image-20200327231230101" style="zoom:50%;" />
<ul>
<li>Heat production (thermogenesis) and body temperature maintenance;</li>
<li>Elevated FFA level is associated with Type 2 diabetes and insulin resistance.</li>
</ul>

      
    </div>

    
    
    
      <footer class="post-footer">
        <div class="post-eof"></div>
      </footer>
  </article>
  
  
  


  
  <nav class="pagination">
    <a class="extend prev" rel="prev" href="/page/31/"><i class="fa fa-angle-left" aria-label="上一页"></i></a><a class="page-number" href="/">1</a><span class="space">&hellip;</span><a class="page-number" href="/page/31/">31</a><span class="page-number current">32</span><a class="page-number" href="/page/33/">33</a><span class="space">&hellip;</span><a class="page-number" href="/page/37/">37</a><a class="extend next" rel="next" href="/page/33/"><i class="fa fa-angle-right" aria-label="下一页"></i></a>
  </nav>



          </div>
          

<script>
  window.addEventListener('tabs:register', () => {
    let { activeClass } = CONFIG.comments;
    if (CONFIG.comments.storage) {
      activeClass = localStorage.getItem('comments_active') || activeClass;
    }
    if (activeClass) {
      let activeTab = document.querySelector(`a[href="#comment-${activeClass}"]`);
      if (activeTab) {
        activeTab.click();
      }
    }
  });
  if (CONFIG.comments.storage) {
    window.addEventListener('tabs:click', event => {
      if (!event.target.matches('.tabs-comment .tab-content .tab-pane')) return;
      let commentClass = event.target.classList[1];
      localStorage.setItem('comments_active', commentClass);
    });
  }
</script>

        </div>
          
  
  <div class="toggle sidebar-toggle">
    <span class="toggle-line toggle-line-first"></span>
    <span class="toggle-line toggle-line-middle"></span>
    <span class="toggle-line toggle-line-last"></span>
  </div>

  <aside class="sidebar">
    <div class="sidebar-inner">

      <ul class="sidebar-nav motion-element">
        <li class="sidebar-nav-toc">
          文章目录
        </li>
        <li class="sidebar-nav-overview">
          站点概览
        </li>
      </ul>

      <!--noindex-->
      <div class="post-toc-wrap sidebar-panel">
      </div>
      <!--/noindex-->

      <div class="site-overview-wrap sidebar-panel">
        <div class="site-author motion-element" itemprop="author" itemscope itemtype="http://schema.org/Person">
    <img class="site-author-image" itemprop="image" alt="向海"
      src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
  <p class="site-author-name" itemprop="name">向海</p>
  <div class="site-description" itemprop="description">希望能活的久一点</div>
</div>
<div class="site-state-wrap motion-element">
  <nav class="site-state">
      <div class="site-state-item site-state-posts">
          <a href="/archives/">
        
          <span class="site-state-item-count">364</span>
          <span class="site-state-item-name">日志</span>
        </a>
      </div>
      <div class="site-state-item site-state-categories">
            <a href="/categories/">
          
        <span class="site-state-item-count">23</span>
        <span class="site-state-item-name">分类</span></a>
      </div>
      <div class="site-state-item site-state-tags">
            <a href="/tags/">
          
        <span class="site-state-item-count">23</span>
        <span class="site-state-item-name">标签</span></a>
      </div>
  </nav>
</div>
  <div class="links-of-author motion-element">
      <span class="links-of-author-item">
        <a href="mailto:zhenyumi@foxmail.com" title="E-Mail → mailto:zhenyumi@foxmail.com" rel="noopener" target="_blank"><i class="fa fa-envelope fa-fw"></i>E-Mail</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://weibo.com/u/2279880515" title="Weibo → https:&#x2F;&#x2F;weibo.com&#x2F;u&#x2F;2279880515" rel="noopener" target="_blank"><i class="fab fa-weibo fa-fw"></i>Weibo</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://twitter.com/ParaDogs_lazy" title="Twitter → https:&#x2F;&#x2F;twitter.com&#x2F;ParaDogs_lazy" rel="noopener" target="_blank"><i class="fab fa-twitter fa-fw"></i>Twitter</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://t.me/Furemu" title="Telegram → https:&#x2F;&#x2F;t.me&#x2F;Furemu" rel="noopener" target="_blank"><i class="fab fa-telegram fa-fw"></i>Telegram</a>
      </span>
  </div>


<!-- none-select-br -->

<p></p>

<!-- hitokoto -->

<div class="hitokoto-title">
	<i class="fa fa-paragraph"></i>
	<b>一言</b>
</div>

<div id="hitokoto">获取中OvO</div>
<i id="hitofrom">获取中OvO</i>

<script src="https://cdn.jsdelivr.net/npm/bluebird@3/js/browser/bluebird.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/whatwg-fetch@2.0.3/fetch.min.js"></script>
<script>
  fetch('https://v1.hitokoto.cn/?c=i')
    .then(function (res){
      return res.json();
    })
    .then(function (data) {
      var hitokoto = document.getElementById('hitokoto');
      hitokoto.innerText = '\xa0\xa0\xa0\xa0\xa0\xa0\xa0' + data.hitokoto;
      var hitofrom = document.getElementById('hitofrom');
      hitofrom.innerText = "——" + data.from + '\xa0'; 
    })
    .catch(function (err) {
      console.error(err);
    })
</script>
      </div>

    </div>
  </aside>
  <div id="sidebar-dimmer"></div>


      </div>
    </main>

    <footer class="footer">
      <div class="footer-inner">
        

        

<div class="copyright">
  
  &copy; 2020 – 
  <span itemprop="copyrightYear">2021</span>
  <span class="with-love">
    <i class="fa fa-heart"></i>
  </span>
  <span class="author" itemprop="copyrightHolder">向海</span>
    <span class="post-meta-divider">|</span>
    <span class="post-meta-item-icon">
      <i class="fa fa-chart-area"></i>
    </span>
      <span class="post-meta-item-text">站点总字数：</span>
    <span title="站点总字数">5.5m</span>
    <span class="post-meta-divider">|</span>
    <span class="post-meta-item-icon">
      <i class="fa fa-coffee"></i>
    </span>
      <span class="post-meta-item-text">站点阅读时长 &asymp;</span>
    <span title="站点阅读时长">82:55</span>
</div><br /> <!-- 换行 -->

<div class="translate-style">
繁/简：<a id="translateLink" href="javascript:translatePage();">繁体
</a>
</div>
<script type="text/javascript" src="/js/tw_cn.js"></script>
<script type="text/javascript">
var defaultEncoding = 2; //网站编写字体是否繁体，1-繁体，2-简体
var translateDelay = 0; //延迟时间,若不在前, 要设定延迟翻译时间, 如100表示100ms,默认为0
var cookieDomain = "https://tding.top/"; //Cookie地址, 一定要设定, 通常为你的网址
var msgToTraditionalChinese = "繁体"; //此处可以更改为你想要显示的文字
var msgToSimplifiedChinese = "简体"; //同上，但两处均不建议更改
var translateButtonId = "translateLink"; //默认互换id
translateInitilization();
</script>

<!-- 网站运行时间的设置 -->
<span id="timeDate">载入天数...</span>
<span id="times">载入时分秒...</span>
<script>
    var now = new Date();
    function createtime() {
        var grt= new Date("06/01/2020 12:00:00");//此处修改你的建站时间或者网站上线时间
        now.setTime(now.getTime()+250);
        days = (now - grt ) / 1000 / 60 / 60 / 24; dnum = Math.floor(days);
        hours = (now - grt ) / 1000 / 60 / 60 - (24 * dnum); hnum = Math.floor(hours);
        if(String(hnum).length ==1 ){hnum = "0" + hnum;} minutes = (now - grt ) / 1000 /60 - (24 * 60 * dnum) - (60 * hnum);
        mnum = Math.floor(minutes); if(String(mnum).length ==1 ){mnum = "0" + mnum;}
        seconds = (now - grt ) / 1000 - (24 * 60 * 60 * dnum) - (60 * 60 * hnum) - (60 * mnum);
        snum = Math.round(seconds); if(String(snum).length ==1 ){snum = "0" + snum;}
        document.getElementById("timeDate").innerHTML = "已正常运行 "+dnum+" 天";
        document.getElementById("times").innerHTML = hnum + " 小时 " + mnum + " 分 " + snum + " 秒 OvO";
    }
setInterval("createtime()",250);
</script>

<br /> <!-- 换行 -->

<!--busuanzi计数-->

    <script async src="//dn-lbstatics.qbox.me/busuanzi/2.3/busuanzi.pure.mini.js"></script>

    <span id="busuanzi_container_site_pv">总访问量<span id="busuanzi_value_site_pv"></span>次</span>
    <span class="post-meta-divider">|</span>
    <span id="busuanzi_container_site_uv">总访客数<span id="busuanzi_value_site_uv"></span>人</span>
    <span class="post-meta-divider">|</span>
<!-- 不蒜子计数初始值纠正 -->
<script>
$(document).ready(function() {

    var int = setInterval(fixCount, 50);  // 50ms周期检测函数
    var countOffset = 20000;  // 初始化首次数据

    function fixCount() {            
       if (document.getElementById("busuanzi_container_site_pv").style.display != "none")
        {
            $("#busuanzi_value_site_pv").html(parseInt($("#busuanzi_value_site_pv").html()) + countOffset); 
            clearInterval(int);
        }                  
        if ($("#busuanzi_container_site_pv").css("display") != "none")
        {
            $("#busuanzi_value_site_uv").html(parseInt($("#busuanzi_value_site_uv").html()) + countOffset); // 加上初始数据 
            clearInterval(int); // 停止检测
        }  
    }
       	
});
</script> 



        
<div class="busuanzi-count">
  <script data-pjax async src="https://busuanzi.ibruce.info/busuanzi/2.3/busuanzi.pure.mini.js"></script>
    <span class="post-meta-item" id="busuanzi_container_site_pv" style="display: none;">
      <span class="post-meta-item-icon">
        <i class="fa fa-eye"></i>
      </span>
      <span class="site-pv" title="总访问量">
        <span id="busuanzi_value_site_pv"></span>
      </span>
    </span>
</div>








      </div>
    </footer>
  </div>

  
  <script src="/lib/anime.min.js"></script>
  <script src="//cdn.jsdelivr.net/gh/theme-next/theme-next-pjax@0/pjax.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/jquery@3/dist/jquery.min.js"></script>
  <script src="//cdn.jsdelivr.net/gh/fancyapps/fancybox@3/dist/jquery.fancybox.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/lozad@1/dist/lozad.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/pangu@4/dist/browser/pangu.min.js"></script>
  <script src="/lib/velocity/velocity.min.js"></script>
  <script src="/lib/velocity/velocity.ui.min.js"></script>

<script src="/js/utils.js"></script>

<script src="/js/motion.js"></script>


<script src="/js/schemes/pisces.js"></script>


<script src="/js/next-boot.js"></script>

<script src="/js/bookmark.js"></script>

  <script>
var pjax = new Pjax({
  selectors: [
    'head title',
    '#page-configurations',
    '.content-wrap',
    '.post-toc-wrap',
    '.languages',
    '#pjax'
  ],
  switches: {
    '.post-toc-wrap': Pjax.switches.innerHTML
  },
  analytics: false,
  cacheBust: false,
  scrollTo : !CONFIG.bookmark.enable
});

window.addEventListener('pjax:success', () => {
  document.querySelectorAll('script[data-pjax], script#page-configurations, #pjax script').forEach(element => {
    var code = element.text || element.textContent || element.innerHTML || '';
    var parent = element.parentNode;
    parent.removeChild(element);
    var script = document.createElement('script');
    if (element.id) {
      script.id = element.id;
    }
    if (element.className) {
      script.className = element.className;
    }
    if (element.type) {
      script.type = element.type;
    }
    if (element.src) {
      script.src = element.src;
      // Force synchronous loading of peripheral JS.
      script.async = false;
    }
    if (element.dataset.pjax !== undefined) {
      script.dataset.pjax = '';
    }
    if (code !== '') {
      script.appendChild(document.createTextNode(code));
    }
    parent.appendChild(script);
  });
  NexT.boot.refresh();
  // Define Motion Sequence & Bootstrap Motion.
  if (CONFIG.motion.enable) {
    NexT.motion.integrator
      .init()
      .add(NexT.motion.middleWares.subMenu)
      .add(NexT.motion.middleWares.postList)
      .bootstrap();
  }
  NexT.utils.updateSidebarPosition();
});
</script>




  




  
<script src="/js/local-search.js"></script>









<script data-pjax>
document.querySelectorAll('.pdfobject-container').forEach(element => {
  let url = element.dataset.target;
  let pdfOpenParams = {
    navpanes : 0,
    toolbar  : 0,
    statusbar: 0,
    pagemode : 'thumbs',
    view     : 'FitH'
  };
  let pdfOpenFragment = '#' + Object.entries(pdfOpenParams).map(([key, value]) => `${key}=${encodeURIComponent(value)}`).join('&');
  let fullURL = `/lib/pdf/web/viewer.html?file=${encodeURIComponent(url)}${pdfOpenFragment}`;

  if (NexT.utils.supportsPDFs()) {
    element.innerHTML = `<embed class="pdfobject" src="${url + pdfOpenFragment}" type="application/pdf" style="height: ${element.dataset.height};">`;
  } else {
    element.innerHTML = `<iframe src="${fullURL}" style="height: ${element.dataset.height};" frameborder="0"></iframe>`;
  }
});
</script>


<script data-pjax>
if (document.querySelectorAll('pre.mermaid').length) {
  NexT.utils.getScript('//cdn.jsdelivr.net/npm/mermaid@8/dist/mermaid.min.js', () => {
    mermaid.initialize({
      theme    : 'forest',
      logLevel : 3,
      flowchart: { curve     : 'linear' },
      gantt    : { axisFormat: '%m/%d/%Y' },
      sequence : { actorMargin: 50 }
    });
  }, window.mermaid);
}
</script>


    <div id="pjax">
  

  
      
<link rel="stylesheet" href="//cdn.jsdelivr.net/npm/katex@0/dist/katex.min.css">
  <script src="//cdn.jsdelivr.net/npm/katex@0/dist/contrib/copy-tex.min.js"></script>
  <link rel="stylesheet" href="//cdn.jsdelivr.net/npm/katex@0/dist/contrib/copy-tex.min.css">


  
  <script src="//cdn.jsdelivr.net/npm/quicklink@1/dist/quicklink.umd.js"></script>
  <script>
      window.addEventListener('load', () => {
      quicklink({
        timeout : 3000,
        priority: true,
        ignores : [uri => uri.includes('#'),uri => uri === 'https://zhenyumi.github.io/page/32/',]
      });
      });
  </script>


<script>
NexT.utils.loadComments(document.querySelector('#valine-comments'), () => {
  NexT.utils.getScript('//cdn.jsdelivr.net/npm/valine@1/dist/Valine.min.js', () => {
    var GUEST = ['nick', 'mail', 'link'];
    var guest = 'nick,mail,link';
    guest = guest.split(',').filter(item => {
      return GUEST.includes(item);
    });
    new Valine({
      el         : '#valine-comments',
      verify     : false,
      notify     : true,
      appId      : 'ErV27FWAFsY2HDPhLVjeIcfR-MdYXbMMI',
      appKey     : 'YyUrjqWLM53k8C1tPcKNaQFN',
      placeholder: "Leave Something?",
      avatar     : 'mm',
      meta       : guest,
      pageSize   : '10' || 10,
      visitor    : false,
      lang       : 'zh-ch' || 'zh-cn',
      path       : location.pathname,
      recordIP   : true,
      serverURLs : ''
    });
  }, window.Valine);
});
</script>

    </div>
</body>
</html>
